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Randomised controlled trials are the gold standard for testing whether a new 
intervention produces change in outcome measures but they do not assess underlying 
mechanisms of action. Process evaluation is an overarching framework for 
studying potential mechanisms in complex interventions but is rarely applied. 
Researchers and funders have increasingly called for the inclusion of process 
evaluations alongside randomised controlled trials of complex interventions but there 
is no standardised approach. This has led to wide variation in frameworks and 
methods used. Psychological interventions are particularly complex as they use the 
collaboration between patient and provider as the conduit for change. Many 
psychological interventions are being tested in healthcare settings for people with 
long-term conditions, such as type 2 diabetes. Patients with type 2 diabetes require 
intensive daily management and have many psychological problems, which contribute 
to sub optimal control. The clinical setting for this thesis is the D6 study, which tested 
whether a nurse led psychological intervention could improve glycaemic control in 
people with type 2 diabetes compared to an attention control condition. A process 
evaluation of D6 is conducted using a process evaluation framework derived from the 




i) To review existing frameworks and methods for conducting process evaluations  
ii) To apply the findings of this review to develop a theoretical framework for process 
evaluations of psychological interventions 
iii) To test the face validity of the framework on a nurse-led psychological 









A scoping study described existing frameworks for process evaluation and methods 
used, informing the development of a 12-component process evaluation framework. 
The framework was tested on a literature review of process evaluations of 
psychological interventions designed to improve outcome in T2D, and applied to the 
D6 cluster RCT, a nurse-led intervention testing whether low-intensity psychological 
therapy could improve self-management in T2D over 12 months versus attention 
control.  
 
The D6 process evaluation comprised of processes implicit in the main statistical 
plan, for example the ‘dose’ of the intervention received, and three additional studies, 
which were (i) a fidelity assessment of audiotaped therapy sessions delivered by D6 
nurses. Independent raters assessed whether D6 nurses achieved competencies in D6 
skills at the start of delivering therapy and compared those skills with nurses in the 
attention control group; (ii) semi-structured interviews explored D6 patient 
perspectives on taking part in D6 and assessed barriers and facilitators to participation 
and; (iii) semi-structured interviews explored D6 nurse perspectives on psychological 
skills training for the D6 study, and barriers and facilitators to taking part. A thematic 




The scoping study showed that the field of process evaluation has developed in a 
haphazard manner with many different frameworks and methods employed. The 
literature review showed that most RCTs of psychological interventions in T2D had 
not reported process evaluations. D6 was not effective at improving glycaemic 
control. The process evaluation showed that (i) there was no difference between the 
average 7.42 (intervention) and 8.30 (attention control) doses received (ii) that nurse 
competency in psychological skills was suboptimal with some evidence of 
contamination (iii) that some participants perceived extra time with nurses positively 
but others did not, and some reported that diabetes management was not a priority and 
(iv) that nurses valued impacting patients’ empowerment but lacked confidence to 
4 
deliver the therapy. The proposed process evaluation framework showed feasibility 




The field of process evaluation is under developed and lacks standardised methods. 
There is a need for a flexible framework that can be applied to meet specific 
intervention requirements, as guidelines cannot be developed using a ‘one size fits all’ 
approach. The proposed framework tightened theoretical concepts, identified 
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Chapter 1: Context and Aims 
 
Chapter Summary  
 
The randomised controlled trial (RCT) is considered the gold standard method for 
testing the effectiveness of a new intervention. However, when it comes to evaluating 
complex interventions, it has its limitations, as the analysis of the treatment effect 
does not assess the underlying mechanisms that might explain any effect of the 
intervention. Process evaluation is an umbrella framework for a range of methods for 
assessing these mechanisms. The concept of process evaluation and the difficulties in 
defining it and its methods are explored in the context of assessing the effectiveness 






‘Science cannot progress without reliable and accurate measurement of what it is you 
are trying to study. The key is measurement, simple as that.’ Robert D. Hare, 
Professor of Psychopathology and Psychophysiology, University of British Columbia 
(Spiegel, 2011).   
 
The gold standard method for testing a new intervention is the RCT (Jadad, 1998). An 
RCT is a comparative study in which participants are allocated randomly to one of 
two groups, either the intervention (or treatment) or the control (which can be usual 
care, standard care, a comparison intervention, waiting list or placebo). This ensures 
that known and unknown confounders that might bias the outcomes are equally 
distributed between the groups. The intervention and the control group are followed 
up in parallel over time. The average changes in primary and secondary outcomes are 
generated and the differences compared using statistical methods. There are many 
permutations of the RCT such as more than 2 parallel groups, stratification by 
important confounders, cluster RCTs, and different ways of ensuring unbiased 
allocation concealment e.g. blinding. Analytical approaches such as intention to treat 
20 
(ITT) analysis aim to provide an estimate of treatment effectiveness by ignoring 
protocol deviations and attrition (Wessely, Slade, & Priebe, 2007). 
 
The RCT is considered the highest quality of evidence to inform clinical practice but 
it does have limitations. When testing for only one active ingredient against a placebo 
such as a new cancer drug that targets a specific immunological factor, the biological 
mechanism to explain the chemical effect has already been hypothesised and is being 
tested while all other parameters are controlled for. A complex intervention on the 
other hand is defined as an intervention with multiple interacting components or 
active ingredients (MRC, 2000). Active ingredients may contribute to the 
effectiveness of the intervention including contextual or process variables that are not 
always possible to quantify, and which vary within and between participants, 
practitioners delivering the intervention, and the organisational and societal context in 
which the intervention is implemented. Under these conditions, it is more difficult to 
interpret the meaning of the effect size. Although the quantitative analysis of the 
primary hypothesis of the RCT can inform whether or not an intervention worked, it 
is not able to explain how or why it worked. The conventional RCT methods do not 
typically record or assess these mechanisms or processes and RCTs are therefore 
limited in their ability to sufficiently analyse the complex interventions made up of 
multiple components (Ashcroft, 2004; Bensing, 2000; Black, 1996; Feinstein & 
Horwitz, 1997; Rothwell, 2005; Sanson-Fisher, Bonevski, Green, & D’Este, 2007). A 
process evaluation provides a solution to this limitation of the RCT of complex 
interventions. 
 
Process evaluation is an umbrella term that captures a range of contextual constructs 
and methodologies used to describe the multi-dimensional and multi-factorial 
mechanisms underlying the effectiveness of a complex intervention. These cannot be 
understood by the effect size derived from the ITT alone (Oakley, Strange, Bonell, 
Allen, & Stephenson, 2006). For example, an RCT of a peer education intervention 
within a gym setting, designed to change sexual behaviours among homosexual men 
in London was found to have no impact on human immunodeficiency virus (HIV) risk 
behaviour. The process evaluation found that peer educators had experienced 
significant communication barriers within the gyms (they found it challenging to 
engage strangers in conversations about sex) resulting in high rates of attrition, a 
21 
finding which not only offered an explanation for the outcome of the trial, but has 
wider implications for the assumption that recruiting peer educators is a low-cost 
approach (Elford, Sherr, Bolding, Serle, & Maguire, 2002). Process evaluations may 
therefore have an explanatory power that enhances the interpretation of the effect size, 





The decision to fund a proposed intervention via the Medical Research Council 
(MRC) or National Institute for Health Research (NIHR) will depend on its evidence 
base and on the needs of the National Health Service (NHS) represented by the 
National Institute for Clinical Health and Excellence (NICE) (Wanless, 2002) (NICE, 
2015). NICE aims to promote clinical excellence in the NHS by developing guidance 
and recommendations on the most effective treatments and establishing research 
priorities. The foundation of NICE guidance is the synthesis of evidence from RCTs 
via systematic reviews, a type of literature review that systematically collates, 
synthesises and critically analyses multiple research studies using a standardised data 
extraction method with the ultimate aim of assessing whether the pooled findings 
offer valid evidence for a given hypothesis or research question (Cochrane 
Collaboration, 2017). NICE proposed 5 levels of evidence-based medicine, which 
include: (i) identifying knowledge gaps and formulating a clear clinical question (ii) 
searching the literature to identify relevant articles (iii) critically appraising articles 
for quality and usefulness of results; always questioning whether the available 
evidence is valid, important and applicable to the individual patients (iv) 
implementing clinically useful findings into practice and (v) evaluating performance 
using audit (Tidy, 2014).  
 
There is an implicit assumption that implementation of evidence based complex 
interventions will automatically lead to an improvement in practice (Speller, 
Wimbush, & Morgan, 2005). However, there is a consistent failure to translate 
research findings into practice; often RCTs of health promotion interventions that are 
found to be efficacious fail to be implemented successfully in applied settings 
22 
(Glasgow, Lichtenstein, & Marcus, 2003) (Glasgow, Klesges, Dzewaltowski, Bull, & 
Estabrooks, 2004) (Clarke, 1995). There are many explanations (i) the intervention 
may be too costly in the real world of budgets (ii) the results of studies with small or 
selected samples and tightly controlled interventions may over-estimate the effect (iii) 
results may not be applicable under different conditions and diverse settings (Glasgow 
& Emmons, 2007; Glasgow et al., 2004; Schoenwald & Hoagwood, 2001). When we 
implement an intervention in health services research we are dealing with complex 
social systems comprising of multiple interactions.  
 
Researchers, and increasingly funders, have called for the inclusion of processes in 
the evaluation of complex interventions, especially in the field of health promotion 
(Black, 1996). However, there is a tension between the concept of ‘scientific rigour’ 
and the need for more flexible but less well defined research designs (Nutbeam, 
1998). There is a need to re-assess the methods used to evaluate interventions, in 
order to avoid drawing false conclusions from research to the detriment of public 
health (Speller, Learmonth, & Harrison, 1997).  
 
The field of complex interventions is itself continually growing in complexity as 
challenges to the population’s health evolve. Interventions developing include those 
that support self management of long term conditions e.g. diabetes, chronic 
obstructive pulmonary disease (COPD), arthritis and stroke. Where once a public or 
community health programme focused on changes to physical processes such as 
development of improved sanitation or educating women about reproductive cycles, 
now it may involve targeting multiple attitudes and health behaviours related to 
reducing risk and management of long-term conditions. The nature of complex 
interventions is multi-faceted and dependent on the social and environmental context 
in which they are implemented. The MRC guidance for developing and evaluating 
complex interventions states that they will have a high number of behaviours 
performed by those delivering and receiving the intervention; will operate on a 
number of organisational levels; will typically have many outcome measures and a 
high degree of flexibility or individual tailoring of the intervention will be involved 
(Craig et al., 2008). For example, interventions to improve the effectiveness of a 
stroke unit will need to account for multiple interacting variables amongst different 
healthcare professionals (doctors, nurses, occupational therapists, physiotherapists) 
23 
and the wide range of treatments each of these deliver such as prescribing, 
administering and monitoring medicines, time spent handling the patient and 
providing emotional support, maximising activities of daily living via aids, and 
improving function. All of these should have some assessment of competency in 
delivering each of these active ingredients. Other contextual variables include time 
allocated to each patient, the extent to which patients receive informal support i.e. 
from their family and friends, the severity of the stroke and other comorbid 
conditions.  
 
Studying variation in characteristics between professionals, patients and sites provides 
an exciting opportunity to maximise RCT findings. While some interventions may be 
effective in one setting, they may fail in another due to variation in interpersonal, 
socio-economic, fiscal, demographic, organisational or political factors (Ferlie & 
Shortell, 2001). Examples of categories of complex intervention include those 
conducted in the community, for example a community-level HIV prevention 
programme for young gay men (Kegeles, Hays, & Coates, 1996); those implemented 
within education systems such as a peer-led sex education intervention at a school 
(Oakley et al., 2006) and those which utilise psychological methods, such as an 
intervention employing the methods of motivational interviewing (MI) in order to 
improve diabetes outcomes in African American adults (Chlebowy et al., 2014).  
 
Interventions that include a psychological element can be particularly complex as they 
use the alliance, collaboration or relationship between patient and provider as the 
conduit for changing the patient’s psychological state (Craig et al., 2008). There is a 
need for research methods to be used to decipher the active ingredients of these 
interventions. These methodologies should be appropriate for the stage of 
development of an intervention and should make use of both quantitative and 
qualitative techniques to provide more nuanced understanding of intervention effects. 
The methods of analysis should be driven by the research question (Mason, 2006). An 
RCT alone may no longer be sufficient to meet the implementation challenges of 
modern healthcare research.  
 
One way forward is to use mixed methods which involves, ‘collecting, analysing and 
interpreting quantitative and qualitative data in a single study or in a series of studies 
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that investigate the same underlying phenomenon’ (Leech & Onwuegbuzie, 2009). 
Adding additional methodologies builds on the RCT’s explanatory power (Newman, 
Ridenour, Newman, & De Marco, 2002). The use of qualitative methods such as 
interviews or focus groups for example can provide rich qualitative data that may be 
used to interpret quantitative results. In addition the use of mixed methods can 
combine empirical precision with descriptive precision (Onwuegbuzie, 2003). Finally, 
the use of mixed methods allows researchers to gain a more comprehensive picture of 
the processes at a macro and micro level; it allows us to zoom out by exploring the 
influence of local policy or other organisational factors, or to zoom in by exploring 
provider attitudes and beliefs (Onwuegbuzie & Leech, 2005). In turn, quantitative 
data may complement qualitative data in compensating for the fact that qualitative 
data cannot be generalised to a wider population. The two sets of methodologies are 
complementary to one another, in particular because their weaknesses do not overlap. 
This has been termed the fundamental principle of mixed methods research (Johnson 
& Turner, 2003). Indeed, a process evaluation of a non-randomised observation or 
intervention study is more limited than that of a RCT as the former cannot assume an 
equal distribution of biases.  
 
The Need for Process Evaluation  
 
Process evaluation is a way of opening the ‘black box’ of research by revealing the 
mechanisms and processes that are active within it (Baranowski & Stables, 2000; 
Linnan, 2002; Moore et al., 2015; Oakley et al., 2006; Saunders, Evans, & Joshi, 
2005). It is still inadequately understood and the literature describes a poorly 
demarcated field characterised by a lack of guidelines for the design and conduct of 
process evaluations, wide variation in terminology used to describe them, varying 
methodologies and inconsistent or incomplete evaluation attempts (Linnan, 2002). 
Where process evaluations are reported, there has been a lack of information and 
depth of reporting, and studies are difficult to replicate (Linnan, 2002). In addition, 
there has been no consistently used framework for conducting a process evaluation 
with many researchers using no framework at all and others making their own 
definitions. While the quality of RCT reporting has gone from strength to strength in 
the iterations of the Consolidated Standards of Reporting Trials (CONSORT) (Begg 
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et al., 1996) until recently the importance of improving methodologies for process 
evaluation has been left behind (Linnan, 2002; Moore et al., 2015).  
 
The Medical Research Council’s Guidance for Evaluating Complex 
Interventions 
 
In 2000 the MRC published a set of guidelines designed to guide researchers in the 
design and evaluation of complex interventions (MRC, 2000). The guidelines advised 
on the planning, evaluation and long-term implementation of a new complex 
intervention using both quantitative and qualitative methods. However, the guidance 
is based almost entirely on the medical model of clinical trial research and was 
criticised for its failure to recognise the complexity of different healthcare 
intervention designs (Mackenzie, O'Donnell, Halliday, Sridharan, & Platt, 2010). A 
revised version of the guidance was released in 2008, including a recommendation 
that researchers consider a process evaluation to be a ‘good investment’. A great deal 
of thought was given to a theoretical understanding of the process evaluation. 
However little practical guidance was provided on how to design and conduct a 
process evaluation, despite its being considered ‘highly valuable' (Craig et al., 2008). 
The guidance has also been critiqued for excluding practical advice including 
methodological suggestions at the expense of theory (De Silva et al., 2014).  
 
As process evaluation research developed and its importance became clear, the MRC 
released ‘Process Evaluation of Complex Interventions: UK Medical Research 
Council Guidance’ in 2015 (Moore et al., 2015). However, the guidance remained 
focused on reviewing previous research in the area and offers little practical advice 
for researchers wishing to plan and conduct an evaluation. In continually emphasising 
the complexity and variety of healthcare interventions and the fact that there is no 
‘one size fits all’ approach, the MRC have produced a guide that could be considered 
vague and difficult to apply to specific research designs. However, the guide is a 
welcome addition to literature available on process evaluation; we must wait for the 
discourse as researchers attempt to apply it. The contents of this thesis aim to 
contribute to this discourse.  
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A series of ‘events and processes’ have been set in motion to update the guidance, 
overseen by a scientific advisory group (Skivington, Matthews, Craig, Simpson, & 
Moore, 2018). However, the update has been subject to delay and is scheduled for 
publication in 2020.   
 
The Current Problem: Lack of Framework  
 
There is a need for a clear and simple framework for the design and conduct of 
process evaluations of complex health interventions that can be used alongside an 
RCT. This would address the problem of inadequate planning and reporting of 
process evaluations in the same way that the CONSORT checklist was designed to 
tackle the problem of inadequate reporting of RCTs (Begg et al., 1996). The 



























Figure 1.1: CONSORT Flow Diagram Reproduced From CONSORT 2010 (Schulz, 




Figure 1.2: CONSORT Checklist reproduced from CONSORT 2010 (Schulz et al., 2010) 
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The checklist focuses on how the trial has been designed, analysed and interpreted, 
while the flow diagram focuses on the flow of participants moving through the RCT. 
The Template for Intervention Description and Replication (TIDieR) checklist and 
guidance expanded on item 5 of the 2010 CONSORT statement, with the aim of 
improving the ‘completeness of reporting’ (Hoffmann et al., 2014). A similar 
checklist for process evaluation could aid researchers in the planning and 
implementation of a process evaluation, defining components and suggesting 
methodologies. Such a checklist does not exist. At present there is considerable 
inconsistency in the components of process evaluation studied, the methodologies 
used to capture data and the reporting of results in the literature. Funding bodies 
increasingly require more information on the extent of planned process evaluations, 
yet there is no definition of standard requirements for the methods by which they are 
conducted and reported in the literature, leading to wide variation and ultimately 
criticism in peer review.  
 
Many RCTs of complex interventions are therefore conducted without any process 
evaluation. For example, an RCT set in Massachusetts, US, tested an MI intervention 
delivered by diabetes educators designed to improve glycaemic control in patients 
with established T2D and poor control in primary care or secondary care. The 
intervention did not lead to improved glycaemic control and the authors reported high 
drop out rates at 6 month follow up (Welch, Zagarins, Feinberg, & Garb, 2011). 
However, since no process evaluation was implemented it is not possible to produce 
any further explanations for these negative findings. There were several potential 
active mechanisms including skill set and competencies of diabetes educators, and 
baseline diabetes attitudes in the patient group that could have been assessed. There 
was also no significant change in HbA1c and perhaps the mean baseline value of 73 
mmol/mol (equivalent to 8.8%) did not cause sufficient concern to motivate the 
patient to change. Similarly, an intervention designed to promote physical activity and 
reduce glycaemic control in patients with poorly controlled T2D was delivered by 
printed information and telephone counselling methods. The RCT found no 
significant effect on HbA1c, despite significantly increasing physical activity (Ismail 
et al., 2010). It is possible that the competencies of telephone counsellors were 
insufficient since they received only 7 hours training but we do not know, as this was 
not studied. We also do not know whether they adhered to the intervention as per 
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protocol. A health coach delivered MI intervention set in China showed significant 
improvements on psychological variables in poorly controlled T2D patients in both 
control and intervention groups, but no differential effect on HbA1c at 12 month 
follow up (Browning et al., 2016). Health coaches were experienced clinicians 
including doctors, nurses and psychologists but we do not know their individual 
competencies in delivering the intervention. Interventions were also adapted ‘to local 
context’, and we do not know what changes were made. Process evaluations could 
measure these variables and potentially offer explanations for these findings.  
 
The Setting for This Thesis 
 
The clinical sample in which this thesis is set is The Diabetes 6 Study (D6), which is 
described in detail in Chapter 5. D6 was a cluster RCT which tested whether practice 
nurses trained in a package of 6 psychological skillsets could improve glycaemic 
control in patients with persistently poorly controlled T2D compared to nurses with 
no psychological skills training. A process evaluation of the D6 study was conducted 
in parallel with the main RCT and continued after the RCT had finished. The author 
worked as a Research Assistant for the duration of the study, attending weekly 
research meetings; taking minutes; filing; data entry and management; searching for 
missing data; recruiting participants, supporting nurses during their training in D6 
psychological skills and collecting qualitative and quantitative data at baseline and 
follow up. The process evaluation for D6 for reporting to its funders comprised of 
processes implicit in the main statistical plan for example the ‘dose’ of the 
intervention received, plus three additional studies, which were: (i) a quantitative 
study assessing the fidelity of implementation of the D6; (ii) a qualitative interview 
study with nurses trained to deliver psychological skills during the D6 study; (iii) a 
qualitative interview study with patients who took part in the D6 study. The author 
conducted a scoping study and literature review to develop a framework for process 






The Aims of This Thesis  
 
i) To review existing frameworks and methods for conducting process evaluations 
(Chapter 3) 
ii) To apply the findings of this review to develop a theoretical framework for process 
evaluations of psychological interventions (Chapters 3 and 4) 
iii) To test the face validity of the framework on a nurse-led psychological 
intervention, the D6 cluster RCT, to improve glycaemic control in T2D (Chapters 5-
8).  
 
Overview of the Structure of This Thesis 
 
Chapter 2: This describes the epidemiology of T2D, outlining its aetiology, cost, 
management and the problem of sub-optimal glycaemic control and non-adherence to 
self-management behaviours. It then describes how psychological therapies may help 
to promote improved self-management. 
 
Chapter 3: A scoping study provides an overview of the history and evolution of 
process evaluation theory and the approaches and methodologies that have been used 
to conduct process evaluations of complex interventions. It will critique the concepts 
of process evaluation and its methods, before proposing a framework of process 
evaluation based on this overview.  
 
Chapter 4: The literature on process evaluation of RCTs of psychological 
interventions designed to improve glycaemic outcomes in T2D will be synthesised. It 
will summarise the components of process evaluation studied and the methods used. 
This will give an update of evidence to date of potential mechanisms that may explain 
the effectiveness or otherwise of psychological interventions in T2D and the research 
gaps that remain outstanding. 
 
Chapter 5: The protocol and main findings of the D6 study are presented, noting the 
key issues to consider in the process evaluation. The methods and results for 3 process 
evaluation components are presented.   
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Chapter 6: A quantitative study assessing the process evaluation component of 
fidelity of implementation of the D6 RCT is described, presenting the background, 
aims, methods, results and discussion.  
 
Chapter 7: A qualitative interview study with D6 nurses is presented, exploring their 
experiences of participating in the study and their experiences of psychological skills 
training. It describes the background, aims, methods, results and discussion. This 
includes the results of 2 process evaluation components.  
 
Chapter 8: A qualitative interview study with D6 patients is described, exploring the 
range and diversity of their experiences of participating in a test of a new 
psychological intervention. It describes the background, aims, methods, results and 
discussion. This includes the results of 2 process evaluation components.  
 
Chapter 9: The final chapter of this thesis is a discussion of the findings including a 
critique of the strengths and limitations of the process evaluation framework proposed 
and the studies that were conducted to test it on the D6 study. The results of the 
process evaluation are discussed within the context of the results of the D6 study and 
overall conclusions drawn. This will lead to a consideration of the clinical and 









Chapter 2: Type 2 Diabetes  
 
 
Chapter Summary  
 
The first chapter outlined the importance of process evaluations of RCTs to improve 
the quality, interpretation and implementation of the main findings. It briefly 
introduced the problem of T2D and the rationale for using a complex psychological 
intervention within primary care to support people with T2D and specifically the 
setting of the D6 study.  
 
This chapter will expand on the clinical problem of T2D by giving an overview of its 
epidemiology, aetiology, complications, treatments and cost. The problem of poor 
adherence to self-care among people with T2D and the growing role of psychological 
therapies in supporting self-management are discussed.  
 
Overview of Diabetes  
 
Diabetes Mellitus refers to a group of chronic metabolic disorders that are concerned 
with production and uses of the hormone insulin (American Diabetes Association, 
2014). Insulin is the principal anabolic hormone of the body, and is produced in 
clusters of β cells in the pancreas, called islets. The purpose of insulin is to help 
transport glucose from the blood stream into the cells of the body, which can then be 
turned into energy or stored for future use. As glucose is not capable of travelling 
directly into the cells where it is needed, its levels in the blood rise, signaling the β 
cells to release insulin. If more glucose is present in the body than is needed, insulin 
helps to store it in the liver, releasing it in between meals or during exercise. A 
common description of insulin is that of a key which unlocks cells, allowing glucose 











There are two main types of diabetes. Type 1 diabetes (T1D) is to be distinguished as 
a condition where the β cells have been completely destroyed by an autoimmune 
reaction, preventing the body from producing any insulin and extraneous insulin 
given as subcutaneous injections is needed for survival. It accounts for approximately 
10% of all cases of diabetes (Atkinson, Eisenbarth, & Michels, 2014). As T1D is not 
the condition relevant to this thesis, it will not be discussed further.  
 
Type 2 Diabetes 
 
In T2D the beta cells either do not produce enough insulin and/or the cells in the body 
are resistant to insulin so that it is not used effectively. As a result, glucose 
accumulates in the blood, leading to hyperglycaemia. Previously known as adult onset 
diabetes, obesity related diabetes and non insulin dependent diabetes mellitus, T2D 
usually manifests later in adulthood (peak onset is in the mid 50’s in African 
Caribbean and Asian people and mid 60’s in Caucasian people) and accounts for 




Insulin resistance or reduced sensitivity is a reduced biological response to insulin. It 
occurs when the levels of insulin released into the blood are high, over a long period 
of time. This results in cells becoming resistant to insulin, which in turn results in 
blood glucose staying in the blood stream stimulating pancreatic β cells to produce 
more insulin in an attempt to compensate. This further contributes to the elevated 
insulin level in the blood, exacerbating the problem (Wilcox, 2005).  
 
In the early stages it is possible to reverse the hyperglycaemic state via diet, exercise 
and lifestyle modification. In recent months there has been media interest in the 
potential of very low calorie diets to reverse T2D, where the aim is to produce 
significant weight-loss (Lean et al., 2017). Adjunct therapies may also include 
medication to increase insulin sensitivity or inhibit glucose production in the liver. As 
greater demands are made on the pancreas to produce insulin, impairment of insulin 
secretion worsens as the disease progresses. In other words T2D is a progressive 
condition, which patients can try to take control of, to reduce or even reverse the rate 
of progression. 
 
It is possible for people to spend many years in a state of pre-diabetes or impaired 
glucose tolerance. Pre-diabetes is defined as fasting plasma glucose levels ranging 
from 6.1-6.9 mmol/l. The World Health Organisation (WHO) states that T2D is 
diagnosed when symptoms (polyuria or polydipsia plus visual disturbance, 
unexplained weight loss, recurrent infection, macrovascular complications, 
retinopathy, nephropathy or neuropathy) are present, plus one of the following (i) a 
random venous plasma glucose concentration ≥ 11.1 mmol/l or (ii) a fasting plasma 
glucose concentration ≥ 7.0 mmol/l (whole blood ≥ 6.1 mmol/l) or (iii) two hour 
plasma glucose concentration ≥ 11.1 mmol/l two hours after 75g anhydrous glucose in 
an oral glucose tolerance test (WHO, 2011). 
 
Sustained hyperglycaemia is associated with a range of macro- and micro-vascular 
complications, leading to increased morbidity and premature mortality (WHO, 2016). 
Hyperglycaemia refers to high blood glucose levels more than 126 mg/dL before a 
meal and more than 8153 mg/dL after a meal. Symptoms may include increased 
urination, particularly at night, increased thirst, headaches and tiredness or lethargy. 
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Complications may be acute or long-term. Acute complications include 
hyperglycaemia and hyperosmolar hyperglycaemic state, a condition in which high 
glucose levels can lead to dehydration and potentially serious complications such as 
coma and death.  
 
Epidemiology of Type 2 Diabetes 
 
In 2014 an estimated 422 million adults were living with diabetes, compared to 108 
million in 1980 (WHO, 2016). Diabetes is one of the most common long term 
conditions in the UK with Diabetes UK estimating that one person every 2 minutes is 
diagnosed – around 700 people per day and 3.6 million people in total (DiabetesUK, 
2016b). It is also estimated that there are around 1.1 million people in the UK who 
have diabetes but have not yet been diagnosed (DiabetesUK, 2016b). If current trends 
persist, one in 3 people will be obese by 2034 and one in 10 will develop T2D 
(DiabetesUK, 2016b). 
 




Coronary artery disease: coronary artery disease, also known as ischaemic heart 
disease, is a disease caused when the coronary arteries become damaged or diseased. 
The primary cause of this is cholesterol-containing deposits called plaque, which 
narrow the arteries, reducing blood flow to the heart (Libby & Theroux, 2005).  
 
Peripheral arterial disease: Peripheral arterial disease is a narrowing of arteries that 
do not supply blood to the heart or brain, most commonly affecting the legs. 
Symptoms include leg pain when walking which resolves with rest; skin ulcers; bluish 
skin; cold skin or poor hair and nail growth (Ouriel, 2001).  
 
Cerebrovascular disease: a stroke occurs when blood flow to the brain is restricted. 
Ischaemic stroke results from insufficient blood flow to the brain, while haemorrhagic 
stroke is the result of bleeding. A patient with hyperglycaemia is at greater risk of 
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stroke and this risk is associated with poorer clinical outcomes including higher 




Micro-vascular complications refer to the damage of the small vessels of certain 
organs within the body. Problems manifest themselves in the eyes, kidneys and the 
peripheral nervous system.  
 
Retinopathy: Diabetic retinopathy is a complication caused by hyperglycaemia 
damaging the retina and is responsible for >80% of blindness in T2D patients (Lee, 
Wong, & Sabanayagam, 2015). Diabetic retinopathy is asymptomatic until advanced 
and patients must therefore be regularly screened using sensitive retinal screening 
techniques. In the case of regular retinal screening (fundoscopy) problems can be 
diagnosed and laser photocoagulation applied before retinopathy becomes too 
advanced. Other eye complications associated with T2D include visual disturbances 
secondary to osmotic changes, the early development of cataracts and glaucoma.   
 
Diabetic neuropathy: Neuropathy is the most common chronic complication of T2D 
and relates to a group of nerve disorders. Neuropathy occurs as a result of damage to 
the small blood vessels that supply the nerves, as a result of high blood glucose. The 
nerve fibres are damaged or destroyed.  Different types of neuropathy include:  
 
i. Sensory neuropathy and the diabetic foot: Sensory neuropathy concerns the 
nerves, which are responsible for transmitting sensations of touch, pain, temperature 
and other sensations from the skin, bone and muscles to the brain, and it is estimated 
that this type of neuropathy may affect up to 26% of people with diabetes (Boulton, 
2005). The most acutely monitored sensory neuropathy is in the feet, where minor 
injuries can be sustained but not noticed by the diabetic person. These injuries, left 
untreated, may develop into infections or ulcers. Symptoms of sensory neuropathy 
may include tingling and numbness; loss of ability to feel pain; loss of ability to detect 
changes in temperature; loss of coordination and burning or shooting pains. The most 
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serious consequence of these complications is amputation, and diabetes is the most 
common cause of lower limb amputation in the UK (DiabetesUK, 2016b). 
 
ii. Autonomic neuropathy: Autonomic neuropathy is concerned with nerves that 
carry signals to the glands and organs. The results of this kind of nerve damage 
include erectile dysfunction in men, gastro paresis, which can lead to bloating, 
constipation or diarrhoea, loss of bladder control, irregular heartbeat and problems 
with sweating (Vinik, Maser, Mitchell, & Freeman, 2003).   
 
iii. Erectile dysfunction: Erectile dysfunction is the most common manifestation of 
autonomic neuropathy in men, a problem that is exacerbated with age and increased 
use of antihypertensive medication and also with macrovascular and microvascular 
disease. Psychological factors also play a role, and may make distinction between 
physical and psychological causes problematic as well as its presentation, assessment 
and management (Malavige & Levy, 2009).  
 
iv. Motor neuropathy: Motor neuropathy concerns the nerves that are responsible 
for movement and can lead to problems with muscle weakness, muscle wasting, 
muscle twitching and cramping (Vinik, 2016).  
 
v. Nephropathy: Kidney disease (nephropathy) is when the kidney function starts to 
fail. It is more common in people with diabetes due to damage to the small blood 
vessels, a process which usually takes at least 20 years (DiabetesUK, 2016a). 
Approximately 3 out of 4 people with diabetes will develop some stage of kidney 
disease during their lifetime and kidney disease accounts for 11% of deaths in T2D 
(UK, 2016). It is the most common cause of dialysis and the epidemic of T2D has 
seen the demand on dialysis units increase, representing one of the most expensive 








Risk Factors  
 
The risk of developing T2D is cumulatively determined by a combination of genetic 
and metabolic factors within a particular environment. Genetics and family history 
combine with increasing age, being overweight or obese, being physically inactive 
and/or having a poor diet to elevate risk. The worldwide epidemic of T2D is rising in 
parallel with the epidemic of obesity (Gan, 2003). 
 
Excess body fat as a result of overweight and obesity is considered the strongest 
overall risk factor, and obesity is estimated to attribute up to 50% of the global 
disease burden. This body fat percentage may be increased by poor dietary 
behaviours, such as high glucose consumption and/or high fat intake and/or reduced 
physical activity. This leads to higher waist circumference and BMI, which is 
associated with increased risk of T2D, although this risk varies among different 
ethnicity populations (Misra, Wasir, & Vikram, 2005).  
 
Other factors identified as indicating a higher than average risk of developing T2D 
include having specific endocrinopathies (e.g. Cushing’s Syndrome), receiving 
treatment with diabetogenic drugs (e.g. high dose glucocorticoids), having had 
gestational diabetes, and cigarette smoking (WHO, 2006).  
 
People may spend many years in a state of pre-diabetes when blood glucose levels are 
higher than normal but do not meet diagnostic criteria. One in 3 adults are estimated 
to have prediabetes in England and therefore have a high risk of developing T2D 
(Mainous, Tanner, Baker, Zayas, & Harle, 2014).  
 
Economic Cost of Diabetes 
 
Diabetes represents a great economic burden, with 10% of NHS budget (£10 billion 
per year) spent on diabetes care – £1 million an hour. The combined direct and 
indirect costs associated with UK diabetes care total £23.7 billion, and this is expected 




People with diabetes are twice as likely to be admitted to hospital, and net ingredient 
prescription costs across primary care in the UK in 2014/5 totaled £803 million. 
Diabetes also contributes 44% of combined angina, myocardial infarction, heart 
failure and stroke hospital bed days (DiabetesUK, 2016a). Diabetes is the most 
common cause of lower limb amputations, renal dialysis and blindness (Hinchliffe, 
Jeffcoate, & Game, 2006).  
 
In the financial year 2015/16 there were 49.7 million items prescribed for diabetes at a 
total net ingredient cost of almost £100, 000 to the NHS. The number of items 
prescribed for drugs used in diabetes was 49.7 million (Digital), 2016). 
 
Management of Type 2 Diabetes 
 
The evidence base for management of T2D is constantly evolving and is a dynamic 
field. NICE summarises the evidence base and regularly updates its guidance (NICE, 
2015). 
 
Self-management: T2D is a progressive condition that requires intensive daily 
management, and there is an increasing expectation among both health professionals 
and patients that a significant part of this responsibility of care rests with the patient. 
The skills required to effectively manage T2D are multiple and include the 
performance of lifestyle behaviours such as adhering to a healthy diet plan and 
exercise regime, administering medication including insulin injections, multiple 
medications (including those to control glucose, blood pressure, cholesterol and 
weight (King, Peacock, & Donnelly, 1999)) and self-monitoring of blood glucose 
levels. A large degree of knowledge is necessary, in combination with self-motivation 
and an appropriate cognitive skills set, such as planning, comprehension and memory. 
However, knowledge and structured education alone do not ensure optimal self-




Non-Pharmacological Treatments  
 
Patient education: Support for people with T2D begins with referral to a patient 
education program such as Diabetes Education for Ongoing and Newly Diagnosed 
Diabetes DESMOND (Davies et al., 2008), X-PERT (Deakin, Cade, Williams, & 
Greenwood, 2006) and the Diabetes Manual (Sturt et al., 2008). Referral to a program 
is recognised as an essential component of NHS diabetes healthcare (NICE, 2011). 
The aim of such programs is to address patients’ individual health beliefs and support 
behaviour change to optimise blood glucose control, cardiovascular risk factors, 
depression and quality of life. While evidence for the effect of these programs on 
clinical outcomes has mainly been inconclusive (Deakin et al., 2006; Khunti et al., 
2012),  a systematic review concluded that small benefits were generally long-lasting 
(Loveman, Frampton, & Clegg, 2008) and the majority of patients find them 
beneficial in terms of acceptance of diagnosis (Ockleford, Shaw, Willars, & Dixon-
Woods, 2008) and increasing diabetes knowledge (Deakin, 2011). Uptake of referrals 
to structured diabetes education, however, is consistently poor (Winkley et al., 2015; 
Winkley et al., 2016).  
 
Lifestyle interventions: Lifestyle intervention is a crucial aspect of T2D self-
management, particularly the maintenance of a healthy diet and physical activity 
levels and there is an urgent need for interventions that produce sustained effects 
(Glasgow, Vogt, & Boles, 1999).  
 
Diet: Dietary management is a crucial aspect of T2D management. People with T2D 
are advised to follow a ‘normal’ balanced diet, which is rich in complex high fibre 
carbohydrates and low in saturated fats and cholesterol. Meals should be taken at 
regular intervals and an effort made to balance calorific intake in order to maintain 
normal body weight. It is recommended that ‘diabetic speciality foods’ are avoided, 
since they typically contain fructose or sorbitol which can lead to side effects such as 
diarrhoea. A landmark study published in The Lancet in 2017 reported the results of 
the DiRECT study, a cluster-randomised RCT which assessed whether an intensive 
weight management program implemented in a primary care setting could achieve 
remission of T2D. Among the sample of 306 patients at 49 primary care practices in 
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Scotland remission was achieved in 46% of intervention group patients at 12 month 
follow up (Lean et al., 2017).  
 
Physical exercise: Regular physical activity is recommended for people with T2D as 
it may have beneficial effects on metabolic risk factors for the development of T2D 
complications (Castaneda et al., 2002). Obesity is associated with insulin resistance, 
hyperinsulinemia, dyslipidemia and hypertension (DesprÉs, 1997). A meta-analysis 
synthesising data from RCTs which tested the effects of exercise on glycaemic 
control and body mass in T2D found that exercise decreased HbA1c sufficiently to 
decrease the risk of diabetic complications (Boulé, Haddad, Kenny, Wells, & Sigal, 
2001).   
 
Pharmacological Treatments  
 
Oral Hypoglycaemic Agents 
 
Biguanides: The only biguanide used in the UK is metformin, usually the first 
medication prescribed if dietary modification and physical activity adjustment have 
not been successful in reducing blood sugar levels (Rojas & Gomes, 2013). The exact 
mechanism of metformin is not understood, but it decreases hepatic glucose 
production and increases sensitivity to insulin (i.e. targets insulin resistance). It does 
not cause weight gain or hypoglycaemia and in obese patients is associated with a 
significant reduction in diabetes related events, mortality and stroke (King et al., 
1999).  
 
Sulphonylureas: The action of sulphonylurea is by stimulating pancreatic insulin 
production (Melander, Bitzén, Faber, & Groop, 1989). Examples include gliclazide 
and glimeprimide. In contrast to metformin, sulphonylureas may induce 
hypoglycaemia as a result of excess insulin production and release. They may also 
induce weight gain, abdominal upset, headaches and hypersensitivity reactions 




Alpha glucosidase inhibitor: Also known as acarbose, this delays the absorption of 
carbohydrates in the intestine, consequently lowering postprandial blood glucose 
levels. This is only effective in patients with adequate β cell function, and the drug 
commonly produces gastrointestinal side effects (Laube, 2002).  
 
Prandial glucose regulators: These work in a similar way to sulphonylureas in that 
they stimulate the cells in the pancreas to produce insulin. They have a faster action, 
but a shorter duration of therapeutic effect and so must be taken half an hour prior to 
meals and if a meal is missed, the dose is not taken (Owens, 1998). Examples include 
repaglinide.  
 
Thiazolidinediones: This group of medicines is known as insulin sensitisers or 
glitazones, reducing insulin resistance and improving sensitivity allowing the insulin 
that is produced by the body (or exogenous insulin injection) to be used more 
effectively. A secondary action is protection of pancreatic cells, allowing them to 
produce insulin for an extended period of time. Side effects include weight gain and 
fluid retention. Thiazolidinediones can be used as a monotherapy or added to 
metformin or sulphonylureas (Schoonjans & Auwerx, 2000).  
 
Incretin Mimetics: Incretin mimetics work by increasing levels of natural gut 
hormones called incretins, which help the body to produce more insulin only when it 
is required i.e. after meals, and reduce the amount of glucose produced by the liver 
when it’s not required. They can also reduce appetite, and the rate at which the 
stomach digests food. Examples include exenatide and liraglutide (Nielsen, 2005).  
 
DPP-4 Inhibitors (gliptins): DPP-4 (dipeptidyl peptidase-4) inhibitors block the 
action of DPP-4, a natural gut hormone that is an incretin antagonist. They are usually 
prescribed for patients who have not responded well to drugs such as metformin and 
sulphonylureas. Examples include sitagliptin and saxagliptin (Scheen, 2010).  
 
SGLT2 Inhibitors: SGLT2 inhibitors works in two ways: i) by reducing the amount 
of glucose re-absorbed at the kidney tubule (it is passed in the urine) and ii) reducing 
the amount of glucose in the blood. Examples include dapagliflozin and empagliflozin 





People with T2D may be advised to begin insulin therapy when blood glucose levels 
cannot be adequately controlled with the use of metformin plus one other oral anti-
diabetic drug; or if that person is hyperglycaemic and would prefer to start insulin 
rather than add another anti-diabetic drug. Insulin may also be used when anti-
diabetic drugs cannot be tolerated or are contraindicated (NICE, 2015). 
 
Reasons that insulin may not be recommended include i) obesity, since insulin use 
may lead to weight gain, ii) risk of hypoglycaemia (when the person’s risk may 
outweigh the potential benefit of taking insulin) iii) needle phobia or anxiety, iv) 
personal choice or v) concerns relating to a license to drive certain vehicles (NICE, 
2015).  
 
There are 3 main types of insulin including animal, human (synthesised to match 
human insulin) and analogue (insulin replicas). Most people use human or analogue 
insulin, although animal insulin is used in some cases. Insulin is then further 
categorised according to the speed at which it works. Rapid acting insulin is usually 
taken just before a meal, acting very fast to minimise the rise in blood sugar that 
follows a meal. Short acting insulin is also usually taken before a meal, although is 
not as fast to act. Rapid and short-acting insulin are often referred to as ‘bolus’ 
injections. Intermediate acting insulins are also known as isophane insulins and are 
often taken in conjunction with short acting insulin. They begin to take effect within 
the first hour of injecting and are followed by a period of peak activity, which can last 
for 7 hours, followed by a tailing off period. Long acting insulins can last for up to 24 
hours and ensure a consistent delivery throughout the day. Intermediate and long-
acting insulins are known as ‘basal’ or background insulins. Usually in T2D 
management people who need insulin start with one injection of basal insulin at night-
time and may then progress to a basal bolus insulin regimen if glycaemic control does 
not improve sufficiently and which can occur in the context of T2D progression and 




The Clinical Problem of Persistent Suboptimal Glycaemic Control 
 
Despite available treatments, a high proportion of patients with T2D remain poorly 
controlled (good blood glucose control is defined as 42-53 mmol/mol (equivalent to 
6-7%), moderate control as 63-74 mmol/mol (equivalent to 7.9-8.9%) and poor 
control as 85-107 mmol/mol (equivalent to 9.9-11.9%) (WHO, 2011). Patients 
struggle to balance the demands of self-management, medication adherence and 
lifestyle modification (Murphy et al., 2017).  
 
Causes of poor glycaemic control among T2D patients specifically include lack of 
diabetes knowledge; poor adherence to lifestyle recommendations; poor adherence to 
insulin or other medication; insulin refusal; side effects; infrequent attendance of 
routine appointments; denial that diabetes is a problem; mental health problems and 
social factors, for example family problems (Khan, Lasker, & Chowdhury, 2011; 
Khattab, Khader, Al-Khawaldeh, & Ajlouni, 2010). 
 
Psychological Problems and Glycaemic Control  
 
Patients with T2D have many psychological problems, which contribute to sub-
optimal glycaemic control. Psychological barriers to adherence include depression, 
anxiety, disordered eating, unhelpful health beliefs, stigma, and diabetes specific fears 
(Ismail, Winkley, & Rabe-Hesketh; Kenardy et al., 2001; Lustman et al., 2000).  
 
The most common mental health problem in people with T2D is depression, with 
rates increased at least 2-fold when compared to the general population, and 
prevalence rates at around 26% (Anderson, Freedland, Clouse, & Lustman, 2001). 
Depression is associated with adverse outcomes in diabetes and is associated, 
however it is measured (by clinical criteria or depression screening measures), with a 
2-5 fold increased risk of mortality (Black, Markides, & Ray, 2003; Ismail, Winkley 
K Fau - Rabe-Hesketh, & Rabe-Hesketh, 2004; Katon et al., 2005).  
 
Cross-sectional studies suggest that depression is associated with sub-optimal 
glycaemic control (Ciechanowski, Katon, & Russo, 2000a; Clark, Hampson, Avery, 
& Simpson, 2004) and some but not all observational studies support these findings 
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(Das-Munshi et al., 2007; Ismail et al., 2004; Katon et al., 2005; Nakahara et al., 
2006). Furthermore, sub-clinical depression and dysthymia may also have prognostic 
significance, since the effect of depression on mortality in those with diabetic foot 
ulcers has been found to be similar regardless of whether depression is mild, moderate 
or severe (Das-Munshi et al., 2007; Lustman, Griffith, Freedland, & Clouse, 1997).  
 
Anxiety is also more common in people with T2D (Grigsby, Anderson, Freedland, 
Clouse, & Lustman, 2002) and a systematic review of 18 studies to determine the 
level of generalised anxiety disorder in diabetes estimated the prevalence at 14% (2-3 
times that of general population), and sub-threshold anxiety at around 27% (Grigsby 
et al., 2002). At present, it remains to be established whether anxiety disorders are 
comorbid with depression or whether they are related to specific self-care activities, 
for example injecting insulin or fear of hypoglycaemia.  
 
Disordered eating, particularly night eating behaviours, is thought to be more 
common in people with T2D (Allison et al., 2007). Its significance may be that it 
contributes to progressive hyperglycaemia, and may be a response to fears of 
hypoglycaemia developing during the night (Allison et al., 2007). In addition, binge 
eating disorder may be more prevalent among the T2D population, with a recent 
systematic review and meta-analysis reporting rates of 6.9% (Cheah, 2008). It is 
associated with a BMI and increased psychological distress (Herpertz et al., 2000; 
Kenardy et al., 2001).  
 
Unhelpful health beliefs have been associated with maladaptive coping behaviours in 
patients with T2D (Searle, Norman, Thompson, & Vedhara, 2007). According to the 
Common Sense Model of Illness Representations, patients’ beliefs about their 
condition fall into 5 categories as follows (i) Identity, including beliefs about 
symptoms (ii) Timeline, including beliefs about the course and duration of the illness 
(iii) Consequences, or beliefs about the effects of the illness (iv) Cause, including 
beliefs about perceived cause and (v) Cure/Control, or beliefs about potential 
recovery from the illness or potential to control it (Leventhal, Brissette, & Leventhal, 
2003). Beliefs about diabetes medications have also predicted poor medication 
adherence, including ‘believing there is no need to take medicines when blood 
glucose is normal’, ‘worrying about side effects of diabetes medicines’ and ‘feeling 
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medicines are hard to take.’ These beliefs are potentially modifiable and are logical 
targets for educational programmes (Mann, Ponieman, Leventhal, & Halm, 2009).  
 
Social stigma is also a problem for people living with T2D. Qualitative research has 
shown that patients are subject to negative stereotyping, discrimination and restricted 
opportunities (for example in their career) (Browne, Ventura, Mosely, & Speight, 
2013). There is significant social stigma surrounding the public injection of insulin, 
with patients reporting ‘contempt’ from strangers as a result of the perception that 
they are ‘intravenous drug addicts’ or ‘self inflicting the disease as a result of over-
indulgence with food.’ Patients may therefore avoid injecting insulin in public, 
representing a barrier to self-management (Tak‐Ying Shiu, Kwan, & Wong, 2003). 
Stigmatisation from healthcare providers can also be a problem, with a systematic 
review concluding that negative attitudes towards obesity can negatively impact 
patients’ self-management (Teixeira & Budd, 2010). Shame and stigma of diabetes 
(e.g. not wishing to tell others of diabetes diagnosis) is also a barrier to attendance at 
structured diabetes education programmes (Winkley et al., 2015).  
 
Diabetes-specific worries can also represent barriers to self-care in T2D and may 
include difficulties in accepting and adjusting to the diagnosis; worries and fears 
about complications; self-testing and injecting; hypoglycaemia; acceptance of insulin 
therapy and concerns about body image and eating (Peyrot et al., 2005a) (Snoek, 
Bremmer, & Hermanns, 2015). For example, one qualitative study conducted in 
primary care practices in Kuala Lumpur found that patients’ resistance to insulin 
treatment was due to fears around self-injection; needle phobia; injection pain; 
embarrassment; social stigma; a belief that insulin can cause organ damage; a belief 
that their diabetes was not serious enough or a belief that insulin was ‘for more 
serious disease only’ (Hassan et al., 2013).  Another qualitative study conducted in 
Singapore found that patients perceived insulin as punishment for failure with their 
current regimen and some refused to acknowledge the need for insulin therapy (Tan et 
al., 2011). Levels of diabetes-distress are higher in primary care patients with T2D 
compared with secondary care in The Netherlands (4 versus 19% respectively) (Stoop 
et al., 2014) and higher in patients from ethnic minority backgrounds (Stoop et al., 
2014) (Strandberg, Graue, Wentzel-Larsen, Peyrot, & Rokne, 2014). Furthermore, 
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measures of diabetes distress have shown moderate to strong correlations with self-
report measures of depression in a sample of 463 T2D patients in the USA (Fisher, 
Glasgow, & Strycker, 2010), 184 patients with T1D (n=51) and T2D (n=133) in 
Australia (Reddy, Wilhelm, & Campbell, 2013) and in 627 outpatients with T1D 
(n=280) and T2D (n=347) in The Netherlands (Van Bastelaar et al., 2010). Some 
studies suggest that the link between glycaemic control and diabetes distress is 
stronger than the link between glycaemic control and depression in T2D (Reddy et al., 
2013) (Fisher et al., 2007) and some studies show that diabetes distress mediates the 
relationship between depression and glycaemic control  (Van Bastelaar et al., 2010) 
(Schmitt et al., 2015).  
 
Can Psychological Therapies Improve Outcome in Type 2 Diabetes?  
 
 
Psychological problems are associated with poor glycaemic control in T2D, for 
example, problems such as depressive disorders (De Groot, Anderson, Freedland, 
Clouse, & Lustman, 2001; Lustman et al., 1997) and disordered eating (Kenardy et 
al., 2001) and are associated with diabetes complications (De Groot et al., 2001) and 
poor glycaemic control (Lustman et al., 1997). In a systematic review and meta-
analysis of RCTs of psychological interventions to improve glycaemic control in 
patients with T2D, psychological interventions were associated with improvements in 
long-term glycaemic control and levels of psychological distress (Ismail et al.).  
 
Psychological approaches may be beneficial in improving adherence to diabetes self 
care behaviours and consequently glycaemic control, particularly if integrated into 
usual diabetes care. Talking therapies, during which the patient and therapist work 
collaboratively to address barriers to self-care and unhelpful health beliefs, may be 
beneficial. The most commonly advocated talking therapies are MI and CBT.  
 
A systematic review of psychological therapies designed to improve outcome in T2D 
found a reduction of ~8 mmol/mol in glycated haemoglobin in those receiving 
psychological therapy, close to the minimum clinical significance. Psychological 
strategies used ranged from behavioural techniques such as stress management and 
relaxation therapy (Surwit et al., 2002) to cognitive strategies designed to target 
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depressive symptoms (Lustman, Griffith, Freedland, Kissel, & Clouse, 1998). 
However, it should be noted that the validity of the findings were limited due to 
methodological limitations of the studies selected for inclusion. An update to the 
review 4 years later found little improvement in the quality of studies and a slightly 
reduced effect size (Alam, Sturt, Lall, & Winkley, 2009). This is discussed further 
within the context of the literature review described in Chapter 4.  
 
Psychological therapies can be beneficial when delivered by experts but this is not a 
practical or affordable solution for the NHS. Experts in psychological therapies are 
costly and their expertise is possibly best reserved for a small group of highly 
complex patients with multiple morbidities (Nicholson, Taylor, Gosden, Trigwell, & 
Ismail, 2009). At present there remains a large sub group of people with T2D and sub-
optimal glycaemic control that would benefit from receiving lower intensity 
psychological support in primary care and it may be that existing nursing staff can be 
trained to deliver this effectively.  
 
One systematic review found no difference in the reduction in HbA1c in those 
interventions delivered by ‘generalists’ i.e. doctors and nurses with no mental health 
training (pooled mean reduction 0.51% 5 mmol/mol (95% CI: -0.50 to 0.04: 9 RCTs 
with a sample size of compared to mental health workers such as psychologists and 
psychotherapists (0.57% or 6 mmol/mol (-0.36; 95% CI: -0.61 to 0.12: 9 RCTs with a 
n=832) sample size of n=561) (Alam et al., 2009). They concluded that training 
generalist clinicians in psychological therapies could represent a viable pathway to 
improved outcome in subgroups of T2D patients with suboptimal glycaemic control. 
 
Primary care practice nurses have been successfully trained to deliver CBT for other 
conditions with some success. For example, an RCT of CBT versus usual care for 
adults with persistent insomnia found that CBT delivered by primary care nurses was 
associated with significant improvements in self-reported sleep latency, wakefulness 
after sleep onset and sleep efficiency and that these improvements were partly 
sustained at follow up (Espie et al., 2007). An RCT of primary care nurse-delivered 
CBT as an adjunct to pharmacological therapy showed significant improvements in 
outcome for patients with irritable bowel syndrome up to 6 months after treatment 
(Kennedy et al., 2005) and studies have shown that primary care nurses find training 
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in psychological therapies such as MI to be a valuable tool for health promotion 
practice (Brobeck, Bergh, Odencrants, & Hildingh, 2011).  
 
Training primary care staff such as practice nurses may therefore represent a cost-
effective solution to the clinical problem of the T2D patient in primary care who 
struggles to achieve optimum glycaemic control as a result of psychological barriers 
to self-care. A recent RCT of collaborative care delivered by practice nurses for 
people with depression and T2D and/or cardiovascular disease found that problem 
solving therapy targeted at improving depressive symptoms integrated into regular 
diabetes care was associated with an improvement on all outcomes (Aiken, Clarke, 
Sloane, Sochalski, & Silber, 2002). A much larger sub-group of T2D patients 
however have sub-clinical depressive symptoms and diabetes related distress, and 
they could potentially benefit from practice nurses trained in psychological therapies, 
something which has not been adequately studied (Aikens, Kiolbasa, & Sobel, 1997; 
Charman, 2000).  
 
Summary and Conclusions  
 
T2D is a global problem that is accelerating in parallel with the global obesity 
epidemic. A condition requiring significant self-management on the part of the 
patient, it demands multiple skills including administration of polypharmacy, blood 
glucose monitoring and adherence to diet and exercise regimes. There are many 
psychological barriers to self-management, which must be addressed if self-
management among those with persistently sub-optimal glycaemic control is to 
improve. However, experts in psychological therapies are a scarce and costly resource 
for the NHS. If existing staff can be trained to deliver psychological therapies to this 









The preceding chapter emphasised the scale of the burden of T2D and the 
psychological difficulties that can interfere with self-management. The evidence for 
the effectiveness of psychological therapies in supporting self-management and 
improving glycaemic control remains unclear. 
 
This chapter will expand the different types of complex interventions, describe the 
different definitions for process evaluation and its importance in the evaluation of the 
RCT. A scoping study of the evolution of process evaluations was conducted which 
showed the various efforts that researchers have made to define them and develop 
frameworks and methods used to conduct process evaluations. Synthesising the 
different approaches, a framework for process evaluation of psychological 
interventions is proposed for preliminary application.  
 
Definition of a Complex Intervention 
 
A complex intervention is a treatment with multiple interacting components (MRC, 
2000). 
 
The MRC states that there are a number of characteristics of complexity, as defined 
by their guidance for developing and evaluating complex interventions (Craig et al., 
2008; Moore et al., 2015; MRC, 2000). These characteristics are: 
 
(i) Number of and interactions between intervention components (in both control and 
experimental conditions) 
(ii) Number and difficulty of behaviours required by those delivering or receiving the 
intervention 
(iii) Number of groups or organisational levels that the intervention is targeting 
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(iv) Number and variability of outcome measures 
(v) Degree of flexibility or tailoring of the intervention permitted. 
 
Complex interventions are widely used in health service, education and social policy 
research and typically present several challenges to researchers as follows: 
 
(i) Problems standardising research design and methodology because of multiple 
variations and interactions between different components 
(ii) Variations in the context to which they are applied 
(iii) Use of appropriate statistical and qualitative methods because the potential active 
ingredient is not clearly defined at the outset. 
 
Examples of complex interventions in different contexts include:  
 
(i) A trial in the service delivery and organisation context, such as one to assess the 
benefits of a specialised hospital pain unit involving complex interdisciplinary 
communication and collaboration, resulting in clinical and administrative challenges 
(Courtenay & Carey, 2008) 
(ii) Interventions designed to assess the behaviour of public health professionals, 
such as an intervention testing a new method of digital treatment decision support. 
Interventions involve training and implementation components and barriers such as 
clinicians’ resistance to change (Kaushal, Shojania, & Bates, 2003) 
(iii) Community interventions such as health education programs targeted at people 
at risk of developing long-term health conditions where fidelity may be difficult to 
measure (Breitenstein et al., 2010) 
(iv) Group psychological interventions such as a meditation group designed to 
reduce anxiety among people with cancer which involves the challenges of 
developing a therapeutic alliance in a group setting and participant and therapist 
barriers to participation (Carlson, Ursuliak, Goodey, Angen, & Speca, 2001) 
(v) Individual psychological interventions such as CBT for people with depression, 
which rely on the therapeutic alliance between patient and therapist and may be 
affected by both parties’ preconceptions regarding psychological therapies (Krupnick 




The type of complex intervention relevant to this thesis is the psychological 
intervention. Therefore, the term psychological intervention will replace complex 
intervention from this point forward.  
 
What is Process Evaluation?  
 
Process evaluation is an umbrella term for a range of methods for evaluating 
psychological interventions. Process evaluations may be conducted before, during or 
after the RCT to understand underlying mechanisms or processes that explain how 
and why the intervention is or is not effective in improving the intended outcome.   
 
The MRC defines process evaluation as, ‘a study which aims to understand the 
functioning of an intervention, by examining implementation, mechanisms of impact, 
and contextual factors. Process evaluation is complementary to, but not a substitute 
for, high quality outcomes evaluation’ (Moore G, 2014).  
 
Process evaluations aim to identify which components and mechanisms are the active 
ingredients contributing to efficacy (Oakley et al., 2006). They may employ a range 
of methodologies to identify these active ingredients, and they can measure multiple 
contextual variables and processes, which may vary between and within study 
participants, interventionists and sites to mediate outcome. The greater the number of 
potential active ingredients in a psychological intervention, the greater the variation in 
the overall conduct of the study and the interpretation of results. It is in this context 
that process evaluation becomes more relevant for interpreting quantitative findings 
and translating into practice. 
 
The basic principles of process evaluation are (Oakley et al., 2006): 
 
(i) The theoretical tenets underpinning an intervention and how they relate to 
intervention components 
(ii) The implementation of the intervention, including the quality and quantity of what 
was delivered 
(iii) The context in which the intervention was delivered 
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(iii) The mechanisms of impact of the intervention 
(iv) How an intervention can be implemented in a given context.  
 
These processes can occur at a number of different levels within the intervention, 
including:    
(i) The patient or participant level  
(ii) The therapy or program level or content  
(iii) The therapist or interventionist level 
(iv) The organisational level 
(v) The societal context.  
 




Despite a general consensus of the basic principles, at the time of writing this thesis, 
there is is no clear consensus as to the most suitable framework for conducting 
process evaluation. While the field of quantitative methods has exploded (for example 
there are now 14 variations on the CONSORT statement), that of process evaluation 
has been somewhat slower. A well-defined framework for process evaluation will 
enable researchers facing an already huge analytical task to make the most efficient, 
parsimonious use of resources by selecting the most appropriate processes from the 




Formative and Summative Process Evaluation  
 
Process evaluations may have both formative and summative purpose. Formative 
process evaluation ensures a programme is feasible, appropriate and acceptable 
(Saunders et al., 2005). The difference between formative and summative evaluation 
was first defined in the 1960’s by Scriven (Tyler, Gagné, & Scriven, 1967) who 
identified the purpose of formative evaluation as being ‘to collect information that can 
be used primarily for ongoing program development and improvement’ and the 
purpose of summative evaluation as being, ‘to make an overall judgment about the 
effectiveness of the program.’ Formative evaluation has been historically under-
researched in comparison to summative (Dehar, Casswell, & Duignan, 1993) although 
in recent years this has begun to change (Berkowitz et al., 2008; Braden, 1992; Evans, 
Scourfield, & Murphy, 2015). 
 
Formative evaluation uses methods such as systematic review to assess evidence base, 
consultations with programme developers and stakeholders to elicit knowledge, 
assumptions and understandings of intervention theory, and interviews with target 
populations to understand contextual influences and ascertain feasibility and 
acceptability of the intervention (Evans et al., 2015; Evans, Raines, & Owen, 1989). 
The MRC process evaluation framework recommends a feasibility and piloting stage 
take place after development of an intervention in order to assess feasibility and 
optimise design (Moore et al., 2015).  
 
Formative evaluation is important because it represents an opportunity to make 
adjustments to a programme at a point when its components are not well established. 
Hornik argued that by the time a programme reaches the point of outcome evaluation, 
too many irreversible commitments have been made (Hornik, 1980). However, Evans 
et al suggested a more ongoing role for formative evaluation of data in their 
definition, which states that formative evaluation is, ‘integrated into the development 
and implementation of a research project. It provides assessment information within a 
feedback loop. This assessment identifies the strengths and weaknesses of the project 
as it progresses. Data obtained from evaluations may be used to modify and redevelop 
the measurement instruments, the research design and the intervention program 
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during the course of implementing a project’ (Evans et al., 1989). McClintock later 
broadened the definition, framing the researcher as not just methodologist but agent of 
change, defining formative evaluation as, ‘the systematic use of empirical procedures 
for appraisal and analysis of programs as a way of providing ongoing information to 
influence decision making and action on policy, resource allocation, and program 
operations’ (Fitzpatrick, 1988; McClintock, 1984). Later definitions consolidated the 
focus on the potential of a formative evaluation to keep a programme on track 
(Helitzer et al., 1999; Israel et al., 1995; McGraw et al., 1994).  
 
Examples of formative evaluation programmes include the formative stage of The 
Stanford Five-City Program, which tested whether a community-wide health 
education in 2 cities can reduce coronary artery disease and stroke over a 64 month 
follow up period (Farquhar et al., 1990). Intervention groups received a health 
education intervention based on a communication-behaviour change model and social 
learning theory (Bandura, 2011). Pilot investigations conducted by the authors as part 
of a formative evaluation focused on the health communication campaign 
programmes and project materials. The formative analysis enabled the authors to 
better define study objectives, define target audience and identify intended 
intervention effects. The second phase of formative research was termed ‘concept 
testing’ and involved an investigation of the clarity of the intervention purpose 
measured by ‘tracking’ whether the programme materials had reached the audience as 
intended (Farquhar et al., 1985).  
 
Recently, researchers have argued that formative process evaluation must become 
more pragmatic (Evans et al., 2015). Pragmatic formative evaluation refers to 
formative evaluations of interventions that are likely to be already used in routine 
practice but have not yet been subjected to rigorous theoretical assessment. Pragmatic 
formative evaluations can therefore provide an evidence base for widely practiced 
interventions about which a number of assumptions have been made, while also 
providing the opportunity to conduct a formative evaluation in a real world setting. 
For example, a pragmatic formative process evaluation of a school based social and 
emotional learning intervention, recommended as best practice in Welsh schools for 
managing challenging behaviour found multiple iatrogenic effects as a result of 
stigmatising targeting practices. Qualitative interviews with 4 students taking part in 
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the study identified stigmatising practices around themes including negative labeling 
of children, leading to both stigma and exclusion of the child; a ‘badge of honour’ 
effect among peers; and amplified deviancy as result of intervention group 
composition. In this case, pragmatic formative evaluation successfully identified that 
intervention methodology was not supportive of processes and outcomes (Evans et al., 
2015).  
 
Summative evaluation refers to overall judgements made about the efficacy of an 
intervention (Tyler et al., 1967). Although an intervention may have been evaluated at 
the formative stage, there is still a need for a process evaluation during the main RCT, 
in order to assess the implementation of the intervention, the quality and quantity of 
what was delivered; to provide an evaluation of the context in which the intervention 
was delivered; evaluate the mechanisms of impact of the intervention; and assess how 
an intervention can be implemented in a given context (Moore et al., 2015). 
Summative evaluation methods are described in detail later in the chapter.  
 
The Purposes of Process Evaluation  
 
There are several reasons why process evaluations are important for planning, 
interpreting, implementing and evaluating a psychological intervention.  
 
(i) Planning a new psychological intervention: They enable researchers to plan new 
interventions, ensuring that each active intervention component is underpinned by a 
relevant theoretical construct. The importance of theory-driven intervention is 
increasingly recognised but the gap between theory and practice can be difficult to 
bridge. A good example of this is the field of intervention mapping, where each 
component of an intervention is mapped onto a theoretical construct and measured 
and evaluated accordingly. Intervention mapping was developed at the turn of the 
century, in parallel with the first attempt to define a framework for process evaluation 
(Bartholomew, Parcel, & Kok, 1998). There are 5 stages to intervention mapping as 










(ii) Evaluate existing interventions: They can enable researchers to evaluate existing 
interventions that are already in routine use. Pragmatic formative process evaluation 
can help to identify the evidence base for an intervention about which several 
assumptions have been made (Evans et al., 2015). Explanations for the existence of 
such an intervention in practice may include, ‘the presumed irrelevance of social 
equipoise; dissonant policy and research timescales; and the perception that an 
intervention will not confer harm’ (Evans et al., 2015). The MRC’s guidance for the 
development and evaluation of complex interventions claims that such an evaluation 
may not be necessary if an intervention is already in place (MRC, 2000). However, an 
established intervention may operate on many implicit theoretical and causal 
assumptions, which should be investigated. A methodological advantage of this type 
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of process evaluation is that it provides the opportunity for analysis within real world 
settings, and in turn is another method by which to capture real world complexities.  
 
(iii) Interpretation of results: They enable researchers to explain why some 
interventions are effective, and some are not. Process evaluations are used to identify 
mechanisms by which an intervention was successful, or to identify those that 
prevented it from working as intended. A process evaluation can answer the important 
question of whether the failure of an intervention was due to the intervention itself, or 
the way that it was implemented. Process evaluation may be used to interpret the 
results of efficacy studies (those which aim to establish whether or not an intervention 
works under ‘ideal’, or tightly controlled conditions); effectiveness studies (those 
which aim to test whether or not an intervention works in ‘real world’ conditions); 
dissemination studies (those which evaluate how best to deliver information to 
enhance public health knowledge); implementation studies (those which assess how 
an evidence based intervention may be implemented within a specific setting); and 
‘scale up’ studies (which aim to evaluate methods for increasing the impact of an 
evidence based intervention) (Flemming, Booth, Hannes, Cargo, & Noyes, 2018).   
 
(iv) Identify mechanisms: They can help us to understand relationships between 
various intervention components. A process evaluation can help illuminate which of 
these methods was most effective in changing behaviour, and which combinations 
were most desirable. Active ingredients may include the therapeutic alliance, patient 
and participant barriers and facilitators to participation, competence of therapist and 
organisational factors such as staff resources and local policies. For example, a health 
promotion intervention may include group and individual psychological therapies 
such as MI, online self-help programmes and print materials such as leaflets.  One UK 
based study compared 4 programs: a single session of individual diabetes education; 2 
sessions of individual education; group education and education with CBT (Campbell, 
Redman, Moffitt, & Sanson-Fisher, 1996). There were no significant differences in 
main outcome measures between groups. A process evaluation focusing on fidelity 
found that patients in the CBT group did not receive follow up phone calls as per 





(v) Replication: Process evaluations enable researchers to replicate previous research 
to a high standard. If an intervention has been effective, it will be repeated, and a 
process evaluation will provide the level of detail necessary to do so. This is 
important when testing an intervention at multiple sites, or in a different context to 
that in which it was originally tested. For example, the Teaching Family Model was a 
treatment program for ‘delinquent, abused and emotionally disturbed children’ 
replicated in group homes across the United States and Canada between 1967-1993. 
Researchers implemented what they termed ‘quality assurance evaluations’ involving 
evaluation at organisational and treatment levels to ensure that the program was 
replicated accurately (Fixsen & Blase, 1993). A process evaluation can help 
researchers state whether any changes in efficacy of the intervention are due to a 
change of the environment in which it was implemented, or a failure of the 
intervention itself. It can help to answer the important question: will the intervention 
produce similar outcomes when applied in different settings? 
 
(vi) Contextual application: Process evaluations illuminate how an intervention may 
be implemented in a given context by optimising the intervention content, leading to 
more efficient use of resources. The MRC and NIHR are the two largest public 
funding bodies of RCTs in the UK, yet they regularly fund RCTs which fail to reach 
recruitment targets or request time and/or financial extensions (McDonald et al., 
2006; Sully, Julious, & Nicholl, 2013). Qualitative trial data can help by streamlining 
feasibility studies, ensuring that a new intervention is acceptable to participants, 
improve trial efficiency, and facilitate interpretation of findings therefore conserving 
resources and directing researchers towards interventions that are more likely to 
succeed in future trials (Donovan et al., 2002; Moore et al., 2015; O'Cathain, Murphy, 
& Nicholl, 2007).  
 
A Scoping Study of the Evolution of Process Evaluation Theory  
 
A scoping study was conducted to establish the evolution of the concept of process 
evaluation and provide a broad summary of frameworks used to date. The results of 
the study were used to develop a new framework for process evaluations of 




A systematic review of the literature focusing on process evaluations of psychological 
interventions was attempted prior to the scoping study but proved prohibitively 
complex for the following reasons:  
 
(i) The number of potential search terms made defining search criteria impractical. 
There are myriad search terms relating to each component of process evaluation 
identified, for each type of intervention and for each disease group. There was also no 
reliable search term for a ‘complex intervention.’   
 
(ii) Many components of process evaluation had not been clearly defined. Studies 
may therefore have measured a component of process evaluation such as ‘reach’ or 
‘dose received’ but not defined it as such. The volume of literature within each 
component of process evaluation became unwieldy and beyond the scope of this 
thesis.  
 
(iii) Process evaluation frameworks varied in their components and were difficult to 
compare. 
  
(iv) In an effort to remain inclusive, defining inclusion and exclusion criteria became 
impossible. The Centre for Reviews and Dissemination Handbook notes the difficulty 
of specifying criteria for complex interventions and that inclusion criteria should 
capture all studies of interest but that criteria which are too narrowly defined risk 
missing studies of interest, while criteria which are too broad may yield data which is 
too hard to compare and synthesise (Khan, Ter Riet, Glanville, Sowden, & Kleijnen, 
2001).  
 
(v) A systematic review is designed to answer one question, which may be composed 
of multiple objectives, not the many questions with corresponding multiple objectives 
posed by the development of a new process evaluation framework.  
 
The field of process evaluation is too complex and heterogeneous in nature to 
facilitate a full systematic review within the scope of this thesis. The results of the 
scoping study yielded a 12 component framework which was then used to assess the 
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literature yielded from a review with much more appropriate, limited criteria. The 
results of this literature review are presented in Chapter 4.  
 
The purposes of a scoping study have been defined as: 
 
(i) To quickly map key concepts underpinning a research area and to establish the 
main sources of evidence available (Arksey & O'Malley, 2005)  
(ii) To synthesise and analyse a wide range of research and non-research material to 
provide greater conceptual clarity about a specific field or topic (Davis, Drey, & 
Gould, 2009) 
(iii) To make preliminary assessment of size and scope of research literature (Grant & 
Booth, 2009) 
(iv) To contextualise knowledge by identifying what we do and do not know, and 





(i) To broadly map the history of process evaluation theory 
(ii) To establish the key constructs underpinning process evaluation theory  
(iii) To establish existing process evaluation frameworks 




Databases (Medline, Embase, and PsycINFO) and the wider evaluation literature 
(texts and evaluation manuals) were searched between the earliest available date and 
07/2013. Studies and frameworks eligible for inclusion were published in English, 
and tested on humans. Reference lists of included studies were checked for eligibility. 
Frameworks were excluded if the authors did not explicitly state that they were 




Search terms included the following keywords and their medical subheadings 
(MeSH). The search strategy for Medline is reported in Appendix 1.  
 
Table 3.1: Scoping Study Search Terms  
Topic Search Terms 
Process Evaluation  Process evaluation, fidelity, adherence, 
implementation, treatment integrity, 
intervention integrity, evaluation study, 
patient satisfaction, process assessment, 
program implementation, program 
delivery 
Methodology Randomised controlled trial, qualitative, 
type III error, ethnography, observational, 
semi-structured interview 
Psychological Intervention Psychological intervention, 
psychotherapy, motivational 
interviewing, cognitive behavioural 
therapy, psychological therapy, 
psychosocial intervention, counselling, 




Studies included in this scoping study were defined as having conducted a process 
evaluation if the authors explicitly stated that they were conducting a process 
evaluation or process measures. Data were extracted on (i) definitions of process 
evaluation (ii) terms used to describe process evaluation components (iii) methods 
used to conduct process evaluations. Studies were excluded if the articles were not 
published in English. A narrative synthesis was conducted to address scoping study 








The narrative synthesis established a brief history of evaluation theory followed by a 
history of the development of the concept of process evaluation. Five process 
evaluation frameworks were identified measuring 11 components. These data were 
used to propose an additional 12-component process evaluation framework.  
 
A Brief History of Evaluation  
 
Humans have evaluated programs informally for thousands of years, with Scriven 
noting that ‘evaluation is a very young discipline - although it is a very old practice’ 
(Scriven, 1996). The first records of scientific evaluation were in the field of 
education in 1792, when quantitative marking was introduced as a method of 
assessing students’ work (Hoskin, 1979). Hoskin described seven periods of 
evaluation: Age of Reform (1792-1900); the Age of Efficiency and Testing (1900-
1930); the Tylerian Age (1930-1945); the Age of Innocence (1946-around 1957); the 
Age of Development (158-1972); the Age of Professionalization (1973-1983) and the 
Age of Expansion and Integration (1983-2000) (Kellaghan & Madaus, 1982). The 
Age of Reform (1792-1900) introduced objective scoring, aggregating and averaging 
of scores, marking a period of educational reform in the UK. A quantitative marking 
system enabled objective ranking of examinees and the aggregating and averaging of 
scores. This marked a crucial initial stage in the development of the field of 
psychometrics and led to the recommendation that teachers’ salaries be determined by 
students’ performance in reading, writing and arithmetic (Kellaghan & Madaus, 
1982). In the second evaluative stage (Age of Efficiency and Testing) from 1900-
1930, there was a new focus, on improving efficiency in testing, influential for 
educational administrators (Worthen & Sanders, 1987) while the Tylerian age (named 
after Ralph Tyler, considered the father of educational evaluation) saw longitudinal 
research into evaluation of the effectiveness of teaching methods. Tyler found that 
instructional objectives could be clarified by stating them in behavioural terms. He 
defined academic instructions in terms of the desired behavioural results, and his 
work formed the basis of criterion based testing (Tyler, 1975). The Age of Innocence 
from 1946-57 represented a period of post-war optimism, and evaluation researchers 
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began to distinguish between different types of ‘learner’ or person being evaluated, at 
the same time recognising the need for tests to be designed to measure specific 
outcomes. Despite this progression, little funding was allocated to educational reform, 
hence the term Age of Innocence (Reiser, 2001). During the 1960’s (The Age of 
Professionalisation) criterion referenced testing was introduced, which replaced norm-
referenced testing with measures of individual performance on sets of established 
criteria, significant because it was able to measure how well an individual performed, 
irrespective of how well others are performing. Finally, The Age of Expansion and 
Integration saw the development of professional organisations and evaluation 
standards (Reiser, 2001). 
 
The Development of the Concept of Process Evaluation 
 
It was during the 1960’s that the concept of process evaluation was probably first 
introduced, although it was not defined as such, with researchers working in health 
education planning defining process evaluation as, ‘monitored by various means, 
including audit, peer review, accreditation, certification, and government or 
administrative surveillance of contracts and grants’ (Green, 1977). Although very 
different to current definitions, this description highlights the importance of 
evaluating a new intervention or program using multiple sources of data. A textbook 
on evaluation described how, ‘an evaluation study may limit its data collection and 
analysis simply to determining whether or not a programme is successful...However, 
an analysis of process can have both administrative and scientific significance, 
particularly where the evaluation indicates that a programme is not working as 
expected’ (Suchman, 1968). 
 
The Age of Professionalization during the 1970’s saw the emergence of evaluation as 
a professional field with professional journals established and universities offering 
courses in process evaluation. Research focused on ‘the issues of improving 
evaluation designs and measuring programme effects’ and the field of process 
evaluation made little progress (Linnan, 2002). Major textbooks of the time made no 




It was not until the 1980's that the field of process evaluation began to develop. It was 
described as assessing, ‘whether specific elements such as facilities, staff, space, or 
services are being… established according to the given program plan’ (Windsor, 
Baranowski, Clark, & Cutter, 1984) and was followed in 1985 by the publication of 
what is considered a key paper in the field of process evaluation research. ‘Avoiding 
Type III Errors in Health Education Program Evaluations: A Case Study’ (Basch, 
Sliepcevich, Gold, Duncan, & Kolbe, 1985) argued that in addition to the more 
familiar Type I error or ‘false positive’ (rejecting a ‘true’ null hypothesis or falsely 
inferring the existence of a result that is not present) or Type II Error (failing to reject 
a ‘false’ null hypothesis or falsely inferring the absence of a result that is present) 
there is a third error to be avoided: Type III.  
 
A Type III Error can be defined as, ‘evaluating a programme that has not been 
adequately implemented’ (Basch et al., 1985). It occurs when implementation has not 
been adequately studied, leading to incorrect inferences about the efficacy of an 
intervention or programme. For example, in a study of a systematic care programme 
for caregivers of dementia patients, it was concluded that an observed difference 
between intervention groups may have been due to a lack of adherence to the 
intervention protocol (Spijker et al., 2013). Although this type of error was not new to 
the literature in general, this represented the first time it had been used in the public 
health service context (Linnan, 2002). The authors highlighted the need for trialists to 
consider that it is not possible to make meaningful conclusions about the efficacy of a 
programme without first establishing quality of implementation. This led to the 
evolution of the process evaluation concept ‘dose delivered’, which refers to how 
much of the intervention was delivered to participants as intended (an example of an 
intervention dose may constitute a session of health education encouraging 
participants to keep a food diary).  
 
An important distinction should be made between a trial of clinical effectiveness and 
a trial of efficacy in which an intervention was not properly delivered (a Type III 
error). While a trial of efficacy can be defined as a trial of an intervention under ideal 
or controlled conditions among a highly selected homogeneous population, a trial of 
effectiveness is one that assesses its performance under ‘real world’ clinical 
conditions in a heterogeneous population. (Singal, Higgins, & Waljee, 2014). Efficacy 
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data is often assumed to represent effectiveness data when in fact an efficacy trial can 
often overstate an intervention’s effect when implemented in clinical practice. While 
efficacy research maximises the likelihood of observing an intervention effect, 
effectiveness research may better account for external patient and provider factors 
such as access to services and adherence to medication, which may moderate the 
effect of the intervention once implemented in clinical practice (Singal et al., 2014). 
This gap between translation of research into clinical practice is well documented 
(Glasgow et al., 2003).  
 
One of the most crucial aspects of quality of implementation is how much a dose of 
the intervention was received as intended. A dose may be delivered to participants but 
that does not mean it was received; for example, participants may be encouraged to 
keep a food diary but if they do not engage in that behaviour, the dose has not been 
received as intended. A dose may also be received where it is not intended, for 
example from a source outside of the intervention program or when an aspect of the 
intervention is delivered to a control group participant. 
 
The concept of ‘dose received’ became defined as such due to the combined efforts of 
3 different studies. These decade-long studies funded by the National Heart, Lung and 
Blood Institute (NHLBI) aimed to establish the effects of community education 
programs on cardiovascular disease and were called The Stanford Five-City Program 
(Farquhar et al., 1990), The Pawtucket Heart Health Programme (Carleton, Lasater, 
Assaf, Feldman, & McKinlay, 1995) and The Minnesota Heart Health Programme 
(Perry, Kelder, Murray, & Klepp, 1992). The research teams involved in these 3 
studies collaborated to establish a consistent approach to measuring the dose of the 
intervention received by their target populations.  
 
The Stanford Five-City Program tested whether community-wide health education 
can reduce coronary artery disease and stroke. The RCT compared 2 intervention 
cities (n=122, 800) and 2 control cities (n=197, 500) on risk factor variables including 
BP, plasma cholesterol, smoking rate, weight and resting pulse rate. Groups were 
compared on these variables at baseline and at 3 time points during a 64-month follow 
up period. Intervention groups received a health education intervention based on a 
communication-behaviour change model and social learning theory (Bandura, 2011). 
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At 30 and 64 month follow up significant changes favouring the treatment groups 
were observed in plasma cholesterol, BP, resting pulse rate and smoking rate. These 
changes resulted in decreases in mortality risk scores (15%) and CHD risk scores 
(16%) (Farquhar et al., 1990). The Pawtucket Heart Health Programme tested whether 
a community health education programme implemented in Pawtucket changed 
cardiovascular risk factors and disease risk relative to comparison communities. A 
total of 15,261 people aged 18-64 took part in 6 surveys over 14 years. Number of 
respondents for each survey ranged from 2037-2955.  Projected CHD rates were 
lower (16%) in Pawtucket during the education programme. This difference reduced 
to 8% post education (Carleton et al., 1995). The Minnesota Heart Health Programme 
tested a community education programme in 6 communities over 10 years (n=7097). 
A community education programme designed to reduce cardiovascular disease risk 
was delivered to 3 communities. No significant differences were found in blood 
cholesterol level, BP, BMI or physical activity. There was a small significant 
treatment effect on smoking prevalence (Luepker et al., 1994).  
 
There are many active ingredients in community education interventions. They 
involve multiple components (e.g. leaflets, television and radio, newspapers and 
direct education including face to face, group and correspondence courses) making it 
difficult to isolate which components have an effect, and which ones have the greatest 
and the least effects. Participants are located throughout the community, making data 
collection difficult. The large scale of such interventions makes implementation 
challenging, as they cannot be as tightly organised as interventions delivered to small 
groups or individuals. Finally, community interventions co-exist with local and 
national programmes, making it difficult to differentiate intervention effects from 
usual practice and changes in policy.  
 
The NHLBI studies used qualitative methods (telephone surveys) to assess whether 
participants had actually received the dose delivered. They discovered that messages 
and programmes similar to those included in their community education interventions 
were being delivered from alternative sources, such as government agencies, 
healthcare providers and voluntary health organisations. They were therefore able to 
adjust their parameters for measuring ‘dose received’ in order to account for the extra 
exposure (Pirie, Stone, Assaf, Flora, & Maschewsky-Schneider, 1994). The concept 
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of ‘dose received’ was expanded to include the total sum of messages and programs 
consumed by participants. Other studies began to adopt the ‘dose delivered’ and ‘dose 
received’ approach (Sorensen et al., 1996).  
 
In the early 1990’s it was suggested that process evaluation could also be used to 
inform the design and development of interventions, and be conducted during the 
lifetime of an RCT rather than consisting of post-hoc implementation assessment. The 
Community Intervention Trial for Smoking Cessation (COMMIT) study tested 
whether a community intervention can reduce the prevalence of adult cigarette 
smoking.  One community within each of 11 matched community pairs (10 in the 
United States, 1 in Canada) was randomly assigned to intervention. Telephone 
surveys at baseline and 5 year follow up showed no intervention effect on heavy 
smoking prevalence. A process evaluation involved an ‘implementation evaluation’, 
alongside other assessments such as ‘quality control’ while the authors emphasised 
the ‘formative role’ that evaluation may play in research design. They suggested that 
there was potential for amending and correcting aspects of the design throughout the 
course of the intervention. They also discuss the idea that process evaluation may 
include both quantitative and qualitative methods (Corbett, Thompson, White, & 
Taylor, 1990).  
 
Implementation Research  
 
The field of implementation research is based on several disciplines and aims to 
understand what, why and how interventions work in real world settings (Peters, 
Adam, Alonge, Agyepong, & Tran, 2013). Implementation research may investigate 
any aspect of implementation, including the processes or factors that affect 
implementation, or the results of implementation. It also intends to test potential 
methods for improvement (Peters et al., 2013).  
 
Some principles of implementation research overlap with those of process evaluation. 
For example implementation research focuses on the context in which an intervention 
is implemented, seeking to understand the environmental conditions that may affect 
outcome. It seeks to examine the contextual effects of real world settings, rather than 
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eliminate variables that may confound effects, for example excluding patients with 
comorbidities. A core aim of implementation research is to ‘enhance the adoption of a 
clinical intervention’ (Curran, Bauer, Mittman, Pyne, & Stetler, 2012) and as such 
may be concerned with any aspect of the intervention including factors which affect 
implementation, effects of implementation, processes of implementation and 
investigating how interventions are implemented in practice.    
Implementation research is particularly concerned with intervention participants, who 
may include stakeholders such as policy makers, executive decision makers, 
practitioners or trial participants. Petersilia observed that, ‘the ideas embodied in 
innovative social programs are not self-executing’ and that what is needed is an, 
‘implementation perspective on innovation — an approach that views post-adoption 
events as crucial and focuses on the actions of those who convert it into practice as 
the key to success or failure’ (Petersilia, 1990).  
It may measure a number of variables including Acceptability (acceptability of the 
intervention to stakeholders); Adoption (the uptake of a new intervention); 
Appropriateness (perceived fit of an intervention); Feasibility (the practical use of an 
intervention); Fidelity (the extent to which the intervention was implemented 
according to protocol); Implementation Cost (the cost of the intervention); Coverage 
(the reach of an intervention) and Sustainability (ongoing adoption of the 
intervention) (Peters et al., 2013), which overlap with some proposed components of 
process evaluation.  
 
Implementation research has been used predominantly to assess the implementation 
of interventions in low income areas or developing countries. For example, a 
systematic review of strategies to improve health service delivery in low and middle 
income countries reviewed 150 studies and concluded that how a strategy is 
implemented is as important as the type of strategy implemented, and identified a 
number of successful implementation strategies, with multiple strategies more 
effective and single and stakeholder consultation a crucial defining element (Peters, 
El Saharty, Siadat, Janovsky, & Vujicic).  
 
Although implementation research has received attention over the past decade, there 
is considerable variation in terminology and confusion about its scope.  The concept 
of implementation is loosely developed and ‘lacks adequate specification of causal 
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mechanisms’ (Paudel, 2009). The concept is used to refer to the process of 
implementation but also the output and sometimes the outcome of the implementation 
process (Winter, 2012).  
 
 
Formalising Process Evaluation  
 
Due to the lack of a formal framework for process evaluation, researchers within the 
health education context continued to independently attempt to define elements. The 
CATCH study, another NHLBI funded trial, examined the effect of a school based 
health education program on cardiovascular disease risk (Perry et al., 1990). A sample 
of 4019 children from San Diego, Houston, New Orleans and Minneapolis were 
measured for risk factors including total cholesterol, obesity and BP at baseline and 
2.5 year follow up. No significant change in the primary outcome measure of total 
cholesterol was observed. The authors conducted a process evaluation as part of the 
trial, to ‘assess the degree of compliance and fidelity to the CATCH interventions.’ 
The evaluation assessed ‘participation,’ ‘dose’, ‘fidelity,’ and ‘compatibility’ (Perry et 
al., 1997). This represented one of the most extensive process evaluations yet 
conducted, covering programme implementation, monitoring of the quality of the 
intervention delivered, and consideration of the environmental context in which the 
intervention took place. However, as there was no consensus among researchers 
during these early studies there was some conceptual overlap between components of 
process evaluation studies, making replication of methods challenging. 
 
In the late 1990’s, the lack of a formal and comprehensive process evaluation 
framework was acknowledged by a group of American public health researchers 
(Glasgow et al., 1999). Outlining ‘5 dimensions of quality’ that they considered 
essential to process evaluation, they formulated the quantitative RE-AIM Framework 
(Reach, Efficacy, Adoption; Implementation and Maintenance), designed to aid 
researchers in evaluating health promotion interventions. The 5 components were: 
 




(ii) Efficacy, concerning the success rate if the intervention was implemented as 
intended, defined as positive outcomes minus negative outcomes 
(iii) Adoption, meaning the proportion and representativeness of settings which adopt 
the programme  
(iv) Implementation, referring to the extent to which the programme was delivered as 
intended  
(v) Maintenance, or the extent to which the health programme or policy is maintained.  
 
The ‘ultimate impact’ of an intervention was considered as its combined effects on 
these 5 evaluative dimensions. The RE-AIM framework, although overlapping with 
some aspects of the field of process evaluation was never actually defined as such, 
and despite its contribution as an attempt to formalise the evaluation process, it fails 
to account for the complexity of many interventions due to its focus solely on 
quantitative measurement.  
  
The first attempt to define a framework for process evaluation as it is currently 
understood came at the turn of the century, in parallel with the development of 
intervention mapping.  Intervention mapping aimed to aid researchers in the design 
and development of new interventions (Bartholomew et al., 1998). It emphasised the 
importance of developing interventions based on current theory first and outlined a 6-
step method for planning a behaviour change intervention. A core component of the 
mapping process involved developing an ‘evaluation model’ as part of a process 
evaluation. The concurrent development of both intervention mapping and process 
evaluation fields was a response to the need for improved evaluation methods due to 
the growing complexity of interventions.  
 
A step change in the methodological advances was when Baranowski and Stables 
developed one of the first attempts at a more comprehensive process evaluation 
framework (Baranowski & Stables, 2000). They defined 11 components of process 
evaluation based on their evaluation of the ‘5 a Day Projects’, a large-scale nutrition 
intervention aimed at promoting fruit and vegetable consumption. The studies, funded 
by The National Cancer Institute, comprised 9 RCTs designed to increase fruit and 
vegetable consumption for the primary prevention of cancer. Three of the studies 
were conducted within elementary schools using classroom curriculums, newsletters, 
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videos and family activities (Davis et al., 2000) (Reynolds et al., 2000; Story et al., 
2000); 1 delivered an intervention to high school students via classroom workshops, 
family activities and dietary change (Davis et al., 2000); 3 targeted adults via work-
site wellness programmes using individual programmes using the Stages of Change 
Model (Prochaska, DiClemente, Velicer, Ginpil, & Norcross, 1985) and broader, 
organisational support networks, family activities and peer education (Beresford, 
Shannon, McLerran, & Thompson, 2000; Hunt, Lederman, Potter, Stoddard, & 
Sorensen, 2000) (Buller et al., 2000); 1 targeted rural African American adults via 
their church using community (Campbell et al., 2000) and individual approaches and 
1 targeted mothers, training their peers as interventionists (Havas, Anliker, Damron, 
Feldman, & Langenberg, 2000).  
 
They defined the components as follows:  
 
(i) Recruitment: the number and characteristics of participants recruited 
(ii) Maintenance: ensuring participants remain in the study 
(iii) Context: aspects of the environment in which the intervention has been 
implemented 
(iv) Resources: the characteristics of agencies, implementers or participants necessary 
to achieve intervention goals 
(v) Implementation: the extent to which the intervention is implemented as planned 
(vi) Reach: the extent to which the target population receives the intervention 
(vii) Barriers: barriers to the implementation of the intervention 
(viii) Exposure: the extent to which participants received (or were exposed to) the 
intervention components 
(ix) Initial use: the extent to which participants conduct the intended behaviours 
promoted by the intervention 
(x) Continued use: the extent to which participants continue to do any of those 
activities 
(xi) Contamination: the extent to which participants receive interventions from 





Baranowski and Stables outlined a useful framework for process evaluation based on 
large-scale studies, however the model has not been widely used. There is some 
conceptual overlap, for example ‘initial use’ and ‘continued use’ have some overlap 
with ‘reach’ in that they measure which behaviours participants engage with as part of 
the intervention. Later models attempted to redefine the components of process 
evaluation.  
 
In their book, 'Process Evaluations for Public Health Interventions and Research', 
Linnan and Steckler (Linnan, 2002), built on this work proposing a tighter framework, 
comprising 7 components as follows:  
 
(i) Context: Aspects of the environment in which the intervention has been 
implemented (including the wider political and social context) 
(ii) Reach: the proportion of the participants that participate in the intervention (e.g. 
measured by attendance) 
(iii) Dose delivered: the amount of each intervention component that was delivered 
(iv) Dose received: the amount of intervention actually received, or engaged with by 
participants 
(v) Fidelity: the extent to which the intervention was delivered as planned 
(vi) Implementation: a composite score indicating the extent to which the intervention 
was implemented and received 
(viii) Recruitment: procedures used to approach and recruit participants.  
 
Linnan and Steckler’s framework, although the most widely used, has been criticised 
for not paying sufficient attention to contextual variables, which may hinder or 
facilitate the implementation of an intervention, such as participant and therapist 
characteristics and behaviours (Wierenga et al., 2013). Contextual variables could be 
considered the most important component of process evaluation and this represents a 
major flaw in the model.  
 
Acknowledging the growing field of evaluation of complex interventions and its 
importance, the MRC published guidelines designed to aid researchers in the 
development and implementation of evaluations (MRC, 2000). This document 
advised matching evaluation techniques to complex research designs, focused on the 
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development and planning of complex interventions, and the importance of evaluating 
the ‘processes of implementation.’ The authors emphasise that active components of 
an intervention should be identified, and recommend an, ‘iterative, phased approach’ 
to their design and implementation, using both quantitative and qualitative methods. 









The model begins with a theoretical phase, designed to assist researchers in 
developing a sound hypothesis. This may overlap with phase 1, the modelling phase, 
which aims to identify underlying mechanisms of the intervention. Phase II represents 
an exploratory phase, as aspects of the trial such as suitability of recruitment 
procedures and feasibility of outcome measures are tested. Phase III is the definitive 
or ‘main’ RCT testing the intervention while Phase IV represents evaluation.  
 
Although the guide represented the first, formal guidance for researchers who wished 
to thoroughly plan and conduct an evaluation, it does not include any mention of 
process evaluation. It was criticised for its failure to recognise the complexity of 
contextual variation between different interventions, and for its theoretical basis, 
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which reflected that adopted in the evaluation of clinical drug trials (Mackenzie et al., 
2010).  
 
In the meantime, many process evaluations continued to be conducted without use of 
a framework. For example, one Netherlands-based evaluation of a nurse-led 
intervention to improve self management in patients with asthma, diabetes and heart 
failure through goal setting and planning of behaviour, measured patients’ self 
efficacy and elicited patients’ and nurses’ perceptions of the intervention, but did not 
use any framework to guide the research (Schreurs, Colland, Kuijer, de Ridder, & van 
Elderen, 2003). Another example is a New Zealand based RCT which tested a 
telephone based counselling intervention designed to promote walking in a sample of 
186 adults aged 65 and older, incorporating techniques drawn from CBT and MI. The 
authors measured participant satisfaction and views about the value of the 
intervention (Kolt et al., 2006). A third study conducted a process evaluation of an 
RCT testing the effect of a coping intervention delivered in 10 sessions, for 168 
patients in The Netherlands with rheumatic diseases, which aimed to increase social 
support and quality of life. They evaluated patients’ opinions about the content and 
structure of the sessions and supervisors’ performance (Savelkoul & de Witte, 2001). 
Researchers and funders were recognising the importance of process evaluation but 
lacked a theoretical framework, formal guidance, examples of good practice or an 
evidence base to guide them.  
 
In 2008, the MRC guidance was updated (Craig et al., 2008), drawing on the expertise 
of researchers with experience of evaluating complex interventions plus literature 
review, process evaluation case studies, workshops, and discussions, which took place 
at conferences and seminars. Feedback was obtained via peer review and appropriate 
revisions made. The authors recognise that evaluation can be ‘highly valuable’ in 
assisting researchers to identify mechanisms or processes by which an intervention 
has worked, for assessing fidelity and quality of implementation and to identify 
contextual factors which may have contributed towards any variations in outcomes. 
They state that process evaluation, while important, is not a substitute for an outcome 
evaluation, but an addition to it. However, this update contained no new guidance for 
the development and conduct of process evaluations. There is little practical advice 
for researchers on how to plan and conduct a process evaluation, and the guidance has 
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been criticised for its failure to include theory driven approaches to evaluation (De 
Silva et al., 2014). Theory driven evaluation is based around a program theory, which 
outlines how those conducting the intervention expect it to work. It is a set of implicit 
assumptions that guide the design of an intervention (Chen & Rossi, 1989). 
 
Researchers, dissatisfied with MRC guidance, began to develop individual 
approaches. One framework (Grant, Treweek, Dreischulte, Foy, & Guthrie, 2013) was 
developed as a response to process evaluation frameworks focusing too heavily on 
qualitative measurement, with insufficient value placed on quantitative methods. 
Grant et al proposed guidance for the evaluation of cluster randomised trials of 
complex interventions, suggesting methods for evaluating the components (Grant et 
al., 2013). The model is shown in Figure 3.4. 
 
The model distinguishes between processes occurring within cluster randomised 
groups and individuals, then assesses maintenance of the intervention, its efficacy, 
and any unintended consequences.  
 






This developed previous frameworks by suggesting suitable methodologies for 
assessment at each stage of process evaluation, specifying suggestions for timings of 
assessments. Despite this, the framework is firmly rooted in the design of the RCT 
and outlines only minimal process evaluation requirements.  
 
A recurring observation in the early evolution of process evaluation research is that 
evaluations have been conducted in the field of community health education or 
education in which samples of the general population are targeted rather than 
individuals. This important work laid the foundation for process evaluations but some 
concepts could not be applied to studies that target individuals. Saunders et al 
recognised this problem and developed a framework for more targeted interventions 
(Saunders et al., 2005). They adapted Linnan and Steckler’s 2002 model, providing a 
step-by-step plan for carrying out a process evaluation, using the example of a school 
based media training programme aimed at decreasing adolescent risk behaviours. 
They hypothesised that by enhancing students’ understanding of media messages they 
become more able to deconstruct them and therefore more resilient to harmful 
messages sometimes enforced by the media (Saunders et al., 2005). They described 7 
elements of process evaluation: 
 
(i) Fidelity: extent to which the intervention is implemented as planned 
(ii) Dose delivered: amount or number of intended units of each intervention or 
component delivered or provided by interventionists 
(iii) Dose received: exposure, or the extent to which participants engaged with or are 
receptive to the intervention 
(iv) Dose received: satisfaction, or the extent to which the participants are satisfied 
with the programme and its elements  
(v) Reach: participation rate 
(vi) Recruitment: the procedures used to approach and attract participants 
(vii) Context: aspects of the intervention, which may influence outcomes.  
 
They provided examples of qualitative and quantitative methods that could be used to 
carry out the evaluation and emphasised that process evaluation can be used for both 




Despite this representing one of the most comprehensive frameworks to date, the 
work is limited by the fact that it is illustrated using the example of a fictional case 
study, not tested on a real world intervention. The model also lacks narrative clarity, 
as it does not present a clear step-by-step process for the conduct of process 
evaluation, for example recruitment is presented at the end. As a result, the 
framework has not been widely used. Many process evaluation studies combined the 
various frameworks to compensate for the fact that none fully met their needs. For 
example, a process evaluation of a year long non-randomised community based 
mental health promotion intervention for 11-14 year old refugee children in Beirut 
focused on promoting the mental health of the children and increasing their 
attachment to school. They based the elements of process evaluation on Linnan and 
Steckler’s framework while the methodologies used were guided by Saunders et al 
(Nakkash et al., 2012). They measured the process evaluation components of ‘fidelity, 
dose delivered, dose received and reach’ but did not measure the components of 
‘recruitment’ or ‘context’. Another study used both the frameworks set out by Linnan 
and Steckler (Linnan, 2002) and Baranowski and Stables (Baranowski & Stables, 
2000) to guide their process evaluations, while referring to the guidelines of Saunders 
et al (Saunders et al., 2005) to plan.  
 
The Depression in Elderly With Long-Term Afflictions (DELTA) trial was a low 
intensity psychological intervention designed to reduce depression in elderly people 
living in The Netherlands with long-term conditions. The intervention was based on 
principles of CBT and self-management and was delivered by nurses to 183 elderly 
people with diabetes or COPD who screened positive for depression. Process 
evaluation questions were formulated in questionnaire format by translating ‘key 
theoretical elements’ of the frameworks described by Linnan and Steckler and 
Baranowski and Stables. They studied the process evaluation elements of reach, 
fidelity, dose received (exposure and satisfaction) and barriers (Jonkers et al., 2007).  
 
While statisticians and epidemiologists once dominated this field of evaluation, now a 
more collaborative approach has been adopted. This is due to growing awareness of 
complex interventions in health settings and increased pressures of long-term 




Bringing us into the 21st century, there has been slow but steady progress. 
Recognising the need for formal guidance in how to conduct process evaluations, the 
MRC published ‘Process Evaluation of Complex Interventions’ in 2015 (Moore et al., 
2015). The guidelines built upon the previous framework for evaluating complex 
interventions, which had failed to mention process evaluation. The guidelines focused 
on three themes of process evaluation:  
(i) Implementation of complex interventions and the methods used to do so 
(ii) The mechanisms of impact: how does the intervention delivered produce change? 
(iii) Context: how does context affect implementation and outcomes? 
  
The MRC model of process evaluation is shown in Figure 3.5.  
 
Figure 3.5: MRC ‘key functions’ of process evaluation, reproduced (with permission) 
from Process Evaluation of Complex Interventions: a Summary of Medical Research 




The MRC guidelines stress that there is no ‘one size fits all’ set of methods for 
process evaluation, which has resulted in a set of guidelines that may be difficult to 
apply to specific research designs. Rather than providing a series of steps to follow or 
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processes that should be measured, the MRC model is cyclical. There remains a need 
for a clear, simple checklist for researchers to use when planning and implementing 
process evaluations, in the style of the CONSORT checklist for the reporting of RCTs 
otherwise there is a risk of a process evaluation becoming unwieldy, more time 
consuming and expensive than conducting the RCT itself. However it could also be 
argued that a good process evaluation of a pilot or feasibility RCT is essential to 
ensure the validity of a definitive RCT. The CONSORT and process evaluation 
checklists should be used in parallel, guiding researchers on the measurement of 
processes and use of mixed methodologies. The MRC is in the process of updating its 
guidance, due for publication in 2020 (Skivington et al., 2018). 
 
The scoping study described the development of the concept of process evaluation, 
existing process evaluation frameworks, their conceptual components and methods. 
Gaps in the literature and a need for an easy to follow framework for the design and 
conduct of evaluations was revealed.  
 
A Framework for Planning, Designing and Conducting a Process Evaluation 
 
The results of the scoping study were used to develop a new framework for process 
evaluations of psychological interventions. 
 
The methods used to develop the framework are as follows: 
 
(i) The scoping study described above established current process evaluation 
frameworks, conceptual components, methodologies used and gaps in the application 
of process evaluation components to psychological interventions 
(ii) Overlapping concepts within each framework were mapped (Table 3.2) 
(iii) The key elements of the frameworks identified are synthesised in the 12-
component framework described below.  
 
This framework was applied as a method of summarising the literature described in 




Table 3.2: Components of Process Evaluation Measured by Most Commonly Cited 
Frameworks 






















   X X 
Recruitment  X X X X  
Maintenance X   X  
Context/Resources X X X X X 
Implementation/Fidelity  X X X X X 
Reach/Dose Delivered  X X X X X 
Barriers and/or 
Facilitators 
X    X 
Exposure/Dose 
Received/Initial Use 
X X X X X 
Mechanisms of Impact      X 
Continued Use/Adoption 
& Maintenance  
X    X 
Contamination  X     
Baranowski and Stables (Baranowski & Stables, 2000) produced the framework with the most components, 
closely followed by the MRC’s recent guidance (Craig et al., 2008). The fewest components were defined by 
Linnan and Steckler (Linnan, 2002), and Saunders et al (Saunders et al., 2005).   
  
The Components of Process Evaluation 
   
1. Formative Process Evaluation  
 
Formative Process Evaluation takes place prior to the main RCT and is used to plan 
and assess feasibility of a new intervention before it is tested. It is concerned with the 
way that theory maps onto different intervention components and has similarities with 
the field of intervention mapping (Bartholomew et al., 1998) but differs in that 
theoretical components may not necessarily be formal academic theories. All 
interventions are ‘theories incarnate’ (Pawson, Greenhalgh, Harvey, & Walshe, 2005) 
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in that they represent a combination of theoretical beliefs that the actions of the 
intervention will lead to the desired outcome. It is commonly recommended that 
public health interventions should be based on formal behaviour change theory 
(NICE, 2014). However, many formal behaviour change theories are in fact weak 
predictors of behaviour (Bartholomew et al., 1998; Shepperd et al., 2009) and 
interventions which are based on formal theory are not always more effective than 
those which are not (Eakin et al., 2014). For example, a meta-analysis of behaviour 
change interventions based on the Theory of Planned Behaviour (Arkes et al., 1991; 
Van Lange, Kruglanski, & Higgins, 2011) concluded that effect sizes for 
interventions varied across behavioural domains (Steinmetz, Knappstein, Ajzen, 
Schmidt, & Kabst, 2016). Each theoretical construct should be identified and 
specified clearly, mapped onto a component of the intervention and plans for 
evaluation made accordingly.  
 
Pragmatic Formative Evaluation may be used to establish an evidence base for an 
intervention that is already in routine use within a healthcare organisation and about 
which a number of assumptions relating to theoretical underpinnings and mechanisms 
of action have been made but have not yet been formally established (Evans et al., 
2015).  
 
2. Acceptability and Social Validity 
 
The Acceptability and Social Validity stage of process evaluation represents a second 
phase of formative process evaluation, concerning whether or not an intervention is 
feasible and acceptable to its potential participants. It involves any pilot or 
exploratory studies that aim to assess feasibility of a full trial. It may also involve 
obtaining feedback from a population with demographics representative of the 
potential trial sample, for example via patient participation and involvement groups 
(PPI). In the UK the use of PPIs in healthcare and social policy research is well 
established, and their value recognised in terms of empowering patients and 
informing development of healthcare services (Health, 2010). The aim has been to 
move towards a more patient centred service and to give insights, which can 
contribute to the planning and design of an intervention. For example, a 2012 
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systematic review (Brett, 2012) found that the positive impacts of PPI groups during 
the planning stages of research were that they helped to identify user-relevant topics 
for the research agenda and helped to prioritise research topics. They also offered 
pragmatic criticism of research protocols and gave feedback on the extent to which 
they felt the research to be relevant or appropriate. Examples of this included 
culturally relevant issues that should be accounted for when undertaking a study in 
certain settings. For example, the Diabetes Interventions Reaching and Educating 
Communities Together (DIRECT) study aimed to identify levels of diabetes-related 
burden among African American communities in North Carolina. However, suspicion 
of federally funded research among African American communities has made this 
difficult, due to instances of historical exploitation and abuse in medical and public 
health research (Corbie‐Smith, Thomas, Williams, & Moody‐Ayers, 1999).  
 
Researchers used PPI at the pilot stage to aid researchers in gaining valuable data on 
the health behaviours of an African American sample. A community advisory board 
was formed, comprising members with a broad representation of the community’s 
civic, religious, social and professional spheres. The board reviewed the acceptability 
of the program materials and methodology, and advised on methods to encourage 
participation. Data were also collected on health status and it was found that African 
Americans were more likely to smoke and have uncontrolled hypertension and were 
less likely to have a single health provider. This data enabled researchers to refine 
methodologies and identify areas for intervention in the main study protocol 
(Engelgau et al., 1998).  
 
3. Recruitment  
 
The recruitment stage of evaluation concerns the strategies used to recruit patients and 
their potential effects on study outcome. Recruitment strategies may often be 
discussed as a limitation of an RCT post-trial but not as a stage of evaluation. The 
Acceptability and Social Validity formative evaluation stage may feed into the 
analysis of Recruitment strategies via the use of patient participation. For example, it 
has been found that PPI groups may assist recruitment by providing greater access to 
research communities (Faulkner, 2006; Rhodes et al., 2002) and by identifying the 
 
85 
most effective ways of accessing participants (Hanley, Truesdale, King, Elbourne, & 
Chalmers, 2001; Wyatt et al., 2008). For example, researchers working on the 
Diabetes Interventions Reaching and Educating Communities Together (DIRECT) 
study maximised recruitment of participants by offering them an extended medical 
examination in addition to blood glucose screening and BP measurement. This 
enabled participants to view the program as a health service to meet their needs rather 
than research activity to meet the needs of researchers. The research team worked 
closely with the community to provide resources for individuals who did not have or 
could not afford regular medical care (Burrus, Liburd, & Burroughs, 1998). Service 
users may also provide valuable information on the wording and appropriateness of 
recruitment documents such as patient invitation letters and patient information 
sheets. For example, researchers working on the DIRECT study changed participant 
information sheets and other printed materials to fifth and sixth grade reading level to 
ensure they were written in language that could be understood by all participants, 
therefore maximising recruitment potential (Paterson, 2004) (Burrus et al., 1998).  
 
4. Dose Delivered  
 
This refers to the number or amount of intervention units that were delivered to the 
participants as planned and represents one of the first process evaluation constructs 
ever defined in the literature (Linnan, 2002). This component of process evaluation is 
required for the conduct of any RCT as per step 13a on the CONSORT checklist 
(Begg et al., 1996). Dose Delivered refers to the proportion of units of the 
intervention that were delivered as intended, and is therefore directly related to 
intervention implementation. Researchers should establish a priori what the 
acceptable proportion of dose received should be. While in a medicinal trial this is 








5. Dose Received 
 
A dose of an intervention may be delivered to a participant, but that does not mean 
that it has been received. A Dose Received is that which is actively ‘used’ or ‘engaged 
with’. In medicinal RCTs measuring dose received is relatively straightforward, for 
instance via prescription charts, measuring the presence of a drug or biomarker in the 
blood, urine or other bodily fluids or tissues. In psychological interventions Dose 
Received has also been termed ‘exposure’ in the process evaluation literature 
(Baranowski & Stables, 2000). For example, a participant may fail to attend a session 
of MI or be late for it, and will therefore not receive any therapeutic dose.  
 
Dose Delivered + Dose Received is equal to the concept of Adherence. If the 
minimum acceptable level of an intervention was delivered to a participant and it is 
accepted that they also received each dose then it is reasonable to conclude that the 
minimum amount of intervention required has been delivered as intended.  
 
6. Programme Implementation/Fidelity 
 
This represents the extent to which the intervention was delivered as planned in the 
protocol. It explores the difference between the planned intervention and the delivered 
intervention (Bond, Evans, Salyers, Williams, & Kim, 2000; Dusenbury, Brannigan, 
Falco, & Hansen, 2003). For example, a physical therapist may be trained in the 
delivery of a novel intervention for the recovery of movement after stroke. However, 
if they do not perform the intervention technique as specified during training, or they 
do not reach competency in that technique, they have not maintained treatment 
fidelity. Fidelity may represent the most difficult process evaluation component to 
assess accurately due to the wide range of methods used to assess it - which are both 
qualitative and quantitative - and the subjective nature of quality ratings. For example, 
even a standardised questionnaire such as the Motivational Interviewing Treatment 
Integrity scale (MITI) (Moyers, Martin T Fau - Manuel, Manuel Jk Fau - 
Hendrickson, Hendrickson Sm Fau - Miller, & Miller, 2005a) relies on some 
subjectivity on the part of the rater. This can be minimised by multiple ratings and 





Measuring fidelity can also help to identify new or unexpected mechanisms of 
change. When testing any new intervention there is potential for disagreement about 
how and why change may occur. Using a behavioural rating system to assess the 
therapist’s fidelity to various aspects of MI can identify which components of therapy 




Most psychological interventions cannot be delivered blind to the participant or the 
provider and therefore it is difficult to ensure delivery is contained only within the 
intervention arm. This is especially the case with psychological interventions where 
the participant has to be aware of receiving talking therapy and of course the therapist 
and in that context so is everyone in the social network e.g. family, friends, other 
health providers. Contamination is defined by Keogh et al as, ‘the process whereby an 
intervention intended for members of the trial (intervention or treatment) arm of a 
study is received by members of another (control) arm’ (Keogh-Brown et al., 2007).  
 
8. Provider Experience  
 
This concerns the experiences of the provider selected to deliver the intervention. 
There are many individual characteristics with the potential to affect outcome, 
including provider responses; personal beliefs and values; previous experience or 
training and capacity to engage. The complexity of psychological skills training 
means that many factors may combine to influence delivery of the intervention, and 
therapists may experience barriers such as concerns about workload, time barriers and 
need for specialist staff (Prytys, Garety, Jolley, Onwumere, & Craig, 2011). This also 
concerns provider satisfaction and the acceptability of the intervention to providers. 
The data gathered at the formative Feasibility and Social Validity stage can be 
compared with post-trial data collected from participants and any discrepancies 




9. Participant Experience 
 
This concerns the experiences of participants who receive the intervention, their 
satisfaction and the degree to which they find the intervention acceptable. There are 
many individual characteristics with the potential to affect outcome, including 
participant responses; interaction between participant and interventionists; personal 
beliefs and values; previous experience or training and capacity to engage. For 
example, in a RCT of behavioural counselling in newly diagnosed T2D, diet was as 
effective as diet and exercise in improving glycaemic control. However, exit 
interviews with participants revealed that this was probably because the latter 
rewarded their exercise with more food which may explain why greater ‘dose’ arm 
(diet plus exercise) was as effective as diet alone (Andrews et al., 2011; Malpass, 
Andrews, & Turner, 2009). One interpretation of these findings is that adding exercise 
does not improve effectiveness but an alternative interpretation is that by adding 
additional behaviour change techniques or education, the patient could be supported 
in not 'rewarding' themselves after exercise thus potentially leading to an increased 
effect. This is an example of the power of process evaluation.  
 
The data gathered in the formative Feasibility and Social Validity stage can also be 





This refers to the environmental setting in which the intervention is implemented that 
have the potential to affect outcome. These may include organisational factors such as 
management structure within the setting where the intervention is being tested, for 
example the hierarchy of healthcare professionals within a hospital outpatient 
department or GP surgery; systems and logistical factors such as the communication 
channels within teams, for example the methods of referral within a hospital triage 
system or political factors such as local or wider national policies and economic 
factors such as available funding and resources.  For example, a longitudinal study 
which followed up 314 fourth-year UK medical students over 11 years found a lack of 
sufficient resources and tensions between colleagues within an organisation may lead 
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to high levels of stress and result in decreased quality of patient care (Firth-Cozens, 
2001).  
 
11. Barriers and Facilitators 
 
Barriers and facilitators may be revealed as a result of exploring other components of 
process evaluation such as Participant Experience or Context. For example, one 
qualitative study explored barriers to adoption of a Telecare health system for elderly 
people. A Telecare health system is a remote method of monitoring changed in an 
individual’s environment, for example sensors to detect falls, flooding or gas (Bower 
et al., 2011).  Reasons for study withdrawal included that the intervention was too 
time consuming and that patients missed the routine of their previous treatment. In 
addition, participants described barriers to participation, which were phrased in terms 
of potential threats to their identity, independence and self-care. The study revealed 
therefore that it may be valuable to address such concerns at the beginning of an RCT, 




An intervention may be successful but is not useful if it cannot be translated into 
practice. Researchers should consider the resources needed in order for a programme 
to be adopted long-term. What can the process evaluation tell us about whether this 
might be possible? Identifying the active ingredients that contributed towards the 
success of an intervention is essential if the intervention is to be replicated and 
adopted. For example, the Diabetes Prevention Programme (DPP) was a large RCT 
which tested whether lifestyle intervention or pharmacological therapy would prevent 
or delay the onset of diabetes in people with impaired glucose tolerance (Group, 
2002). The lifestyle intervention was administered to 1,079 participants and was 
highly effective, with a 58% reduction in the incidence of T2D. A key feature of the 
intervention that contributed towards the successful outcome was intensity. Methods 
used included individual lifestyle coaching delivered in 16 x 30 minute sessions over 
24 weeks; behavioural self-management strategies; supervised physical activity with 
free gym membership; adherence strategies; ethnically tailored material and an 
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extensive support, training and feedback network. This intervention was effective but 
was not suitable for direct translation into practice as it was a) resource heavy b) the 
sample was not representative as participants were highly selected and c) the 
intervention was delivered within an expert multi-disciplinary team. The intervention 
was designed for efficacy and not community implementation (Ackermann & 
Marrero, 2007; Garfield et al., 2003). However, NHS England is currently rolling out 
a version of the DPP called ‘Healthier You’ as a pilot digital phase. Up to 5000 
patients with non-diabetic hyperglycaemia will be recruited over 6 months and 
offered access to digital interventions for 12 months. Digital intervention strategies 
include wearable exercise monitors; health coaching apps; online peer support groups 
and the ability to monitor and set goals electronically. Online self-monitoring may 
have the same impact as face to face interventions (NHS England, 2018).  
 
Process Evaluation Methodology  
 
A process evaluation assesses multiple components, using multiple methodologies, 
which may be quantitative and qualitative. Process evaluation research has evolved, 
moving from the use of occasional qualitative methods after the conduct of RCTs 
(Lewin, Glenton, & Oxman, 2009) to the use of mixed methods, and there is 
increasing evidence that the use of both quantitative and qualitative methods together 
can facilitate deeper understanding (Curry, Nembhard, & Bradley, 2009; O'Cathain et 
al., 2007; Snowdon, 2015).  
 
The use of multiple methodologies in research is often termed ‘triangulation’ 
(Campbell & Fiske, 1959; Jick, 1979) referring to a method of cross validation, where 
sets of results using different methods are found to be congruent, yielding comparable 
data. Triangulation can be used to evaluate complex interventions via the use of both 
quantitative and qualitative methods. For example, when exploring the reasons why a 
psychological intervention did not work, it may be noted by observers of therapist 
training that some therapists appear less confident than others, and this finding may 
be corroborated by a questionnaire which reveals that self-efficacy among those 
therapists is low, providing a more nuanced and hopeful interpretation of the observed 
findings. The use of mixed methods is therefore an important feature of process 
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evaluation, and wherever possible, both quantitative and qualitative methodologies 
should be used. This is in line with the current view that quantitative and qualitative 
methods can be complementary rather than rival sets of methodologies, since a greater 
number of viewpoints allows for greater accuracy of results (Jick, 1979). The use of 
multiple methods however does not mean that the data must be synthesised, but rather 
that it should be used to build a more complete picture. There is much debate about 
the advantages and disadvantages of attempting to combine data collected using 
quantitative and qualitative methods however and some researchers suggest that these 
two paradigms may be more useful as complementary perspectives, rather than in 
combination (Sale, Lohfeld, & Brazil, 2002). In the following section, a description of 
methodological approaches to process evaluation is given.  These methods are 






















Table 3.3: Proposed Summary of Dimensions and Methodologies to Consider in a 









Mapping of theory to 
intervention 
Feasibility study  Literature review  
Ethnography  
Intervention mapping  
Acceptability and 
Social Validity 
Establishing feasibility and 
acceptability of the 
intervention from potential 






Recruitment How may the recruitment 
process selected cause 
participation bias?   
Feasibility study  Literature review 
 
Dose Delivered The amount of 
intervention delivered to 
participants.  
Checklist records of 
dose delivered  
Structured observation  
Audiotapes of sessions 
Dose Received The amount of 
intervention received by 
participants.  
Behavioural coding 
systems e.g. MITI 
Questionnaire 
Structured observation 
Virtual monitoring e.g. 
digital feedback 









The extent to which the 
intervention was delivered 
as intended.  
Behavioural coding 
systems e.g. MITI 
Questionnaires 
Structured observation 
Audiotapes of sessions 
Observational study  
Contamination The extent to which the 
intervention was 
contaminated by other 
sources, or the extent to 
which the control group 
received the intervention.  
Randomised controlled 
trial design  
Interview 
Focus group 
Observational study  
Provider 
Experience 






The experience of 
participants. 
Questionnaire  Interview 
Focus group  
Context The wider organisational 
and societal context that 
the intervention is taking 
place within.  
Local policy checklists  
Service use data  
Ethnography  
Interview 
Focus group  
Policy review  
Observational study  
Barriers and 
Facilitators 
Aspects of implementation 
that hindered or 
contributed to the success 
of the intervention.  
Statistical analysis  
Questionnaire 
Interview  
Focus group  
Observational study  
Adoption Considerations of the 
potential for long-term 
implementation of the 
intervention as a result of 
the process evaluation. 





Synthesis or comparison 





Quantitative Measures Used in Process Evaluation 
 
A well-designed process evaluation framework should encompass both quantitative 
and qualitative methods.  
 
1. Treatment Satisfaction Using Structured Questionnaires 
 
Structured questionnaires may be self-report or administered by a researcher. Their 
advantage is that they are simple to use, cheap and convenient. However, self-report 
questionnaires in particular may be subject to social desirability bias (Van de Mortel, 
2008) whereby people choose to present a favourable image of themselves rather than 
provide a true response in order to please the therapist and researchers. This may also 
apply in the case of self-report rating scales for therapists delivering a psychological 
intervention, whereby the participant may be reluctant to indicate that the therapists 
did not perform a task as expected. They are therefore unreliable reporters of their 
own behaviour and that of their therapists. Questionnaires may also be used to explore 
the amount of an intervention received by participants. For example, a therapist may 
report that an intervention dose has been delivered as intended, but a participant 
questionnaire may indicate that the intervention dose was not received, for example if 
a patient is asked whether they completed homework set for a CBT session. If 
possible, established reliable and valid measures should be used, and where new 
measures are devised for the purposes of the research their psychometric properties 
need to be optimised before use. 
 
 
2. Fidelity Using Behavioural Coding Systems  
 
Coding of behaviour is the gold standard measurement for rating fidelity of 
implementation of psychological interventions. A sample of audiotaped intervention 
sessions may be selected and rated using a behavioural coding system such as the 
MITI (Moyers et al., 2005a) designed to measure fidelity to the practice of 
motivational interviewing or the Behaviour Change Counselling Index (BECCI) 
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(Lane et al., 2005) designed to measure fidelity to the practice of CBT. These data can 
be used to identify how much of the intervention was delivered as planned and 
identify mechanisms for change. Advantages of these coding systems include that 
they are useful in clinical settings where rigour in supervision and evaluation is 
needed and the fact that they measure specific clinician behaviours. Another 
advantage of the MITI is the rating of clinician empathy, a core characteristic of MI. 
The MITI has also demonstrated acceptable psychometric properties across a variety 
of research settings (Campbell et al., 2009) (Martino, Ball, Nich, Frankforter, & 
Carroll, 2008) (Turrisi et al., 2009). A disadvantage of these systems is that rating 
remains subjective, although this problem can be addressed via the assessment of 
inter-rater reliability. The systems are also useful where it is inappropriate for an 
observer to be present during the intervention session.  
 
Structured observation may also be used. Intervention sessions are observed by a 
trained rater who records data on intervention delivery using a structured coding form. 
A disadvantage of this method is the Hawthorne Effect, or the fact that participants 
will alter their behaviour as a result of the knowledge that they are being observed 
(McCarney et al., 2007). This is not likely in the case of observing therapists 
however, as if they have not reached competence prior to observation, they are 
unlikely to do so simply as a result of being observed. Observation also has the 
potential to improve therapists’ performance. This method may be inappropriate in 
the case of one-on-one sessions, where the presence of an observer may alter the 
therapeutic alliance and introduce a measurement bias.  
 
 
3. Assessing Dose Delivered, Dose Received and Recruitment with Secondary 
Analysis of Routine Data 
 
Secondary analysis of routine data may include, for example, the analysis of service 
use records, which can be used to measure Dose Delivered and Dose Received. An 
advantage of using such data is that it avoids potential bias and also has the benefit of 
providing a large amount of data at no extra cost. Reliability and validity of the data is 
a concern however, since it is not always possible to ascertain by whom and under 
what circumstances the data were collected. Examples of secondary service use data 
 
95 
may include records of patient attendance at appointments; pharmacy prescription 
data; GP routine data such as that collected for Quality and Outcomes Framework 
(QoF) (Calvert, Shankar, McManus, Lester, & Freemantle, 2009); hospital bed 
utilisation data; vaccination records and other electronic health records or ‘big health 
care data’ (Schneeweiss, 2014).  
 
Qualitative Measures Used in Process Evaluation  
 
1. Intervention Mapping  
 
Intervention mapping relates to the mapping of theoretical constructs onto active 
components of the intervention. All interventions are ‘theories incarnate’ (Pawson et 
al., 2005) in that they represent a combination of beliefs about theory that the actions 
of the intervention will lead to the desired outcome. Each theoretical construct should 
be identified and specified clearly, mapped onto a component of the intervention and 
plans for evaluation made accordingly. An example of an intervention that has been 
mapped onto a theoretical model is MI, which is based on the Transtheoretical Model 
of Change (Prochaska & DiClemente, 1982) (DiClemente & Prochaska, 1998). This 
biopsychosocial model conceptualises the process of intentional behaviour change. It 
integrates key constructs from other behaviour change theories into a wider model of 
health behaviour change. The model posits 6 core constructs that represent different 
stages of change including (i) Precontemplation (no intention to take action within the 
next 6 months) (ii) Contemplation (intend to take action within the next 6 months) 
(iii) Preparation (intends to take action within the next 30 days and has taken some 
behavioural steps towards this action) (iv) Action (changed overt behaviour for less 
than 6 months) (v) Maintenance (changed overt behaviour for more than 6 months) 
(vi) Termination (no temptation to relapse and 100% confidence). Stages of change 
may occur in linear sequence although non-linear progression and regression to 
former stages is also common. The model has been criticised for its inability to 
capture the complexity of health behaviours. For example physical activity is not a 
single behaviour but a category of different specific actions including leisure, work 
and sport activities. People may hold different beliefs about self-efficacy for example 
in relation to these different categories of activity (Brug et al., 2004). A further 
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criticism includes the fact that the stages are based on arbitrary time periods, which 
has implications for matching the theory to an intervention such as MI. For example, 
a smoker who plans to stop smoking is in the preparation stage if this is within the 
next 30 days (provided they have made a quit attempt that lasted 24 hours in the past 
12 months) but only the contemplation stage if it is in 31 days’ time. If the stages are 
not qualitatively distinct, there is no reason to predict that different factors will 
influence different stage transitions (Sutton, 2001). The model also ignores the 
formation of habit through systems of punishment and reward. These are processes 
which operate outside of conscious awareness and therefore do not follow the 
conscious decision-making process outlined in The Transtheoretical Model 
(Robinson, 2003). Finally, a major flaw of the model is the lack of evidence to 
support it and studies have shown that the model is no better at predicting behaviour 
than a question which asks, ‘are you planning to change your behaviour?’ (Abrams, 
Herzog, Emmons, & Linnan, 2000).  
 
There is now general consensus that MI lacks a coherent theoretical underpinning. It 
was not derived from theory but arose from principles underlying intuitive clinical 
practice (Hettema, Steele, & Miller, 2005). However, several additional theoretical 
influences contributed to its development including (i) Rogers’ Client Centred 
Counselling where the main agent of change is the therapist rather than a specific 
treatment method (Rogers, 1951) (ii) Cognitive Dissonance Theory which describes 
the discomfort that results from an incompatibility between two currently held 
cognitions or a belief and a behaviour (Festinger, 1962) (iii) the Theory of 
Psychological Resistance which holds that a threat to, or loss of a freedom, motivates 
the individual to restore (or maintain) that freedom (Brehm, 1966) and (iv) Bandura’s 
concept of self-efficacy which is the belief that one is capable of achieving desired 
goals (Bandura, 2011). More recently, Self Determination Theory has been proposed 
as an alternative theoretical rationale for an enhanced understanding of the 
mechanisms of MI. The foundation of the theory is that people have a natural 
curiosity about the world and a desire to better themselves. The theory proposes that 
behaviours lie along a continuum of autonomy, which reflects the extent to which a 
person is committed to a behaviour. The MI practitioner supports the person to 




A related method for specifying the proposed active ingredients of a complex 
intervention is Behaviour Change Technique (BCT) Taxonomy (Michie et al., 2013). 
This consensually agreed hierarchical taxonomy of techniques may be used at the 
Formative Evaluation stage. The taxonomy consists of 93 distinct BCTs, which were 
agreed by expert consensus. Work is currently being undertaken to link the taxonomy 
to theoretical underpinnings of complex interventions (Michie, 2016).  
 
2. Focus Groups or Group Interviews  
 
Focus groups and group interviews gather large amounts of data in one session, which 
can give insights into the range and diversity of participants’ attitudes, experiences 
and feelings in an efficient manner. It may also reveal group complexities or the 
intricacies of group dynamics. However, there is the potential for participants to be 
influenced by one another and to change their views according to social desirability 
and suggestibility depending on their personality types. The data collected are also 
limited to the topic guide and skills of the interviewer’s coding and interpreting. Some 
participants may also be more dominant or reserved than others, limiting their 
potential. This may lead to a bias where the views of some participants are under 
represented. These data also need to be collected soon after the intervention has been 
administered to participants in order to ensure maximum recall of information. While 
the interview is an efficient use of patient and researcher time, analysing and 
interpreting the data is time consuming and vulnerable to researcher biases too.  
 
3. Semi Structured Interviews 
 
Individual interviews with participants or providers offer an opportunity to collect 
some of the most in depth and valuable data. They allow for the researcher to explore 
an individual’s experience of an intervention and offer great flexibility, particularly 
where interviews are semi structured, with open ended questions which allow for 
follow up prompting and probing.  They are particularly useful when there is a 
concern that a group situation may prevent a respondent from providing a truthful 
answer. They may also be used prior to the commencement of an RCT as part of 
consultation with stakeholders and programme interventionists to provide valuable 
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data on feasibility and acceptability. Despite these advantages however, they can be 
time consuming and costly as a large amount of data must be collected and analysed.  
 
4. Unstructured Observation  
 
This differs from quantitative structured observation in that the observer does not 
make use of a checklist or rating scale with which to record observed behaviour. 
Observers may make field notes about the process of training therapists in a new 
psychological intervention, for example, or they may be gatekeepers such as 
employers who have observed the impact of a new referral system on the structure 
and dynamic within their organisation. A further example may be the observations of 
regional policy makers or coordinators who are able to make broader observations. A 
disadvantage of this method is that ratings are subjective.  
 
5. Ethnography  
 
Ethnography is a methodology that allows the observation of participants in a natural, 
real world setting. The aim of the method is to collect data in as natural a setting as 
possible, as people go about their day-to-day lives. An example of this may include 
observing a stroke unit, and may include real time data collection from one 
participant, or with several of their colleagues. This method may be most appropriate 
at the feasibility stage of a process evaluation, where it can provide insight into the 
real world setting in which an intervention will potentially be implemented.  
 
A summary of the 12 process evaluation components, their definitions and matching 
quantitative and qualitative methodologies can be found in Table 3.3. A checklist for 
researchers designing a process evaluation can be seen in Figure 3.6. 
 
Systematic Review (Quantitative or Qualitative) 
 
A systematic review may be either quantitative or qualitative and aims to answer a 
specific research question by systematically identifying, selecting and critically 
appraising all research within a specified area. It is used prior to the RCT to provide 
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an overview of the field of study and help identify gaps in the literature. There is well 
established guidance for conducting these reviews, including the PRISMA statement 
(Preferred Reporting Items of Systematic Reviews and Meta-Analyses) (Moher, 
Liberati, Tetzlaff, Altman, & Group, 2009) . PRISMA is an evidence based minimum 
set of items for reporting in systematic reviews and meta-analyses. It comprises a 
checklist and flow diagram, which delineate clear steps and requirements for 
researchers undertaking a review of RCTs.  
 
Qualitative systematic reviews are less common but their presence in the literature is 
growing, with the first qualitative systematic review published in The Cochrane 
Database in November 2013 (Gülmezoglu, Chandler, Shepperd, & Pantoja, 2013). 
Guidance on synthesising quantitative and qualitative data has since been published 
(Siddaway, Wood, & Hedges, 2019)
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Figure 3.6: Process Evaluation: A Proposed Checklist for Researchers  
 
Process Evaluation Component  Question                                                  Completed 
 
1a: Formative Process Evaluation  How do theoretical constructs                           




1b: Assess Acceptability/Social Validity   Is the proposed intervention  
                                                                    feasible and acceptable to potential  




1c: Recruitment How will strategies used to  
                                                                  recruit participants potentially  




2a: Dose Delivered How much of the intervention  
                                                                  was delivered to participants  












2b: Dose Received How much of the intervention  




2c: Fidelity of Implementation How far did the therapist  
                                                                  implement the intervention  




3e: Contamination  Was there contamination  




3b: Provider Experience What can be learned from the  





3a: Participant Experience  What can be learned from the  




3c: Context What can be learned from  
                                                                  exploration of the environmental  






3d: Barriers and Facilitators  What were the barriers and  
                                                                   facilitators to intervention  






3f: Adoption What can the process evaluation  
                                                                   tell us about whether a programme  
                                                                   can be adopted long-term? 
   





Strengths and Limitations of Scoping Study and Framework Development  
 
The scoping study, which summarised the history of the field, established the most 
commonly used frameworks, identified overlapping concepts and gaps in the field 
was informative as it identified recurrent themes for conducting process evaluation 
which could be synthesised into a proposed framework. A more comprehensive 
systematic review was attempted but for reasons of complexity described earlier in 
this chapter, was not feasible.  
The advantage of this scoping study is that a broad range of evidence was summarised 
and synthesised in a way that would not have been possible with a tightly defined set 
of criteria. This is an appropriate method for summarising an emerging area of 
literature where data cannot be standardised and synthesised in the conventional 
methods required for formal systematic review. 
While a scoping study provides a broad overview of a poorly defined area of research, 
it is likely that this approach excludes studies of interest to this thesis. Studies were 
only included if the authors explicitly stated that they were carrying out a process 
evaluation, and it is likely that some studies of interest do not. The field of process 
evaluation, while under developed in relation to psychological interventions, may be 
better developed in areas such as occupational psychology. For example, a systematic 
review of studies focusing on individual or organisational level workplace stress 
management identified 84 studies which met inclusion criteria, although the authors 
concluded that fewer than half the studies presented any findings linking process 
evaluation and outcome evaluation, suggesting that incomplete reporting of process 
evaluations to a replicable level is a widespread problem (Murta, Sanderson, & 
Oldenburg, 2007).   
 
Further limitations include a lack of detailed methodological steps, which would 
allow the scoping study and development of the framework to be replicated. There are 
no clear standardised methods for conducting a scoping study, which leaves methods 
open to researcher interpretation. The data from a scoping study has to be interpreted 
without an assessment of quality as would occur in a systematic review.  
 
A strength of this study is that the framework was developed based on theoretical 
constructs, which can be translated into research questions. The role of theory is 
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crucial in enhancing explanatory power and predictive capability (Green, 2000). 
These theoretical concepts were used to underpin a checklist which can be used in a 
pragmatic way, in addition to the CONSORT statement for the design and conduct of 
RCTs and which has potential for other applications beyond the RCT, such as 
application to non-randomised studies, interventions which are already in routine use 
and quality improvement studies. These potential applications are discussed further in 
Chapter 9.  
 
Summary and Conclusions 
 
The concept of process evaluation originated in the 1980’s in the community health 
intervention context. Psychological interventions are also type of complex 
intervention. Its methodological developments have been haphazard and although 
several attempts have been made to increase the awareness of the concept of process 
evaluation, it remains a poorly developed field. In more recent years, there have been 
attempts to describe the concept more fully, such as by the MRC, although the 
guidance remains theoretical.  
 
Existing process evaluation frameworks, although representing important 
advancement of the field, are limited in their definition and depth of clarification of 
process evaluation components, with significant overlap, a lack of clear guidance for 
researchers wishing to conduct a process evaluation, including potential 
methodologies, and failure to account for the complexity of interventions due to 
reliance too heavily on either quantitative or qualitative measurement.  
 
Derived from scoping the literature, twelve components of process evaluation are 
proposed. This is based on the themes that continuously emerge from theoretical 
discussions in the literature and should therefore be studied when testing a new, 
complex, psychological intervention. These components include Formative 
Evaluation; Acceptability and Social Validity; Recruitment; Dose Delivered; Dose 
Received; Programme Implementation/Fidelity; Contamination; Provider 
Experience; Participant Experience; Context; Barriers and Facilitators; and 
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Adoption. A range of (not exclusive) potential methodologies that can be used to 
study each component and a checklist for researchers is provided.  
 
The next chapter will review the literature on process evaluations used to evaluate 




































Chapter 4: Literature Review  
 
Chapter Summary  
 
Chapter 3 outlined the purpose and importance of process evaluations of 
psychological interventions. The history of the field was described, including 
frameworks designed to aid researchers conducting process evaluations. A new 
framework was outlined, comprised of 12 processes that could be evaluated to 
understand the mechanisms of action of a psychological intervention. Quantitative 
and qualitative methods that could be used to measure the processes were described.  
 
This chapter reviews RCTs of psychological interventions in T2D, describing the 
processes measured and the methods used to evaluate them. The process evaluation 
components identified and synthesised as a framework in Chapter 3 are used to 




1. To identify all studies reporting a process evaluation of an RCT of a psychological 
intervention to improve glycaemic control and other biomedical outcomes in T2D 
2. To identify and describe the process evaluation components studied  
3. To identify and describe the methods used to conduct the process evaluations. 
4. To synthesise the range of process evaluation components and methods in order to 
identify any common or recurrent processes and methods.  
5. To identify gaps in conducting process evaluation of psychological interventions 







Studies were identified in two phases, outlined in detail below. Phase 1 identified 
RCTs published 1966 – 2003. Phase 2 identified RCTs published 2003 -2016. All 
RCTs identified from both reviews are included in this review.   
 
Phase 1:  Studies were identified from a previously published systematic review and 
meta-analysis of RCTs of psychological interventions to improve glycaemic control 
in T2D originally led by my supervisors (Ismail et al., 2004). This work represented 
an important advance on previous systematic reviews in the area, which did not fully 
distinguish between: educational and psychological interventions; T1D and T2D; or 
randomised and non-randomised trials (Brown, 1992; Griffin, Kinmonth, Skinner, & 
Kelly, 1999; Meca, Rodriguez, & Alcazar, 1998; Norris, Engelgau, & Narayan, 2001; 
Snoek & Skinner, 2002).  
 
The protocol for the study was peer reviewed and published in the Cochrane Database 
of Systematic Reviews (Cochrane Collaboration, 2017), and QUORUM (Quality of 
Reporting of Meta-analyses) guidelines were followed (David, Cook Deborah, Susan, 
Ingram, & Drummond, 1994) . Studies were identified via search of Medline, 
PsychINFO, EMBASE, and the Cochrane Central Register of Controlled Trials. The 
search strategy is provided in Appendix 1. Studies were eligible for inclusion if they 
were RCTs of a psychological intervention, for adult (18 years or older) patients with 
a diagnosis of T2D. Studies that did not explicitly label their method of intervention 
were included if they described one or more psychological techniques, which could be 
coded into one of the following categories: supportive or counseling therapy; CBT; 
brief psychodynamic psychotherapy or interpersonal psychotherapy. The criteria 
defining a psychological intervention were (i) reliance on communication using a 
therapeutic alliance between patient and therapist (ii) they were facilitated by a 
trained professional e.g. psychologist, psychotherapist, therapist in training or other 
trained professional supervised by a clinical psychologist or therapist (iii) the 
intervention was based on a psychological theory or model (iv) the intervention aimed 
to improve outcome in emotional, cognitive, and behavioural functioning, including 
adherence. Main outcome measures were long-term glycaemic control as measured by 
HbA1c. Secondary outcomes were body weight and psychological distress. Of the 25 
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RCTs identified, 12 were suitable for meta-analysis, which found that psychological 
therapies resulted in significantly better glycaemic control. This approximated to an 
absolute difference of 0.76% in HbA1c. However, ambiguous or vague descriptions 
of psychological interventions resulted in conclusions that the type of therapy that 
was most effective, and for which subgroup of patients, remained unclear.  
 
Phase 2: Studies published were identified by the same methods as Phase 1. This 
review was conducted and led by the student’s supervisors (KI and KW) and funded 
by an NIHR Health Technology Assessment grant from 01/01/2016 – 31/12/2017. 
Databases searched included CENTRAL, CINAHL, Embase, Medline, PsychINFO 
and Web of Science. RCTs were considered eligible for inclusion if they recruited 
participants with T2D and evaluated a psychological therapy designed to improve 
diabetes control. This work represents an important update to the previous review, 
because it used exactly the same methodology as the phase 1 review, which remains 
the most robust and comprehensive review of the impact of psychological therapies 




Studies included in the review for this thesis were defined as having conducted a 
process evaluation if the authors had either (i) stated they were conducting a process 
evaluation or process measures; (ii) carried out measures labeled with widely used 
process evaluation terminology e.g. ‘dose received’; (iii) assessed a contextual 
component of the intervention such as participant or provider experience. However, as 
the construct of process evaluation was not widely understood or described until the 
past 5 years or so, we included studies that described a process measure even if it had 
not been defined as such, based on the assumption that the researchers had conducted 
the analysis ‘in the spirit of process evaluation’. For example, a study may have 
measured fidelity of the intervention, but fidelity was not labelled as part of a process 
evaluation. In cases where methods or terminology were unclear, or process 
evaluation data were not reported, individual authors were contacted for clarification. 
An attempt to contact 56 authors was made, which yielded 5 responses (2 authors 
reported that no process evaluation was conducted, 2 authors reported no awareness 
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of process evaluation and 1 author responded with additional contact details, which 
did not yield a response). Trials were excluded if the article was not published in 
English. 
 
Papers were searched for mentions of process evaluation or process evaluation 
measures which were conducted parallel to the RCT. Process evaluation papers were 
located by searching relevant online databases. If the authors had assessed a 
contextual component of the intervention such as participant or provider experience 
but not explicitly stated this was part of a process evaluation, searches of relevant 




Seventy-three RCTs were identified. Three were immediately excluded, as they were 
not reported in English, leaving 70 RCTs eligible for final review. Twenty-one RCTs 
were identified in Phase 1 and 49 RCTs in Phase 2. The number of studies that did 
and did not carry out process evaluations is detailed in the flow chart (Figure 4.1). 
The aims and extent of process evaluations conducted, if any, are summarised in 
Table 4.1. Of 70 trials identified, only 14 (20%) conducted any process evaluation 
(Adolfsson, Walker-Engström, Smide, & Wikblad, 2007; Blackberry et al., 2013; 
Campbell et al., 1996; Gabbay et al., 2013; Goode, Winkler, Reeves, & Eakin, 2015; 
Hill-Briggs et al., 2011; Jansink et al., 2013; Keogh et al., 2011; McKay, King, Eakin, 
Seeley, & Glasgow, 2001; Melkus et al., 2010; Moriyama et al., 2009; Pibernik-
Okanovic, Begic, Ajdukovic, Andrijasevic, & Metelko, 2009; Waker, 2012; West, 
DiLillo, Bursac, Gore, & Greene, 2007). The components of process evaluation 
studied and the methods used are summarised in Tables 4.2 and 4.3 respectively. In 8 
studies (61.5%) process evaluations were reported as part of the main RCT paper or 
thesis (Campbell et al., 1996; Hill-Briggs et al., 2011; Keogh et al., 2011; McKay et 
al., 2001; Melkus et al., 2010; Moriyama et al., 2009; Waker, 2012; West et al., 
2007). The results of 2 process evaluations (16%) remain unpublished and therefore 
are not reported and 4 studies (29%) published process evaluation data as parallel 
studies (one of those published data as 2 separate papers) (Adolfsson et al., 2007; 
Jansink et al., 2013; Pibernik-Okanovic et al., 2009) (Adolfsson, Starrin, Smide, & 
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Wikblad, 2008; Adolfsson et al., 2007; Blackberry et al., 2013; Dellasega, Añel-
Tiangco, & Gabbay, 2012; Furler et al., 2008; Gabbay et al., 2013; Goode et al., 2015; 
Walker et al., 2011).  
 
Just 2 studies (Blackberry et al., 2013; Keogh et al., 2011) explicitly stated that the 
authors had conducted a process evaluation, while 3 studies (Campbell et al., 1996; 
McKay et al., 2001; West et al., 2007) reported ‘process measures’. The remaining 9 













Table 4.1: Process Evaluations of Randomised Controlled Trials of Psychological Interventions to Improve Glycaemic Outcome in 
Patients with Type 2 Diabetes. Phase 1 (1966-2003) and phase 2 (2003-2016) 
Authors, year, 
country, reference  
Authors, year, 
country, 




Model and duration of 
psychological therapy 
in intervention group 
versus control group 
Standardise




Components of PE 
conducted 
Methods used to 
conduct PE 
Rabkin et al, 1983, 
Canada (Rabkin, 
Boyko, Wilson, & 
Streja, 1983) 




HbA1c; skin fold 
thickness; weight loss at 6 
and 12 weeks follow up.  
Group CBT versus 
individual counselling 
(6-9 sessions) for 6 
weeks.  
1.10 (0.43 to 
1.77) 
Not reported.   Not reported.   
Wing et al, 1985, 
USA (Wing, 
Epstein, Nowalk, 
Koeske, & Hagg, 
1985) 






HbA1c; weight; BMI; 
BP; cholesterol at 2, 4, 10 
and 16 months follow up.  
Group CBT for 16 
sessions over 16 weeks, 




Not reported.   Not reported.   
Hartwell et al, 1986, 
USA (Hartwell, 








HbA1c; weight; lipids; 
body fat at 3 months 
follow up; and all of the 
above plus graded 
exercise test at 6 months 
follow up.  
Weekly group CBT for 
10 weeks, versus 
education only control 




Not reported.   Not reported.   
White et al 1986, 
USA (White, 
Carnahan, Nugent, 
Iwaoka, & Dodson, 
1986) 
Not reported.   
 
 
HbA1c, weight at 3 and 6 
months follow up.  
 
 
Group CBT for 6 
months (10 sessions), 
versus advice-education 




Not reported.   Not reported.   
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Table 4.1 continued  
Heitzmann et al 
1987, USA 
(Heitzmann, Kaplan, 







Not reported.   HbA1c; weight; body fat 
at 18 months follow up.  
Group and individual 
CBT for 7 weekly 
sessions versus 
education only control 




Not reported.   Not reported.   
Campbell et al 1990, 
Australia (Campbell 
et al., 1990) 
 
 
Not reported.   Dietary compliance and 
fasting glucose at 1 
month, 3 months and 6 
months follow up.  
Group counseling for 11 
weeks (22 hours, 
staggered) versus 




Not reported.   Not reported.   
Wing et al, 1991, 
USA (Wing, 
Marcus, Epstein, & 
Jawad, 1991) 
 
Not reported.   HbA1c; fasting glucose; 
weight; BMI at week 24, 
28, 40 and 72 week 
follow up.  
Couple therapy (CBT) 
for 20 sessions, versus 




Not reported.   Not reported.   
D’Eramo-Melkus et 








Not reported.   HbA1c; fasting glucose; 
weight at 3 and 6 months 
follow up.  
Group education weight 
reductions intervention 
plus counselling (13 
sessions) or education 
and weight reduction 
intervention alone (12 
sessions) versus 




Not reported.   Not reported.   
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Table 4.1 continued 
Boehm et al 1993, 
USA (Boehmk, 








Not reported.   HbA1c; weight pre and 
post treatment.  
Individual CBT in three 
groups focusing on 
medication adherence, 
behavioural strategies or 
behavioural strategies 
plus instruction, versus 
attention control. 
Treatment period 
average = 12.8 months, 
no. sessions 
unspecified.  
- 0·68 (-1·33 
to -0·03) 
Not reported.   Not reported.   
Lane et al 1993, 
USA (Lane, 
McCaskill, Ross, 
Feinglos, & Surwit, 
1993) 
 
Not reported.   HbA1c, Ghb levels; 
glucose tolerance at 3, 4, 




weekly for 12 months, 
versus education only 




Not reported.   Not reported.   
Campbell et al 1996, 
Australia (Campbell 








in RCT paper.  
HbA1c; BMI; lipids; BP 
at 3, 6 and 12 months.  
Group education, 
individual education, 
individual CBT or 
minimal intervention 
for 12 months (3 initial 
sessions followed by 





Dose delivered; dose 
received  
Checklist of session 
duration; audiotaped 
sample of sessions 
(quantitative ratings)  
Aikens et al, 1997, 




Not reported.   HbA1c; glucose tolerance 
at weeks 1, 9 and 16.  
Group CBT for 6 
sessions over 8 weeks, 
versus usual care 




Not reported.   Not reported.   
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Table 4.1 continued 






Not reported.   HbA1c; fasting glucose; 
stress; anxiety; depression 
pre and post treatment.   
Group CBT for 6 
sessions over 6 weeks, 
versus usual care 




Not reported.   Not reported.   
Jablon et al, 1997, 
USA (Jablon, 
Naliboff, Gilmore, 
& Rosenthal, 1997) 
 
Not reported.   Glucose tolerance; 
fructosamine; HbA1c; 
stress via EMG and EDR 
pre and post treatment.  
Stress reduction training 
for 4 weekly sessions 
versus usual care 





Not reported.   Not reported.   
Smith et al, 1997, 
USA (Smith, 
Heckemeyer, Kratt, 
& Mason, 1997) 
 
 
Not reported.   BMI; fasting glucose; 
treatment adherence at 
baseline and post 
treatment (4 months).  
Weight control 
counselling plus MI 
versus standard weight 
control counselling for 





Not reported.   Not reported.   
Lustman et al 1998, 





Not reported.   HbA1c; depression post 
treatment and at 6 month 
follow up.  
Group CBT and 
education biweekly for 
10 weeks, versus 





Not reported.   Not reported.   
Ridgeway et al, 
1999, USA 
(Ridgeway et al., 
1999) 
 
Not reported.   HbA1c; fasting glucose; 
weight; lipids at 3, 6 and 
12 months follow up.  
Monthly group CBT 
and education for 6 
months versus usual 




Not reported.   Not reported.   
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Table 4.1 continued 
McKay et al 2001, 





in RCT paper.  
HbA1c, physical activity; 
depression at 8-week 
follow up.  
Individual CBT for 8 











with structured and 
unstructured 
components  
Kenardy et al 2002, 
Australia (Kenardy, 
Mensch, Bowen, 
Green, & Walton, 
2002) 
Not reported.   HbA1c, disordered 
eating; psychological 
wellbeing post treatment 
and at 12 week follow up.   
Weekly group CBT for 






Not reported.   Not reported.   
Surwit et al 2002, 
USA (Surwit et al., 
2002) 
Not reported.   HbA1c at 2, 4, 6 and 12 
months follow up.  
Group CBT and 
education for 5 sessions 
over 2 months versus 




Not reported.   Not reported.   
Tsujiuchi et al 2002, 
Japan (Tsujiuchi et 
al., 2002) 
Not reported.   HbA1c; fasting glucose; 
lipids; BP; BMI at pre 
and post treatment.  
Group relaxation/CBT 
weekly for 4 months 





Not reported.   Not reported.   
Clark et al, 2004, 
UK (Clark et al., 
2004)  
(Studies from this 
point forward were 
identified in Phase 
2) 
 
Not reported.   HbA1c; physical activity; 
BMI; dietary behaviour; 
self-care activities at 3 
and 12 months follow up.  
Individual MI (4 in 
person sessions plus 3 





Not reported.   Not reported.   
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Table 4.1 continued 
Keeratiyutawong et 






Not reported.   HbA1c at 3 and 6 months 
follow up.  
Group CBT and 
education for 5 hours 
over 5 months versus 





Not reported.   Not reported.   
Adolfsson et al. 
2007, Sweden 
(Adolfsson et al., 
2007) 
Adolfsson et al. 
2008, Sweden 
(Adolfsson et al., 
2008) 
HbA1c; weight; BMI at 8 
week follow up.  
Empowerment group 
education for 5 sessions 
over 7 months, versus 





patient experience.  
Session records; 
Patient interviews.  
West et al 2007, 





main RCT paper. 
HbA1c; weight; BMI at 6, 
12 and 18 months follow 
up.  
Behavioural weight 
control program for 18 
months with group MI 
over 5 sessions, versus 







Ratings of audiotaped 
sessions using MITI 
French et al, 2008, 





Not reported.   HbA1c, well-being, 
illness and medication 
beliefs, beliefs about 
blood glucose self-
monitoring at 3, 6, 9 and 
12 months.  
Online access to an 8 
week personalized goal 
setting intervention 
versus information only 
control group.   
0.06 
(-0.21-0.34) 
Not reported.   Not reported.   
Moriyama et al, 
2009, Japan 






Reported in main 
RCT paper.  
HbA1c, physiological 
measures associated with 
risk factors at 3, 6, 9 and 
12 months follow up.  
Self-management 
education over 12 
months (monthly 
sessions) versus usual 









ended questionnaire  
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Table 4.1 continued 
Pibernik-Okanovic 
et al, 2009, Croatia 
(Pibernik-Okanovic 






symptoms at 6 and 12 
months follow up.  
Group (4 sessions) and 
individual (2 monthly 
telephone calls) psycho-
educational intervention 
for 12 months versus 










Sacco et al 2009, 
USA (Sacco, 
Malone, Morrison, 
Friedman, & Wells, 
2009) 




depressive symptoms pre 
and post intervention.  
Psycho-educational 
telephone coaching  
(weekly for 3 months 
then bi-weekly for 3 
months) versus usual 




Not reported.   Not reported.   
Stuckey et al 2009, 
USA (Stuckey et al., 
2009) 
Not reported.   HbA1c; lipids; BP, 
cholesterol at 2 weeks, 6 
weeks, 3 months, 6 
months, 12 months, then 
6 monthly.  
Self-management 
education and MI for 2 
years (2 weeks, 6 
weeks, 3 months, 6 
months, 12 months, 
then 6 monthly) versus 




Not reported.   Not reported.   
De Greef et al, 
2010, Belgium (De 
Greef, Deforche, 






Not reported.   HbA1c, physical activity 
at 12 weeks and 1 year 
follow up.  
Cognitive behavioural 
intervention using 
mixed methods for 12 
weeks (5 sessions) plus 
1 booster session, 
versus usual care 




Not reported.   Not reported.   
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Table 4.1 continued 
D'Eramo Melkus et 
al, 2010, USA 




main RCT paper.  
HbA1c; cardiovascular 
risk profile at 3, 6, 9, 12 
and 24 months follow up.  
Cognitive behavioural 
diabetes self-
management and coping 
skills training for 12 
months (11 weekly 
group sessions) versus 






fidelity; barriers and 
facilitators  
Session records; 
Trainer observation of 
CBT delivery; open-
ended questionnaire  
Heisler et al, 2010, 
USA (Heisler, 
Vijan, Makki, & 
Piette, 2010) 
 
Not reported.   HbA1c at 6 month follow 
up.  
Weekly reciprocal peer 
support for 6 months 
versus enhanced usual 




Not reported.   Not reported.   
Pourisharif et al 
2010, Iran 
(Pourisharif et al., 
2010)  
Not reported.   BMI and HbA1c 9 weeks 
post intervention.  
Cognitive behavioural 
group training and MI 
for 4 sessions versus no 




Not reported.   Not reported.   
Shi et al, 2010, 
China (Shi, 




Not reported.   HbA1c and self-efficacy 
at 1 and 4 months follow 
up.  
 
Weekly education and 
self-efficacy promotion 
for 4 weeks versus 





Not reported.   Not reported.   
Wolever et al, 2010, 




Not reported.   Exercise and medication 
adherence; psychological 
functioning; HbA1c at 
post treatment follow up. 
Integrative Health 
Coaching for 14 
sessions over 6 months 
versus usual care 




Not reported.   Not reported.   
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Table 4.1 continued 
Osborn et al, 2010, 








Not reported.   Food label reading; 
dietary adherence; 
physical activity; HbA1c 
immediately post 
intervention and 3 months 
post intervention.  
MI for 3 90-minute 
sessions versus usual 




Not reported.   Not reported.   
Castelnuovo et al 
2011, Italy 







Not reported.   HbA1c, weight at 
discharge from hospital 
then 3, 6 and 12 months 
follow up.  
Nutritional counselling, 
CBT and physical 
activity training for 12 
months (1 month 
inpatient programme 
followed by internet 
based resources) versus 





Not reported.   Not reported.   
De Greef et al, 
2011, Belgium (De 
Greef, Deforche, 










Not reported.   HBA1c, physical activity 
at 12 weeks follow up.  
Multiple behaviour 
change techniques 
including CBT and MI 
for 12 weeks (3 x 90 
minute sessions). 
Delivered individually 
or in groups versus no 




Not reported.   Not reported.   
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Table 4.1 continued 
Hill-Briggs et al, 
2011, USA (Hill-









in main RCT 
paper.  
HbA1c; BP; cholesterol 
post intervention and 3 
months post intervention 
follow up.  
Intensive education and 
problem solving self-
management training  (9 
sessions) or condensed 
problem solving and 
education training (2 
sessions) versus no 















Keogh et al 2011, 
Ireland (Keogh et 
al., 2011) 





reported in main 
RCT paper 






at 6 month follow up.   
MI for 3 weekly 
sessions versus usual 




Dose delivered and 
received; fidelity; 





quantitative analysis of 
tapes using checklists; 
open-ended 
questionnaire; focus 
group; field notes 
Lamers et al 2011, 
Netherlands 
(Lamers, Jonkers Cc 
Fau - Bosma, 
Bosma H Fau - 
Knottnerus, 
Knottnerus Ja Fau - 





Not reported.   HbA1c (collected from 
GP records); disease 
related quality of life at 1 




intervention for an 
average of four sessions 
versus usual care 




Not reported.   Not reported.   
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Table 4.1 continued 
Piette et al, 2011, 







Not reported.   HbA1c at 12 month 
follow up.  
Telephone delivered 
weekly CBT for 12 
weeks, plus 9 booster 
sessions (12 months in 
total), versus enhanced 




Not reported.   Not reported.   
Welch et al 2011, 






Not reported.   HbA1c at 3 and 6 month 
follow up.  
MI and diabetes self-
management education 
for 4 sessions over 6 
months versus diabetes 
self-management 




Not reported.   Not reported.   
García-Huidobro et 
al 2011, Chile 
(García-Huidobro, 





Not reported.   HbA1c at 6 and 12 month 
follow up.  
Family and individual 
counselling (5 sessions) 
for 12 months, versus 




Not reported.   Not reported.   
Chen et al 2012, 
Taiwan (Chen, 





Not reported.   HbA1c at 3 month follow 
up.  
MI for 1 hour, versus 





Not reported.   Not reported.   
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Table 4.1 continued 
Hartmann et al, 
2012, Germany 
(Hartmann et al., 
2012) 
Not reported.   HbA1c, progression of 
nephropathy post 
treatment and once a year 
for 5 years.   
Mindfulness based 
stress reduction 
intervention once a 
week for 8 weeks, with 
a booster session after 6 





Not reported.   Not reported.   
Penckofer et al 
2012, USA 
(Penckofer et al., 
2012) 
Not reported.   HbA1c, depression at 3 
and 6 months follow up.  
CBT weekly for 8 
weeks plus 2 booster 
sessions, versus no 




Not reported.   Not reported.   





Published as part 
of thesis.  
HbA1c and self 
management behaviours  
post treatment and 3 
month follow up.  
MI for two 60 minute 
sessions versus usual 








Session data; Rating of 
audiotaped sessions 
using MITI; structured 
and open-ended 
questionnaire  
Blackberry et al 
2013, Australia 












Furler et al, 





HbA1c at 18 months.   Educational and 
empowerment based 
‘telephone coaching’ for 
15 months (9 sessions), 









Session data; focus 
groups exploring the 




Walker et al, 
2011, Australia 
(Walker et al., 
2011) 
HbA1c at 18 months.   Educational and 
empowerment based 
‘telephone coaching’ for 
15 months (9 sessions), 
versus usual care 
control. 





experience   
Random sample of 
sessions recorded and 
analysed qualitatively; 
research staff field 
notes; interviews and 
focus groups with 




Table 4.1 continued 
Gabbay et al 2013, 








Dellasega et al, 
2012, USA 
(Dellasega et al., 
2012) 
HbA1c at 2 year follow 
up.   
MI for two years (8 
sessions), versus usual 











rated using BECCI and 
other reviewer; focus 
groups with patients to 
determine acceptability 
of MI.  
Jansink et al, 2013, 
The Netherlands 







HbA1c; diet; physical 
activity at 14 months 
follow up.  
Education, lifestyle 
counselling and MI for 
14 months versus usual 








Session data; follow up 
meeting/focus group 
post intervention. 








Not reported.   HbA1C; fasting glucose; 
lipid profile; 
albumin/creatinine ratio; 
BMI and blood pressure 
at 12 month follow up. 
 
Education and 
counseling for 4 
sessions over 12 months 





Not reported.   Not reported.   
Safren et al 2013, 







Not reported.   HbA1c, medication 
adherence; depression at 
12 month follow up.  
CBT for 12 months (9-
12 sessions) versus 





Not reported.   Not reported.   
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Table 4.1 continued 
Trief et al, 2013, 
USA (Trief et al., 
2013) 
 
Not reported.   Medication adherence; 
HbA1c at yearly follow 
up for 5 years.  
Education and goal 
setting by video phone, 
every 5-6 weeks for 5 
years, versus usual care 




Not reported.   Not reported.   
Welschen 2013, The 
Netherlands 
(Welschen et al., 
2013) 
 
Not reported.   HbA1c, CHD risk at 6 
and 12 months follow up.  
CBT for 6 sessions over 
6 months versus usual 




Not reported.   Not reported.   
Plotnikoff et al 
2013, Australia 
(Plotnikoff et al., 
2013) 
Not reported.   Physical activity; HbA1c 
at 6, 12 and 18 months.  
Education and 
telephone counseling 
every 3 months for 12 
months versus enhanced 
education versus 





Not reported.   Not reported.   
Chao et al, 2014, 
China (Chao et al., 
2014) 
Not reported.   Fasting glucose at 18 





once a month for 18 
months versus usual 




Not reported.   Not reported.   
Li et al, 2014, China 




Not reported.   HbA1c at 6 months 
follow up.  
Monthly MI for 7 
months versus 





Not reported.   Not reported.   
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Table 4.1 continued 
Lynch et al 2014, 




Not reported.   HbA1c, weight at 6 
months follow up.  
Education, behavioural 
skills training and social 
support for 18 sessions 
plus weekly phone 
calls, versus education 




Not reported.   Not reported.   
Eakin et al, 2014, 
Australia (Eakin et 
al., 2014)  
Goode et al, 
2015 (Goode et 
al., 2015)   
Weight; physical activity; 
HbA1c at 18 and 24 
months.  
MI for 18 months 
(maximum of 27 phone 
calls) versus usual care 





Dose delivered, dose 
received.  
Number of telephone 
counselling calls 
completed.    
Rothschild et al 
2014, USA 




Not reported.   HbA1c at 12 and 24 
months follow up.  
Education and self-
management training 
for 2 years (36 visits) 
versus education only 




Not reported.   Not reported.   
Chlebowy et al 
2014, USA 
(Chlebowy et al., 
2014) 
 
Not reported.   HbA1c; random serum 
glucose; BMI at 3 months 
follow up.  
MI for 3 months (6 
sessions) versus usual 




Not reported.   Not reported.   
Young et al, 2014, 





Not reported.   HbA1c, self-efficacy; 
physical and mental QoL; 
satisfaction with diabetes 
care at 9 months follow 
up.  
MI via video phone for 
5 sessions over 9 
months versus usual 




Not reported.   Not reported.   
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Table 4.1 continued 
Chen et al, 2015, 
Taiwan (Chen, 
Wang, Lin, Hsu, & 
Chen, 2015)  
Not reported.   HbA1c post treatment and 
3 months post treatment 
follow up.  
Empowerment 
programme for 3 
months (monthly visits 
with 3 follow up phone 
calls per month) versus 





Not reported.   Not reported.   





Not reported.   HbA1c; cholesterol at 18 
months follow up.  
Education and MI for 
18 months versus 
adherence information 
group or usual care 




Not reported.   Not reported.   
Browning et al, 
2016, China 
(Browning et al., 
2016) 
Not reported.   HbA1c at 12 months 
follow up.  
MI for 12 months 8 
face-to-face and 8 
telephone sessions) 
versus usual care 




Not reported.   Not reported.   
Huang et al, 2016, 








Not reported.   HbA1c; mental and 
physical QoL; BMI and 
depression at post 
intervention and 3 months 
post intervention follow 
up.  
Mi and CBT for12 
sessions over 3 months 
versus usual care 




Not reported.   Not reported.   
 
128 
Table 4.1 continued 





& Rutten, 2016) 
Not reported.   HbA1c, diabetes related 
distress at 5 months 
follow up.  
Intervention based on 
Social Cognitive 
Theory (Bandura, 2011) 
and Leventhal’s 
Common Sense Model 
(Leventhal et al., 2003) 
for 3 sessions over 2 
months versus an 




Not reported.   Not reported.   
Kim et al 2016, 
USA (Kim et al., 
2016) 
Not reported.   HbA1c; cholesterol; 
lipids at 12 months follow 
up.  
12 sessions of group 
education and self-
management training 
for 12 months plus 4 
counselling sessions 
versus no treatment 




Not reported.   Not reported.   
BMI = Body Mass Index; BP = Blood Pressure; CBT = Cognitive Behavioural Therapy; CHD = Coronary Heart Disease; EDR = Electrodermal Response; EMG 
= Electromyogram; MI = Motivational Interviewing; PE = Process Evaluation; QoL = Quality of Life.  
 








Components of Process Evaluation Reported  
 
The components of process evaluation studied by the RCTs selected for review are 
summarised in Table 4.2.  
 
Just 1 study (Blackberry et al., 2013) conducted a Formative Process Evaluation prior 
to the main RCT. Blackberry et al conducted a prospective, cluster randomised RCT 
in Australia to evaluate the effectiveness of goal focused telephone coaching 
delivered by practice nurses in improving glycaemic control in people with T2D 
(n=473). The unit of cluster was the patient’s GP surgery. Nurses received 2 days 
training in a telephone coaching programme, delivering 8 telephone sessions and 1 
face to face session per patient. At 18 month post-baseline follow up, no significant 
difference was observed between control and intervention groups. Prior to the main 
study, the authors conducted a Formative Process Evaluation underpinned by a 
theoretical framework, using focus groups to explore the role of health professionals 
in encouraging self-management. They concluded that self-management support 
should be part of an ongoing and established relationship between health professional 
and patient, although this approach should be individually tailored (Furler et al., 
2008). However, they did not report how this information informed the future design 
of their RCT. This was the most comprehensive process evaluation of the studies 
reviewed, assessing 6 of the potential 12 process evaluation components outlined in 
Chapter 3. The full process evaluation comprised the pre-trial focus groups exploring 
health professionals’ views on self-management (Formative Evaluation); quantitative 
session data (Dose Delivered); a sample of sessions recorded and rated qualitatively; 
research staff field notes (Dose Received, Fidelity); interviews and focus groups 
(Participant Experience, Provider Experience). The process evaluation revealed the 
complexity of patients’ diabetes management within their social contexts and revealed 
differing styles of intervention delivery among health providers (Walker et al., 2011). 
The analysis of audiotaped sessions enabled the authors to define two styles of 
consultation: ‘treat to target’ and ‘personalized care’, which correspond to directive 
and non-directive approaches. The data revealed how healthcare professionals vary in 
their approaches, which could be included as a variable in future analyses. The data 
provided important information about social context, which can be ignored within a 
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standard RCT. The authors concluded that further research is needed into ‘the 
mechanisms of social context in the way people manage their health.’ These findings 
were particularly important in light of the non-significant outcome.  
 
Data on consultation style also emerged from the process evaluation of an RCT 
conducted by Adolfsson et al (Adolfsson, Smide, Gregeby, Fernström, & Wikblad, 
2004) who tested the efficacy of nurse and physician delivered empowerment group 
education versus usual diabetes care in improving diabetes outcomes among 101 
patients at 7 ‘primary care centres’ in central Sweden. No significant differences were 
found on main outcome measures, although patients’ confidence in diabetes 
knowledge was significantly higher than the control group at 12 months post baseline. 
The researchers conducted semi-structured interviews with patients after treatment to 
investigate Participant Experience and found that two different styles of 
communication emerged from the data. In the usual care group, relationships between 
patient and provider were ‘vertical’, meaning that the provider directed the 
conversation, giving patients instructions about diabetes management, which they 
were expected to follow. By contrast, the intervention group experienced ‘horizontal’ 
interactions, where patient and provider formulated a self-management plan via a 
collaborative process.  
 
Campbell et al conducted a 4 arm RCT comparing the effects of a group education 
program (n=66), an individual education program (n=57), a behavioural program 
(n=59) and a minimal contact program (n=59) on T2D outcomes was conducted in 
Australia (Campbell et al., 1996). The four groups were not differentially effective on 
measures of HbA1c and BMI at 3, 6 and 12 months post-baseline. The authors used 
checklists of attendance sessions to measure Dose Delivered and audiotaped a sample 
of consultations to measure Fidelity, finding that patients adhered to intervention 
protocols. The process evaluation data suggest that the intervention was delivered 
according to protocol and the implication is that the results indicate a true failure of 
the intervention, rather than protocol deviation.  
 
Eakin et al conducted a 2 arm RCT comparing a telephone delivered behavioural 
weight loss intervention targeting primary care T2D patients in Australia with usual 
care (n=78). The inter vention included goal setting, personalised feedback, strategies 
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for overcoming personal barriers and peer support. They observed a moderate 
improvement in physical activity levels in both arms but there were no significant 
between group differences on outcome measures. The authors used records of 
telephone sessions completed to assess Dose delivered and Dose received finding that 
call completion was significantly associated with weight loss but no other outcome 
variables (including physical activity level or HbA1c). Those with a previous 
diagnosis of depression or anxiety were also disproportionately represented in the 
‘low call completion’ group. Mood disorders are often associated with suboptimal 
diabetes control (Lustman et al., 2000). This process evaluation data shows that in 
choosing not to screen out patients with previous diagnoses of depression and anxiety 
contributed to the low call completion rate and therefore the completion of the RCT 
according to protocol.  
 
Waker conducted an RCT to test the efficacy of MI in improving HbA1c and self-
management behaviours among 154 participants with T2D in Cincinnati, US (Waker, 
2012). Patients were recruited from their GP surgery, with those in the intervention 
group receiving 2 usual care and 2 x 60-minute MI sessions (versus 2 usual care 
appointments in the control group). The hypothesis that participants receiving the MI 
intervention would demonstrate significant improvements in HbA1c and self-
management behavioural outcomes was not supported. Fidelity was assessed using a 
random sample of audiotaped intervention sessions, rated using the MITI. The 
intervention was delivered according to protocol. These results show that the failure 
of the intervention is likely attributable to the intervention design, rather than protocol 
deviation. Intervention group participants also completed an acceptability 
questionnaire providing responses on a 7-point Likert scale, assessing Participant 
Experience. Participants rated the intervention as acceptable and helpful (mean 6.07 
for acceptability and 5.23 for helpfulness). Participants also made suggestions for 
improvement, expressing the desire for more MI sessions, more frequent sessions and 
group sessions. Since participants were only offered 2 sessions of MI, these data 
suggest that increasing the amount of sessions may improve outcome.  
 
D’Eramo Melkus et al tested the efficacy of a 10-week diabetes self-management and 
coping skills intervention versus usual education and diabetes care on physiological 
and psychosocial outcomes in 109 African American women with T2D in primary 
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care. Findings suggested that the combination of diabetes self-management and 
coping skills may lead to improvements in metabolic control. They observed 
significant improvements in HbA1c in both groups at 3 months, and these changes 
were sustained at 12 and 24 months follow up. The authors collected data on Dose 
Delivered and Barriers and Facilitators to participation in the study. The quantitative 
data revealed that participants who didn’t attend sessions had lower levels of 
education and income and were less likely to be working. They also had poorer 
quality of life (QoL) in all domains. This data may be used to inform the design of 
future interventions, which could provide more intensive or individualised care for 
those who need it. Qualitative data focusing on Barriers and Facilitators established 
specific reasons for non-attendance, including stressful life events such as the death of 
a child or spouse (including 2 by murder), incarceration of a child and the onset of 
illness in a child. The qualitative data revealed the complexity of the social context 
from which this sample was drawn. They concluded that future interventions should 
be more comprehensive, addressing the physiological and psychosocial needs of 
patients in a setting that is convenient for them (Melkus et al., 2010).  
 
McKay et al conducted an RCT comparing a physical activity intervention with an 
information only condition. Seventy-eight T2D patients recruited across the US and 
Canada were randomised to receive either an intervention comprising goal-setting and 
feedback, strategies to overcome barriers, access to an online ‘personal coach’ and 
peer group support, versus information only. No significant difference in activity 
levels was observed between the 2 groups. Process evaluation data including records 
of the amount of Dose Delivered showed a steep decline in the amount of sessions 
delivered over the 8 weeks of the trial, which may partly explain null findings. The 
authors also conducted a post-trial ‘user satisfaction survey’ to assess Participant 
Experience, finding that intervention participants reported greater satisfaction than 
those in the information only group. They reported that 88% of participants found the 
intervention helpful compared to 35% in the information only group (McKay et al., 
2001). This data contradicts the behaviour of participants and highlights the need for 





Pibernick-Okanovic et al conducted an RCT in Croatia, comparing a group and 
individual psycho-educational intervention delivered over 12 months, designed to 
reduce depressive symptoms, with diabetes care as usual. Fifty patients with mild to 
moderate depressive symptoms and T2D were randomly assigned to control or 
intervention groups. Intervention group participants received 4 psycho-educational 
sessions aimed at enabling self-management of depressive symptoms. They found 
statistically significant improvements in both depressive symptoms and HbA1c in 
both control and intervention conditions at 6 and 12 months post-baseline. However, 
no significant between group differences were observed. The authors concluded that 
the additional attention received by participants in their ‘usual care’ condition 
(participants also received depression screening and feedback) could explain the 
significant improvements in outcome observed within the group. The qualitative 
evaluation of Participant Experience of taking part in the RCT supported this 
hypothesis. Qualitative data showed that participants found the sense of being 
supported and cared for the most valuable aspect of participation. This was a common 
element to both experimental groups and therefore offers an explanation for the 
results (Pibernik-Okanovic et al., 2009). Qualitative data collected as part of a process 
evaluation allowed the researchers to support a hypothetical explanation.  
 
The remaining 6 RCTs attempted partial process evaluation but methods were either 
insufficiently sensitive to capture data or data were not reported. For example, Hill-
Briggs et al conducted an RCT of an education and problem solving self-management 
program delivered in both an intensive and condensed format, aimed at improving 
HbA1c and reducing cardiovascular risk factors among 56 African American men in 
Baltimore. They reported significant improvement in HbA1c at 3-month follow up. 
Patients completed satisfaction ratings post intervention, which showed they found it 
helpful and easy to understand. Participants in the intensive intervention group 
reported they learned more than those in the condensed group (Hill-Briggs et al., 
2011). Although it useful to know that participants were happy with an intervention, 
the data tell us little beyond that, highlighting the need for deeper qualitative 
investigation as part of a process evaluation.  
 
Similarly, Moriyama et al conducted an RCT of a self-management education 
intervention versus usual care, aimed at improving HbA1c and physiological 
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measures associated with cardiovascular risk factors at 12 month follow up. The 
intervention group (n = 42) received <30 min of monthly interviews in Hiroshima, 
Japan, based on the programme’s textbook and biweekly telephone calls from a nurse 
educator. Significant improvements were observed in HbA1c and risk factor 
variables. Quantitative data from structured questionnaires revealed that participants 
felt the program to be valuable (95%). They also reported that the length of sessions 
was neither ‘long nor short’ (76.3% in the intervention group) which may indicate a 
central response bias. 100% of patients felt the program was ‘necessary’. Open-ended 
questionnaire responses revealed that participants felt the program was ‘easy to 
understand’ and ‘it was good to set individual goals and get proper advice’ 
(Moriyama et al., 2009). These findings can be used to inform the design of future 
interventions, but would benefit from further qualitative exploration.  
 
Gabbay et al conducted an RCT comparing the effect of MI over a 2-year period on 
diabetes self-management and HbA1c, versus usual care. A significant improvement 
in HbA1c was observed among the intervention group comprising 232 patients at 12 
primary care clinics in Pennsylvania, US, but it was unclear if this was due to 
increased attention, increased provider interaction or improved knowledge from 
educational material. Fidelity of the intervention was monitored by review of 
audiotaped sessions by two MI experts. The results are not reported in detail but the 
authors state that interventionists were MI adherent (Gabbay et al., 2013). It would be 
interesting to see complete fidelity data in order to better understand the origin of 
treatment effects.  
  
West et al conducted an RCT of an 18-month, group-based behavioral obesity 
treatment, with 217 overweight women randomised to individual sessions of MI or 
attention control as an adjunct to a weight control programme. Participants in the MI 
group lost significantly more weight at 6 and 18 months and had significantly lower 
HbA1c at 6 months although this improvement was not sustained at 18 months follow 
up. Attendance records and self-monitoring diaries were used to monitor intervention 
Dose Delivered and the authors reported that those in the MI group submitted 
significantly more self-monitoring diaries than those in the attention control group. 
Randomly selected audiotapes of recorded MI sessions were reviewed weekly by 2 
 
135 
clinical psychologists to assess Fidelity to MI. The results are not reported (West et 
al., 2007).  
 
Keogh et al conducted an RCT to test the effectiveness of a psychological, family-
based intervention aimed at improving outcome in patients with poorly controlled 
T2D (n=121) in a large suburban hospital in Ireland. Intervention group participants 
received 3 weekly sessions (2 45-minute sessions delivered at home, 1 15-minute 
telephone session) delivered by a health psychologist who received 16 hours of 
training in MI. The intervention group showed significant improvement in HbA1c at 
6-month follow-up and also significant improvements in beliefs about diabetes, 
psychological wellbeing, diet, exercise, and family support. The authors measured 
Dose Delivered and Fidelity components of process evaluation, and report that the 
intervention was delivered according to protocol, although data are not presented 
(Keogh et al., 2011). In a protocol paper the authors state they will use focus groups 
and structured questionnaires to assess participant experience of the intervention but 
these data are not published (Keogh et al., 2007). 
 
Jansink et al conducted a cluster RCT to test the effect of an education, lifestyle 
counselling and MI intervention on HbA1c, diet and physical activity levels. Patients 
(n=940) were recruited from 58 primary care practices in The Netherlands. No 
significant’ effect on outcome variables compared with usual care was observed at 14 
months follow up. Nurses were invited to participate in a focus group/follow up 
meeting post trial although participation was low (37%) and data are not reported 













Table 4.2: Components of Process Evaluation Studied by Randomised Controlled 






















































































































Campbell et al 1996, Australia 
(Campbell et al., 1996) 
   X X X       
McKay et al 2001, USA 
(McKay et al., 2001) 
   X     X    
Adolfsson et al. 2007, Sweden 
(Adolfsson et al., 2007) 
   X     X    
West et al 2007, USA (West et 
al., 2007) 
   X  X       
Moriyama et al, 2009, Japan 
(Moriyama et al., 2009) 
   X     X    
Pibernik-Okanovic et al, 2009, 
Croatia (Pibernik-Okanovic et 
al., 2009) 
   X     X    
D'Eramo Melkus et al, 2010, 
USA (Melkus et al., 2010) 
   X  X     X  
Hill-Briggs et al, 2011, USA 
(Hill-Briggs et al., 2011) 
   X  X   X    
Keogh et al 2011, Ireland 
(Keogh et al., 2011) 
   X X X   X    
Waker et al 2012, USA 
(thesis) (Waker, 2012) 
   X  X   X    
Blackberry et al 2013, 
Australia (Blackberry et al., 
2013) 
X X  X X X  X X    
Gabbay et al 2013, USA 
(Gabbay et al., 2013) 
   X  X   X    
Jansink et al, 2013, The 
Netherlands (Jansink et al., 
2013) 




Selection and Combination of Methods 
 
Table 4.3 summarises the methods used to conduct the process evaluations.  
 
All studies collected quantitative process evaluation data. This is unsurprising, as the 
CONSORT statement requires researchers to collect data on the amount of 
intervention Dose Delivered. Ten studies collected additional quantitative data, with 5 
obtaining quantitative ratings of audio recordings (Campbell et al., 1996; Gabbay et 
al., 2013; Keogh et al., 2011; Waker, 2012; West et al., 2007) and 5 using structured 
questionnaires (Hill-Briggs et al., 2011; Keogh et al., 2011; McKay et al., 2001; 
Moriyama et al., 2009; Waker, 2012). For example, West et al conducted an 18-
month RCT testing the effectiveness of a group based behavioural obesity treatment 
using MI versus an attention control condition. Women in the intervention group had 
lost significantly more weight at 6 and 12-month follow up. Attendance records were 
used to track patient engagement with the intervention. Results showed that 
intervention group participants were significantly more engaged with the intervention 
during the intervention phase of the trial, after which time their attendance at follow 
up sessions was equal to those in the control group (West et al., 2007).  
 
Nine studies (77%) collected some form of qualitative data, with 4 studies obtaining 
qualitative data from audiotaped recordings (Blackberry et al., 2013; Gabbay et al., 
2013; Hill-Briggs et al., 2011; Keogh et al., 2011), 5 studies using open-ended 
questionnaires (Keogh et al., 2011; McKay et al., 2001; Melkus et al., 2010; 
Moriyama et al., 2009; Walker et al., 2011), 4 studies using interview methods 
(Adolfsson et al., 2007; Blackberry et al., 2013; Pibernik-Okanovic et al., 2009), 3 
studies using focus groups (Blackberry et al., 2013; Gabbay et al., 2013; Jansink et 
al., 2013; McKay et al., 2001) and 3 studies using observational data (some studies 
employed more than one of these methods in combination) (Blackberry et al., 2013; 
Keogh et al., 2011; Melkus et al., 2010).  
 
Discounting quantitative data collected as a requirement of CONSORT, only 5 studies 
collected both quantitative and qualitative data as part of their process evaluations 
(Gabbay et al., 2013; Keogh et al., 2011; McKay et al., 2001; Melkus et al., 2010; 
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Waker, 2012). The use of mixed methods is a core feature of process evaluation and 
this review suggests that this requirement is not consistently met. 
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Qualitative Methods  
Campbell et al, 
1996, Australia 
(Campbell et al., 
1996) 
Individual CBT for 12 
months, aimed at 
improving HbA1c and 
reducing cardiovascular 
risk factors.  
Session attendance 
(Dose Delivered), 
including checklist of 
session duration. 




McKay et al, 
2001, USA 
(McKay et al., 
2001) 
Individual CBT for 8 
weeks, aimed at increasing 




Website usage data 








Experience).   
Questionnaire with 
structured and unstructured 
components, yielding 
quantitative and qualitative 
data (Participant 
Experience).   





education for 7 months, 
aimed at reducing HbA1c 
and cardiovascular risk 
factors. 




West et al, 2007, 
USA (West et 
al., 2007) 
Behavioural weight control 
program for 18 months, and 
individual and group MI for 
12 months, aimed at 
reducing HbA1c and 
cardiovascular risk factors.  
Session records (Dose 
Delivered) and 
quantitative data from 
ratings of audiotaped 
sessions (Fidelity). 
None reported.  





for 12 months aimed at 
improving HbA1c and 
physiological measures 
associated with risk factors.  
Session records (Dose 
Delivered), quantitative 





Okanovic etc al, 
2009, Croatia 
(Pibernik-
Okanovic et al., 
2009) 
Group and individual 
psycho-educational 
intervention for 12 months 
aimed at reducing 
depressive symptoms.  
Session use data (Dose 
Delivered) 
Patient interviews 
(Participant Experience).   
D’Eramo 
Melkus et al, 
2010, USA 
(D'Eramo-




and coping skills training 
for 12 months aimed at 
improving HbA1c and 
cardiovascular risk profile.  
Session use data (Dose 
Delivered), trainer 
observation of CBT 
delivery (Fidelity) 
Open-ended questionnaires 
(Barriers and Facilitators). 
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Table 4.3 continued  





Education and problem 
solving self-management 
training for a maximum of 
9 sessions, aimed at 
improving HbA1c and 
reducing cardiovascular 
risk factors.  








None reported.  
Keogh et al, 
2011, Ireland 
(Keogh et al., 
2007) 
MI for 3 sessions, aimed at 
improving HbA1c, altering 
illness perceptions and 
improving psychological 
wellbeing. 
Session data (Dose 
Delivered), quantitative 
and qualitative analysis 










MI for two 60-minute 
sessions, aimed at 
improving HbA1c and self-
management behaviours.  
Session data (Dose 
Delivered), quantitative 
rating of audiotaped 
sessions (Fidelity), 
Structured and open-ended 
questionnaires (Participant 
Experience). 






‘telephone coaching’ for 15 
months, aimed at 
improving HbA1c.  
Session data (Dose 
Delivered) 
Focus groups pre-trial 
exploring health 
professionals views on self-
management (Formative 
Evaluation), sample of 
sessions recorded and rated 
qualitatively, research staff 
field notes (Dose Received, 
Fidelity), interviews and 
focus groups (Participant 
Experience, Provider 
Experience).  
Gabbay et al, 
2013, USA 
(Gabbay et al., 
2013) 
MI over a 2-year period, 
aimed at improving HbA1c.  
 
Session data (Dose 




Focus groups (Participant 
Experience). 
Jansink et al, 
2013, The 
Netherlands 
(Jansink et al., 
2013)  
Education, lifestyle 
counselling and MI for 14 
months aimed at improving 
HbA1c, diet and physical 
activity levels. 
Session data (Dose 
Delivered) 
Follow up meeting/focus 
groups (Patient Experience, 
Provider Experience). 
Keane et al 
2014, Australia 
((Goode et al., 
2015)  
Telephone counselling over 
18 months, aimed at 
increasing physical activity 
and promoting weight loss 
and improving HbA1c.   
Session use data (Dose 
Delivered, Dose 
Received) 





Summary of Findings  
 
None of the studies identified for review reported process evaluation data on all 12 
components of process evaluation outlined in Chapter 3, and none of the studies 
reported process evaluation data on Recruitment, Contamination or Adoption. These 
components may provide valuable data on mechanisms of impact within an 
intervention. For example, the study of Recruitment may be able to tell researchers 
how their chosen method of recruitment is or is not reaching the target population 
they want to study, or if there is a participation bias. An example of this could be a 
study that recruits participants via the postal service, and which may potentially 
under-recruit as participants may find letters easier to ignore than a phone call where 
they are actively engaged with a researcher. The reason that observations about 
Recruitment or Contamination were not reported by any study reviewed may be that 
they are more likely to be reported as study limitations than as a component of 
process evaluation. No studies reported any assessment of intervention Adoption, 
which may be due to limitations in resources. At present, process evaluation research 
is under-developed and it is unlikely that researchers are considering putting adoption 
evaluation strategies in place.   
 
Aside from components on which no data were reported, the most understudied 
components were Formative Process Evaluation, Dose Received, Provider 
Experience and Barriers and Facilitators. Formative Process Evaluation pre-trial can 
reveal the acceptability and feasibility of a new intervention to its potential 
participants and also within its organisational setting. For example, a pilot study using 
focus groups may reveal the acceptability of an intervention to participants, which 
may inform design of the main RCT. It may also be crucial for specifying theoretical 
constructs upon which an intervention is based, which in turn allows researchers to 
clearly identify which constructs and their components contributed towards outcome. 
It may be that this is an under represented component of process evaluation due to 
financial and time constraints as many research teams may not have resources to carry 
out feasibility studies or other pre-trial research. However, a comprehensive process 
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evaluation should ideally be implemented at all stages of research design including 
formative stages, during trial implementation and post-trial. It is noteworthy that in 
the lifespan of this PhD, the NIHR has updated its requirements for funding of RCTs, 
requiring formative evaluation of pilot studies before funding will be granted (NIHR, 
2017). 
 
Provider experience may also be crucial in determining ‘how and why’ an 
intervention did or did not work. Many studies explored participants’ experience of 
taking part in their study but did not extend this to providers. Again, this may be due 
to lack of resources. Providers may also be more difficult to engage, and may be keen 
to claim back time having already committed valuable resources to the study. They 
are also smaller in number than participants and represent a smaller potential sample, 
resulting in a study being under powered if many decline to participate.   
 
Studying Barriers and Facilitators to protocol implementation can also reveal 
important processes that may be crucial for informing the design of future 
interventions. In some cases it may be that barriers and facilitators were explored as 
part of Participant Experience, but these data were not reported, particularly if the 
process evaluation was not published separately from the main RCT.  
 
Dose Delivered was always studied as a result of its being a requirement of the 
CONSORT checklist for the reporting of RCTs. The next most studied components 
were Dose Received, Fidelity and Participant Experience. Potential reasons for this 
include (i) the concepts of Dose Delivered and Dose Received are some of the most 
established components of process evaluation (ii) Fidelity is an established and 
familiar concept within the literature, developed prior to that of process evaluation 
theory and (iii) Participant Experience represents a low resource option for collecting 
further data, as consent has been obtained and contact pathways between the research 
team and participant established.   
 
The most commonly used methodology was quantitative session usage data 
measuring Dose Delivered. This was followed by rated audiotapes of intervention 
sessions, structured questionnaires and open-ended questionnaires. Observational data 
and interview studies were the least employed methodologies.  
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What Did the Process Evaluation Data Tell Us?  
 
Over the past 20 years many RCTs have tested the effectiveness of psychological 
interventions designed to improve outcome in poorly controlled T2D. The majority of 
RCTs tested group or individually delivered, low intensity interventions based on 
CBT, MI, or a combination of both. These psychological interventions were 
commonly delivered by primary care practitioners or other non-specialist healthcare 
professionals with little or minimal training in intervention techniques.  
 
The literature review shows that the effect sizes of these RCTs are getting smaller and 
we must find out why. For example, if the design of future interventions continue to 
incorporate psychological techniques delivered by non-specialists, we need to know 
which are the best candidates for training, and the best ways to support them. If future 
research continues to focus on low-intensity psychological techniques, we must reveal 
their mechanisms of action (e.g. the collaborative relationship between patient and 
provider), by collecting qualitative process data. Process evaluation can offer possible 
explanations for diminishing treatment effects and provide researchers with a research 
strategy going forward.  
 
Strengths and Limitations of This Literature Review  
 
There are a number of strengths to this literature review. This is the first review of 
process evaluations of psychological interventions designed to improve glycaemic 
control in T2D. It therefore represents an important step in furthering understanding 
of the current state of process evaluation research in this field. It is also, to our 
knowledge, the first literature review of process evaluations of RCTs of psychological 
interventions designed to improve outcomes in any long-term condition. 
 
The literature review was also conducted using data from two systematic reviews of 
RCTs of psychological interventions designed to improve outcome in poorly 
controlled T2D (Ismail et al., 2004). There is no consensus on conducting a process 
evaluation, and therefore no consensus on how to conduct a literature review in the 
area. This approach added to the literature in a meaningful way, rather than starting 
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afresh. A further benefit of adopting this approach is that the literature was narrowed 
to a field more relevant to this thesis, exploring process evaluations of studies relevant 
to the T2D epidemic. The inclusion criteria for the review were generous, including 
studies that specified they had conducted a process evaluation, and also those which 
did not. This approach was chosen with the aim of identifying all attempts at process 
evaluation, despite terminological variation. It was then possible to synthesise studies 
without being limited by wide variation in terminology and frameworks, which in turn 
enabled more meaningful comparisons between studies. Establishing an a priori 
framework allowed for structured discussion proceeding from theoretical deduction 
rather than simple observation.  
 
However, there are a number of important weaknesses. The review could not include 
process evaluations of RCTs of interventions conducted in different contexts, e.g. in 
community settings. The findings may therefore not be generalisable to other types of 
intervention in different long-term conditions. Much process evaluation work has 
taken place within the health education context, which this review does not include. It 
is possible therefore, that developments within the process evaluation field may have 
been missed due to the exclusion of this category. This work was conducted to inform 
the wider findings of the D6 Study, and therefore focused on psychological 
interventions in T2D in order to make parsimonious use of limited resources. The 
scoping study described in Chapter 3 demonstrated that process evaluation studies 
conducted within the health education context are numerous and may have provided a 
deeper understanding of the field. However, conducting a literature review of all 
process evaluations carried out within different settings and populations represents an 
amount of work far beyond the scope of this thesis and more equivalent to several 
PhDs.   
 
A systematic review of process evaluations of occupational stress management 
interventions alone identified 84 studies that met inclusion criteria. The authors 
identified stress management interventions conducted within health, education and 
industrial settings, which utilised diverse methods including assertiveness training, 
structural re-organisation, relaxation and information giving. The framework outlined 
by Linnan and Steckler was used to identify process evaluation components measured 
(Linnan, 2002). The authors concluded that the quality of process evaluations between 
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studies was highly variable and the link between process and outcome evaluation 
rarely assessed. They also concluded that while the framework of Linnan and Steckler 
was a ‘useful guide’ for the conduct of process evaluation, it may be advisable to 
consider the addition of other components to the framework which are appropriate to 
the occupational stress management context, such as ‘change in intermediate 
outcomes’ (Murta et al., 2007). This suggests that specific adaptations may be 
necessary for use within specific contexts, underlining the importance of conducting 
focused research before attempting generalisation to other contexts.   
 
Finally, it is not possible to discriminate with certainty between process evaluations 
that were not reported, and those that were not conducted at all. Researchers may 
have conducted evaluations but not published their findings. 
 
Future Research  
 
Future process evaluation research should work towards consensus on components of 
process evaluation studied and methods used. Process evaluation data should be 
reported and synthesised with RCT findings. At present there is wide variation in 
process evaluation frameworks and the field is on the cusp of rapid development.   
 
This represents an exciting challenge for researchers. We must begin employing these 
methods to uncover reasons for the downward trend in effect sizes of RCTs which are 
not performing as well as their underpinning theories would predict. Process 
evaluation can answer questions such as (i) are we using the wrong theory to predict 
behaviour change? (ii) are the psychological techniques employed being delivered 
incorrectly, or by the wrong people? (iii) are these psychological techniques being 
delivered to the wrong patient group? We can begin to offer explanations for results 




This review highlights inconsistency and the limited extent in the elements of process 
evaluation reported in the literature and methodology used. Historically, researchers 
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have been unaware of process evaluation and the development of the field has been 
haphazard, conducted on an individual basis in the absence of formal guidance. 
Funding bodies did not require researchers to plan for process evaluations and there is 
no process evaluation education as part of clinical trials training (Council, 2015). 
Including process evaluation guidance in CONSORT guidelines for example would 
mean researchers are required to include it in their research design. The aims of 
process evaluations have therefore been inadequately defined and many studies 
conducted a minimal process evaluation, adding just one or two other elements to 
their main RCT design. Among studies which did carry out evaluations, results were 
rarely fully reported, nor discussed within the context of the main trial findings and it 
may be that in some cases, data were collected but not reported. In general, limited 
attention has been applied to linking the aims of an evaluation with informing 
improved intervention implementation and understanding of outcomes. 
Methodologically, the field of process evaluation seems to be one where ‘anything 
goes’. There is a lack of consistency and it is very difficult to apply assessments of 
quality or make meaningful comparisons. There is therefore a clear need for a process 
evaluations framework which can be followed in a linear manner, in line with the 
format of the CONSORT checklist for RCTs. Process evaluation aims should be 
clearly stated and their link with specific outcomes clearly defined. Findings should 
be discussed in the context of main trial outcomes. The field of process evaluation 
needs to catch up with the measurement of RCTs in terms of importance and quality 
of assessment, in order to sit alongside CONSORT. The process evaluation 
framework proposed and tested in this review shows promising results and offers a 
credible starting point.   
 









The previous chapter applied a process evaluation framework to a systematic review of RCTs 
of psychological interventions to improve glycaemic control in T2D, described and 
summarised the components of process evaluation studied and the methods used.  
 
This chapter presents the protocol of D6 and its ITT findings. D6 is a cluster RCT comparing 
the effectiveness of a nurse led psychological intervention designed to improve glycaemic 
control in people with T2D. The methods and findings of process evaluations 1 and 2, which 
assess the components of Dose Delivered and Dose Received are also presented.  
 
Background and Clinical Problem 
 
Suboptimal glycaemic control in T2D remains a major health problem despite the 
implementation of intensive medical regimens following landmark research such as the UK 
Prospective Diabetes Study (UKPDS) (King et al., 1999). The UKPDS was a randomised, 
prospective, multi-centre trial of glucose lowering agents. It convincingly found that the rate 
of progression of complications of T2D, previously regarded as unavoidable, could be 
reduced by improvements in glycaemic control and/or BP (UK Prospective Diabetes Study 
Group, 1998). Intensive insulin therapy in patients with T2D was associated with reduced 
risk of micro-vascular and macro-vascular complications, and these results were shown to 
persist at 10-year follow up (Holman, Paul, Bethel, Matthews, & Neil, 2008). Optimum 
glycaemic levels remain difficult to achieve in the T2D population, despite this landmark 
study and those similar. For example, an RCT of a stepwise intensive behavioural treatment 
versus standard treatment of risk factors with microalbuminuria, designed to slow the 
initiation and progression of microvascular complications in microalbuminuric patients with 
T2D, found significantly lower rates of progression to nephropathy, progression of 
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retinopathy and progression of autonomic neuropathy than those in the usual care group 
(Gæde, Vedel, Parving, & Pedersen, 1999) (Wallace & Matthews, 2000). 
 
This spurred the development of educational programs to support self-management. 
DESMOND (Diabetes Education and Self Management for Ongoing and Diagnosed), 
a diabetes education and self-management course considered a cornerstone of T2D 
management, was interpreted as effective in improving knowledge about T2D and improving 
quality of life. However the UK National Diabetes Audit suggested that prevalence of uptake 
of structured education programs for newly diagnosed T2D vary between 0 and 48% 
(HSCIC, 2012). Reasons for this vary and include psychological barriers such as shame and 
stigma of diabetes (Winkley et al., 2016), provider barriers with primary care professionals 
not referring and organisational barriers such as frequency, location and marketing of the 
educational programs.  
 
Other initiatives include the QOF for diabetes, introduced in primary care (Calvert et al., 
2009), where significant responsibility for the care of patients with T2D now falls (Kane, 
2001). However, the system has failed to benefit T2D patients with persistent sub-optimal 
control (Calvert et al., 2009). QOF aimed to improve quality of care via a system of financial 
reward for general practice surgeries for delivering a minimum number of care processes 
such as recording of HbA1c, BP and changes in patient health status. Indicators for diabetes 
constituted the largest of any clinical area, yet a follow up study found that the QOF approach 
had failed to capture patients with suboptimal control in its assessment (Calvert et al., 2009).   
 
The reasons for persistent sub-optimal control despite these major adaptations to national 
guidelines are multifactorial, and psychological barriers such as depression and diabetes-
specific worries related to managing the multiple self-care tasks required of patients represent 
a major part of the problem. Rates of depression are increased two-fold in diabetes compared 
to the general population and it is associated with reduced self-management (Ciechanowski et 
al., 2000a; Egede & Zheng, 2003), poorer glycaemic control (Lustman et al., 2000) and a 2-5 
fold increase in mortality (Katon et al., 2005) (Ismail, Winkley, Daniel, Chalder, & Edmonds, 
2006). Diabetes specific psychological worries include difficulties in accepting and adjusting 
to the diabetes diagnosis including shame, self blame, guilt; worries and fears about potential 
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diabetes complications, fear of self-testing and injecting, fear of hypoglycaemia and fear of 
insulin therapy, concerns about body image and weight gain and disordered eating (Peyrot et 
al., 2005a).  
 
Role of Psychological Treatments in Management of Type 2 Diabetes  
 
Based on the observation that there is a high prevalence of psychological problems in T2D 
and that these are likely to be associated with reduced self management, there is face validity 
that psychological treatments may be an important adjunct in contributing towards improved 
glycaemic control in a population where pharmacological interventions alone may be 
effective but not as efficacious (UK Prospective Diabetes Study Group, 1998). Patients are 
required to perform a variety of self-care behaviours in order to achieve optimum glycaemic 
control, including dietary modification, exercise, self-monitoring of blood glucose, foot care, 
and adherence to medication. Psychological therapies can help by establishing a rapport 
between patient and therapist in which they are able to work collaboratively to identify, 
challenge and modify health beliefs and barriers to these self-care tasks (Nicholson et al., 
2009).  
 
Psychological treatments used commonly in medical settings in the UK include MI and CBT. 
MI is a brief (usually 1 to 4 sessions) counselling style designed to enhance motivation to 
change problematic health behaviors by exploring and resolving ambivalence about change 
(Rollnick & Miller, 1995). CBT is a longer therapy (usually a minimum of 6 to 12 sessions) 
that aims to enable the patient to identify, challenge and substitute unhelpful cognitions and 
behaviors with more constructive ones (Beck, 1963; Lang, 1970). It is a method of eliciting 
thoughts via Socratic dialogue, which encourages the patient to identify their own 
problematic thoughts through questioning enquiry. This uncovers the possibility of 
alternative thoughts, which can be assimilated into a strategy for behavioural change (Beck, 
2011). Examples of Socratic questions include, ‘what have you found has worked for you 




Could Health Professionals Deliver Psychological Care in Diabetes? 
 
Experts in both diabetes and psychological techniques are rare and costly (Roberts, 2007), 
and their expertise is best reserved for a small but highly complex group of multi-morbid 
patients (Katon et al., 2005; Trude & Stoddard, 2003). However, there are large sub-groups 
of people with T2D, mostly in primary care, who struggle to achieve optimal glycaemic 
control despite intensive medical therapies. It may be that health care professionals who 
deliver usual diabetes care could use specific psychological techniques to manage less severe 
but more common barriers to self-care (Alam et al., 2009). If practice nurses can be trained to 
competently deliver integrated psychological and diabetes care, this would represent a 
potentially cost effective opportunity to expand their existing role as providers of diabetes 
counselling, while simultaneously reducing the level of burden on psychological services and 
on patients (Nicholson et al., 2009). The use of MI and CBT skills is associated with 
clinically and statistically significant improvements in glycaemic control in hospital patients 
with T1D (Ismail et al., 2008a), but there is little evidence that these techniques can also be 
delivered to T2D patients by primary care healthcare professionals such as general practice 
nurses.  
 
One systematic review found no difference in the reduction in HbA1c in those interventions 
delivered by ‘generalists’ (pooled mean reduction 0.51% (95% CI: -0.50 to 0.04: 9 RCTs 
with a sample size of n=832) compared to psychotherapists (0.57% (-0.36; 95% CI: -0.61 to 
0.12: 9 RCTs with a sample size of n=561) (Alam et al., 2009). It was concluded that training 
generalist clinicians in psychological therapies could represent a viable pathway to improved 
outcome in subgroups of T2D patients with sub optimal glycaemic control.  
 
There is evidence in substance misuse settings that integrating CBT and Motivational 
Enhancement Therapy (MET) may increase its efficacy (Haddock et al., 2003; Miller & 
Rollnick, 2002; Parsons, Rosof, Punzalan, & Maria, 2005). MET is closely related to MI in 
that whereas MI was originally developed as 1 session MET has a few more sessions, 
typically 4. During the lifetime of this thesis, the term MET is barely used and subsumed into 
the MI label. In a multi-centre, three arm parallel RCT, when these 2 therapies were 
combined, it was found that this combination was associated with an HbA1c reduction of just 
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less than 0.5% compared to usual diabetes care in people with poorly controlled T1D but 
MET on its own was not (Ismail et al., 2008a). This method of integrating MI and CBT as an 




Diabetes care delivered by practice nurses trained in a set of 6 psychological skills based on 
MI and CBT, is more effective than usual diabetes care delivered by practice nurses in 
improving glycaemic control in people with T2D and persistent suboptimal glycaemic control 




(i) Diabetes care delivered by practice nurses trained in psychological skills is more effective 
than usual diabetes care in reducing cardiovascular risk factors (body mass index, lipids, BP) 
(ii) Practice nurses trained in psychological skills are more effective in improving a) 
depression and b) diabetes related psychological wellbeing than practice nurses who do not 
receive the training 
(iii) Diabetes care delivered by practice nurses trained in psychological skills is more cost-
effective than usual care in improving diabetes control 
(iv) The number of D6 intervention sessions attended is associated with sustained 
improvements in diabetes control. 
 
Design and Setting 
 
A definitive 2 parallel arm cluster RCT. Cluster randomisation was employed to avoid 
contamination between experimental conditions. Clusters were moderate to large GP 
practices (defined as having ≥ 6000 patients registered), set within the Lambeth, Southwark, 
Lewisham, Wandsworth and Bexley Primary Care Trusts (PCT) (now referred to as Clinical 
Commissioning Groups). Surgeries with list sizes < 6,000 patients were invited to combine 
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into one cluster in order to meet the requirements for sample size. This represented a 
population of 1.43 million patients who were invited to take part if they attended a practice 
with a practice nurse providing diabetes care. A 2-phase approach to cluster recruitment was 
adopted in order to address slow recruitment as a result of organisational challenges faced 
due to the imminent implementation of the Health and Social Care Act 2012. This Act 
involved significant reorganisation of NHS structures relating to management, funding, 
accountability and regulations (The National Archives, 2012). 
 
Study Population and Study Criteria  
 
The target population was people with T2D and persistent sub-optimal glycaemic control, 
despite primary care team delivery of NICE guidelines adapted for local settings.  The 
diagnosis of T2D by primary care physicians in South London was based on WHO clinical 
criteria. It was anticipated that 5000 registered patients would have an HbA1c >7.4% of 
whom ~ 2500 would have persistent HbA1c ≥9.0% based on data from QOF (Gulliford, 
Naithani, & Morgan, 2007). Index of Multiple Deprivation rank score was used to assess 
relative deprivation of GP surgery locations (Department for Communities and Local 




(i) Adults aged between 18-79 years 
(ii) Duration of diabetes for ≥ 2 years since diagnosis 
(iii) Persistent suboptimal glycaemic control defined as HbA1c  ≥ 64 mmol/mol% (equivalent 
to 8%) on two occasions, once in the past 18 months and HbA1c at time of recruitment. 
Original inclusion criteria required one HBA1c result but this was amended via research 
ethics committee to better capture a persistently poorly controlled population. It had been 
previously lowered from 69.5mmol/mol% (equivalent to 8.5%) to 64 mol/mol (equivalent to 






(i) Severe mental disorders, defined as schizophrenia; manic depression; depressive 
psychosis; active suicidal ideation; learning disability; dementia; alcohol and substance 
dependence; severe personality disorders; terminal illnesses and severe end stage diabetes 
complications 
(ii) Morbid obesity with a BMI >50kg/m2 (as this group of patients typically have concurrent 
serious medical problems) 
(iii) Housebound, or dependent on a formal carer (patients were required to attend the surgery 
for regular face to face appointments) 
(iv) No phone or Internet access (these methods were options for the delivery of part of the 
intervention) 
(v) Patients who were unable to speak conversational English (as D6 is a talking therapy) 
(vi) Patients undergoing psychotherapy at the time of recruitment 
(vii) Patients with Patient Health Questionnaire-9 (PHQ-9) scores >20 were reviewed by the 
research psychiatrist or their GP to assess if s/he should be excluded in case they had 




Eligible GP practices were invited to participate by the PCT diabetes champion, clinical 
leads, general practice managers, the primary care research network (PCRN) and the research 
team (not including the PhD candidate). GP practices were offered financial compensation 
for their participation (£10,000 per practice).  If more than 1 nurse provided diabetes care at a 
participating practice, the lead GP selected the most appropriate nurse to participate in D6. 
Phase 1 recruitment of practices took place from 1st June 2010 – 30th September 2010. Phase 
2 recruitment of practices took place from 1st October 2010 – 29th April 2011. Participant 
recruitment took place from 1st September 2010 – 29th July 2011 for Phase 1 and 1st March 
2011 – 31st October 2011 for Phase 2. The practices’ electronic diabetes registers were 
screened for all current cases of diabetes and a list of all those potentially eligible was 
generated. The lead GP (for diabetes) sent letters to potentially eligible patients describing 
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the study and inviting participation. Interested patients were invited to meet a D6 researcher, 
usually at the patient’s own practice, to complete baseline clinical data collection and study 
questionnaires. At that visit, they were asked to undertake an additional fasting blood test. 
The researcher also accessed each participant’s medical notes to confirm patient histories 
with regard to medical history and therapies.  
 
Each baseline data collection visit took approximately 60 minutes. If the researcher did not 
take a fasting blood sample at this initial visit, an extra attendance at the practice or other 
local phlebotomy service was required.  
 
Randomisation and Allocation Concealment 
 
Randomisation of the GP surgeries (unit of cluster) was conducted by an independent clinical 
trials unit using a random number generator to assign equal numbers of surgeries to each arm 
at each of the two waves. Allocation concealment was conducted by holding the 
randomisation list by an independent manager in a password-locked computer. 
Randomisation of clusters was intended to take place after all patients had been recruited but 
in this pragmatic trial this was leading to unacceptable delays in the training of nurses and 
some patients were recruited after randomisation of the general practices but this information 
was not given to the researcher or the patient until all baseline data were collected. Baseline 
data were collected before randomisation and research workers were blind to allocation for 




The core research team comprised Professor Stephanie Amiel (Chief Investigator); Professor 
Khalida Ismail (Co-Investigator); Dr Kirsty Winkley (NIHR Post-Doctoral Fellow); Dr 
Nicole DeZoyza (Clinical Psychologist); Dr Daniel Stahl (Trial Statistician); Dr Anita Patel 
(Health Economist); Chris Turner (Research Assistant and Trial Manager); Helen Graves 




Professors Amiel and Ismail were responsible for the design and overall conduct of the trial; 
Dr Winkley was responsible for the setting up and overall management of the trial; Dr Stahl 
was the trial statistician, responsible for statistical analysis; Dr Patel was responsible for the 
health economic assessment; Chris Turner was responsible for data collection and day to day 
trial management; Sarah Mann and Helen Graves were responsible for recruitment of 




The following measures were taken at baseline: 
 
Socio-demographic: Age; gender; self-report ethnicity; partnership status; number of 
children; employment status and occupation and educational attainment data were obtained 
from the patient by the D6 research assistant.  
 
Biological: A fasting blood sample was used to measure HbA1c; lipid profile; full blood 
count; thyroid function and fasting plasma glucose. Incidence of hypoglycaemia for the last 
year and history of cardiovascular disease were taken by history from the patient and checked 
against their GP practice medical records. Date of diagnosis and HbA1c results from the last 
year were also obtained from records. Albumin:creatinine ratio to examine nephropathy was 
measured in a random urine sample; retinopathy was assessed from the most recent fundal 
photograph from the community based eye complication screening services; neuropathy was 
measured using 10g monofilament, and vibration perception testing using a biosthesiometer 
was assessed by the D6 research assistant, as were BP and BMI.  
 
Psychological: Depression was measured using the PHQ-9, a self-report 9-item depression 
screening questionnaire (Kroenke, Spitzer, & Williams, 2001); the Self Care Inventory-
Revised version was used to assess adherence to diabetes related self-care activities 
(Weinger, Butler, Welch, & La Greca, 2005); the Diabetes Distress Scale was used to assess 
severity of diabetes related thoughts and stressors (Polonsky et al., 2005); the Diabetes Fear 
of injecting and Self Testing Questionnaire was used to measure fears around blood glucose 
testing and administering insulin (Mollema, Snoek, Pouwer, Heine, & van der Ploeg, 2000); 
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The Barriers to Insulin Treatment Questionnaire was used to assess concerns regarding 
insulin use (Petrak et al., 2007); Dysfunctional Attitude Scale to assess depressogenic 
cognitions (Weissman & Beck, 1978); Brief Illness Perception Questionnaire to measure 
health beliefs (Petrie & Weinman, 1997); Current Cognitive Status was assessed using the 
Wechsler Test of Adult Reading (Wechsler, 2001), the Telephone Interview for Cognitive 
Status [TICS-M] (Brandt, Spencer, & Folstein, 1988), the Trail Making Test (Reitan, 1992), 
the Rey Auditory Verbal Learning Test (Schmidt, 1996) and the Verbal Fluency Test. 
 
Economic: Quality of Life was measured using the Short Form 12 Health Status 
Questionnaire to measure quality of life (Ware Jr, Kosinski, & Keller, 1996) and other 
economic evaluation data using the Client Service Receipt Inventory (CSRI) for a 
retrospective period of 6 months (Chisholm et al., 2000). 
 
 
Description of Intervention 
 
Group 1: Usual Care Attention Control 
 
As there is marked variation in usual care for people with sub optimal T2D control, practice 
nurses delivered usual care as recommended by NICE and adapted for the local population 
(NIHR, 2002). To control for attention effects, practice nurses in both usual care attention 
control and intervention groups were required to see patients for the same number of 
appointments at the same frequency.  Patients were therefore invited to attend 6 x 30 minute 
face to face sessions followed by a further 6 face to face sessions in a format agreed with the 
patient (phone, email, or face to face).  
 
Group 2: Usual Care Plus D6 
 
Usual care based on NICE guidelines continued as described above. In addition, the D6 
intervention was designed to address psychological problems that may have been 




The D6 intervention took place over 6 face-to-face sessions and a further 6 sessions in a 
format agreed with the patient. Each session was up to 30 minutes and delivered at the 
following frequency: Sessions 1-6 (fortnightly), Sessions 7-10 (monthly) and Sessions 11-12 
(two monthly). The focus of the intervention was on increasing the patient’s motivation to 
improve their diabetes control in the first instance. The nurse and patient then worked 
collaboratively to address key self-care behaviours such as medication adherence, self-
testing, physical activity and dietary changes.  
 
A summary of skills used in the D6 intervention is presented in Table 5.1.  
 
Training of D6 Nurses  
 
Training in D6 skills was provided by an experienced clinical psychologist in the form of 
interactive training workshops and regular supervision. Interactive training workshops were 
conducted over 12 x 3 hourly sessions and the nurses provided with the D6 handbook for 
ongoing reference (see Appendix IV). Nurses were trained in 6 D6 skills, including active 
listening, managing resistance, directing change, supporting self-efficacy, addressing health 
beliefs and shaping behaviours. These are summarised in Table 5.1. The overall aim was to 
enhance patients’ motivation to improve their diabetes control by collaboratively addressing 
key self care behaviours such as adherence to medication, blood sugar monitoring, dietary 
changes and physical activity levels. Training emphasised that the overall ‘spirit’ of MI and 
attitude of the clinician was more important than focusing on the specific skills. Nurses were 
required to practice D6 skills by integrating them into consultations with their existing 
diabetes caseload. Nurses attended monthly supervision with the trial clinical psychologist 
either in person at group sessions provided at King’s College Hospital or over the telephone 
if they were unable to attend. As a last resort, email support was provided on an individual 
basis. Nurses were required to record all D6 consultations on a digital recorder provided by 
the research team (used to assess fidelity, described in Chapter 6) and to provide a sample 






Table 5.1: Summary of Skills Taught in D6 Intervention (The D6 Training Manual provided in Appendix V)  
Skill Content 
Active Listening In active listening, the patient is seen as the ‘expert’ and the clinician resists the reflex to tell them what is best. The clinician 
demonstrates interest and empathy, which form the building blocks of therapeutic rapport. Active listening forms the cornerstone of 
motivational interviewing.  
 
Active listening includes the use of open questions, affirmations, reflections and summaries, as well as elements of non-verbal 
communication.  
 
Open questions allow the patient to provide more information rather than a simple ‘yes or no’ response, enabling the clinician to learn 
more about their motivation to change and shifting the balance of power towards the patient. 
 
Affirmations are statements made by the clinician that demonstrate support. These may include statements that show support for the 
patient’s behaviour, show support for positive attributes e.g. aptitude for multitasking or validate their efforts in managing their 
condition.  
 
Reflections show the patient that the clinician has listened and understood what they have said. A simple reflection includes a basic 
acknowledgement of what the patient has said, while a complex reflection adds something more. This may involve strategic use of a 
statement to emphasise ambivalence, roll with resistance or elicit change talk.  
 
Summaries are reflective statements allow the clinician to pause, summarise and reflect on a consultation. Often, a summary can 
provide an opportunity to redirect the consultation.  
Rolling with 
Resistance 
How to side step resistance and maximise collaboration with the patient. Resistance is a normal part of the change process and occurs 
when the patient and clinician are at different stages of change. Skills used to assess readiness to change and move patients forward in a 
collaborative way are therefore important.  
 
Techniques involved in managing resistance include dealing with barriers to active resistance, dealing with avoidance (passive 




Techniques include:  
 
(i) Selective Attention to focus on the ‘green shoots’, which arise from a mixture of positive and negative statements from the patient. 
The clinician focuses on the most positive ‘green shoot’ statement and redirects attention towards it.  
 
(ii) Positive Reframing may be used to reframe the patient’s negative statement, providing a more optimistic view.  
 
(iii) Overshooting Reflections involves inflating the patient’s statement to create an opportunity for positive change talk.  
 
(iv) Asking a ‘Typical Day’ question can prompt patients with little to say to reflect on their usual activities, providing non-threatening 
subject matter.  
 
(v) Asking a ‘Values Question’ may be useful for patients in the precontemplation stage of change. Talking about other areas of life can 
provide a useful starting point for a conversation that examines how the patient’s day to day life impacts their diabetes control.  
 
(vi) Normalising involves communicating to the patient that their difficulties in managing their condition are normal, which gives them 
permission to communicate their struggles.  
 
(vii) Providing a Simple Reflection may be helpful in diffusing an emotive situation. 
 
 (viii) Taking a One Down Position can provide relief in a hostile situation. The clinician acknowledges shared responsibility for a 
challenge faced by the patient, enabling them to redirect the consultation.  
  
Directing Change This introduces a range of techniques to bring about ‘change talk’ in the patient including decisional balances, eliciting patient values, 
developing discrepancy between goals and current behaviours, and adapting the consultation to match the stage of change of the 
patient.  
 
DARN Questions are used to direct change by encouraging patients to express their own reasons for change. DARN is an acronym for 
Desire (‘wants, wishes, likes’); Ability (‘can, could, able’); Reason (stating a specific reason for change); and Need (‘need to, must 




Amplifying Change Talk. When change talk happened it should be acknowledged and amplified. The ‘green shoots’ should be 
encouraged to grow.  Providing affirmations, encouraging elaboration and selective attention techniques may be used.  
 
CAT Questions are used once a patient is ready to act, are designed to move the patient closer to activation and address potential 
barriers. Cat is an acronym for Commitment (‘will, intend, going to’); Activation (‘ready, willing to’); and Taking steps (‘reporting 
recent action towards change’).  
Supporting Self 
Efficacy 
This includes ways to elicit solutions or coping strategies from the patient rather than the clinician. It considers how to provide clinical 
information in a way that doesn’t undermine patient autonomy.  Techniques for supporting self-efficacy include Affirmations and 
Solution Focused Questions.  
 
A clinician makes an affirmation when they highlight a behaviour the patient has successfully performed and explicitly acknowledge 
the link between their actions and any positive consequences.  
 
Solution Focused Questions involve eliciting change talk through the use of CAT questions and other questions designed to enable 




Includes techniques to elicit unhelpful health beliefs, which might be standing in the way of behaviour change and provides nurses with 
tools e.g. visual aids to address common misperceptions in diabetes and skills to monitor a patient’s understanding.  
 
Identifying underlying health beliefs is the first step and may present challenges when the patient themselves is not aware of their 
beliefs or they may be unwilling to share them. This underlines the importance of building rapport between patient and clinician (e.g. 
Active Listening). Techniques used to elicit health beliefs may be ‘upward arrow’ or downward arrow’. Upward arrow questions 
involve asking the patient why x behaviour is beneficial to them with the aim of identifying a gap in knowledge. Downward arrow 
questions involve asking the patient why x behaviour is detrimental to them with the aim of finding out what the patient is 
misunderstanding or distorting.  
 
Once an understanding of health beliefs has been gained the clinician may begin forming new ones (cognitive restructuring). This may 
include working with unhelpful thinking style including catastrophising, personalising, providing ‘all or nothing’ responses, 






This includes techniques to help patients who are ready to change e.g. problem solving, goal setting, core anxiety management and 
supporting behaviour change by setting realistic goals, encouraging experimentation and managing setbacks.  
 
Goal setting involves breaking down a large task into smaller, non-threatening steps. Goals must be SMART: Specific, Meaningful, 
Attainable, Rewarding and Time based.  
 
In order to support the patient the clinician may play devil’s advocate. This enables the discussion of potential setbacks and solutions.  
 
Anxiety management may take the form of controlled breathing exercises, progressive muscle relaxation and distraction techniques.  
 
Positive reinforcement may be used to provide rewards for positive behaviour change.  
 




Adherence to The Protocol 
 
Deviations from the intended 6 face-to-face treatment sessions and additional 6 sessions 
represent the dose of the D6 intervention delivered to patients. The minimum intended dose 
of the intervention to satisfy adherence by the patient was 1 session, and this was considered 
the minimal effective dose of the intervention, in line with MI interventions in diabetes and 
primary care populations (Heinrich, Candel, Schaper, & de Vries, 2010) (VanBuskirk & 
Wetherell, 2014). As variation in the timing of visits was anticipated, the visit window was 
defined as the number of sessions completed with the 12-month period. For example, if the 
patient was seen 3 times only within 12 months, they were not offered further sessions. The 
time interval between each session was recorded. Intervention dose delivered will be reported 
as numbers (% of intervention group) of patients attending each session.  
 
Adherence to the D6 intervention was measured using the Motivational Interviewing 
Treatment Integrity Scale (MITI) (Moyers, Martin, Manuel, & Ernst, 2007) and the 
Behaviour Change Counselling Index (BECCI) (Lane, 2002). Adherence to the protocol by 
practice nurses was assessed by review of audiotaped intervention sessions. Both measures 
and their data are described in detail in Chapter 6.  
 
To be MI adherent nurses were required to score >90% on the ‘Beginning Proficiency 
subscale and >3 on the Empathy subscale of the MITI. These subscales were chosen because 
MI Adherence and Empathy have been shown to be predictive of treatment success (Apodaca 
& Longabaugh, 2009; Moyers & Miller, 2013). Nurse competency is described in detail in 
Chapter 6.  
 
Loss to Follow Up and Other Missing Data 
 
When a patient wished to withdraw from the trial, consent was sought to retain existing data 
and to continue to collect data from the patient’s routine care. If appropriate data on T2D 
control could be collected within an appropriate time frame, they were included. Main 
analyses used follow-up data at 15 and 18 months post-randomisation, with a 3-month 
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window either side. For the analyses data taken at 15 months ± 1.5 months was used for the 
15 months follow-up measurement and ± 1.5 months as follow-up measurements for 18 





The trial statistician conducted the D6 data analysis. Data were analysed using STATA 9. 
The sample characteristics were described. Twenty-nine participants with HbA1c <64 
mmol/mol (equivalent to 8%) contrary to the study criteria were included and this represented 
a protocol violation. We performed a sensitivity analysis by including a binary covariate of 
this protocol violation (yes/no) in the model. ANCOVA was used to estimate differences 
between MI and the usual care attention control group in HbA1c level at 18 months using 
baseline HbA1c and other possible confounding variables as covariates. Subsidiary outcomes 
(such as lipids and weight) were analysed in the same way. Treatment effects on secondary 
outcomes at 18 months (fasting triglycerides, BP, BMI, quality of life, Client Service Receipt 
Inventory and Depressive symptoms) and longitudinal effects of HbA1c levels of the 
invention groups over the time course of the study were assessed in a similar way, using 
generalisations of the linear mixed model to allow for non-normal distributed data where 




A 10·9 mmol/mol difference in HbA1c in D6 compared to standard care was the minimal 
clinically acceptable reduction at 18 months taking into account: (a) baseline HbA1c and (b) 
that standard care may produce a 2·2 mmol/mol (equivalent to 0·2%) reduction in HbA1c for 
the placebo effect of participating in a RCT (actual difference between groups 8·8 mmol/mol 
(equivalent to 0·8%), equivalent to a moderate effect size of d=0·55). Assuming 20% 
dropout, we needed 360 patients at 80% power at two-sided alpha-level of 5%. Therefore 20 
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practices with 18 patients per arm required. We took account of clustering by practice. 
Assuming two practices per arm dropped out, we needed 24 practices with a total patient size 
of 24 x18=432 patients. The required sample size adjusted for a clustering intra-correlation 
coefficient (ICC) effect of 0·05 was 81x1·7=138 patients per arm (inflation factor 1·7).  
 
We recruited 334 patients of which 231 had at least one follow-up in 24 clusters. The average 
cluster size was therefore 10 patients per cluster, smaller than our assumed size of 15 patients 
per cluster with a post-hoc power of 77% (STATA 13 clsampsi function) at two-sided alpha-
level of 5% (Batistatou, Roberts, & Roberts, 2014).  
 
Process Evaluation  
 
The ideal process evaluation would study all 12 process evaluation components as outlined in 
Chapter 3. A full process evaluation was planned, however due to limited time and resources 
the following 8 components were studied. The reasons for this are discussed further in 
Chapter 9.  
 
Recruitment: recruitment strategies were consistently reassessed and amended for the 
duration of the RCT recruitment period. 
 
Dose Delivered: assessed via records of attendance at D6 sessions.   
 
Dose Received: assessed via records of attendance at D6 sessions. Multilevel modelling was 
used to determine the developmental trajectories of HbA1c across the 18 months to determine 
the association between number of sessions and other potential covariates and rate of change 
of HbA1c.  
 
Fidelity: assessed via a sample of audiotaped D6 intervention sessions and independently 
rated using the MITI and BECCI. Full methods and results are reported in Chapter 6.  
 
Contamination: Assessed using audiotaped D6 intervention sessions and everyday contact 
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with D6 nurses. Research Assistants were required to provide support to nurses participating 
in the study, regularly meeting to address problems they were experiencing in adhering to D6 
protocol.  
 
Provider Experience: assessed via semi-structured interviews with nurses who took part in 
D6. Full methods and results are reported in Chapter 7. 
 
Participant Experience: assessed via semi-structured interviews with participants in D6. 
Full methods and results are reported in Chapter 8.  
 
Barriers and Facilitators: assessed via semi-structured interview of participants and nurses 
who took part in D6. Full methods and results are reported in Chapters 7 and 8.  
 
The components of Formative and Theoretical Evaluation; Formative Acceptability and 
Social Validity; Context and Adoption were not formally studied part of this thesis but are 
discussed in Chapter 9.  
 
Results of The D6 Study  
 
Figure 5.1 shows the recruitment and randomisation timeline of D6. Of 116 GP practices 
invited, 26 agreed to participate. Two practices dropped out prior to randomisation, which 
took place on 29th October 2010 and Phase 2 on 27th May 2011. One D6 practice dropped out 
after randomisation, before the nurse received the training, and before all patients were 
recruited (those who consented remained in the ITT analysis). Twenty-four GP practice 
clusters were randomised, with three clusters formed by combining two practices.  
 
Across all clusters, there were n=995 potentially eligible participants identified from the 
diabetes registers. Of the n=451 who consented for eligibility and participation, n=334 were 
recruited. Twelve practice clusters were randomly assigned to standard care (n=164 patients) 
and 12 to standard care plus D6 (n=170). One D6 practice dropped out after randomisation, 
before the nurse received the training, and before all patients were recruited (those who 
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consented remained in the ITT analysis). Invited practices that participated (n=24) compared 
to those that did not (n=89) had higher mean patient list sizes (12180 (SD 5099) vs. 10091 
(SD 3894), p=0·03) but no difference in Index of Multiple Deprivation rank score (10049 




A protocol violation at the beginning of recruitment meant that 29 patients were recruited 












































































All GP practices with list size >6000 in 
Lambeth, Southwark, Lewisham, Bexley & 
Wandsworth invited to participate (n = 116) 
Practices consenting to 
participate (n = 26)  
Practices refused, unable to 
participate or did not reply (n 
= 90) 
Practices dropping out (n=2)  
  Practices participating (n = 24)  
Patients pre-screened for eligibility (n = 995)  
Patients assessed for eligibility (n = 451)  
Cluster randomisation 24 
Patients excluded due to ineligibility (n 
= 117)  
 
- No baseline HbA1c (n = 31) 
- Phase 1 HbA1c 
<69.4mmol/mol (n = 67) 
- BMI > 50kg/m2 (n = 5) 
- Practice withdrew/patient not 
seen (n = 14) 
D6 D6 
Practices lost to follow up 
(n = 1) 
Patients without HbA1c 
measurement at either 
follow up (n = 56) 
Practices lost to follow up 
(n = 0) 
Patients without HbA1c 
measurement at either 
follow up (n = 47) 
Intention to treat analysis included: 
- 12 practices, 114 patients 
- 109 patients with HbA1c 
measurement at 18 months  
- 5 patients with HbA1c 
measurement at only 15 
months  
Intention to treat analysis included: 
- 12 practices, 117 patients 
- 110 patients with HbA1c 
measurement at 18 months  
- 7 patients with HbA1c 
measurement at only 15 
months  




































The mean age of participants was 58·9 years (SD 11·2), 51·2% were female, and the 
proportion who were White, African/Caribbean or Asian/Other was 40·4%, 43·1% 
and 16·6%, respectively. The median duration of diabetes was 9 years (interquartile 
range 5–12 years) and 43·0% of patients were taking insulin at baseline. The mean 



























Table 5.2: Baseline Characteristics of Participants Randomly Assigned to Receive D6 
or Standard Care 
Variable* D6  
(n=164) 
Standard Care  
 (n=170) 
Total 
Age (years) 59·0 (11·1) 58·9 (11·4) 58·9 (11·2) 
Gender      
 Male 82 (50·0%) 81 (47·7%) 163 (48·8%) 
 Female 82 (50·0%) 89 (52·4%) 171 (51·2%) 
Ethnicity       
 White 60 (36·8%) 74 (43·8%) 134 (40·4%) 
 African/Caribbean 81 (49·7%) 62 (36·7%) 143 (43·1%) 
 Asian/Other 22 (13·5%) 33 (19·5%) 55 (16·6%) 
Relationship status       
 Married or Cohabiting 82 (50·3%) 89 (52·7%) 171 (51·5%) 
 Separated/Divorced/Widowed 52 (31·9%) 45 (26·6%) 97 (29·2%) 
 Single 29 (17·8%) 35 (20·7%) 64 (19·3%) 
Education level       
 A levels or higher 47 (29·2%) 43 (25·8%) 90 (27·4%) 
 O level or GCSE equivalent 68 (42·2%) 48 (28·7%) 116 (35·4%) 
 No formal qualifications 46 (28·6%) 76 (45·5%) 122 (37·2%) 
Employment       
 Yes1 69 (42·1%) 70 (41·2%) 139 (41·6%) 
 No2 95 (57·9%) 100 (58·8%) 195 (58·4%) 
Borough      
 Lambeth 83 (50·6%) 42 (24·7%) 125 (37·4%) 
 Southwark 25 (15·2%) 40 (23·5%) 65 (19·5%) 
 Lewisham 19 (11·6%) 52 (30·6%) 71 (21·3%) 
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Table 5.2 continued 
 Wandsworth 37 (22·6%) 24 (14·1%) 61 (18·3%) 
 Bexley 0 (0·0%) 12 (7·1%) 12 (3·6%) 
Diabetes duration (years) 10 (7–13) 9 (5–12) 9 (6–12) 
BMI (kg/m2) 32·0 (5·6) 31·9 (6·6) 31·9 (6·1) 
Systolic blood pressure (mm/Hg) 135·2 (16·9) 133·2 (17·3) 134·2 (17·1) 
Diastolic blood pressure (mm/Hg) 79·5 (9·8) 79·0 (10·3) 79·2 (10·1) 
Total cholesterol (mmol/L) 4·3 (1·1) 4·2 (1·2) 4·2 (1·2) 
Fasting triglycerides (mmol/L) 1·7 (1·2) 1·7 (1·3) 1·7 (1·3) 
Taking insulin      
 
 Yes 
75 (46·3%) 66 (39·8%) 141 (43·0%) 
Any retinopathy      
 Yes 59 (35·9%) 65 (38·2%) 124 (37·1%) 
 No 105 (64·0%) 105 (61·8%) 210 (62·9%) 
Albumin:Creatinine ratio      
 Negative 65 (59·1%) 83 (69·8%) 148 (64·6%) 
 Positive 45 (40·9%) 36 (30·3%) 81 (35·4%) 
Protein:Creatinine ratio      
 Negative 33 (76·7%) 17 (77·3%) 50 (76·9%) 
 Positive 10 (23·3%) 5 (22·7%) 15 (23·1%) 
Foot ulcers      
 Yes 9 (5·6%) 12 (7·1%) 21 (6·4%) 
 No 152 (94·4%) 157 (92·9%) 309 (93·6%) 
Macrovascular disease       
 Yes 61 (37·2%) 55 (32·4%) 116 (34·7%) 
 No 103 (62·8%) 115 (67·7%) 218 (65·3%) 
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Table 5.2 continued 
Patient Health Questionnaire-9 score       
 ≥10 31 (20·4%) 35 (22·4%) 66 (21·4%) 
 <10 121 (79·6%) 121 (77·6%) 242 (78·6%) 
Diabetes Distress Scale (mean item 
score) 
2·1 (1·7–2·7) 2·0 (1·6–2·7) 2·1 (1·6–2·7) 
Data are n (%), median (IQR), or mean (SD), as appropriate. 
1Yes = full time, part-time, student or self-employed; 2No = retired/unemployed/not seeking 
employment 
*Values missing for age (n=1), ethnicity (n=2), relationship status (n=2), education level (n=6), 
diabetes duration (n=20), body mass index (n=5), systolic blood pressure (n=25), diastolic blood 
pressure (n=26), HbA1c (n=1), total cholesterol (n=53), fasting triglycerides (n=58), insulin (n=6), 
albumin:creatinine ratio (n=105), protein:creatinine ratio (n=269), foot ulcers (n=2), Patient Health 
Questionnaire-9 (n=26), diabetes distress scale (n=27). 
 
 






The mean number of sessions attended was 7·42 (SD 4·4) and 8·20 (SD 4·4) in the 
D6 and standard care plus attention control groups, based on n=139 and n=121 non-
missing observations, respectively.  
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Primary outcome data at 18-month follow-up were collected for n=219 (65·6%). 
Twelve participants had missing 18-month HbA1c data but complete 15-month 
HbA1c data, yielding a total n=231 for the primary outcome analysis. There was a 
non-significant larger proportion with missing HbA1c in the D6 group compared to 
standard care (35·9% versus 32·9%, respectively) and were more likely to be 
African/Caribbean or Asian/Other, with no other differences in baseline 
characteristics.  
 
In the ITT analysis there was no significant difference in mean HbA1c at follow-up in 
the D6 group compared to the standard care group (mean difference -0·79 mmol/mol, 
95% CI -5·75–4·18) (Table 5.3) The ICC for the clustering effect of nurse was 0·02 
(95% CI 0·001–0·37). There was no evidence of an association between the number 
of D6 sessions attended and HbA1c at 18 months within the D6 group (-0·44 mmol 
HbA1c per additional session attended, 95% CI -1·28–0·41).  
 
Linear mixed models showed no significant effects of the intervention on the 
secondary outcomes including BMI, blood pressure, fasting triglyceride or 

















Table 5.3: Results from D6 Primary and Secondary Outcome Measures 







Estimated Mean Difference: 
D6 vs. standard care (95% 
CI) 
Primary       
HbA1c (mol/mmol)* 332 231 -0·79 (-5·75–4·18) 
Secondary       
BMI (kg/m2)* 329 152 -0·08 (-1·12–0·97) 
Total cholesterol* 281 140 -0·08 (-0·42–0·27) 
Systolic blood pressure 
(mm/Hg)* 
309 198 -1·35 (-6·85–4·14) 
Diastolic blood pressure 
(mm/Hg)* 
308 198 1·22 (-1·87–4·32) 
Fasting triglycerides** 276 135 0·02 (-0·22–0·26) 
Patient Health Questionnaire-
9 Score*** 
308 114 -0·18 (-1·30–0·94) 
*Estimates based on linear combination from linear mixed-effects model with fixed effects of time 
(15 or 18 months),  an interaction between time and randomisation group, randomisation phase, 
borough and baseline values of the outcome, a random effect for GP practice nurse clustering and 
with unstructured covariance matrix to account for dependency of repeated observations. 
**Estimates based on linear combination from linear mixed-effects model with fixed effects of time 
(15 months or 18 months), an interaction between time and randomisation group, randomisation 
phase, borough and baseline values of the outcome, a random effect for GP practice nurse clustering 
and with independent covariance structure due to convergence issues when estimating non-zero 
covariances. 
***Collected at 18 months only. Estimates based on linear combination from linear mixed model 
with fixed effects of randomisation phase, borough, baseline value and  random within-cluster effect 






Results were similar for the sensitivity analysis using practice as the clustering 
variable in place of nurse as cluster. A sensitivity analysis including a binary 
covariate for those 29 participants with baseline HbA1c <64 mmol/mol did not show 
any effect on the primary outcome. Similarly, the sensitivity analysis using multiple 
imputation to account for missingness in HbA1c showed no evidence of a group 
difference.  
 
There were 43 serious adverse events reported after 18 months for 38 different 
participants (n=14 and n=24 in D6 and standard care group respectively). These were 
coded as cardiovascular (n=11), injury (n=5), cancer (n=4), infection (n=5), diabetes-
related (n=3), psychiatric (n=2) and other (n=10). There was no difference in the 
distribution of serious adverse events between the 2 groups. Two participants died 
during the trial, secondary to cancer.  
 
Results of Process Evaluation Components Recruitment, Dose Delivered and 




Due to difficulties recruiting patients from a poorly controlled T2D population, 2 
inclusion criteria were amended via research ethics committee.  
 
Original inclusion criteria required one HBA1c result ≥ 64 mmol/mol% (equivalent to 
8%) in the past 18 months but this was amended via research ethics committee to 2 
HBA1c results ≥ 64 mmol/mol%, once in the past 18 months and once at recruitment, 
in order to better capture a persistently poorly controlled population.  
 
Due to difficulties in achieving adequate sample size, HbA1c was lowered from 







Dose Delivered and Dose Received 
 
Data on Dose Delivered were collected as a requirement of CONSORT guidelines for 
the design and conduct of RCTs. The mean number of sessions attended was 7.42 (SD 
4.4) and 8.20 (SD 4.4) in the D6 and standard care plus attention control groups, 
based on n=139 and n=121 non-missing observations, respectively. Dose Delivered 
and Dose Received represent the measurement in a psychological intervention, in 
contrast to a pharmaceutical intervention for example, when the patient is prescribed a 




This was a cluster RCT to test the effectiveness of a low intensity psychological 
intervention to support self-management in people with T2D to improve their 
glycaemic control and other biomedical outcomes. The main finding was that training 
nurses in psychological skills drawn from MI and CBT did not result in significant 
changes in glycaemic control or any secondary outcomes in people with T2D and 
persistent sub-optimal glycaemic control when compared to usual care with attention 
control.  
 
Strengths and Limitations  
 
Strengths of this study are that it was a pragmatic design, conducted in a real world, 
primary care setting in an ethnically diverse area of South London. The sample 
represented the diversity of the wider T2D population and typical NHS nurses 
(Gulliford et al., 2007). The D6 intervention was developed in line with the current 
evidence base, underpinned by theoretical concepts. This intervention was then 
manualised, and Fidelity of implementation was measured (Chapter 6). In addition, a 
cluster randomised design was employed in order to reduce the risk of contamination 
between intervention and control group participants e.g. if an intervention nurse were 




Limitations of this study included poor uptake by GP practices invited to participate, 
at a rate of 20%. Practices were offered backfill payment as an incentive to 
participate, and to cover the cost of the nurse who would be required to give time to 
the D6 trial, but many declined despite this. Practices that were privately owned, non-
NHS practices did not respond to invitation to participate. A protocol amendment 
during the course of the study lowered HbA1c inclusion threshold, as recruitment rate 
of this hard to reach population was slow. BMI was also raised to 50kg/m. Sensitivity 
analyses showed that these changes did not alter effect size. There was also a protocol 
violation at the beginning of recruitment which saw n = 29 patients recruited below 
minimum HbA1c requirements. Sensitivity analysis showed that this did not affect 
primary outcome.  
 
Can the process evaluation help explain the non-significant findings?  
 
 
The literature review in the previous chapter found that the majority of RCTs of 
psychological interventions to improve outcome in T2D were low intensity designs 
delivered by non-specialists. D6 shared these characteristics. However, where most 
RCTs have been subjected to minimal process evaluations, 8 of the 12 components of 
process evaluation outlined in Chapter 3 were applied to D6 (with the remaining 4 
components discussed in Chapter 9).   
 
Patient attendance at D6 sessions was problematic, with average 50% attendance rate, 
meaning they did not receive the full ‘dose’ of D6 intervention. No dose response 
relationship was observed. These results may be explained by the fact that D6 focused 
on reaching a population with established, poorly controlled T2D who were reluctant 
to engage with healthcare providers. Patients were also difficult to engage at follow 
up, with many refusing to attend follow up appointments despite repeated invitation 
and intensive project management by researchers. Patients had average disease 
duration of 10 years, yet reported low levels of diabetes related distress, suggesting a 
state of denial. Chapter 8 explores Patient Perspectives and Barriers and Facilitators 
to attendance.  
 
The non-significant results may also be partly explained by nurse factors, explored in 
the Fidelity study in Chapter 6, which found that proficiency in most MI and CBT 
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domains was sub-optimal and similar to the control group. The qualitative study 
reported in Chapter 7 explores Provider Experience and Barriers and Facilitators to 
intervention implementation, and suggests that this group of nurses did not possess 
inherent baseline characteristics conducive to the acquisition of psychological skills. 





D6 represented a novel exploration of the benefits of combining MI and CBT with the 
aim of improving glycaemic control in patients with T2D and persistent sub-optimal 
glycaemic control. Results were non-significant with the clinical implication that 
training primary care nurses in psychological skills does not lead to improvements in 
self-management in patients with T2D. It may be that MI and CBT do not apply to the 
T2D population, a possibility since these therapies were developed within the 
addiction and mood disorders context, for use with patients with alcohol and drug 
addiction (MI) and depression (CBT). In addition, both of these therapies are 
designed to target single issues, while management of T2D is highly complex, 
involving multiple physical and psychological challenges. The need for further 
research into the most effective therapies for T2D patients is clear, and process 




Chapter 6: Assessing Fidelity and Competencies of Practice 
Nurses Delivering Motivational Interviewing and Cognitive 
Behavioural Therapy to Support Self-Management in Type 




In Chapter 5, the protocol for the single blind cluster RCT comparing the D6 
intervention with usual diabetes care was described. The main ITT findings and 
quantitative components on Recruitment, Dose Delivered and Dose Received of the 
process evaluation were reported.  
 
This chapter describes a study that was conducted as part of the process evaluation of 
D6. The study aimed to assess the Fidelity component of process evaluation as 
outlined in Chapter 3. The different definitions of treatment fidelity and the rationale 
and importance for measuring fidelity when attempting to understand the mechanisms 
of action of a psychological intervention are discussed. The chapter then discusses the 
methodological complexity of measuring fidelity, particularly in the context of MI. 
The aims, methods and results of the D6 fidelity study are reported, followed by a 
discussion of whether they inform a better understanding of why the D6 RCT 
outcome was negative.  
 
Definitions of Fidelity 
 
A working definition of treatment fidelity is that it refers to ‘confirmation that the 
manipulation of the independent variable occurred as planned’ (Moncher & Prinz, 
1991).  
 
Several different terms have been used to describe intervention fidelity, including 
‘implementation fidelity’ (Breitenstein et al., 2010), ‘fidelity of implementation’ 
(Dusenbury et al., 2003; Sánchez et al., 2007), ‘fidelity’ (Fixsen, Naoom, Blase, & 
Friedman, 2005), ‘treatment fidelity’, (Bellg et al., 2004) ‘treatment integrity’ (Lane, 
Bocian, MacMillan, & Gresham, 2004), and ‘intervention fidelity’ (Santacroce, 
 
180 
Maccarelli, & Grey, 2004). All these terms capture the same underlying construct, 
namely, is the intervention being delivered as intended? Treatment fidelity is the term 
that will be used in this thesis to refer to the set of methodologies used to monitor and 
enhance the reliability and validity of a behavioural intervention.  
 
The Rationale for Considering Treatment Fidelity  
 
Assessment of treatment fidelity and quality of implementation assists in interpreting 
primary outcomes, provides contextual information, and potentially explains why an 
intervention did or did not work (Oakley et al., 2006). If the treatment has not been 
implemented according to protocol, what did the interventionists or therapists then 
deliver, what is the level of fidelity required for the research community to replicate 
and/or commissioners to translate it, (Cook, Campbell, & Day, 1979; Glasziou et al., 
2010). In the absence of an assessment of fidelity we cannot be sure that an effective 
intervention was as a result of the intervention itself, or another factor(s) related to the 
study such as the sample selection, or omitted. Conversely, if an intervention did not 
work, we cannot be sure that non-significant results were due to the failure of the 
intervention itself or a failure of implementation. For instance, a classic example of 
implementation failure was reported as part of an RCT designed to help ex-offenders 
find employment using a combination of job coaching and one on one sessions with 
ex-offenders trained in readjusting existing offenders to daily life. However, it was 
reported that only 1 in 20 participants actually received the intervention as per 
protocol. This was because of several factors that interfered with implementation, 
namely an observed bias in which the interventionists appeared to focus attention on a 
subset of participants, high interventionist turnover, and administrative difficulties 
which led to delays in contacting participants (Dobson & Cook, 1980). The null 
outcome could therefore not be attributed to the intervention that was described. The 
authors concluded that they had evaluated a ‘phantom programme’ and speculated 
that the original protocol, properly implemented, may have had a positive outcome.  
 
This type of implementation failure is also known as a Type III error, which Scanlon 
et al defined as follows, ‘Statisticians worry about two type of errors... Type I error is 
rejecting a hypothesis when it should be accepted; Type II error is accepting a 
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hypothesis when it should be rejected. Researchers commonly make two other types 
of errors when conducting process evaluations: Type III error is measuring something 
that does not exist; Type IV error is measuring something that is of no interest to 
management and policy makers’ (Scanlon, Horst, Nay, Schmidt, & Waller, 1977). A 
Type III error may lead to potentially effective new interventions being prematurely 
abandoned, or to ineffective interventions being erroneously adopted (Dobson & 
Cook, 1980).  
 
Defining the Concept of Treatment Fidelity  
 
Historically, the assessment of treatment fidelity has been problematic as there is no 
consensus on how it should be conducted (Dusenbury et al., 2010). This has led to 
different interpretations, making selection of appropriate research methods subjective 
and making the comparison of fidelity between different studies difficult. A review 
article published in 1991 attempted to synthesise fidelity research drawn from subject 
areas of clinical psychology, behaviour therapy, psychiatry and marital family therapy 
(Moncher & Prinz, 1991). The review evaluated 359 ‘treatment outcome’ studies, 
conducted between 1980-1988, assessing the extent of their assessment of fidelity. 
The review concluded that, although there had been significant improvements in the 
assessment of treatment fidelity, the majority of the studies (55%) had omitted to do 
so. However, the review made an important contribution towards the assessment of 
the quality of previous fidelity research, by identifying methods used to train those 
delivering complex interventions; the procedures used to promote fidelity in 
intervention delivery; aspects of treatment studied; methods used for assessing fidelity 
and extent of utilisation of treatment fidelity assessment in the interpretation of 
results.  
 
Some researchers have defined treatment fidelity as an all-encompassing concept, 
comprising exposure, dose and participant engagement (Dane & Schneider, 1998), 
while others have suggested that multiple components must be studied separately in 
order to achieve a comprehensive picture of treatment fidelity. This latter approach is 
supported by literature reviews of fidelity studies, which have concluded that studies 
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have included too few components when assessing intervention fidelity (Dane & 
Schneider, 1998; Dusenbury et al., 2003).  
 
In process evaluation research, fidelity is defined as a distinct concept alongside other 
process evaluation components. For example, in their framework for process 
evaluation, Linnan and Steckler defined fidelity as ‘the extent to which an 
intervention was implemented as planned’ (Linnan, 2002). They then considered this 
concept of fidelity as useful in combination with the concepts of ‘dose’ and ‘reach’ in 
creating a picture of overall treatment implementation.  
 
This is theoretically similar to the concept of treatment fidelity later adopted by the 
MRC in their process evaluation guidance (Moore et al., 2015). They refer to a 
definition which defines fidelity as a combination of ‘content’ (similar to Linnan and 
Steckler’s fidelity), frequency and duration of delivery (similar to Linnan and 
Steckler’s dose) and ‘coverage’ (Linnan and Steckler’s reach) (Carroll et al., 2007). In 
this framework, fidelity is moderated by factors such as intervention complexity, with 
a more complex intervention considered more difficult to assess for fidelity than a 
simple one (Carroll et al., 2007; Hasson, 2010).  
 
The most recent guidelines for process evaluation produced by the MRC propose a 
definition of treatment fidelity but do not provide specific guidelines for the 
assessment of treatment fidelity of complex psychological interventions, instead 
giving general descriptions of methodologies, with no recommendations for a gold 
standard method. This leaves us a better understanding of the construct but no 
consensus on what should be measured and how (Moore G, 2014). 
 
A concept of fidelity now commonly used in RCTs of psychological interventions is 
therapist adherence and competence (Boswell et al., 2013; Mars et al., 2013; Martino 
et al., 2008; Santacroce et al., 2004). The constructs of adherence and competence are 
separate but related. According to Mars et al (Mars et al., 2013) adherence is defined 
as ‘the extent to which a person delivers the essential content, delivery strategies and 
theories prescribed by the intervention designers and avoids activities proscribed by 
them’ while competence refers to ‘the level of ‘skill’ demonstrated by those 
delivering an intervention and may include the ability to respond appropriately to a 
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wide variety of contextual cues.’ Assessing adherence to the planned intervention 
alone does not give a comprehensive picture of overall fidelity (Dusenbury et al., 
2003). Adherence is frequently measured at the programme level of implementation, 
where it refers to the extent to which implementation of the intervention in the target 
setting was consistent with that set out in protocol. Competence is less frequently 




Therapist competence is defined as, ‘the extent that a given treatment is conducted in 
accordance with the instructions or intentions of the respective treatment manual’ 
although historically experts have disagreed on the definition (Kazantzis, 2003). Early 
definitions focused on therapists’ ability to engage the client in a beneficial 
therapeutic relationship (Cooper, 1975; Strupp, 1986). Definitions were later 
expanded to include multiple dimensions which argued the importance of basing 
therapeutic programmes on theoretical approaches (Schaffer, 1983). In recent years, 
there has been increased interest in competency-based practice in line with increased 
demands for accountability, leading to a ‘competencies based movement’ (Kaslow & 
Keilin, 2006). A multidimensional definition of competence defined by Kaslow 
includes ‘intervention competencies’ and specifically the assessment of competencies 
within RCTs. A review of studies assessing the relationship between therapist 
competence and therapeutic outcome found small but positive correlations between 
therapist competence and patient outcome in several limited domains and concluded 
that larger sample sizes are needed to more accurately capture clinical effect. For 
example in one trial of CBT versus usual care in reducing recurrent deliberate self 
harm, a random sample of 49 audiotape CBT sessions delivered by 21 therapists was 
rated to assess therapist competence. At 6 month follow up there was a small but 
statistically significant relationship between therapist competence and observer rated 
depression. There was no association between therapist competence and number of 
self harm episodes during follow up (Davidson et al., 2004). A small number of 
studies demonstrated no relationship between therapist competence and therapeutic 
outcome with the authors speculating that this may be due to the restricted range of 
competencies among experienced therapists. For example, in a study examining the 
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influence of therapist adherence and competence in delivering emotion focused 
therapy on client reprocessing of child abuse memories, no significant effect on 
symptomatic improvement was observed (Paivio, Holowaty, & Hall, 2004). The 
reviewers concluded that more studies including a wider range of competencies (e.g. 
among trainees or non-specialists) is needed (Barber, Sharpless, Klostermann, & 
McCarthy, 2007).  
 
A further challenge is the assessment of competence over time. A traditional view 
was that once a therapist achieves competence they retain it for a lengthy period of 
time e.g. months or years. However, studies have shown great variation in therapists’ 
performance in delivering MI over time (Forsberg, Forsberg, Lindqvist, & Helgason, 
2010). A pilot study assessing the effects of a two day MI training workshop for staff 
working within probation services found that therapists showed an increase in MI 
skills after training completion, but that these skills were not maintained at 3 month 
follow up (Miller & Mount, 2001), while another found that behavioural health 
providers with low baseline skills showed a decrease in newly acquired MI skills at 4 
month follow up (Moyers et al., 2008). Interventions that are observed as effective in 
the original RCT often are less effective when implemented into routine care. One 
explanation could be that the level of competency and fidelity was higher in the RCT 
and could not be replicated when translated into clinical practice but because the level 
of competency was not measured we do not know what skills to teach at what level 
and what level of supervision is needed for maintenance of these skills (Fixsen et al., 
2005). If interventions are to be adopted in practice by different therapists with 
different levels of expertise, it is essential that researchers understand the level and 
degree of fidelity and competency required to implement an intervention reliably 
(Glasgow et al., 2003). It is now argued that even the most experienced therapists 
require continued competence assessment (Kazantzis, 2003).  
 
Despite widespread use of MI and CBT, many studies do not assess the competence 
with which they were delivered (Lai, Cahill, Qin, & Tang, 2010; Moyers, Miller, & 
Hendrickson, 2005b). Therapists vary widely in a number of characteristics, which 
may affect the delivery of a psychological intervention. These may include: 
motivation to engage with the practice of MI (nurses may not be interested in 
adopting an enhanced role); interpersonal skills (e.g. nurses may not have sufficient 
 
185 
capacity to empathise) and previous training (some nurses may have previous 
experience of psychological skills training) (Moyers et al., 2005b). This potential for 
variation may be further increased when acquiring and using MI skills falls outside 
the therapist’s usual job remit for example the qualitative study described in Chapter 7 
found that GP practice nurses trained in psychological skills aimed at improving self-
management in T2D found that nurses lacked confidence to step outside their 
established role (Graves, Garrett, Amiel, Ismail, & Winkley, 2016).  
 
The Fidelity Versus Adaptation Debate 
 
While it is crucial to assess whether or not an intervention was implemented 
according to protocol, there is a debate in the literature about the relative merits of 
adhering strictly to protocol for the study duration, versus allowing room for changes 
to sampling strategies, timings, localities and other factors (Shen, Yang, Cao, & 
Warfield, 2008). Some researchers argue that ‘true’ fidelity to the protocol is 
necessary, that adaptation is a mistake (Szulanski & Winter, 2002) and that 
programme modification makes evaluation across different settings challenging 
(Boruch & Gomez, 1977). Others argue that programmes must be modified to local 
conditions to ‘maximise efficiency as well as local ownership’ (Fairweather & 
Tornatzky, 2013; Shen et al., 2008). Differences in local populations, resources, 
budgets and organisational factors may all necessitate changes to protocol (Johnsen et 
al., 1999). Many researchers therefore posit a mixed fidelity-adaption approach, 
which identifies which programme components require absolute fidelity to the 
original protocol and which may be adapted. Several approaches have been proposed. 
Leff and Mulkern (Leff & Mulkern, 2002) and Kelly et al (Kelly, Heckman, 
Stevenson, & Williams, 2000) posit an empirical approach involving the 
deconstruction of protocols and individual testing of components across multiple 
sites. Components determined not critical in determining outcome may then be 
adapted across different settings, although the method requires significant resources. 
Others have posited an approach which allow changes to protocol up to the point of 
‘drastic mutation’, or up to the point at which the programme’s integrity would be 
effected by further dilution (Hall cited in (Blakely et al., 1987), although this method 
is vulnerable to varying interpretations of ‘drastic’. A third approach posits that 
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changes may be made providing they do not contradict underlying programme theory 
(Price, Friedland, Choi, & Caplan, 1998). This approach allows staff across multiple 
sites to adapt programmes to local context.  
 
In an intervention such as D6, which required multiple nurses to deliver an 
intervention across multiple sites, some adaptation to local circumstances is expected. 
The potential effects of these adaptations are covered in the discussion section of this 
chapter.  
 
Measuring Treatment Fidelity  
 
Methods used in the assessment of treatment fidelity of complex interventions include 
interventionist/clinician self-report; participant self-report; ethnographic data and 
rating of audiotaped intervention sessions (Mowbray, Holter, Teague, & Bybee, 
2003).  
 
Self-Reported Treatment Fidelity  
 
Self-reported treatment fidelity is the most subjective method of assessing treatment 
fidelity and therefore the most likely to be biased (Carroll et al., 2002). For example, 
in a secondary analysis of an RCT examining the effects of 2 different supervision 
conditions on the development of MI skills, therapists reported their use of a variety 
of MI adherent techniques, but independent observers found a much more limited use 
of these techniques (Wain et al., 2015). Supervision conditions included tele-
conferencing supervision of 5 x weekly counselling sessions including simulated 
interactions with actors posing as patients. Each session was monitored by a 
supervisor and who provided real time feedback and written follow up feedback. The 
second supervision condition was tape-based, for participants who completed 5 x 
weekly audio taped simulated interactions with actors playing patients. The audiotape 
was sent to the supervisor who provided written feedback in addition to verbal 
feedback via telephone. Participants in a ‘workshop only’ training condition received 
no feedback. Participants’ self-reported ability increased with supervision but self-
report was not an indicator of objectively measured increased skill. Similarly, another 
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RCT found low concordance between therapist self-reports of psychotherapeutic 
strategies used with children with disruptive behaviour and observer ratings (Hurlburt, 
Garland, Nguyen, & Brookman-Frazee, 2010). Sixty three videotaped therapy 
sessions delivered to 18 children and their caregivers in community outpatient clinics 
by 11 therapists were assessed. Analyses focused on frequency, type and intensity of 
goals and strategies pursued in therapy sessions. Therapists reported an average of 2.5 
more goals and strategies per session than those identified by observational coders. 
Self-report strategies are therefore too limited by their potential social desirability 
effects and variation in rater competencies to be valid fidelity assessment tools.  
 
Ethnographic Data  
 
Other methods of obtaining fidelity data include observational data collected by a 
trained observer (Resnicow et al., 1998), although this method is rarely employed 
since it is very resource intensive, and has the potential to produce reactions from the 
therapist and/or patient under observation which may affect any treatment effect and 
which may not sufficiently reflect real world practice (Sheridan, Swanger-Gagné, 
Welch, Kwon, & Garbacz, 2009). The observer is likely to be a senior expert of the 
intervention and will have a vested interest in over estimating fidelity.  
 
Rating of Audiotaped Intervention Sessions  
 
A well recognised standard method for assessment of treatment fidelity is the 
recording and coding of intervention sessions using audiotape and checklist rating 
methods (Bellg et al., 2004). Audiotape recordings minimise bias in that they remove 
potential for subjective reporting of the contents of an intervention session. Reliable 
and valid checklists can then be used in order to assess (i) dose of the intervention 
delivered as planned, (ii) dose of the intervention that was delivered to the control 
group and (iii) to what extent the competence of therapists was maintained during the 
study. However this too is vulnerable to errors unless carefully monitored: the 
therapists can 'lose' the equipment or locate it out of recording range; patients and 
therapists may not give consent; the rater may introduce his/her own biases in rating 
fidelity by accents, gender.   
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The main aim of this chapter is to assess whether D6 nurses adhered to the manual 
and whether they had achieved competency in the MI and CBT skills to support self-
management in patients with poorly controlled T2D compared to an attention control 
condition.  
 
Specifically the aim of the treatment fidelity is to examine:  
i) Whether D6 nurses achieved competencies in the D6 skills at the start of delivering 
therapy 





All nurses who participated in the D6 RCT were required by protocol to digitally 
record their appointments with patients. A representative sample of the tapes from 
both trial arms was selected to assess fidelity and competency. Nurses were randomly 
allocated to receive training in D6 or to attention control. 
 
The Training Program in D6 
 
The psychological skills training program for nurses in the intervention arm of the 
RCT was developed and delivered by an experienced clinical psychologist Band 8a. 
The initial interactive training workshops were conducted over 12 x 3-hourly sessions 
based on a manual that the nurses could use for self directed learning, revision, 
reference and clinical aid. The focus of the intervention was on increasing patients’ 
motivation to improve their diabetes control and then collaboratively addressing key 
self-care behaviours such as medication adherence, blood glucose testing, physical 




Techniques Taught in Motivational Interviewing and Cognitive Behavioural 
Therapy  
 
These psychological interventions are both evidence-based approaches aimed at 
producing behavioural change in a range of settings, and there is evidence that 
integrating MI and CBT may be beneficial (Arkowitz, 2004).  
 
MI is a collaborative, person-centred approach to working with people in order to 
elicit and strengthen their motivation and commitment to change (Miller & Rollnick, 
2002). It was originally developed for use in the substance abuse context, when 
counsellors, particularly those working with alcohol abuse, noted a large amount of 
conflict within patients, particularly poor motivation, denial and resistance. These 
qualities were considered ingrained within the clients themselves, until Miller 
developed the hypothesis that the style in which clients were spoken to may have the 
potential to either enhance or decrease their level of motivation to change (Miller, 
2000).  
 
MI was then developed as a specific counselling style, which provided counsellors 
with skills to explore the client’s uncertainty about change and reduce resistance. A 
central guiding tenet of the approach is that the motivation to change should come 
from within the client, and not be imposed upon them by the counsellor. There are 
three main concepts, which are central to the motivational interviewing approach, as 
follows: 
 
(i) Readiness: This concept is borrowed from the Stages of Change Model of Health 
Behaviour (Prochaska et al., 1985), which emerged in parallel with the field of MI 
and is based on the principle that people have different needs to be addressed, 
depending on their stage of readiness to change. It provided useful inspiration for the 
concept of readiness underpinning MI, which states that moving too far ahead of the 
patient’s stage of readiness to change will result in their resistance. Furthermore, 
readiness underpins two tenets of MI, which are importance and confidence. 
Importance refers to the individual’s evaluation of the importance of making personal 
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changes, while confidence refers to the person’s willingness and confidence in their 
ability to change. 
 
(ii) Ambivalence: Ambivalence about change refers to the way that a patient may 
simultaneously feel the desire to change but also the desire to resist it. The job of the 
therapist is to harness the innate motivation within the client by encouraging them to 
recognise problems, to express desire to change their behaviour, and to feel that they 
have the ability to do so. This enable the client to hear themselves expressing the 
desire for change, rather than simply being told they must do it.  
 
(iii) Sustain Talk: Sustain talk is related to the concept of denial and refers to the 
reluctance on the part of the client to make any progress. When it becomes clear that 
the counsellor’s views are not congruent with those of the client, resistance occurs.  
 
In addition, there are principles underpinning the practice of MI. These are: 
‘expressing empathy’; ‘rolling with resistance’; ‘supporting self-efficacy’ and 
developing discrepancy’.  
 
(i) Expressing empathy: The counsellor makes simple empathic statements and more 
complex statements designed to highlight aspects of the client’s problem that might 
encourage the resolution of ambivalence.  
 
(ii) Rolling with resistance: This is concerned with the maintenance of harmony 
throughout the session and it concerns the need to avoid confronting the client 
directly.  
 
(iii) Supporting self-efficacy: Self-efficacy can predict successful behaviour change 
(Maddux, 2016). Emphasis is placed on eliciting innate self-efficacy, rather than 
attempting to impose it directly onto the patient. 
  
(iv) Developing discrepancy: The discrepancy between the client’s personal values 
and desires for the future and the self-destructive nature of their behaviour is not 




The skills used in motivational interviewing are ‘empathic listening skills’, ‘eliciting 
self-motivating statements’ (change talk), and ‘responding to resistance’, as follows:   
 
(i) Empathic listening skills: these comprise open questions, affirmation, summarising 
and reflective listening. 
 
(ii) Eliciting self-motivating statements (change talk): the counsellor elicits arguments 
for the case to change from the client, rather than imposing them upon the client.  
 
(iii) Responding to resistance: the counsellor should respond constructively to 
resistance, which can be viewed as damaged rapport between the client and 
counsellor. The counsellor should acknowledge the patients’ difficulty by focus on 
the positive. 
 
Techniques Taught in Cognitive Behavioural Therapy  
 
CBT attempts to modify behaviours by altering thoughts, interpretations and 
assumptions. Negative patterns of thought about the self and about the world are 
challenged with the aim of changing undesirable patterns of behaviour (Beck, 2011). 
The approach focuses on difficulties in the present, and relies on an alliance and 
shared view of the problem between the client and the therapist.  
 
Problems are identified and understood in terms of the relationship between thoughts, 
feelings and behaviours. This then leads to the development of personal goals and 
strategies. There are a number of key elements to CBT, which together combine to 
bring about change; these are as follows:  
 
(i) The therapeutic alliance: a trusting, safe relationship between client and therapist is 
essential to bring about change (although not sufficient on its own). 
 
(ii) Collaboration: the relationship between client and therapist is viewed as 




(iii) Formulation: A map or hypothesis of problems is formulated, within the context 
of an evidence-based, CBT framework. 
 
(iv) Socratic dialogue: A method of communicating which focuses on guided 
discovery. The client should be gently guided towards the realisation that there are 
alternative ways of thinking.  
 
(v) Goal setting: Goals are set in between sessions; these goals often include 
behavioural experiments designed to challenge unhelpful thoughts and assumptions. 
 
Combining Motivational Interviewing and Cognitive Behavioural Therapy  
 
There is evidence in substance misuse settings that integrating CBT and MET may 
increase their efficacy (Haddock et al., 2003; Parsons et al., 2005). In a three arm 
parallel RCT, when these two therapies were combined (which meant more sessions), 
treatment was associated with an HbA1c reduction of 0.5% compared to usual 
diabetes care in people with poorly controlled type 1 diabetes but MET on its own 
was not (Ismail et al., 2008a). The combination of MI and CBT as a treatment to 
improve poor glycaemic control in T2D has not yet been tested and that was the aim 




Nurses attended monthly supervision with the trial clinical psychologist either in 
person at monthly group sessions or over the telephone if they were not able to attend. 
E-mail support was also offered for individual cases.  
 
Assessment of Fidelity to Motivational Interviewing  
 
MI is a brief (usually 1-4 sessions) counselling method for enhancing motivation to 
change problematic health behaviors by exploring and resolving ambivalence about 
change (Miller & Rollnick, 2002). In order to make meaningful assessments of 
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treatment fidelity, reliable and valid assessment tools are needed to rate audiotaped 
intervention sessions. Typical rating scales include (i) the Yale Adherence and 
Competence Scale (YACS) which includes 3 subscales measuring 'general' aspects of 
drug abuse treatment (assessment, general support, goals of treatment) (Corvino et al., 
2000). Validation of the YACS using data from an RCT indicated that the scales have 
excellent reliability, factor structure, concurrent and discriminant validity (Carroll et 
al., 2000) (ii) the Motivational Interviewing Skill Code (MISC) yields global scores 
on qualitative dimensions of theoretical importance to MI followed by quantitative 
behaviour counts, and has acceptable psychometric properties (Miller, 2000) (iii) the 
Motivational Interviewing Process Code (MIPC) comprises 25 items split into two 
subscales assessing functional and dysfunctional skills, both rated on a 5-point Likert 
scale however its utility as a measure is questionable as it is not satisfactorily 
validated (Wallace & Turner, 2009) (Barsky & Coleman, 2001) (iv) the Motivational 
Interviewing Supervision and Training Scale (MISTS), which comprises behaviour 
counts and global ratings of aspects of MI, although would benefit from further 
statistical analysis to assess validity such as factor analysis (Madson, Campbell, 
Barrett, Brondino, & Melchert, 2005) (Wallace & Turner, 2009) and (v) the 
Motivational Interviewing Treatment Integrity Scale (MITI) (Moyers et al., 2005a).  
 
The most widely used rating scale of fidelity to MI is the MITI, which has a number 
of advantages. Its reduced length and complexity compared to the measure which 
preceded it, the MISC, means that it is useful in training, supervision, and research 
settings (Madson et al., 2005). It has also been found to have adequate reliability and 
validity (Moyers, Martin, Catley, Harris, & Ahluwalia, 2003) with an inter-correlation 
coefficient of .51 to estimate interrater reliability of global ratings for 
empathy/understanding and .58 for spirit of MI. The ICCs for the behavioural counts 
ranged from .57 to .96 (Moyers, Martin, Manuel, Hendrickson, & Miller) and these 
coefficients have been considered adequate according to the classification of clinical 
significance (Cicchetti, 1994).  
 
The MITI, version 3.0 was used to measure competence and skills used in both 
groups of nurses (Moyers et al., 2007). The MITI was designed to assess how well or 
how poorly a therapist is delivering MI. It was designed as both a measure of 
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treatment fidelity for RCTs with an MI component and as a tool to provide feedback 
for therapists outside of a research environment.  
 
The MITI comprises two components: Behaviour Counts and Global Scores. 
Behaviour counts are simple counts of the occurrence of therapist behaviours 
throughout the interview. In this instance the coder is not required to make any 
interpretation of quality. Global scores require the coder to select a single number 
from a 5-point scale to characterise the interaction. Global scores therefore represent a 
‘global judgement.’ The 5 global dimensions rated are Evocation, Collaboration, 
Autonomy/Support, Direction, and Empathy. Both Behaviour Counts and Global 
Scores are rated during a single review of a 20-minute segment of a recording. Five 
summary scores are produced including Global Spirit Rating; Percent Complex 
Reflections; Percent Open Questions; Reflection-to-Question Ratio and Percent MI 
Adherent.  
 
The Global Spirit score and Empathy scores were selected as the most relevant 
measures for assessing fidelity in D6 as they are intended to capture the overall 
competence of the therapist in using MI, and the extent to which the therapist 
understands, or attempts to understand the patient’s perspective. Since they are 
comprised of the Evocation, Collaboration, Autonomy/Support scores, these measures 
were considered superfluous in this instance. Further measures of interventionist 
behaviours included the use of simple reflections, complex reflections, open questions 
and closed-ended questions. Scores are also calculated for MI adherent and non-
adherent counselling behaviours.  
 
Tools for Measuring Fidelity to Cognitive Behavioural Therapy  
 
CBT is also a brief but longer therapy (usually a minimum of 6-12 sessions) that aims 
to enable the patient to identify, challenge and substitute unhelpful cognitions and 
behaviours with more constructive ones (Beck, 2011). Rating scales used to measure 
therapist treatment fidelity to CBT include the Cognitive Therapy Rating Scale 
(CTRS), comprising 13 items measured on a 6-point Likert scale with high internal 
consistency and adequate average inter-rater reliability (Young & Beck, 1980) 
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(Blackburn et al., 2001). An alternative is the Collaborative Study Psychotherapy 
Rating Scale (CSRPS) (Hollon et al., 1988) which is composed of 96 items rated on a 
7-point Likert scale.  
 
A more general tool used to assess fidelity to behaviour change counseling methods 
such as MI and CBT is the Behaviour Change Counselling Index (BECCI) (Lane et 
al., 2005). It is designed to measure fidelity to methods of behaviour change 
counselling in which the client is encouraged to make their own decisions about 
positive change. It has therefore been used to measure fidelity to a range of behaviour 
change techniques (Beck et al., 2015; Spanou et al., 2010) more applicable to CBT 
(Britton et al., 2015; Olsen, Smith, Oei, & Douglas, 2012).  
 
The BECCI consists of an 11-item checklist across 4 domains, which include Agenda 
Setting and Permission Seeking; The Why and How of Change in Behaviour; The 
Whole Consultation and Talk about Targets. The rater scores the degree to which the 
therapist has performed each item on the checklist on a 5-point Likert scale. Scores on 
individual items are therefore produced alongside a global score in the form of the 
BECCI Practitioner Score, produced by calculating the mean of all individual items.   
 
It is a brief, easy to use measure more applicable to D6, where the aim was not to 
train practice nurses to the level of CBT therapists but to enable them to acquire basic 
skills in behaviour change techniques. It was included here in order to assess nurses’ 
competence in eliciting patients’ thoughts and cognitions, therefore addressing the 




All nurses were required by protocol to digitally record their D6 treatment 
consultations. Nurses completed training over 3 months. It comprised 3 hours per 
week, interactive classroom activities, a training caseload (average 3-5 non-study 
patients), and weekly supervision of audiotaped sessions.  
 
During training, nurses were required to submit the following recorded consultations: 
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Weeks 2-8: 1 x 10 minute consultation per week, rating themselves via coding form.   
Weeks 9-10: 1 x 10 minutes consultation per week with feedback provided from 
trainer.   
Week 11: 1 x 10min consultation submitted for a competency assessment, rated by an 
independent rater using MITI and BECCI.  
 
However, there were a number of issues with obtaining recordings. Nurses were 
provided with digital, battery operated devices in order to record their consultations 
but problems did arise, for example batteries running out, nurses misplacing 
recorders, nurses forgetting to use recorders, and nurses not realising that the recorder 
was switched off. 
 
The total number of recordings was 353 recordings from 154 participants (31 
participants with one recording; 47 with two; and 76 with three) with 266 of them 
usable. The sample of recordings from tapes used to assess fidelity was n=69.  
 
Tapes were selected using random sampling stratified by participant. Either 1 or 2 
tapes from session numbers 1, 3, and 4 were selected for each participant who had at 
least 1 recording. The tapes could be of any length with the treatment centre 
identifiable. Three recordings were under 20 minutes in length, in which case the rater 
selected the next longest recording for that nurse until a 20-minute segment was 
reached. In 2 cases recordings were unusable as nurses did not identify themselves 
and therefore could not be assigned to a surgery.  
 
Two clinical psychologists rated a sample of 20-minute windows of 69 tapes using the 
MITI, and a third psychologist rated the same sample of tapes using the BECCI. The 
MITI requires formal training, which the two clinical psychologists had previously 
undertaken. The BECCI manual requires raters to complete a list of required reading 








Statistical analyses were conducted using SPSS Version 23. To assess inter-rater 
reliability for the MITI global scores and BECCI practitioner scores, intra-class 
correlation coefficients were estimated using a two-way mixed model. The model had 
a fixed effect for rater and a random effect for recording in order to account for 
clustering and it assessed consistency between individual ratings. As the data were not 
normally distributed, Wilcoxon-Mann-Whitney tests were used in addition to t tests to 
compare the nurses’ fidelity of delivery of the intervention in comparison to the 





Twenty-three nurses participated in D6; 11 were randomised to the intervention and 
12 to the control group. The mean age of nurses was 48 years (SD 8.47), all were 
female and the proportion who were White, Black and Asian/Other was 61% (n=14), 
26% (n=6) and 13% (n=3) respectively. Nurses worked in GP practices in 5 South 
London boroughs. Prior training/experience in delivering psychological techniques is 
presented in Table 6.1. Data were not obtained for 6 nurses as data on previous 












Table 6.1: Level of Nurse Training in Psychological Techniques  
 Intervention (n) Control (n) 
Some experience as part of nursing 
qualification  
1 0 
MI training as part of Co-Creating Health 
Program (Foundation) 
1 0 
1 day or less of MI training  1 1 
MI training as part of smoking cessation 
course  
1 1 
Module as part of degree course  1 1 
No previous training 4 5 




Estimates of intra-class correlation coefficients for the global MITI scores and BECCI 
practitioner score are reported in Table 6.2. Inter-rater reliability was greater for 
MITI, where all ratings were for the 20-minute section in the middle of each tape, 
compared to BECCI, where one coder rated 20-minute windows (due to time 












Table 6.2: Intraclass Correlation Coefficients for MITI* Global Scores and 
BECCI** Practitioner Score 
Domain ICC 95% confidence 
interval 
MITI global spirit 0.87 0.77-0.93 
MITI global empathy 0.91 0.86-0.94 
BECCI practitioner score  0.71 0.49-0.85 
*MITI: Motivational Interviewing Treatment Integrity Scale (Moyers et al., 2007); 
**BECCI: Behaviour Change Counselling Index (Lane, 2002) 
 
Nurse Adherence  
 
The mean number of sessions attended was 7.42 (SD 4.4) and 8.20 (SD 4.4) in the D6 
and standard care plus attention control groups, based on n=139 and n=121 non-
missing observations, respectively. Nurses therefore completed just over half of the 




The trial manager, who was MITI trained, assessed post-training adherence and 
competency of all nurses in the intervention group using the MITI and BECCI rating 
scales. One tape was submitted by each nurse at the end of training and rated on each 
of the 2 scales. Thresholds provided by the MITI manual were considered too high for 
the context of this study, where consultations included clinical communications that 
would not be part of a standard MI consultation but part of the role of the practice 
nurse (for example, a physical examination, prescribing, and giving medical advice 
when requested or deemed clinically necessary). Instead, nurses were rated as non-
adherent if they advised, confronted, or directed the patient. Any such nurses were 
given extra training then reassessed. It was assumed that nurses who were being 
adherent to the manual but who did not meet minimum MITI competency levels were 




Assessment of competency after training in the intervention group ranged from 56 - 
100% with mean average 86% competency. This is lower than the percentage MI-
adherent threshold for ‘beginning competency’ score of 90% stated in the MITI 
training manual. One nurse did not reach minimal competency post-training. She was 
therefore given extra training by the clinical psychologist and upon reassessment was 
found to be competent to deliver the therapy. Fidelity data measured during the 
intervention were missing for 5 nurses, primarily because of faults with the tape 
recordings. Mean MITI and BECCI competency scores post-training are presented in 
Table 6.3. 
 
 Table 6.3: Nurse Competence Scores Post-Training (mean; SD) 
Global Spirit 3.42 (0.67) 




BECCI  2.78 (0.50) 
 
Fidelity Analysis  
 
Mann-Whitney U tests revealed a significant difference in the MITI scores of nurses 
in the intervention and control arms of the RCT on the % Open Questions scale (U = 
350, z = -2.79, p = 0.005), with nurses in the intervention group asking significantly 
more open questions than those in the control group. A significant difference between 
the two groups was also observed on the Reflection/Question Ratio scale (U = 750, z 
= 2.12, p = 0.03), with nurses in the control group having a higher ratio of reflections 
to questions.  No significant differences were found between the 2 groups on Global 
Spirit (U = 454, z = -1.51, p = 0.13), Global Empathy (U = 456, z = -1.54, p = 0.12), 
% Complex Reflections (U = 646, z = 0.84, p = 0.40), or % MI Adherent (U = 508, z 




A t-test showed a significant difference in the BECCI practitioner scores of nurses 
between the treatment arms, with a higher score in the intervention group (t 
(262)=5.75, p<0.001, 95% CI 0.23-0.47). 
 
Mean scores for MITI and BECCI summary scales by treatment group are presented 
in Table 6.4.  
 
Table 6.4: Mean Scores for MITI and BECCI Summary Scales by Treatment 
Group 






MITI Minimum Mean 
Competency (proficiency 
benchmark)  
Global Spirit 2.87 (0.90) 3.23 (1.12) 4 (3.5) 
Global Empathy 2.49 (0.98) 2.91 (1.26) 4 (3.5)  
% Complex Reflections 0.40 (0.17) 0.35 (0.20) 50 (40) 
% Open Questions 0.25 (0.14) 0.36 (0.17) 70 (50) 
Reflection/Question 
Ratio 
1.0 (0.83) 0.65 (0.42) 2 (1) 
% MI Adherent 0.54 (0.28) 0.58 (0.32) 100 (90) 
BECCI practitioner 
score 





This chapter describes the fidelity assessment of D6, a nurse-led psychological 
intervention in the context of a cluster RCT aimed at improving persistent sub-
optimal glycaemic control in people with T2D. Nurses who received D6 training 
asked more open questions and fewer reflections in relation to questions during D6 
consultations than control group nurses. They also had higher BECCI practitioner 
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scores. However, no significant differences in competency levels were found between 
the 2 groups on the majority of MITI summary domains.  
 
A strength of this study is that quantitative methods were employed to measure 
fidelity, with experienced MI practitioners using standardised rating scales. 
Conducting quantitative fidelity analysis is rare. Keogh et al conducted an RCT to test 
the efficacy of a family-based MI intervention designed to improve outcome in 
patients with T2D versus usual care. They observed significantly reduced HbA1c in 
the intervention group versus control at 6 month follow up and significant 
improvements in beliefs about diabetes, psychological well-being, diet, exercise, and 
family support. Fidelity was assessed via a sample of audiotaped intervention 
sessions, rated qualitatively and quantitatively using (unspecified) MI and illness 
perceptions checklists. Results are not reported, although the authors state that ‘the 
intervention was delivered per protocol’ (Keogh et al., 2011). By contrast, Gabbay et 
al conducted a 2-year pragmatic RCT to examine the effect of MI delivered by Nurse 
Case Managers (NCMs) compared to usual care control in improving outcome in 
patients with T2D. Significant improvements in HbA1c were observed within groups 
but did not differ between groups at the end of the study. Fidelity was measured 
monthly by MI experts using the BECCI and NCMs were given on-going feedback 
based on this evaluation. It is reasonable to conclude therefore that significant 
improvements in HbA1c were due to the intervention. The effect did not persist over 
time, however, and there was substantial loss of active engagement with the nurse 
(32%) during the follow up period (follow up HbA1c values were obtained from 
clinical records). This may account for the lack of significant reduction in HbA1c 
observed at 2-year follow up (Gabbay et al., 2013).  
 
The sample size could be considered a further limitation of this study, although the 69 
tapes rated represent almost a third of the potential sample. Issues with quality and 
length of recordings plus time and budget constraints made increasing sample size 
impossible. It is possible that some consultations of interest were missed due to issues 
with recordings.  
 
It is also possible that the quantitative assessment scales did not fully capture 
treatment fidelity in this sample of non-specialists. The MITI has been criticised for 
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its lack of sensitivity in capturing overall clinician competence. Although it is able to 
capture MI relevant attributes such as empathy and use of micro skills, it may not 
provide adequate assessment of principles such as eliciting change talk, a complex MI 
skill which is important when attempting to capture overall therapist competence and 
fidelity (Madson & Campbell, 2006) (Wallace & Turner, 2009). This may mean that 
the measure fails to make an accurate overall assessment, particularly during training. 
However, it has also been suggested that the MITI may be best suited for measuring 
entry level competence or foundational level skills in MI, which have been shown to 
account for 70% of client engagement during an MI session (Moyers et al., 2005a).  
 
There are a number of possible reasons why D6 nurses did not deliver the intervention 
with high fidelity. This includes the possibility that training was not sufficient; nurse 
factors such as difficulty learning MI skills; pressure to participate in D6; 
performance anxiety and contamination; patient factors such as difficulties in 
accessing a hard to reach population and the lack of a D6 pilot study. 
 
Fidelity is comprised of adherence + competence (Boswell et al., 2013; Mars et al., 
2013; Martino et al., 2008; Santacroce et al., 2004). As nurses delivered, on average, 
only 1 more than half the intervention sessions required by the D6 protocol they could 
not be considered adherent. In terms of competence, analysis of a random sample of 
sessions showed that proficiency in most MI and CBT domains was below beginner 
proficiency level and similar to standard care, suggesting that these real-world 
practice nurses could not be trained in basic psychological skills using the protocol in 
this study. Nurses particularly struggled to deliver complex reflections and may have 
benefited from further training in this skill. It may be that the nurses, relatively 
lacking in MI skills compared to specialised psychologists, were dependent on 
manualised MI instructions. Manual guided MI has been found in meta-analysis to 
adversely affect levels of patient-centredness (Hettema et al., 2005).  
 
The aim of this study was to assess nurses’ competency post-training as part of the 
fidelity analysis of D6, therefore competency over time was not measured. However, 
assessment of competency over time may have shown whether nurses increased or 
decreased in competency, or stayed the same for the duration of the study, providing 
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important process evaluation data and having implications for the training of non-
specialists in psychological skills.  
 
Despite starting at a reasonably equal level of clinical experience as nurses, it may be 
that some would have benefited from extra training or supervision. Although the 
group format of supervision sessions allowed for peer learning, perhaps some nurses 
needed additional intensive individual training and supervision but neither the nurse 
nor clinical psychologist had the resources for this. 
 
There may not have been enough time in the session to integrate diabetes care with 
delivery of psychological techniques, and the task of delivering diabetes nursing care 
simultaneously with psychological therapy was too complex in practice. This is a skill 
that may require advanced training perhaps suited to nurse practitioners with pre-
existing psychotherapist skills. This possible reduction in the potency of ‘pure’ MI 
may also have contributed to lower fidelity ratings, as there was not sufficient time in 
each session to deliver MI.  
 
Nurses did not self-select to participate in D6. The recruitment of GP practices for 
cluster randomisation was made via the practice manager, senior GP or diabetes GP 
lead in the first instance. They were then responsible for identifying and allocating a 
diabetes nurse from their practice to take part in the study. Some nurses were more 
enthusiastic about their participation than others, and the results of a separate 
qualitative nurse study, reported in Chapter 7, support this theory. Nurses were 
resistant to recruitment into the study and difficult to retain. It is possible that we 
ignored warning signs that nurses were under pressure in an effort to maintain study 
momentum.  
 
Nurses were aware that they were being audiotaped and may have felt pressure to use 
skills effectively, a situation that has the potential for negative effects on performance 
in addition to social desirability effects. Additionally, although D6 appointments were 
longer than standard clinical appointments, nurses were required to submit a ten-
minute segment for assessment, and it may be that not all skills rated as part of the 




Other factors that may have influenced nurses’ ability to deliver the intervention to 
protocol include patient barriers, for example some patients were highly resistant and 
may have presented a challenge to experienced psychologists. This is a difficult to 
engage, high-risk clinical group with a duration of T2D averaging 10 years, plus 
persistent hyperglycaemia yet low levels of diabetes distress, suggesting a state of 
denial. This is explored further in the qualitative study described in Chapter 8.  
 
Findings are further complicated by evidence of contamination in the control group in 
one instance, where a nurse who was disappointed not to be randomised to the 
intervention group made extra effort to research D6 skills and deliver them to 
patients. In fact, the control group may have been counter-productive. The 2 groups 
differed significantly on reflection/question ratio, although this difference was not in 
the expected direction. Nurses in the control group used significantly more reflective 
statements in relation to questions than nurses in the intervention group. It is possible 
that control group nurses spent more time talking in an effort to fill the extra 
appointment time, due to the attention control design of the trial. Nurses were 
required to spend extra time with patients, but did not receive any direction on how 
use this time, except to provide care as usual.  
 
Multiple adaptations to local circumstances were made which raises questions within 
the context of the fidelity versus adaptation debate (Shen et al., 2008).  Local changes 
implemented across study sites included variation in the time of day that D6 
researchers were able to see D6 patients in their respective surgeries due to 
restrictions on space and opening hours. In addition, some patients were required to 
make an extra visit to a local phlebotomy service if a blood sample could not be 
obtained during their D6 appointment, the location of which was dependent on 
individual circumstances. Finally, some nurses were required to see patients at an 
additional local surgery in order to meet cluster size requirements. While some 
researchers argue that ‘true’ fidelity to the protocol is necessary (Szulanski & Winter, 
2002) in a real world setting a mixed fidelity-adaptation approach is necessary in 
order to account for site-specific circumstances. However, it is possible that patients 
may have felt less motivated to participate in D6 if they were required to make extra 
appointments or to attend the surgery at inconvenient times. It is also possible that 
nurses who were required to attend 2 surgeries felt additional burden.  
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Conducting a pilot study, although time consuming and expensive, may have avoided 




This chapter shows that while the theoretical construct of fidelity of psychological 
interventions remains relatively clear, there is no consensus on how to measure it. The 
gold standard for measuring treatment fidelity appears to be objective ratings of 
audiotaped sessions, rated using a valid fidelity scale.  
 
We applied this method to the D6 study and found that D6 nurses achieved minimum 
competency in most D6 skills, asking more open questions and fewer reflections in 
relation to questions during D6 consultations than control group nurses. They also had 
significantly higher BECCI practitioner scores. However, while statistically 
significant in comparison to the control group the absolute scores were not clinically 
significantly different.  
 
This suboptimal fidelity may explain why the D6 intervention returned a null finding; 
the patients did not receive a sufficient level of intervention. There are many possible 
explanations for this, including patient and nurse factors. In the next chapter nurse 






Chapter 7: Psychological Skills Training to Support 
Diabetes Self-Management: Qualitative Assessment of 
Nurses’ Experiences.  
 
Chapter Summary  
 
In the previous chapter we learnt that fidelity of the D6 RCT was suboptimal and the 
intervention was not implemented as intended. This may be why the main D6 RCT 
returned non-significant findings. Some potential explanations for this poor fidelity 
were posited including nurse and patient factors. This chapter will qualitatively 
explore the nurse experience of participating in D6.   
 
This chapter reports on a study designed to measure the provider experience 
component of the process evaluation of D6. Three key themes emerged from the 
qualitative data including (i) positive and negative impact of D6 on nurses’ practice 
(ii) overstepping professional boundaries and (iii) concerns about degree of support 
from physicians at participating practices. These themes revealed barriers and 
facilitators to nurses’ participation in D6 and their perceived mechanisms of the D6 
intervention, including transferring responsibility of T2D care to the patient and the 
benefits of extra time spent with them. The strengths and limitations of the study 




The management and organisation of care for people with T2D and other long-term 
conditions has changed significantly within the last 15 years. Since the introduction of 
the GP contracts of 1990 and 2004, primary care professionals in the UK such as GPs 
and practice nurses are required to take significant responsibility for disease 
management with support from specialist services when necessary (Roland, 2007) 
(NHS Employers, 2004).  
 
The evidence for efficacy of specific psychological treatments such as MI as tools to 
support patients’ self-management is growing, and their use becoming more 
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widespread. (Lloyd, Gill, & Stone, 2013) (Ciechanowski, Katon, & Russo, 2000b; 
Peyrot et al., 2005b). However, there is a shortage of nurses who are specialists in 
psychology and behaviour change management to deliver these interventions (Katon, 
Von Korff, Lin, & Simon, 2001; Trude, 2003), and expert mental health providers are 
costly, scarce and rarely have specialist diabetes knowledge. There is therefore a 
skills gap, which if closed would have significant long-term benefits for patients.  
 
If existing general practice staff can be trained to deliver psychological therapies 
effectively, they may provide a cost effective solution to this problem (Winkley, 
Ismail, Landau, & Eisler, 2006). For example, a ‘nurse-coaching intervention’ which 
employed behavioural change strategies for women with T2D was effective in 
improving diet and exercise behaviours and reducing diabetes related distress 
(Whittemore, Melkus, Sullivan, & Grey, 2004). The prior experience of the nurse 
coaches is not described in this study, but there is evidence that diabetes specialist 
nurses can be trained to deliver MI and CBT and these are associated with significant 
improvements in glycaemic control in people with T1D (Ismail et al., 2008b). 
Diabetes nurses have been trained to deliver diabetes-specific therapy while 
maintaining psychological treatment fidelity (Maissi, 2011) and primary care nurses 
have been trained successfully to use motivational techniques to improve oral 
medication adherence in people with T2D (Hardeman et al., 2014). An intervention 
incorporating treatment delivered by primary care nurses could be integrated into a 
Stepped Care Model, in which the ‘least restrictive’ currently available treatment is 
recommended, referring to the amount of specialist intervention required (Bower & 
Gilbody, 2005).  
 
Data on nurses’ attitudes towards delivering psychological techniques is lacking, 
although some studies suggest that they may experience discomfort when dealing 
with mental health problems such as depression as part of their general practice (Naji 
et al., 2004). Further studies suggest that practice nurses may lack confidence in their 
ability to manage mental health problems (Byng, Weaver, & Bury, 2002). In an RCT 
comparing 2 practice nurse delivered psychological treatments with GP treatment as 
usual for Chronic Fatigue Syndrome (CFS), 3 nurses delivered either a programme of 
‘pragmatic rehabilitation’ encompassing principles of CBT and Graded Exercise 
Therapy (GET) or a programme of ‘supportive listening’ (a form of non-directive 
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counselling) to a sample of 296 CFS patients in the UK. Each intervention was 
delivered in parallel over 18 weeks with 5 face to face home visits interspersed with 5 
telephone sessions.  Patients receiving pragmatic rehabilitation showed short term 
improvements in fatigue compared with GP treatment as usual but these 
improvements were not sustained at 1 year follow up. No statistically significant 
differences were found for patients in the supportive listening group versus GP care as 
usual (Wearden et al., 2006). A qualitative study exploring the experiences of the 
practice nurses delivering the intervention found 4 themes (i) being a novice therapist 
(ii) engaging patients in the therapeutic model (iii) dealing with emotions and (iv) 
complexity of primary care. While the nurses were highly experienced primary care 
nurses, they found the novel role of therapist challenging as they had a relatively 
limited range of therapeutic skills to draw upon and were required to learn new 
boundaries. They also felt challenged and scrutinised by ‘expert patients’ with high 
levels of knowledge about CFS. Nurses also experienced difficulties in managing 
patients’ resistance to treatment, and expressed concerns about the short treatment 
period, which they felt opened up a ‘can of worms’. Finally, nurses felt overwhelmed 
by the complexity of patients’ comorbidities and social circumstances. Nurses also 
reported positive effects of the intervention, including the development of strategies 
for managing tensions such as ‘validating patients’ illness experiences’, flexibility 
with arranging sessions, emotional support from peers and regular supervision from 
an experienced therapist. The challenges faced by practice nurses in this study relating 
to role adjustment, complexity of cases and organisational context may partly explain 
the non-significant findings of the main RCT, as nurses may have lacked confidence 
to implement therapies to protocol (Peters et al., 2011).    
 
In environments where specialist healthcare resources are particularly limited, such as 
low and middle-income countries, studies have found that non-specialist mental 
health workers trained to deliver psychological therapies experience a number of 
barriers and facilitators to the implementation of an intervention. For example one 
qualitative study investigated non-specialist healthcare providers’ views on 
participating in the Programme for Improving Mental Healthcare (PRIME) study, 
which generated evidence on the implementation and scaling up of integrated care 
packages for priority mental health problems in countries including Ethiopia, India, 
Nepal, South Africa, and Uganda. Participants reported benefits of the intervention 
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including increased access to services, money and time, and the opportunity to 
integrate existing support networks, such as traditional healers in the community. 
However, they also reported challenges, including social stigma, increased workload, 
transportation issues and lack of on-going supervision from an experienced clinician 
(Mendenhall et al., 2014).  A systematic review by the same research group (PRIME) 
found common themes emerge when investigating the impact of training non-
specialist healthcare providers to perform tasks usually required of specialists. They 
reviewed studies from 14 low and middle income countries and found a scarcity of 
individuals who were suitable to perform tasks, variable self-perceived competency 
across non-specialist healthcare providers, a lack of training and subsequent 
supervision and high burden of increased workload (Padmanathan & De Silva, 2013). 
These consistently emerging themes are important considerations for researchers 
conducting tests of interventions delivered by non-specialists, as they may affect 
quality of intervention delivery.  
 
The D6 Study described in Chapter 5 was an RCT testing whether general practice 




The aims of the current study are (i) to explore the process evaluation component of 
Provider Experience and (ii) to identify Barriers and Facilitators to nurses’ 




All 23 nurses who participated in the D6 study were invited to interview. Nurses in 
the intervention arm had received training according to the D6 manual, which had 
been delivered by a clinical psychologist over 12 weekly sessions. During the 
intervention delivery period, nurses in the intervention arm had had monthly group 
supervision sessions with the psychologist. Nurses in both arms had attended an 
introductory session, which reviewed current NICE guidelines and psychological 
therapies for diabetes. Nurses in both arms aimed to deliver 12 x 30 minute 
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individualised, audiotaped patient sessions over 12 months. The intervention 
comprised techniques drawn from MI and CBT.  
 
Semi-structured interviews were conducted with individual nurses at their place of 
work. They took place after their participation in D6 had ended. The topic guide was 
developed using observational data collected during monthly supervision sessions 
with intervention nurses and an interview with a member of the research team who 
recruited the nurses into the study (2nd supervisor KW). Two interview topic guides 
(one for nurses allocated to the intervention arm and one for nurses allocated to 
attention control) were developed in response to this preliminary research, and 
included (see Appendix IV): experiences of D6 training; supervision and support 
(intervention group only); the D6 intervention (intervention group only); self-
awareness; interaction with study patients; and views about psychological research.  
 
The 2 interview topic guides consisted of open questions to elicit free responses, with 
follow up questions for prompting and probing. The interview was piloted with 2 
nurses (1 intervention, 1 control), to assess relevance and comprehension of topic 
guides. No changes to the interview schedules were necessary and the data were 
included in the main study. Fifteen of the 16 interviews were audio recorded and 
transcribed verbatim. One interview was not recorded at the request of the nurse. In 
this instance the researcher took notes throughout the interview, which were checked 
and approved by the nurse concerned. 
 
A thematic analysis approach was used to analyse the data, allowing the researcher to 
compare and contrast themes across participants. The specific method used was 
framework analysis (Ritchie, 2011). Framework analysis was developed for use in 
large scale social policy research before gaining popularity as a method for analysing 
medical and healthcare research data (Ritchie, 2011). It is defined by the output of a 
‘matrix,’ which uses rows and columns to organise data by case (case = interviewee). 
The matrix allows data to be compared and contrasted across and within individual 
cases so that broad themes may be identified without losing individual context.  
 




(i) Transcription: interviews were transcribed verbatim by a professional independent 
transcription service with the exception of 1 interview, which was transcribed by the 
researcher.  
 
(ii) Familiarisation: the researcher read all transcripts and listened to sections of the 
recording where context was unclear and tone of voice important. Brief notes were 
made on potential points of interest.  
 
(iii) Coding: The researcher coded all transcripts, highlighting relevant sections of 
text, assigning coding labels (themes) and making relevant notes.  
 
(iv) Developing and applying a working analytical framework: when the researcher 
had completed coding, themes were discussed with supervisors until consensus was 
reached. A set of codes with definitions was produced, forming an analytical 
framework. An independent researcher coded a sample (n = 3) of interviews to assess 
inter-rater reliability. The coding structure did not require amendment.  
 
(v) Charting data into the framework matrix: The data were entered into and managed 
using the qualitative computer software program Nvivo 11 (QSR, 2016). The matrix 
comprised 1 row per participant and 1 column per code.  
 
(vi) Interpreting the data: the framework matrix was reviewed and connections made 
between participants and themes. Any discrepancies were discussed with supervisors. 
Themes were explored with the question ‘how does this relate to the quality of 
implementation of the intervention?’ in mind.   
 
Rationale for Employing Framework Analysis  
 
There are a number of advantages to employing framework analysis which promote 
rigour and transparency, including (i) summarising the data, making it practical to 
discuss individual cases within the research team without the need for researchers to 
read entire transcripts (ii) charting the data which requires the researcher to closely 
examine each participant’s subjective experience prior to interpretation (iii) the visual 
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structure of the matrix is easy to follow (iv) the method as a whole is highly 
systematic and clearly structured (v) it is not aligned with a particular theoretical 
approach or epistemological viewpoint meaning it can be used for inductive or 
deductive analysis e.g. the researcher may use theoretical constructs to deductively, or 
use an inductive approach to identify theme within the data which are then discussed 
using theories from the literature (Gale, Heath, Cameron, Rashid, & Redwood, 2013).  
 
Reflexivity in Qualitative Research  
 
Reflexivity in qualitative research refers to a method of attending researcher effects at 
every stage of the research process in order to improve validity (Malterud, 2001). The 
researcher reflects on the way research is carried out and understands how the process 
of undertaking research has potentially affected outcomes. The background and 
position of the researcher will affect their angle of investigation, selection of methods, 
interpretation of findings and conclusions drawn. As the researcher plays such a 
crucial role in collection, analysis and interpretation of data in qualitative research, it 
is essential that we understand their position, perspective, beliefs and values (Koch & 





Of 23 eligible nurses, 7 did not respond to repeated (n = 3) invitations to participate. 
Sixteen nurses therefore participated (9 randomised to the intervention and 7 to the 
control group). All were female (n = 16), with a mean age of 50 (SD = 7.17) years. 
The distribution of ethnicity was white 50% (n = 8), black 31% (n = 5) and 
Asian/other 19% (n = 3).  Nurses worked in GP surgeries in 4 South London 
boroughs. The distribution of nurse by borough was 44% (n = 7), 25% (n = 4), 19% (n 
= 3) and 13 % (n = 2). Nurses were interviewed as soon as possible after the 
intervention period had ended with interviews conducted at their individual GP 




Of the intervention group nurses interviewed, 11% had previously received a training 
module in psychological therapies as part of a degree course (n =1), 11% had received 
training in MI as part of a previous role in smoking cessation (n =1), 11% had 
received some training as part of a nursing qualification (n=1) and 67% (n=6) had not 
received any previous training in psychological therapies. Of the control group nurses 
interviewed, 14% had received some training in psychological therapies as part of a 
degree course (n=1), 29% had received 1 day or less of training in MI (n=2), 14% 
(n=1) had received some MI training as part of the Co-creating Health program 
(Wallace, 2012), 14% had received some MI training as part of a previous role in 
smoking cessation (n=1) and 43% had not received any training in psychological 




Three key themes were identified in relation to the nurses’ experiences of 
participating in the D6 study (i) positive and negative impact of D6, (ii) professional 
boundaries and (iii) support. There were sub-themes within each of these main 
themes.  
 
1. Positive and Negative Impact of D6 
 
 Transferring Responsibility to the Patient 
Of the 16 nurses interviewed, 6 (of 9) nurses in the intervention group felt that D6 had 
a positive impact in the sense that the D6 skills helped to transfer some responsibility 
of diabetes management back to the patient.  They reported that patients felt 
empowered. 
 
“...with the motivational interviewing... it’s going to ...give them that control, 
and want to change, and this is what happened.” (PTP14L, Asian/Other, aged 
46-55 years, intervention group) 
 
One nurse felt that this emphasis on patient self-regulation had reduced her own sense 




“I was psychologically and physically tired because I was taking on too much, 
I was carrying the patient’s responsibility and so the positive for me...is now 
my consultations are less stressful...” (PTP06L, Black, aged 46-55 years, 
intervention group) 
 
One control group nurse felt that the extra time with patients mandated by the study 
protocol for both intervention and control arms played a part in encouraging patients 
to change their behaviour. 
 
“If you’re seeing somebody really very regularly...the patient will have to 
keep saying to me ‘oh no, actually I’m still not doing my exercise, I’m still not 
doing that’, it really puts the onus on them.” (PTP02L, White British, aged 46-




Five nurses from the intervention group felt they had gained valuable skills from the 
D6 training, which could be used with other patient groups. 
 
“...what’s so good about the D6... it’s so versatile, you can use the same skill 
in many areas, like sexual health...I’m always praising the D6 for what it’s 
done for me, as a clinician.” (PTP14L, Asian/Other, aged 46-55 years, 
intervention group)” 
 
“I also had a group of patients that were very poorly controlled and had very 
complex problems...and I was seeing that group alongside my D6 with the 
same frequency... I’ve been able to improve the control from a big percentage 
of our patients.” (PTP06L, Black, aged 46-55 years, intervention group) 
 
Time Luxury 
Three nurses from the intervention group and five nurses in the control group reported 
feeling that the length of D6 appointments was a luxury. D6 appointments were 30 
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minutes long for the intervention and control group. They felt able to address wider, 
lifestyle-related concerns.  
 
“I think the length of the appointments most nurses would say reinforce what 
we always knew, that we need more than ten minutes.” (PTP06L, Black, aged 
46-55 years, intervention group) 
 
“... It gives us...that opportunity to actually listen to the patients...because, like 
I said, normal check... we don’t listen.” (PTP15W, Black, aged 56-60 years, 
intervention group) 
 
“It gave you the time to actually sit with a patient... address their concerns, 
and try to relieve their fears and anxiety.” (PTP05S, Black, aged 46-55 years, 
control group) 
 
“...it’s a luxury having thirty minute appointments for people, huge 
luxury.”(PTP02L, White, aged 46-55 years, control group) 
 
“I was able to just do a bit more touchy-feely you know stuff rather than just 





Of the 16 nurses interviewed, 13 (8 intervention, 5 control) described ‘patient 
barriers’ as a negative aspect of D6.  
 
Ten nurses (6 intervention, 4 control) experienced problems with patient non-
attendance and lack of willing to commit to D-6 appointments.  
 
“When it actually came to making the commitment they weren’t prepared to 




“I would say the chaotic ones who could have really done with the help tended 
to either…not attend follow-up or…just drop off.” (PTP09L, White, aged 46-
55 years, control group) 
 
Four of these nurses felt that some patients did not consider diabetes self-management 
to be a priority.  
 
“…not everybody wants to make changes in life, people are happy just 
plodding along…” (PTP04W, Asian/Other, aged 30-45 years, intervention 
group) 
 
“…it’s not a priority to them, there’s too many other things going on.” 
(PTP13L, White, aged 46-55 years, control group) 
 
Four nurses felt that lack of patient engagement was a problem.  
 
“...some patients they don’t come out with anything so...I’m not supposed to 
tell the answers and where I used to tell the answers all our life as nurses” 
(PTP07S, Black, aged 30-45 years, intervention group) 
 
“Most of them, they don’t even believe they have diabetes.” (PTP16L Black, 
aged 30-45 years, intervention group) 
 
Three nurses suggested that low IQ may be a barrier for some patients. 
  
“If someone has a low IQ it is very hard to get them to participate.” (PTP04W, 
Asian/Other, aged 30-45 years, intervention group) 
 
Time Management Barriers 
Time management issues were raised as a barrier for 8 of the nurses interviewed (4 
intervention and 4 control group). Three nurses talked about the extra work created by 
D-6, and how they found it difficult to manage the study in addition to their already 




“...my workload is so heavy and fast moving I seldomly have the luxury of 
reflection time...when you are studying a new skill and working it’s fine when 
you’re in the classroom, but...if we weren’t getting those frequent 
[supervision] meetings it would not have been that easy.” (PTP06L, Black, 
aged 46-55 years, intervention group) 
 
Five nurses expressed concerns about the practicality of integrating D6 within an 
existing primary care service. 
 
“...what this research is asking us is a lot...why would you want to do a 
research that in real life will never, ever take place or couldn’t?” (PTP11S, 
Asian/Other, aged 46-55 years, control group) 
 
“I knew it wouldn’t work if I just tried to do it in the normal sessions...with the 
pressure on appointments.” (PTP13L, White, aged 46-55 years, control 
group) 
 
The amount of administration time involved in participating in D6 was a concern for 
two of the nurses interviewed. This included time spent recording patient 
consultations.  
 
“because I liaise with you... it wasn’t a big problem but...when we were 
told...that we have to write this, we have to record this...I thought it will never 
happen, it cannot happen.” (PTP11S, Asian/Other, aged 46-55 years, control 
group) 
 
Change of Pace 
The D6 appointments lasted for half an hour, and four of the nurses (2 intervention, 2 
control) felt the impact of a change of pace. 
 
“Because you’re seeing them so regularly it can get a little bit...awkward... 
when you’re thinking “oh I’ve got to see you again in two weeks and I’ve got 





“Our consultations are ten minutes so if you haven’t got what [you need] then 
you have to make another appointment...the patients...weren’t used to that at 
all and it was a bit uncomfortable...” (PTP01L, White, aged 56-60 years, 
intervention group) 
 
One nurse felt guilty about conducting D6 appointments in regular surgery hours and 
expressed concerns that colleagues may have felt she was doing less work than others.  
 
“I did feel that actually it looked like I could have been doing other things... 
especially when you’ve got a really busy practice.” (PTP02L, White, aged 46-
55 years, control group) 
 
2.  Professional Boundaries  
 
Over-Stepping Role 
One control and 3 intervention group nurses expressed concerns about over-stepping 
their role when delivering the D6 intervention.  
 
“They didn’t use it for diabetes, they used it to...unload their problems on me 
and I didn’t know how to deal with these problems because I am not a 
psychologist, I’m only a nurse.” (PTP04W, Asian/Other, aged 30-45 years, 
intervention group) 
 
“I would keep reflecting back to them and doing reflective listening but 
because I’m not trained in psychological therapies I was actually quite 
concerned at some points...that I might be over stepping my role in terms of 
my competence.” (PTP12S, White, aged 56-60 years, control group) 
 
Harassing the Patient  
Having experienced problems with patient attendance throughout the study, one 
control group and three intervention group nurses felt that they were harassing 




“The time that you spend trying to get patients in... you almost feel like you 
are kind of bothering them.” (PTP05S, Black, aged 46-55 years, control 
group) 
 
“That was horrendous...there were so many phone calls...and when you get 
them they will say they’ll come and then they don’t.” (PTP04W, Asian/Other, 
aged 30-45 years, intervention group) 
 
Role Adjustment 
Four nurses in the intervention group and 2 in the control talked about the 
professional role adjustment that was required by them to participate in the D6 Study. 
They felt they had to change the style of their consultations.  
 
“...I didn’t feel confident and was thinking, what should I say next, what 
should I do next.” (PTP04W, Asian/Other, aged 30-45 years, intervention 
group) 
 
“...thinking about what the patient’s saying and thinking ‘oh my God, I’ve got 
to use this...skill to get this information out of them” (PTP03L, White, aged 
30-45 years, intervention group) 
 
3. Support  
 
Support from participating surgery  
The need for support from the practice physician was raised as an issue by seven of 
the nurses (4 intervention, 3 control).   
 
Three of the nurses talked about the money that had been paid to the practice as an 
incentive to participate in D6 and felt it was unfair they had not received any of it 
themselves. 
 
“I don’t know if any nurses who [are] taking part were paid... although we 
took ...the time... for the patients but none of us got...even a £10 bonus.” 




The above participant went on to say that she was surprised to receive little support to 
participate in the study, considering the financial benefit for the practice. 
 
 “I find that although I did take part it was up to me to convince them to let me 
go [and participate in D6] even though there was monetary incentive for 
them.” (PTP11S, Asian/Other, aged 46-55 years, control group)” 
 
Three other nurses expressed feelings that they were undervalued.  
 
“I had to fight, I said “okay I’m going to leave the D6... you’re the ones who 
get the money for D6. I’m not getting anything...I would like to help my 
patients but if you have got any problems with me doing the D6 then I will 
leave ...and help with open surgery’ ...they were not that supportive really.” 
(PTP07S, Black, aged 30-45 years, intervention group)” 
 
“They were very pleased with the money but...that was about it really, the 
support wasn’t really there...” (PTP01L, White, aged 56-60 years, 
intervention group)” 
 
“It’s just another affront of how doctors think... they could take the services 
and the expertise of nurses and use it to their advantage with no 
recognition....” (PTP06L, Black, aged 46-55 years, intervention group)” 
 
The need for extra support from other teams such as administration and IT was raised 
by four of the nurses.  
 
“I think if I was to do this again I think we would need the whole practice 
team [to help] and [receive] input from different departments.” (PTP05S, 
Black, aged 46-55 years, control group) 
 
“The good thing is we had an admin person who was specifically there for 
diabetes, so she was...willing to help and support...” (PTP09L, White, 46-55 





Four of the intervention group nurses highlighted the importance of supervision from 
the psychologist at King’s. 
 
“it give you that opportunity to offload and you get input from everybody...and 
it also reinforces, okay right, so I was on the right track...I’m really going to 
miss that.” (PTP06L, Asian/Other, aged 46-55 years, intervention group) 
 
“...we discuss our difficult patients...and we get some suggestions of how to 
deal with those that are not getting on well. So I think... it’s helping a lot 
going to those sessions” (PTP07S, Black, aged 30-45 years, intervention 
group) 
 
Two of the nurses felt however that more supervision would have been helpful.  
 
“...perhaps because I didn’t have any psychology background a bit more input 





The aim of this study was to explore primary care nurses’ experience of psychological 
skills training as part of the D6 Study. Three main themes emerged from the data, (i) 
positive and negative impact of D6, (ii) professional boundaries and (iii) need for 
support. There were two sub-themes (‘transferrable skills’ and ‘supervision’) 
mentioned only by nurses in the intervention group, as these nurses were the only 
group to receive D6 skills training and supervision. Two sub-themes (‘time 
management barriers’ and ‘change of pace’) were mentioned equally by intervention 
and control group nurses. These two groups would have faced similar challenges in 
fitting D6 appointments into their schedules due to the attention control design of the 




Nurses in both groups cited patient barriers as the most significant obstacle preventing 
them from implementing D6 according to protocol, including lack of attendance at 
appointments, lack of willingness to commit to scheduled appointments and patients 
not prioritising diabetes self-management. This may be explained by the fact that the 
D6 sample was drawn from a population with poor glycaemic control who are likely 
to have lower levels of commitment to self-management and poorer records of 
attendance at their primary care practice. Nurses in both groups also raised concerns 
about professional boundaries; however more nurses in the intervention group were 
concerned that they were harassing patients to come to appointments and it may be 
that nurses in this arm felt more responsibility to ensure patient attendance at 
appointments having received the D6 training. Some nurses in the intervention arm 
also felt that they were over-stepping their professional role when using MI skills or 
dealing with emotive consultations, as they were not qualified as psychologists. This 
is consistent with studies showing that practice nurses fear becoming involved in 
consultations about mental health as they feel inadequately equipped to deal with any 
psychological problems that may arise (Gray et al., 1999; Nolan, Murray, & 
Dallender, 1999).  This is also consistent with the finding that nurses in both groups 
felt they needed to adjust their role in order to facilitate the use of D6 skills 
(intervention group), or to fill longer appointment times (control group).  
 
Nurses in both groups felt that they had been under-supported by their practice during 
their participation in D6, and some felt that they were entitled to financial 
compensation. The need for input from other practice departments was highlighted, 
and it is worth noting that nurses required significant support from the D6 research 
team. This finding is consistent with studies which have found that non specialist 
healthcare providers trained to deliver specialist therapies require significant support 
from supervisors (Padmanathan & De Silva, 2013). 
 
 
Strengths and Limitations  
 
A strength of this study is that it was developed a priori as part of the process 
evaluation of the D6 Study. The results of the RCT were not known at the time of 
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data collection or analysis, so there is less bias in nurse or researcher reporting. A 
systematic, established approach to data analysis was used and inter-reliability 
analysis conducted by an independent researcher. However framework analysis is 
time consuming and resource intensive, particularly within the context of a PhD. 
Qualitative analysis generates rich data, offering a deep level of understanding of the 
phenomenon under investigation. However, it requires significant time to collect and 
analyse and requires the researcher to develop skills in coding and thematic 
interpretation. Data interpretation is subjective and reflexivity important in order to 
minimise bias.  
 
One approach to further minimise bias would be for the researcher to keep a reflexive 
research diary to record reflections on each stage of research design and data 
collection that may have methodological and theoretical implications. For example, a 
research diary of the semi-structured interview process would involve recording the 
interview experience, covering practical issues in addition to observations of the 
interview as a social experience. It may also involve reflections on the success (or 
otherwise) of the interview and note any emotional observations (e.g. did the 
researcher feel irritated). Observations noted in a reflexive diary may have led to extra 
vigilance during triangulation. For example, in a report of a reflexive diary used 
during a PhD focusing on management research, the author concluded that reflexive 
diarising had prompted her to consider supplementary methods of analysis, fuelled 
theoretical discussions and impacted analytical decisions (Nadin & Cassell, 2006).  
 
Researcher effects on collection, analysis and interpretation of data are a crucial 
consideration in qualitative research. A limitation of this study is that the researcher 
held the position of D6 research assistant for the duration of the intervention period 
and had regular prior contact with 14/16 nurses. Nurses who were in contact with the 
researcher for the duration of the intervention (and to a lesser extent those who 
weren’t) may have felt unable to fully disclose their feelings about D6 due to a social 
desirability bias (Van de Mortel, 2008). They may have feared disappointing or 
offending the researcher and by extension the research team. Nurses required 
significant supervision from Research Assistants for the duration of the D6 
intervention and it is possible that the researcher’s knowledge of challenges faced by 
nurses framed the design of interview schedules, the conduct of the interviews, 
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analysis of data and interpretation of results. Although triangulation was used in order 
to minimise bias in analysis of data, significant potential for bias remains. A potential 
solution to this problem could have been the use of multiple, independent 
interviewers, although limited resources prohibited this.  
 
A further limitation is that the sample of nurses was not optimal. Seven nurses did not 
respond to repeated invitations to participate (2 intervention and 5 control group), 
representing a significant portion of ‘missed’ data. The data are also not transferable 
(a concept synonymous with generalisability) to different healthcare professional 
populations or contexts. However, the sampling in qualitative research is not designed 
to be representative of a wider population but purposive to capture the diversity 
around a phenomenon. Every effort should be made to provide ‘thick description’, a 
term coined by Lincoln and Guba (Guba & Lincoln, 1985) to describe a ‘technique in 
which a qualitative researcher provides a robust and detailed account of their 
experiences during data collection’. Details of the research setting should be 
described, including time and place of interviews and implicit biases, which may 
affect responses. The reader may then construct an impression of the research 
environment, which allows them to more accurately judge the transferability of results 




This qualitative study found that primary care nurses trained in psychological skills 
perceived that those skills were valuable and transferable in a primary care setting, 
despite the existence of time management and patient barriers to attendance. The 
utilisation of psychological skills within this setting requires significant role 
adjustment for nurses, which may be aided by additional support from physicians, the 
wider practice team and a qualified psychologist. As expectations rise for more 
management of long-term conditions in primary care, its staff will need more skills in 
behaviour change. The findings of this study indicate that nurses working in primary 
care require significant support from other practice team members and a qualified 
psychologist in order to adjust their consultation style and schedule within a busy 
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general practice.  When this support is received however, they can feel more capable 
and competent to deliver a psychological therapy. 
 
Qualitative evaluation of psychological interventions may help to reveal mechanisms 
which hinder or promote implementation of the intervention according to protocol. 
Future research may involve incorporating qualitative studies into the analysis plan of 
RCTs of similar interventions in different settings and with different populations to 




Chapter 8: Patients’ Experiences of Participating in a 
Randomised Controlled Trial of a Psychological Therapy 
Designed to Improve Sub-Optimal Glycaemic Control In 




In the previous chapter we learnt that although nurses felt that psychological skills 
training can have a positive impact on patient care, significant role adjustment is 
required, and appropriate support strategies must be implemented.  
 
This chapter explores patients’ experiences of participating in D6. The rationale for 
collecting patient feedback when conducting a process evaluation and the different 
methods that can be used will be described. Using individual qualitative interview 
methods, the main finding was that patients experienced a number of barriers and 
facilitators to their participation in D6. These findings are discussed in an attempt to 
further understand the Barriers and Facilitators in delivering psychological care to 




Psychological Barriers to Diabetes Self Care 
 
Persistent sub optimal glycaemic control of T2D remains a significant problem, 
despite the development of evidence based pharmacological, educational and lifestyle 
interventions (King et al., 1999), with T2D increasingly recognised as a huge 
psychological burden for the patient due to the level of self-management required 
(Jallinoja et al., 2007). People with T2D are expected to take significant responsibility 
for disease management through the implementation of lifestyle adjustments, which 
may include dietary changes, increases in physical activity, improved concordance 
with oral hypoglycaemic agents and self-administration of insulin injections, self-
 
228 
monitoring of blood glucose and bodily changes, all of which may reduce the rate of 
disease progression (Winkley et al., 2016). However, many people find these 
adjustments difficult despite support from healthcare providers, and many have 
psychological barriers to implementing and adopting these behaviours (Snoek et al., 
2011). 
 
The psychological barriers to diabetes self-management are numerous and can include 
mood disturbances (Lustman et al., 1997), disordered eating (Herpertz et al., 1998) 
and diabetes-specific fears. People with T2D are twice as likely to suffer from 
depression than the general population (Ali, Stone, Peters, Davies, & Khunti, 2006) 
and depression is associated with lower adherence to oral hypoglycaemic, 
antihypertensive, and lipid-lowering medications (Lin et al., 2004) and lower 
adherence to self-care behaviours such as physical activity and diet (Ciechanowski et 
al., 2000a). Depression is also associated with an increased risk for diabetes 
complications such as diabetic retinopathy, nephropathy, neuropathy and 
macrovascular complications and sexual dysfunction (De Groot et al., 2001). Rates of 
anxiety in patients with diabetes may also be higher than those typically reported in 
the general population (Peyrot et al., 2005a), and the presence of anxiety is associated 
with increased prevalence of diabetes-related complications (Wu et al., 2011). One 
study found that diabetes-specific distress mediated the relationship between 
depression and glycaemic control in patients with both T1D and T2D (Van Bastelaar 
et al., 2010).  
 
Psychological barriers to insulin injections also represent a major problem. Insulin is 
safe (although there are risks to its use), effective and the most potent drug available 
with the potential to achieve optimal glycaemic targets (NICE, 2015). However, it is 
often not introduced early or to optimal therapeutic targets to benefit patients in terms 
of improving glycaemic control and reducing risk of diabetes complications (Brunton, 
Davis, & Renda, 2006). Fears around insulin can represent significant psychological 
barriers, for example one study exploring patient attitudes towards insulin found that 
fears and negative emotions related to insulin were much more commonly discussed 
than positive ones, and included worries about the pain and hassle of injecting insulin, 
fear of hypoglycaemia and concerns that diabetes had progressed to a more serious 
phase (Hunt, Valenzuela, & Pugh, 1997). Another study reported that patients did not 
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perceive their illness as serious enough to warrant taking insulin with others worried 
they might become addicted to it (Nakar, Yitzhaki, Rosenberg, & Vinker, 2007). 
‘Psychological insulin resistance’ is a term that is sometimes used, with many people 
reporting multiple reasons for resisting insulin use, even once prescribed. Additional 
reasons for this include fear that insulin use will restrict lifestyle, low self-efficacy 
with regards to administering insulin, fears that insulin will harm the body and fears 
that once insulin has been started, it cannot be stopped (Polonsky et al., 2005).   
 
Disordered eating may also be a barrier to diabetes self-management, with 
abnormalities of eating attitudes and behaviour associated with impaired metabolic 
control (Mannucci et al., 2002). Binge eating disorder in particular may be an 
independent risk factor for T2D (Herpertz et al., 2000; Kenardy et al., 2001) and has 
been shown to precede T2D (Herpertz et al., 1998), particularly in younger and 
African American populations (Meneghini, Spadola, & Florez, 2006). In addition, 
clinical and subclinical levels of binge eating have been associated with greater 
incidence of depressive symptoms and impaired quality of life in the T2D population 
(Wilfley, 2011).  
 
One of the most significant psychological barriers to the self-management of T2D is 
that people lack motivation or are unwilling to take responsibility for self-
management of their disease. They may be unable to accept the chronic nature of T2D 
and come to terms with the significant lifestyle adjustments necessary in order to 
manage it effectively (Brown et al., 2002). In addition, people with T2D may 
experience low levels of self-efficacy with respect to their abilities to manage their 
diabetes effectively, with a perception that their fate is out of their hands (Glasgow, 
Toobert, & Gillette, 2001). 
 
A large study involving 3649 people with T2D from 62 general practices in England 
found a significant relationship between psychological barriers to self-care and 
diabetes related complications of the eyes, feet, legs, kidneys and heart, reinforcing 




Addressing Psychological Barriers to Diabetes Self-care 
 
Addressing such psychological barriers may represent a cost effective method of 
improving glycaemic control in this population, avoiding the need for further 
pharmacological intervention. As summarised in Chapter 4, there have been several 
systematic reviews of RCTs of psychological interventions to improve glycaemic 
control which together suggest that psychological interventions may be associated 
with a small improvement in glycaemic control but there were methodological 
limitations, namely small sample size and poorly described interventions (Alam et al., 
2009; Ismail et al.). More recent reviews have used broader terminology when 
identifying studies, encompassing educational interventions (which may have a 
psychological component) and other psychosocial programmes. These studies have 
found small effect sizes however and are again limited by methodological weaknesses 
(Harkness et al., 2010; Heinrich, Schaper, & de Vries, 2015; Schellenberg, Dryden, 
Vandermeer, Ha, & Korownyk, 2013).  
 
Evaluating Psychological Therapies Delivered in Primary Care  
 
In order to fully evaluate the impact of psychological therapies delivered in primary 
care, it is necessary to evaluate their delivery from the patients’ perspective. Patients’ 
values about psychological treatments have rarely been studied but insights into 
patients’ perspectives on diabetes self-management in a general practice setting can 
give insight into how treatments are perceived and valued, and how they are best 
delivered in order to make change. For example, one study synthesised qualitative 
research on lay experiences of diabetes and diabetes care, reviewing 10 qualitative 
studies of adult patients’ perspectives of diabetes care in the UK. The authors used 
meta-ethnographic methods to synthesise the research, finding that patients feel ‘the 
need to be permitted to care for themselves’ and need support from the care team in 
order to accomplish this, but feel they do not receive that support when their control is 
sub-optimal, i.e. they do not receive it when they need it most (Wikblad, 1991). 
Another qualitative study explored UK primary care patients’ perspectives on foot 
complications in T2D using one on one interviews, revealing that some patients do 
not take advice on self-care due to communication problems with health professionals 
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(Gale, Vedhara, Searle, Kemple, & Campbell, 2008). A qualitative interview study 
exploring 18 T2D patients’ perspectives of blood glucose self-monitoring found that 
self-monitoring decreased over time as patients felt that GPs perceived lack of interest 
in readings as meaning they were not worth continuing. Only 3 patients were self-
monitoring as advised in their initial diabetes education at 12-month follow up (Peel, 
Douglas, & Lawton, 2007). Exploring patients’ views can therefore often tell us about 
the ‘how and why’ of their behaviour, revealing reasons behind the incongruence 
between providers’ and patients’ views of self-management (Cohen, Tripp-Reimer, 




The aims of the current study are (i) to explore the process evaluation component of 
Participant Experience and (ii) to identify Barriers and Facilitators to patients’ 




The Current Study 
 
A stratified convenience sample of patients who participated in D6 was invited to 
interview. A sampling matrix was stratified by demographic characteristics and 











Table 8.1: Original Sampling Matrix 
Sample Characteristic Intervention Control 
Age   
30-50 years 10-15 10-15 
51-82 years 10-15 10-15 
Ethnicity    
White  5-8 5-8 
Black  5-8 5-8 
Asian 5-8 5-8 
Other 5-8 5-8 
Gender   
Male 10-15 10-15 
Female 10-15 10-15 
Borough   
Lewisham 5-8 5-8 
Lambeth 5-8 5-8 
Southwark 5-8 5-8 
Wandsworth 5-8 5-8 
 
 
Semi-structured interviews were conducted by the D6 researcher (PhD candidate) at 
each patient’s GP surgery after completing their final D6 follow up appointment. 
Time between final follow up appointment and interview ranged from 21-82 days, 
with a mean interim duration of 48 days. The topic guide was developed based on the 
observations and experiences of the D6 researcher (PhD candidate) who recruited 
patients into the study and was in contact with many of them for the duration of the 
intervention. Observations were collected in note format during the study. 
Observations were noted based on conversations over the phone and in person with 
patients who were participating in D6 and concerned reasons why patients were not 
able to attend D6 appointments; the researcher’s own experience and nurses’ 
experiences of frequency of D6 appointments and how their timing might affect 
patients; feedback from nurses and patients on content of sessions and researchers’ 
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instincts and curiosity in relation to patients’ views on psychological treatments. An 
interview topic guide was developed covering: views on the timetable of the study 
and its sessions; barriers to attending; views on the treatment received and views on 
psychological research in general. These guides were discussed within the research 
team and refined until consensus reached. The topic guides consisted of open 
questions to elicit free responses, with follow up questions for prompting and probing. 
The interview guide is included in Appendix IV. 
 
The interview was piloted with 2 patients (1 intervention, 1 control) to assess 
comprehension and relevance of questions. No changes to the schedule were 
necessary and the data were included in the main study. All 18 interviews were 
recorded and transcribed verbatim.  
 
A thematic analysis approach was used to analyse the data, allowing the researcher to 
compare and contrast themes across participants. The specific method used was 
framework analysis (Ritchie, 2011). Framework analysis was developed for use in 
large scale social policy research before gaining popularity as a method for analysing 
medical and healthcare research data (Ritchie, 2011). It is defined by the output of a 
‘matrix,’ which uses rows and columns to organise data by case (case = interviewee). 
The matrix allows data to be compared and contrasted across and within individual 
cases so that broad themes may be identified without losing individual context.  
 
The stages of framework analysis were as follows: 
 
(i) Transcription: interviews were transcribed verbatim by a professional independent 
transcription service with the exception of 2 interviews, which were transcribed by the 
researcher.  
 
(ii) Familiarisation: the researcher read all transcripts and listened to sections of the 
recording where context was unclear and tone of voice important. Brief notes were 
made on potential points of interest in order to inform the next stage of analysis.  
 
(iii) Coding: The researcher coded all transcripts, highlighting relevant sections of 




(iv) Developing and applying a working analytical framework: when the researcher 
had completed coding, themes were discussed with supervisors until consensus was 
reached. A set of codes with definitions was produced, forming an analytical 
framework. An independent researcher coded a sample (n = 3) of interviews to assess 
inter-rater reliability. The coding structure did not require amendment.  
 
(v) Charting data into the framework matrix: The data were entered into and managed 
using the qualitative computer software program Nvivo 11 (QSR, 2016). The matrix 
comprised 1 row per participant and 1 column per code.  
 
(vi) Interpreting the data: the framework matrix was reviewed and connections made 
between participants and themes. Any discrepancies were discussed with supervisors. 
Themes were explored with the question ‘how does this relate to the quality of 
implementation of the intervention?’ in mind.   
 
Rationale for Employing Framework Analysis  
 
There are a number of advantages to employing framework analysis which promote 
rigour and transparency, including (i) summarising the data, making it practical to 
discuss individual cases within the research team without the need for researchers to 
read entire transcripts (ii) charting the data which requires the researcher to closely 
examine each participant’s subjective experience prior to interpretation (iii) the visual 
structure of the matrix is easy to follow (iv) the method as a whole is highly 
systematic and clearly structured (v) it is not aligned with a particular theoretical 
approach or epistemological viewpoint meaning it can be used for inductive or 
deductive analysis e.g. the researcher may use theoretical constructs to deductively, or 
use an inductive approach to identify theme within the data which are then discussed 






Reflexivity in Qualitative Research  
 
Reflexivity in qualitative research refers to a method of attending researcher effects at 
every stage of the research process in order to improve validity (Malterud, 2001). The 
uses methods such as a reflexive diary to record thoughts and feelings on the way 
research is conducted in order to make sense of how the research process has 
potentially affected outcomes. The researcher’s background and employment will 
affect their angle of investigation, selection of methodologies, interpretation of 
findings and conclusions drawn. It is essential that we understand the researcher’s 
position, perspective, beliefs and values (Koch & Harrington, 1998). As Malterud 
notes however, ‘preconceptions are not the same as bias, unless the researcher fails to 
mention them.’ (Malterud, 2001) These factors will therefore be discussed as 




As part of D6, nurses allocated to the intervention arm were trained in 6 psychological 
skills drawn from MI and CBT. Training was received through interactive training 
workshops and ongoing support from a clinical psychologist. Nurses were asked to 
practice skills learned during the training workshops by integrating them into their 
practice with their caseload at that time. Nurses then delivered usual care plus D6 
psychological skills to patients for at least 6 face to face sessions followed by a 
further 6 appointments in a format agreed with the patient (e.g. either in person or 
over the telephone). Each session lasted 20 – 30 minutes. Time between appointments 
increased over the duration of the intervention, reducing in frequency. The frequency 













Nurses in the attention control condition were required to deliver appointments at the 
same frequency and duration but without any psychological skills training.  
 
Sample Characteristics  
 
Of the 103 patients invited to participate in the study, 48 did not respond to repeated 
invitations to participate and 37 refused to participate. Eighteen patients therefore 
participated (11 had been randomised to the intervention and 7 to the attention control 


















Table 8.2: Sample Characteristics (n = 18) 
 Intervention Control  
Mean age (years) 62 55 
Ethnicity (%)   
White  45.5 100 
Black  45.5  
Asian/Other  9  
Borough   
Lambeth  7 2 
Wandsworth 4  
Lewisham   2 
Southwark  3 
Employment Status    
Employed  2 3 
Unemployed 1 2 
Retired  8 2 
Mean interview duration 
in minutes (SD)  

















Table 8.3:  Sampling Matrix Showing Actual Numbers 
Recruited 
Sample Characteristic Intervention Control 
Age   
30-50 years 7 5 
51-82 years 4 2 
Ethnicity    
White  5 8 
Black  5 0 
Asian 1 0 
Other 0 0 
Gender   
Male 4 4 
Female 7 3 
Borough   
Lewisham 0 2 
Lambeth 7 2 
Southwark 0 3 




















Table 8.4: Individual Patient Characteristics Showing Number of D6 Sessions and 
Interview Data (n = 18) 
Patient ID  Age  Ethnicity Number of D6 
Sessions Attended  
Number of Days 






001 65 White British 12 46 46.01 
002 49 White British  12 61 35.36 
003 45 Asian British 11 30 27.32 
004 36 White  12 35 45.00 
005 68 Black British  12 62 46.02 
007 76 Black British  12 28 36.31 
009 70 White British  12 54 38.01 
010 77 Black British  9 65 36.04 
011 50 White British  9 82 44.10 
012 69 White  11 65 54.00 
014 60 White  8 45 33.12 
015 51 Black British  10 66 38.23 
016 55 White British  12 21 33.02 
017 63 White British 11 36 45.00 
018 43 Black British  10 65 44.25 
019 61 White British 12 55 46.2 
020 68 White British  12 41 42.23 





The key themes identified in relation to patients’ experiences of participating in D6 
related to (i) content and frequency of appointments (ii) successful behaviour change 
and barriers to behaviour change (iii) positive and negative views about nurses and 







1: Frequency and Content of Appointments  
 
Seven patients felt they benefitted from spending extra time with their nurse during 
the D6 study (3 intervention, 4 control).  
Three patients in the intervention group felt that the extra time available for D6 
appointments was a positive aspect of their participation.  
 
‘It was a good length of time ‘cos we were able to get everything in.’ (PTP018, 
intervention group) 
 
‘We talk as well like, ‘how are you?’ or whatever… I would call it relaxed…’ 
(PTP012, intervention group) 
 
Four patients in the control group felt that the half hour appointment times were 
preferable to the usual 10-minute appointments as they were able to discuss wider 
issues with their nurse.  
 
‘It was a polite conversation…asking how things are going in your life…not medical 
straight off…’ (PTP001, control group) 
 
‘It wasn’t pressurised or pushed, you know what I mean… you couldn’t do it in ten 
minutes…’ (PTP002, control group) 
 
A total of 4 (2 intervention, 2 control) patients interviewed felt motivated by the 
frequency of the appointments.  
 
‘I saw it as accountability with the stuff that was put in place for me, that kind of 
discipline worked and helped…’ (PTP015, intervention group) 
 
‘It actually felt like I wasn’t alone with the diabetes, like someone really cared… it 
was much easier for example to check the blood sugar levels because I knew in one 




Three patients (control group) commented that they miss the extra appointments and 
support now that the study has finished.  
 
‘I was a bit wary to be quite honest and I think rightly so because you had that 
support for that year, and then to suddenly go to nothing.’ (PTP002, control group) 
 
However, 4 patients (2 intervention, 2 control) felt that the appointments were too 
frequent.  
 
‘It’s awkward and you feel as if… you’re over here every day of the week.’ (PTP017, 
control group).  
 
Three patients in the intervention group were also dissatisfied with the content of their 
appointments.  
 
‘I felt it should be more informative, and if I didn’t ask, nothing would have been 
said…it should be more regulated.’ (PTP009, intervention group) 
 
‘I don’t think she elaborated on her training really.’ (PTP011, intervention group).  
 
2: Barriers and Facilitators to Behaviour Change  
 
A total of 10 patients (6 intervention, 4 control) felt they made positive changes to 
their diabetes management as a result of participating in the D6 Study.  
 
Six intervention group patients reported positive behaviour changes as a result of their 
sessions with the D6 nurse.  
 
‘Very informative…opened my eyes to a lot of things…my way of eating, my way of 
living…what she was getting me to do, to say to myself, you can deny it if you want 




‘She was very, very helpful to me because it helped me a lot by writing and knowing 
what I’m eating and I’m doing wrong things in my body with the sugar.’ (PTP003, 
intervention group) 
 
‘I started to introduce a lot of wholemeal bread and all that, and that helped a lot.’ 
(PTP011, intervention group) 
 
‘The first change, the dramatic change is the insulin, so I’m happy about that.’ 
(PTP012, intervention group) 
 
However, patients also experienced barriers to behaviour change, including having 
other priorities over managing their diabetes, mentioned by 7 patients (4 intervention, 
3 control).  
 
‘I just get my priorities wrong… this is the most important thing but something else 
comes up and I can’t make the meeting and it goes out of the window.’ (PTP018, 
intervention group).  
 
‘Depression just sometimes overrides the diabetes.’ (PTP002, control group).  
 
Five patients in the intervention group denied that their diabetes was a problem.  
 
‘I’m all right, my diabetes, no problem, no problem.’ (PTP005, intervention group). 
 
Three patients (2 intervention, 1 control) described how a lack of symptoms meant 
they weren’t motivated to manage their diabetes effectively.  
 
‘Well for me, I don’t feel that sick, so the longer appointment she give me, it doesn’t 
make any difference’ (PTP007, intervention group) 
 
Four patients (2 intervention, 2 control) felt that they were addicted to food or sugar. 
 
‘The thing is food is a drug, it’s literally a drug and it’s very hard to avoid something 




‘Well I’ve been told not to eat sugar, but I’m afraid I’m addicted to it.’ (PTP001, 
control group)  
 
3: Positive and Negative Aspects of Nurse Manner  
 
Patients made positive and negative comments about aspects of nurses’ manner or 
behaviour.  
 
Ten patients (7 intervention, 3 control) made positive statements about the manner of 
their D6 nurse.  
 
‘She’s lovely… if she’s strict with you then you took notice!’ (PTP017, control group)  
 
‘She was very good… very clear… she was always very personable as well.’ 
(PTP015, intervention group)  
 
‘It was someone that was concerned about the patient and which makes a hell of a 
difference to someone that just goes in and oh, you don’t know what you’re talking 
about, get out sort of thing.’ (PTP001, control group) 
 
However, 3 patients (1 intervention, 2 control) felt a lack of empathy from their nurse.  
 
‘When I first met her I thought she was a little bit of, not to say aggressive, but…’ 
(PTP016, control group)  
 
‘She has gradually got angrier and angrier with me.’ (PTP019, intervention group) 
 
4: Reasons for Taking Part  
 
Eight participants discussed their reasons for taking part in D6 (5 intervention, 3 





‘I don’t mind that, since I have retired I’ve got all the time.’ (PTP012, intervention 
group) 
 
‘Yeah I don’t mind if it’s helping someone.’ (PTP016, control group) 
‘No it was to help other people, I thought well if they can learn something from me, 
you know.’ (PTP017, control group) 
 
Others didn’t understand why they were taking part.  
 
‘This was for a survey for whatever it was, what we was doing wasn’t it?’ (PTP020, 
intervention group) 
 
‘I didn’t really understand what I was doing but I just took part in it.’ (PTP019, 
intervention group) 
 
‘…It’s a wee bit of company and a good chinwag…’ (PTP02, control group) 
 
Summary of Key Findings 
 
Patients felt they benefited from spending extra time with the nurse, yet there was no 
significant improvement in HbA1c.  
 
Patients reported barriers to their participation in D6, including having priorities other 
than managing their diabetes, denying that their diabetes was a problem, and feeling 
addicted to food or sugar.  
 
Patients reported feeling positive about their participation, yet were unclear why they 







The aim of this study was to explore patients’ experiences of taking part in a 
psychological intervention, D6. The most important findings identified from emergent 
themes included perceived positive impact of spending extra time with the nurse on 
patients’ diabetes self-management and barriers to their attendance at D6 
appointments. Patients in both control and intervention groups reported making 
positive changes as a result of additional, extended appointments, and patients in both 
control and intervention groups described feeling motivated by the extra sessions, yet 
no significant change was observed in HbA1c. Patients also reported a range of 
barriers to attendance despite 72% of the sample being retired or unemployed. These 
barriers included having other priorities and denying that diabetes is a problem.  
 
A strength of this study is that it was developed a priori as part of the process 
evaluation of D6 and the data were collected without any knowledge of the main 
study outcome. The sample was also representative in terms of gender and age.  
 
A limitation is that the main study data had been analysed before the interview data 
analysis had been concluded and it is therefore not possible to rule out any potential 
bias in interpretation. It is also not possible to generalise the results to the wider D6 
sample, although the findings may be transferable. Transferability in qualitative 
research refers to the ability of future researchers to assess shared characteristics 
between their own population under study and that of previous research. Providing 
rich and ‘thick description’ is essential to enable future researchers to engage in 
transfer of results (Guba & Lincoln, 1985).  
 
The sample drawn for this qualitative study was not ethnically diverse, despite a 
representative D6 sample. It may be that non-white patients failed to engage with the 
study as a whole as it failed to deliver the D6 therapy in a culturally sensitive way. 
Marin defined culturally appropriate interventions as those which are based on the 
cultural values of the group of interest and that therapeutic strategies are based on the 
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expectations and behavioural preferences of the ethnic groups under study (Marín, 
1990). It is possible that D6 did not meet these criteria.  
 
There was a high rate of non-response to invitation to participate in this qualitative 
study. In order to qualify for inclusion in D6, patients were required to have had 
persistent sub-optimal glycaemic control over an 18-month period, defined initially as 
HbA1c ≥ 69.5 mmol/mol (equivalent to 8.5%) on two occasions. This was then 
lowered to HbA1c ≥ 64 mmol/mol (equivalent to 8%) due to delayed recruitment but 
still represented significant poor control. It may be that this group of patients 
represents a particular challenge to healthcare services in that they are resistant to 
change via this relatively low key psychological approach. These patients have had 
diabetes for a long time and it may be that various attempts to support their change 
over the years by methods such as structured education, nurse and dietary counselling 
have failed. We know that their GP is aware of their persistent sub-optimal HbA1c 
due to pre-existing QOF data, so there is another explanation for their lack of control. 
The number of sessions attended by the D6 patients who participated in this 
qualitative study shows that they were not representative of the D6 sample in this 
respect. We therefore cannot conclude that the Barriers and Facilitators to 
participation they reported are representative of those who failed to attend a larger 
number of sessions. Recruitment stopped at 18 patients as saturation of themes had 
been reached, but considering this bias in the sample, it would have been beneficial to 
extend recruitment in an attempt to capture the views of patients who had attended 
fewer sessions. However, this would have necessitated a recruitment period longer 
than was practical for this PhD. Ideally, interviews for this qualitative study would 
have been conducted close to the date of patients’ last D6 session, but a third were 
conducted 6-8 weeks later. It is possible that patients did not recall some details that 
may have been of interest.  
 
The barriers to behaviour change identified included not prioritising diabetes 
management, denying that diabetes is a problem and feeling addicted to food or sugar.  
The finding that patients are not prioritising diabetes management in particular is 
consistent with findings from a qualitative exploration of D6 nurses’ views on taking 
part in D6 (Graves et al., 2016), where nurses described their own perceptions that 
patients were reluctant to make changes to their diabetes management and failing to 
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engage (described in Chapter 7). This is consistent with the wider qualitative literature 
on diabetes management. For example O Connor et al conducted focus groups and in 
depth interviews with 34 diabetes patients in New England who had previously 
participated in a 4 day diabetes education programme. They found that patients who 
failed to show less than 20% improvement in HbA1c at follow up were more likely to 
view diabetes as not serious, were more fearful of insulin, did not make adequate 
changes to their diet and were less accepting of their diagnosis (O'Connor, Crabtree, 
& Yanoshik, 1997). Cohen et al conducted ‘guided ethnographic interviews’ with 39 
people with T1D and T2D and 15 healthcare providers and found that more than half 
the patients felt their diabetes was not severe and only a minority of people developed 
complications. The authors concluded that accepting the seriousness of diabetes was 
necessary before management could be prioritised and speculated that this could take 
several decades post diagnosis (Cohen et al., 1994).   
 
A possible explanation for D6 patients not prioritising their diabetes management may 
be that the sample was drawn from a population with persistent sub-optimal 
glycaemic control and an average disease duration of 10 years who were likely to 
exhibit lower levels of commitment to self-management. This is consistent with other 
studies, which have found that a major barrier to the management of T2D is patients’ 
unwillingness to change their habits, and this represents a more significant barrier to 
change than their lack of knowledge of the risks involved (Jallinoja et al., 2007; 
Jansink, Braspenning, van der Weijden, Elwyn, & Grol, 2010). Knowledge alone 
appears to be insufficient to bring about behaviour change. It may also be that nurses 
were not confident in discussing in-depth diabetes management at the frequency and 
length required by D6 appointments, due to their varying experience and knowledge 
of T2D. The findings may also represent a lack of willingness by the nurse to become 
involved in patients’ mental health management, consistent with findings in CHD 
management, where nurses did not feel competent to engage patients about mental 
health issues. A qualitative interview study exploring practice nurses’ experiences of 
managing depression in a sample of CHD patients in primary care found that 11 
nurses expressed uncertainty as to their perceived role and responsibility in managing 
patients’ mental health issues. They also reported a lack of training, interest or time 
(Barley, Walters, Tylee, & Murray, 2012). Qualitative studies exploring aspects of 
diabetes care show however that patients expect more from their healthcare provider 
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than checkups and prescriptions. For example, Wikblad et al conducted a qualitative 
study with 55 T1D patients in Uppsala, Sweden. They found that patients wanted 
‘more than laboratory measurements’ and that they wanted a more holistic approach 
to their care. They also found that patients with the most satisfactory metabolic 
control had the best experiences with healthcare providers, and that those with 
‘unsatisfactory control’ had to conceal their true behaviours (Wikblad, 1991). It may 
be that D6 nurses did not have the skills to elicit information from patients that they 
felt uncomfortable providing.  
 
The current study also revealed that patients were not always clear about their reasons 
for participating in D6, stating that they decided to participate due to a desire to help 
other patients, rather than to improve their own diabetes control. Some patients didn’t 
appear clear on the purpose of the study, and there was a general sense that patients 
took part because they were asked to by their healthcare provider. This is consistent 
with research into patient participation, which has found that some patients are more 
passive than others due to a complex interplay of personal, physician and contextual 
factors or that their participation is altruistic rather than a motivation to achieve better 
health for themselves (Street & Haidet, 2011). This group of patients is also likely 
more difficult to engage as the intervention was targeting a ‘hard-to-reach’ population 
(defined in this context as patients who rarely engage with their healthcare provider) 
with persistent sub-optimal control. It may be that these patients have a history of 
attending appointments yet not engaging with their content in a meaningful way.  
 
A further limitation of the study is that the researcher conducting the interviews was 
also a researcher on the D6 Study, responsible for recruiting patients and, in some 
cases, performing administrative tasks relating to their participation, such as calling to 
remind them of appointments. While only 3 patients who participated in this 
qualitative study were recruited into D6 by the researcher, it is possible (although not 
certain) that she had contact with all of them via telephone.  
 
The problem of researcher bias in this qualitative study was not adequately addressed 
via the practice of reflexivity. Reflexivity involves reflecting on the way research was 
carried out and understanding how that process can affect outcome (Hardy, Phillips, 
& Clegg, 2001). Reasons why a researcher may be biased include i) psychological 
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discomfort (ii) lack of preparation to conduct the interviews and iii) the researcher not 
conducting interviews in an appropriate manner (Mehra, 2002). In the current study, it 
is the degree of affinity the researcher had with participants that should have received 
closer scrutiny. Data may have been missed due to the tendency of researchers to 
‘only discover what they think they don’t know, rather than opening up their inquiries 
to encompass also what they don’t know they don’t know.’ (Chenail, 2011). The 
interview schedule was piloted with 2 participants, with 2 interviews coded by an 
independent rater in an attempt to triangulate data. However, a reflexive diary would 
have represented a further appropriate measure.  
 
There is an argument that all researchers should use a reflective diary, regardless of 
epistemological position (Nadin & Cassell, 2006) although it is particularly important 
for the qualitative researcher. A reflexive stance when conducting research allows the 
researcher to adopt a position of critical self-exploration. A reflexive diary may take 
the form of a notebook or computer document. With the progress of this thesis in 
mind, a reflexive diary may have been beneficial throughout the D6 timeline, in order 
to record thoughts and frustrations during previous interactions with patients, which 
may later have affected collection of data for this qualitative study. It would also have 
been appropriate to make notes on the development of interview schedules, 
discussions with supervisors and other colleagues, and to track the process of data 
collection throughout (Nadin & Cassell, 2006). Reflections on interviews with 
patients could have included thoughts on how well the interview was conducted as a 
social encounter, any emergent themes, the researcher’s feelings throughout the 
interview (which may have influenced time spent with the participant, and the extent 
of follow up questions asked) and methodological considerations such as efficacy of 
the interview schedule.  
 
‘Interviewing the investigator’ is an additional technique which may be employed in 
order to reduce potential bias. In this approach, the researcher assumes the role of 
study participant while a supervisor interviews them, or the researcher can assume 
both roles. An attempt to recreate a setting similar to that in which actual interviews 
will be conducted should be made wherever possible and the interview recorded. The 
interview recording should be reviewed and critiqued by supervisor and researcher 
and notes made on what worked well and what did not. Questions for prompting and 
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probing can be judged on their success or not in extracting information and any 
reactions to what is said (or not said) analysed. Modifications can be made to the 
interview schedule. (Chenail, 2011) Responses, frustrations, thoughts and impressions 
may be recorded in a reflexive diary.   
 
The researcher was also responsible for generating the interview schedules for the 
qualitative study, and in doing so became ‘an instrument through which data for the 
study [were] collected or generated’ (Chenail, 2011). The researcher themselves 
becomes a tool throughout the research process, and it is their interaction with 
participants which facilitates the flow of communication and generates data. The use 
of open-ended questions is designed to ensure that respondents are free to answer in 
their own words as far as possible. Follow up questions for prompting and probing are 
then employed. However, it can take many years to master the skill of qualitative 
interviewing, and it is possible that some data were missed (Sofaer, 2002).  
 
Finally, it is not possible to generalise the results of this qualitative study to the D6 
population as a whole due to the high rate of attendance among the sample at D6 
appointments, when the majority of D6 patients did not attend the full 12 sessions 
according to protocol. They do however represent a small sample of poorly controlled 
T2D patients who, despite attending appointments and expressing enthusiasm for 





This study found that while patients may report benefits from participating in a study 
such as D6, these do not translate to actual changes in behaviour and glycaemic 
control. While patients made positive statements about therapy, a significant minority 
disagreed. This suggests that more work is needed to establish whether practice nurses 
need additional training or whether the idea that they can be trained to deliver 










This thesis has made the case for the importance of process evaluation, reviewing the 
evolution of the field and its potential to interpret psychological interventions. A 
preliminary framework was proposed which included qualitative and quantitative 
methods, and the feasibility of this framework to deliver a process evaluation was 
tested on a cluster RCT of a psychological intervention to improve glycaemic control 
in T2D.  
 
Aims of this Thesis  
 
The specific aims of this thesis were i) to review existing frameworks and methods 
for conducting process evaluations (Chapter 3); ii) to apply the findings of this review 
to develop a theoretical framework for process evaluations of psychological 
interventions (Chapter 3 and 4); iii) to test the face validity of the framework on a 
nurse-led psychological intervention, the D6 cluster RCT, to improve glycaemic 
control in T2D (Chapters 5-8).  
 
This final chapter will summarise key findings from the literature reviews and the 
application of the theoretical framework to D6. The feasibility of the framework is 
assessed and a revised version proposed. Strengths and weaknesses of the 
methodological approaches taken in this thesis are discussed, and opportunities and 
challenges for future research are considered. 
 
Summary of Findings  
 
The scoping of the literature on theoretical underpinnings of PE (Chapter 3) led to an 
overview of the history and evolution of process evaluation theory and 
methodologies. Process evaluation has had a rich but chequered history beginning in 
the 1960’s when the concept was introduced but not formally described, with many 
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researchers attempting to measure components in the absence of a framework. The 
original concepts of process evaluation were founded in health education in the late 
1990s, and several theoretical frameworks produced over the following 3 decades. 
Baranowski and Stables (Baranowski & Stables, 2000) defined an 11 component 
framework based on a large scale public health intervention which was not widely 
adopted but laid the foundation for future researchers such as Linnan and Steckler 
(Linnan, 2002), who proposed a tighter, 7 component framework. This framework 
enjoyed some success but was criticised for its lack of attention to intervention 
context. Saunders et al (Saunders et al., 2005) built on the framework but failed to test 
it in real world conditions and the model was not widely used. A further framework 
by Grant et al focused on suitable methodologies but was firmly grounded in the RCT 
design with a heavy focus on quantitative measurement and minimal qualitative 
methods (Grant et al., 2013). In recent years the MRC produced guidance that has 
been more widely used but criticised for its lack of adaptability to specific research 
designs, lack of guidance on methods and failure to tackle the synthesis of 
quantitative and qualitative methodologies.  
 
While each framework had merit, no single example was sufficient for application to 
complex interventions such as modern psychological interventions. The scoping study 
allowed for identification of recurrent concepts, for example, Baranowski and 
Stables’ components of ‘initial use’ and ‘continued use’ overlap with ‘reach’ while 
the concept of ‘exposure’ overlaps with others’ definitions of ‘dose received’. 
Components were amalgamated into a new preliminary framework, which offered a 
checklist approach for application to complex interventions. An attempt was made to 
synthesise components into a single framework for the purpose of conducting process 
evaluations of psychological interventions. The 12 components proposed were 
Formative Process Evaluation; Acceptability and Social Validity; Recruitment; Dose 
Delivered; Dose Received; Programme Implementation/Fidelity; Contamination; 
Provider Experience; Participant Experience; Context; Barriers and Facilitators; 
and Adoption as summarised in Figure 3.4.  
 
The feasibility of the framework was tested on a systematic review of psychological 
interventions to improve glycaemic control and other biomedical outcomes in T2D. It 
was used to identify and describe process evaluation components studied and methods 
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used. T2D was deliberately chosen for pragmatic reasons as well as being a common 
clinical condition. The review found that most RCTs had conducted very minimal 
process evaluations. The most commonly studied components of process evaluation 
were Dose Delivered, Fidelity and Participant Experience. The most understudied 
components were Formative Evaluation, Dose Delivered, Provider Experience and 
Barriers and Facilitators. The most commonly used methodology was quantitative 
session attendance data measuring Dose Delivered, for example patient attendance at 
therapy sessions. The next most commonly used process evaluation methodologies 
were ratings of audiotaped intervention sessions assessing Fidelity, structured 
questionnaires assessing treatment satisfaction (Participant Experience) and open-
ended questionnaires assessing Participant Experience. Observational methods and 
semi-structured interview were the least employed methodologies.  
 
The scoping study and literature review highlighted the need and provided very 
preliminary face validity for, a user friendly, consensus framework for delivering 
process evaluations of psychological interventions. The proposed framework was 
tested further on an RCT of the effectiveness of a psychological intervention to 
improve glycaemic control in T2D, the D6 study.  
 
Summary of the Process Evaluation of D6  
 
Findings are summarised according to process evaluation component. 
 
Formative Process Evaluation  
 
Formative Process Evaluation ensures a programme is feasible, appropriate and 
acceptable (Saunders et al., 2005). Conducting formative theoretical and practical 
evaluation prior to the development of an RCT is likely omitted from process 
evaluations due to time and budgetary restrictions. Formative evaluation may also be 
considered a standard component of a research programme and therefore not 
recognised as a process evaluation component. Development of an RCT may include 
PPI; collaborative presentation and discussion; consultation with allied healthcare 
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professionals; consolidation of results from previously conducted RCTs and 
observation from researchers’ professional practice.  
 
A feasibility evaluation of D6 occurred prior to the lifetime of this thesis, and was not 
formally described as Formative Process Evaluation. The senior investigators applied 
their learning from a very closely related study, the ADaPT Study (Ismail et al., 
2010). This 3 arm parallel RCT compared whether (i) MI + CBT compared with usual 
care (ii) MI compared with usual care or (iii) MI + CBT compared with MI was more 
effective in improving glycaemic control in people with type 1 diabetes when 
delivered by hospital based nurses with additional training in these techniques. They 
conducted a fidelity assessment alongside the RCT, analysing therapeutic sessions for 
themes. Their findings that an integrated MI and CBT approach could be taught to 
diabetes nurses who could reach basic competency and this could lead to small but 
clinically significant improvements in glycaemic control was considered sufficient on 
a theoretical basis. They made the assumption that ‘nurses are nurses’ and their 
specialism or the conditions they work with are not relevant and therefore it was 
acceptable to transfer the training from a hospital based diabetes nurse to a primary 
care practice nurse (D6). The former specialises in in-depth diabetes and often of a 
higher agenda-for-change grade whereas the latter has a broader range of skills 
perhaps at less depth. If a formal Formative Process Evaluation or feasibility study of 
D6 had been conducted this assumption may have been challenged and may have led 
to a different training programme. 
 
Formative Process Evaluation also encompasses the process of mapping theoretical 
underpinnings onto intervention components. In D6, the 6 psychological skills taught 
were drawn from MI and CBT. However, the mechanisms by which MI asserts its 
effects remain poorly understood (Romano & Peters, 2016). The components of 
client-centeredness and facilitation of change talk are of utmost importance in Miller 
and Rollnick’s theory of MI and may offer the best explanation of how MI may 
produce behaviour change (Romano & Peters, 2016). Miller and Rose offer two 
causal hypotheses focusing on these components, which they classify as ‘relational 
and technical’ and which aim to account for the effect of MI (Miller & Rose, 2009). 
The relational hypothesis is concerned with the combination of Empathy and MI 
Spirit and how together they may evoke behaviour change. The technical hypothesis 
 
255 
posits that the therapist’s consistent and proficient use of MI-adherent behaviour will 
elicit and reinforce change talk and that this change talk is related to behavioural 
outcome. The components of MI Spirit, Empathy and Adherence to MI were 
identified as central to the D6 intervention and measured as part of the Fidelity study 
described in Chapter 6 and discussed later in this chapter.  
 
Acceptability and Social Validity  
 
It was not possible to apply the Acceptability and Social Validity components of the 
proposed framework as the D6 study had started prior to the lifetime of this thesis. 
The acceptability and social validity of a proposed RCT is concerned with whether or 
not an intervention is feasible and acceptable to potential participants and involves 
pilot or exploratory studies that aim to assess full-trial feasibility for example using 
PPI groups. While these represent important process evaluation components, it may 
be that they can be more usefully collapsed into Formative Process Evaluation in 
order to simplify the framework. A revised process evaluation framework is presented 




Recruitment processes are reported as part of CONSORT guidelines and commonly 
discussed as a limitation or strength in the main RCT paper. They are also a crucial 
aspect of a process evaluation but are not often described as such. General practice 
cluster uptake to D6 was low (20%), despite the offer of generous nurse backfill 
payments (£10,000 per practice). A possible explanation for this is a cohort effect of 
lack of resources within general practices in combination with national restructuring 
of primary care services. Practices may also prioritise meeting QOF targets due to 
financial incentives, or there may be staff shortages, for example of GPs. Anecdotally 
many practices said that they were in debt but did not want the backfill because they 
did not have a nurse or did not want to release the nurse. It is possible that uptake of 
D6 would have been greater in a suburban setting outside London, but the population 
would not be representative of the ethnic and social diversity of people with T2D as 




Recruitment processes are considered and potentially amended throughout the RCT. 
As discussed in Chapter 5, patient recruitment strategies for D6 were amended to 
address difficulties recruiting from a poorly controlled T2D population. Original 
inclusion criteria required one HBA1c result ≥ 64 mmol/mol% (equivalent to 8%) in 
the past 18 months but this was amended via research ethics committee to 2 HBA1c 
results ≥ 64 mmol/mol%, once in the past 18 months and once at recruitment, in order 
to better capture a persistently poorly controlled population. HbA1c was also lowered 
from 69.5mmol/mol% (equivalent to 8.5%) to 64 mol/mol (equivalent to 8%).  
 
The D6 study was also slightly underpowered at 77% (versus target of 80%) and it 
may be that face-to-face recruitment strategies may have been more effective, if 
labour intensive. However, this was a pragmatic design implemented in a real world 
setting (Eakin et al., 2014).  
 
Dose Delivered  
 
Patient attendance was a problem in D6, with average 50% attendance rate. Half the 
patients therefore did not receive the full dose of the intervention. Explanations for 
this could include that patients may have wanted more help to control their T2D but 
did not want to make the practical steps towards attending sessions. They may also 
have agreed to participate in order to please the D6 researcher or practice nurse 
without any intention to take part, or may not have fully comprehended the 
commitment to the study even though they had given informed consent, or changed 
their minds. Patients may also have experienced barriers to attendance, discussed 
further below. 
 
Dose Received  
 
The extent of the Dose Received by participants is reported less frequently than Dose 
Delivered in RCTs of psychological interventions. The terms are hard to separate and 
may be more useful in combination. This is a well-known problem in the field of 
pharmacological prescribing. Many patients do not adhere to their medications as 
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prescribed (Osterberg & Blaschke, 2005) and there has been extensive research into 
the difference between prescriptions issued and those collected (Hess, Raebel, 
Conner, & Malone, 2006), or prescriptions issued versus medications self-
administered (DiMatteo, 2004). Adherence to a dose of medication is notoriously hard 
to measure and even administration of medication can be partial or intermittent 
(DiMatteo, 2004). However, while getting a prescription (Dose Delivered) is an 
action separated from ingesting a tablet (Dose Received). It may be useful to combine 
the concepts of Dose Delivered and Dose Received in future process evaluations of 
psychological interventions where both are taking place simultaneously (e.g. during a 
therapy session). It may therefore be useful to combine the two terms so that Dose 
Delivered + Dose Received = Adherence. If the minimum acceptable level of an 
intervention was delivered to a participant and it is accepted that they also received 
each dose then it is reasonable to conclude that the minimum amount of intervention 
required has been delivered as intended. The concepts of Dose Delivered and Dose 
Received have been combined as Adherence in the revised framework presented later 
in the chapter.  
 
The mean number of D6 doses received was lower than intended. There was no 
evidence of an association between the number of D6 intervention doses delivered 
and HbA1c at 12 month follow up. A meta-analytic review of self-management 
education interventions for adults with T2D found that dose was significantly 
associated with greater effect sizes for diabetes knowledge and metabolic control. 
However, this effect did not extend to self-management behaviours (Fan & Sidani, 
2009). Assessing the dose-response relationship in psychotherapy is even more 
complex with evidence that acute and chronic symptoms may improve at different 
rates, in different long-term conditions and settings (Hansen, Lambert, & Forman, 
2002). It may be that different strategies or intervention types are necessary to address 
different aspects of self-management.  
 
Programme Implementation/Fidelity  
 
Fidelity is a commonly studied component of process evaluation. An explanation may 
be that Fidelity is an established concept within the literature. Fidelity enables the 
researcher to establish whether a successful intervention worked as a result of the 
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intervention itself, or another factor that was added to the intervention or omitted 
from it. Conversely, if an intervention did not work, we cannot be sure that non-
significant results were due to the failure of the intervention itself or a failure of 
implementation.  
 
Overall, the Fidelity analysis showed that D6 was not implemented according to 
protocol, and provided information about the absence of specific competencies. This 
data is crucial for accurately interpreting the results of a trial, which aimed to assess 
whether or not practice nurses can be trained to deliver psychological skills in place 
of mental health professionals. It may be that they cannot, and that the delivery of MI 
is best suited to specialists in psychological healthcare. If nurses or other allied health 
professionals are to be trained in psychological skills, it may be that the best approach 
is to select nurses based on their previous experience and aptitude for reaching 
required competencies. Allowances were made for the fact that D6 skills were 
delivered as part of research consultations and as such did not represent real world 
practice.  
 
Contamination   
 
Most complex psychological interventions cannot be delivered blind to participants or 
providers and it is therefore difficult to contain delivery of treatment within the 
intervention arm. It may be that researchers consider strategies such as cluster 
randomisation sufficient to control for potential contamination. However, it is 
possible that participants may still receive the intervention from other sources. This 
was observed within D6, as a nurse in the control group attempted to learn D6 skills 
and deliver them to her patients. This was accounted for in the main RCT analysis.  
 
It may be helpful to combine the component of Contamination with that of 
Programme Implementation/Fidelity since the two concepts are closely related. 
Fidelity may encompass the verification of the occurrence of essential components, in 
addition to the absence of treatment contamination (Leeuw, Goossens, De Vet, & 





Provider Experience  
 
The process evaluation of D6 showed that nurses perceived the D6 intervention as 
useful but that it required significant role readjustment on their part. When combined 
with the results from the fidelity analysis, which showed that the majority of nurses 
did not deliver the intervention as intended, this provides some explanation for the 
non-significant D6 findings.  
 
Further barriers to implementation of the D6 protocol were revealed by a qualitative 
interview study exploring nurses’ experience of taking part. Nurses cited many patient 
behaviours as barriers to their practice, including lack of attendance at appointments, 
lack of willingness to commit to scheduled appointments and patients not prioritising 
diabetes self-management, something which may be explained by the fact that the D6 
sample was drawn from a hard to reach population with 10 years average disease 
duration. Patients were chosen because they had persistent sub-optimal glycaemic 
control and consequently were likely to have had low levels of commitment to self-
management and poor records of attendance at healthcare appointments.  
 
In addition, nurses cited many barriers to practice, including some resentment towards 
the lack of financial compensation for their time commitment (despite financial 
compensation being made to their practice) and the requirement that they assimilate 
D6 practice into their already busy workload. Nurses also struggled to deliver specific 
aspects of MI therapy such as complex reflections, which suggest that these skills 
may be particularly difficult for a non-specialist to provide.  
 
Nurses were concerned about over-stepping professional boundaries, particularly 
when dealing with highly emotive consultations, and many felt they were not properly 
qualified to deliver the D6 intervention. If allied health professionals are to be trained 
to deliver psychological skills as part of routine care then it is essential that this 
barrier is addressed in future research. Since it was also found that nurses perceived 
D6 skills as valuable and transferable in a clinical setting, it may be the problem is 
one of confidence in using the skills, and not one of motivation to learn them.  
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The organisational context also appeared to be crucial in determining whether D6 
nurses were able to implement the intervention according to protocol, with some 
nurses revealing that they felt under supported by their practice. They highlighted the 
need for future research to provide support from other departments within the general 
practice, such as IT and reception teams, in order for an intervention such as D6 to be 
successfully implemented. 
 
Participant Experience  
 
The literature review showed that Participant Experience was a commonly measured 
component of process evaluation. Although qualitative interview studies are time 
consuming to conduct, transcribe and analyse, rich data are captured and the 
population is easily accessible thanks to their established participation in the main 
RCT.  
  
There is significant conceptual overlap with Barriers and Facilitators and Fidelity in 
that the data captured by participant experience helps to explain the no-dose effect of 
D6. However, since qualitative interviews exploring Participant Experience are 
capable of capturing data on every aspect of participation in the study there is an 
argument for its continuation as a separate component of process evaluation.  
 
The process evaluation of D6 showed that participants felt they benefited from 
spending extra time with the nurse, yet the D6 RCT analysis showed no significant 
improvement in HbA1c. Their perceived benefits did not translate to actual behaviour 
change. Any benefits that patients did derive from the intervention may have arisen as 
a result of a power dynamic between the patient and provider, the former relying on 
the latter to provide crucial healthcare. A social desirability effect may have provided 
an incentive to change behaviour. Patients reported positive aspects of consultations 
including frequency, increased diabetes knowledge and positive nurse manner. A 
mechanism of action of the D6 intervention may have been a sense of collaboration 
between patient and provider. Anecdotal data from tape recordings also suggest that 
nurses’ tone of voice was often harsh and critical (bearing in mind that raters did not 
know patients’ study arm allocation), and it may be that intervention nurses who had 




Patients in the control group may also have reported benefits from spending extra 
time with the nurse as a result of the ‘treatment as usual’ control condition study 
design of D6. This type of control group assumes that patients ordinarily receive a 
certain level of care from nurses, but this may not be the case. Nurses may have been 
working harder to provide ‘usual care’ as recommended by NICE and adapted for the 
local population (NIHR, 2002) as a result of participating in the study (Freedland, 
Mohr, Davidson, & Schwartz, 2011). In addition, the D6 research assistants made 
frequent visits to each nurse to ensure they were supported administratively and also 
helped them contact D6 patients for appointments, which may have resulted in 
patients attending ‘usual care’ appointments more frequently.  It’s possible that the 
D6 usual care control condition systematically improved the ‘usual care’ received by 
control participants. However, while ‘no treatment’ control conditions are suitable for 
an effectiveness trial of a drug at a university teaching hospital for example, it would 
not have been ethical to use a ‘true’ control condition in an efficacy trial such as D6 
due to the risks of depriving participants of their routine monitoring and therapies 




The literature review revealed that Context is rarely studied as part of a process 
evaluation. It concerns the extent to which the wider context within which the 
intervention was implemented has the potential to effect outcome.  
 
An evaluation of Context was planned as part of this PhD, and presented to the NIHR 
as part of a PhD Research Fellowship application (2012). The proposed thesis was 
shortlisted and the candidate invited to interview. However, the panel felt the thesis 
was too ambitious in its scale and it was not funded. The component of Context was 
therefore excluded as a much larger piece of work, on the advice of the panel.  
 
Exploration of the Context component of process evaluation may represent a costly 
endeavor, as examining contextual variables such as workplace systems and team 
communication channels may require methods which are labour intensive and 
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resource-consuming. Proposed methodologies for assessing Context included 2 
separate studies; first, an ethnographic examination to observe organisational 
processes and changes in GP practice working as a result of D6. Proposed methods 
included shadowing a purposive sample of D6 nurses with the aim of observing the 
impact of D6 on working patterns and other organisational changes, using prompts to 
elicit process data from D6 nurses and colleagues/other staff. This data could be 
analysed for themes and mapped within and across GP practices. Analysis could be 
conducted using NVivo software where appropriate. 
 
The second proposed study was an examination of national and local policies on 
training health professionals in psychological skills to support patients' self-
management. The aim would be to map current understanding, expectation and 
delivery of education and training needs in psychological skills for health 
professionals (especially nurses) delivering diabetes care at local (Clinical 
Commissioning Group), regional and national level. Proposed methods included a 
scoping study of policy documents and grey literature and interviews of key leaders in 
statutory and third sector organisations responsible for policy (NHS Diabetes, NICE, 
Diabetes UK, GP leads for diabetes in Commissioning Groups within D6). Data could 
be analysed to produce a thematic framework against which the implementation of 
policies on training health professionals to delivery psychological therapies would be 
examined.  
 
Although these studies were not funded, there were a number of observations made, 
which may explain contextual factors. For example, difficulties recruiting general 
practices into D6 were potentially confounded by the coincidental restructuring of 
primary care services, with the responsibility of management for T2D patients 
shifting from secondary to primary care, putting additional strain on services. It may 
also be that there is currently no societal desire for psychological support for T2D as 
there is for T1D. For example the ‘cognitive and psychological effects of living with 
type 1 diabetes’ are in the top 10 research priorities for Diabetes UK (UK, 2011) but 
T2D is not. It is possible that the D6 intervention was not tested at the right time.   
Further contextual factors that may have contributed towards the null finding could be 
that the inner city setting within which D6 was implemented represented an 
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inappropriate setting for a psychological intervention when patients are already 
struggling to cope with the demands of chaotic city living.  
 
Barrier and Facilitators  
 
Barriers and Facilitators to intervention implementation were also not commonly 
reported, potentially due to financial and time related restrictions. Exploring the 
reasons why patients and healthcare providers felt they were not able to engage with 
or deliver the intervention as planned, or vice versa, represents another drain on what 
may be limited resources, particularly once the main RCT data collection has finished 
and focus is shifted towards analysis.  
 
Important barriers to diabetes self-management were revealed by the qualitative 
participant study, which supported the findings of the qualitative study conducted 
with providers and vice versa. Patients reported feeling they had other priorities more 
important than managing their diabetes, consistent with the finding from the nurse 
study indicating that patients were unwilling to engage and reluctant to make changes 
to their diabetes self-management. It may be that interventions designed to tackle 
social and psychological issues together could be more effective in managing diabetes 
(Doherty et al., 2016).  
 
A further finding that emerged from patient interview data was that many patients 
were unclear why they were participating in D6. Reasons for participation included 
the desire to help others, or the fact that they had been asked to do so by their 
healthcare provider. This again highlights the difficulty of attempting to enhance 
motivation to change in such a hard to reach population, who have little or no 




None of the process evaluations reviewed reported data on the component Adoption. 
This is unsurprising considering that data do not emerge until several years after the 
main RCT has ended. It also raises questions about the usefulness of the Adoption 
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concept in the process evaluation framework. It has therefore been removed from the 
revised version.    
 
Overall Assessment of This Process Evaluation Framework 
 
The application of the framework to D6 yielded three useful sets of data in addition to 
that collected as part of the D6 RCT including i) fidelity data, which revealed that the 
intervention was not implemented as planned ii) qualitative data on barriers to 
implementation experienced by nurses, which have implications for the design of 
future research and iii) qualitative data from patients that were consistent with the 
barriers cited by nurses and with what is already known about attempting to reach this 
particular sub-set of patients with persistent sub-optimal control.  
 
These data will be crucial in informing the design of future research. In the absence of 
a process evaluation of D6, there would be no data on whether or not the intervention 
did or did not work as a result of the design itself or a feature of implementation. The 
process evaluation has told us that failure of implementation may be one part of the 
explanation of the outcome of the D6 trial. We also know that there were barriers to 
successful implementation other than nurses’ competencies, which were cited by both 
nurses and patients and should be addressed in future research designs. The process 
evaluation data revealed that practice nurses may not be suited to psychological skills 
acquisition and that this specific sub-group of patients may not be an appropriate 
target for MI intervention. 
 
The 12-component framework tested on D6 was a useful starting point for conducting 
a process evaluation of a psychological intervention. However, it became clear 
throughout testing that some components may be more usefully combined in order to 
avoid conceptual overlap.  
 
Revised Process Evaluation Framework Components  
 











Mapping theoretical underpinnings of the intervention design onto potential active components. Pilot or exploratory studies are conducted to ensure that the 
proposed intervention is feasible, appropriate and acceptable to potential participants.  
Recruitment  Determining the most appropriate recruitment strategies and considering their impact on study outcome. 
Monitoring and adapting recruitment strategies throughout the RCT to maximise uptake and efficiency.  
Adherence Dose delivered + dose received = adherence. If the minimum acceptable level of an intervention was delivered to a participant and it is accepted that they also 
received each dose then it is reasonable to conclude that the minimum amount of intervention required has been delivered as intended. 
Programme 
Implementation/Fidelity  
Measuring whether or not the intervention was implemented according to protocol in order to answer the question: did a successful intervention work/not work as a 
result of the intervention itself, or another factor that was added to the intervention or omitted from it?  
An assessment of contamination should be made to establish whether control group participants have received elements of the intervention.    
Provider Experience  This concerns the experiences of the provider selected to deliver the intervention. There are many individual characteristics with the potential to affect outcome, 
including provider responses; personal beliefs and values; previous experience or training and capacity to engage.  
Participant Experience  This concerns the experiences of participants who receive the intervention, their satisfaction and the degree to which they find the intervention acceptable. There 
are many individual characteristics with the potential to affect outcome, including participant responses; interaction between participant and interventionists; 
personal beliefs and values; previous experience or training and capacity to engage 
Context  This refers to the environmental setting in which the intervention is implemented that have the potential to affect outcome. These may include organisational 
factors, systems and logistical factors, system or political factors such as local or wider national policies and economic factors such as available funding and 
resources.  
Barriers and Facilitators  An exploration of the barriers or facilitators to the implementation of the intervention as per protocol. These may be revealed through exploration of other process 







Strengths and Limitations  
 
There are a number of strengths and limitations of this thesis concerning the scoping 
study and literature review, development of the framework and its application to the 
D6 study.  
 
The framework proposed in this thesis was developed as a result of the scoping study 
described in Chapter 3. The advantage of a scoping study is its ability to synthesise a 
poorly demarcated area of research, which would have been very challenging using 
traditional systematic review methodology. For example, a review of worksite health 
promotion programmes identified 307 studies alone, of which 22 published a process 
evaluation (Wierenga et al., 2013), and just 8 based their evaluation on a theoretical 
framework. A review of studies in occupational stress management which 
incorporated process evaluation identified 52 studies which reported on an aspect of 
process evaluation (Murta et al., 2007) and fewer than half presented any findings 
linking the process evaluation with outcome. A review of process evaluations of 
school based vaccinations identified 14 studies which met inclusion criteria, 
concluding that more controlled studies are required to provide the public health 
community with the best evidence and evaluation data on how best to implement 
school based vaccination studies (Robbins, Ward, & Skinner, 2011). These reviews 
show that while there are bodies of research present in a variety of fields, their results 
are consistent with that of process evaluation research in general, which is a poorly 
defined field comprised of conflicting approaches. However, despite this complexity 
within the literature, it is likely that studies of interest were excluded from the scoping 
study to the potential detriment of framework development. 
 
Both a strength and a limitation of this thesis is that it focuses exclusively on process 
evaluations of psychological interventions in T2D. As the first review of process 
evaluations of psychological interventions designed to improve glycaemic control in 
T2D it represents an important step in furthering understanding of the current state of 
process evaluation research in this field. The literature was narrowed to a field 
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relevant to this thesis, exploring process evaluations of studies relevant to the T2D 
epidemic. The inclusion criteria for the review were generous, including studies that 
specified they had conducted a process evaluation, and also those which did not. This 
approach was chosen with the aim of identifying all attempts at process evaluation, 
despite terminological variation. Studies were synthesised without being limited by 
this considerable variation in terminology and frameworks, which in turn enabled 
more meaningful comparisons between studies. Establishing an a priori framework 
allowed for structured discussion proceeding from theoretical deduction rather than 
simple observation.  
 
However, as the review could not include process evaluations of RCTs of 
interventions conducted in different contexts, e.g. in community settings, the findings 
may not be generalisable to other interventions in different long-term conditions. 
Much process evaluation work has taken place within the health education context, 
which this review does not include. It is possible that important research within the 
process evaluation field may have been missed due to the exclusion of this category.  
For example, a community based mental health promotion intervention for refugee 
children living in a Palestinian camp in Beirut, Lebanon highlighted the challenges 
and complexity of implementing a process evaluation within a severely disadvantaged 
community in the Eastern Mediterranean region (Nakkash et al., 2012). The 
Quaderoon (‘We are Capable’) intervention was a year-long social skill building 
intervention for children aged 11-14 years, their parents and teachers, aimed at 
promoting mental health of the children and increasing their attachment to school. 
The intervention was informed by stress inoculation training, improving social 
awareness/social problem solving and a positive youth development programme. It 
consisted of 45 sessions with children, 15 with parents and 6 workshops with 
teachers. In addition the intervention implementation and process evaluation were 
guided by a Community Youth Coalition group, established specifically for the 
project and comprising 17 Non-Governmental Associations working with youth 
members and residents of the camp, research team members and funders. The process 
evaluation focused on dose delivered, dose received, fidelity, satisfaction and reach. 
The process evaluation showed that session objectives were achieved and intervention 
activities implemented as planned although attendance was low. Children reported a 
high level of satisfaction with sessions. Qualitative methods such as meetings of the 
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implementation and research team and observational data collected by field 
coordinators were used to address problems with intervention delivery as they arose, 
resulting in changes of intervention structure and content while the intervention was 
in progress. Challenges to implementation included the size of the research team and 
corresponding variation in delivering the intervention and interacting with children. 
The unique context of the intervention presented significant challenges, not least the 
escalation of conflict between Israel and Hamas in 2008 leading to the war in Gaza. 
The children participating in the study were deeply distressed by political events. 
Other challenges to conducting process evaluation included competing demands on 
researchers, difficulty in conveying the importance of process evaluation to the wider 
research team and political events interfering with data collection. Limitations 
included reliance on self-report data from internal evaluators and a lack of data 
gathered from children participating in the intervention. This study reports a complex 
intervention in which process evaluation was particularly ambitious and important in 
revealing challenges to implementation.  
 
A strength of this thesis is that the process evaluation strategy for D6 was developed 
and based on theoretical concepts. The process evaluation framework was developed 
as a result of literature review, summary of previous frameworks used and 
components of process evaluation previously studied. These theoretical constructs 
were then translated into research questions. The role of theory is crucial in the 
development of any research that may lead to evidence based practice as it enhances 
explanatory power and predictive capability (Green, 2000). In turn these theoretical 
concepts were used to develop a framework for process evaluation that is designed as 
a checklist for researchers. The aim was to provide an aid to planning and evaluation 
which can be used in a similar way to the CONSORT checklist, designed to aid 
researchers in the design and conduct of RCTs. One of the main aims of the 
CONSORT checklist is to provide completeness and transparency of reporting of 
results and this too, is the aim of the process evaluation checklist. The two checklists 
differ considerably however in the types of data they are capturing. The CONSORT 
checklist was designed to ensure that biases in the conduct of an RCT are minimised 
to reduce the risk of over or under estimating effect sizes.  On the other hand, the 
process evaluation checklist is designed specifically to enhance the understanding of 
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the complexity of an intervention, by capturing all the data that a standard RCT does 
not.  
 
Similar checklists designed to improve the reporting of other types of research 
followed the development of CONSORT, including Quality of Reporting of Meta 
Analysis (QUOROM) (McDonough, 2003); Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) (Moher et al., 2009); Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) (Von Elm et al., 
2008); Standards for Quality Improvement Reporting Excellence (SQUIRE) 
(Davidoff & Mooney, 2008); Critical Appraisal Skills Program (CASP); (UK, 2017); 
Template for Intervention Description and Replication (TIDIER)  (Hoffmann et al., 
2014)and Consolidated Criteria for Reporting Qualitative Research (COREQ) (Booth, 
Hannes, Harden, Noyes, & Harris, 2014).  
 
The QUOROM statement preceded the development of PRISMA, with both designed 
to enhance the conduct and reporting of systematic reviews and meta-analyses. The 
PRISMA statement consists of a 27-item checklist and four-phase flow diagram 
including items considered essential for the proper conduct of systematic reviews. 
STROBE is concerned with epidemiological studies, SQUIRE with the reporting of 
quality improvement studies within healthcare settings, and COREQ with the conduct 
and reporting of qualitative research, specifically interviews and focus groups. 
 
The advantage of such checklists is that they are developed collaboratively by groups 
of experts and as such benefit from their pooled knowledge and experience. They are 
also developed over many years, and are the result of large amounts of research. The 
original CONSORT checklist for example, was developed by 13 scientists and revised 
by 31 (Begg et al., 1996); PRISMA was developed collaboratively by a group of  ‘29 
review authors, methodologists, clinicians, medical editors, and consumers’ (Moher et 
al., 2009); the STROBE website lists 20 research group members; SQUIRE was 
drafted by ’30 stakeholders’ (Davidoff & Mooney, 2008) and COREQ was developed 
by a research team at the School of Public Health, University of Sydney. A limitation 
of the proposed process evaluation framework set out in this thesis, then, is that it was 
developed without such a dedicated research team and the researcher’s resources, in 
terms of expertise, experience and time available, were very limited in comparison. 
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Nonetheless, a clear strength of this thesis is that a process evaluation framework was 
developed and used, when many process evaluation studies have not.  
 
However, a lack of standardised methods for conducting scoping studies means that 
selection of appropriate methodology is open to researcher interpretation and the data 
from a scoping study has to be interpreted without an assessment of quality as would 
occur in a systematic review (Davis et al., 2009). It could be argued therefore that the 
study presented in Chapter 3 does not delineate the methodological steps taken 
towards framework development clearly enough.  
 
There are also some important limitations relating to the process evaluation of D6, in 
particular the study research team. The researcher responsible for conducting the 
process evaluation and writing this thesis was also a research assistant for the duration 
of D6, responsible for recruitment of patients into the trial, data collection, 
management of D6 nurses and trial administration. As Co-Investigator, the 
researcher’s first supervisor was responsible for the design and overall conduct of the 
trial (KI). As an NIHR Post-Doctoral Fellow, the researcher’s second supervisor was 
responsible for the setting up and overall management of the trial (KW).   
 
The researcher’s former position as D6 research assistant represents a source of bias 
in terms of her ability to objectively evaluate the study. Bias ‘is a lack of neutrality or 
prejudice’ (Attia, 2005) and it can occur at any stage of planning, conducting, or 
evaluating an intervention. While the RCT study design aimed to minimise bias using 
random allocation of participants and allocation concealment, the dual role of the 
researcher may have influenced findings. For example, the researcher supervised 9/16 
nurses for the duration of their participation in D6 (helping arrange patients’ 
appointments patients and providing administrative support), and also interviewed 
them for the qualitative study reported in Chapter 7. This increases the potential for 
social desirability bias, as nurses may have felt uncomfortable disclosing their true 
thoughts about D6 to the researcher, or may have wanted to gain her approval. The 
same problem is relevant to the qualitative study described in Chapter 8 in which the 
D6 researcher interviewed D6 participants (3/18 patients were recruited into D6, and 




The analysis of data emerging from both qualitative studies may also have been 
subject to researcher confirmation bias. Confirmation bias refers to the ‘seeking or 
interpreting of evidence in ways that are partial to existing beliefs, expectations or a 
hypothesis in hand’ (Nickerson, 1998). It is possible that the researcher interpreted 
qualitative interview data with her own observations throughout the duration of the 
RCT in mind, although a sample of interviews from both nurse and participant 
qualitative studies was coded by an independent rater to address this. As discussed in 
Chapters 7 and 8, greater reflexivity in the conduct of the qualitative research and 
keeping a reflexive diary for the duration could have further addressed these potential 
limitations.  
 
In addition, the positions of the researcher’s supervisors as Co-Investigator and NIHR 
Post-Doctoral Fellow meant they were responsible for the design and overall conduct 
of the trial and as such may have been reluctant to identify flaws in the trial, which 
may have impacted on the evaluation presented in this thesis. However, the D6 study 
was peer reviewed before funding and monitored by an independent Trial Steering 
Committee and Data Monitoring and Ethics Committee for the duration of the RCT. It 
is therefore implicit that other senior academics considered the formative evaluation 
and design of the trial to be satisfactory.  
 
While the position of the D6 researcher and her supervisors represented potential 
sources of bias, this thesis optimised the use of D6 by testing the efficacy of a new 
intervention, conducting a process evaluation and evaluating the feasibility of a 
process evaluation framework tested in a real world setting within a very limited 
budget. Other studies have shown similar results, for example, a qualitative study of 
healthcare professionals’ perspectives of barriers and facilitators to the delivery of 
support for people with severe mental health problems and T2D found that healthcare 
professionals felt ‘hard wired’ to focus on their own specialism, despite 
acknowledging they felt unskilled in other areas, similar to the barriers cited by D6 
nurses (Papachristou Nadal et al., 2020).  
 
A strength of this thesis is that the framework was tested on an RCT of a new 
intervention conducted in a real world, primary care setting. Seven of 12 components 
presented in the original framework were studied (Fidelity, Participant Experience, 
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Provider Experience and Barriers and Facilitators as three stand alone studies, and 
Recruitment, Dose Delivered/Dose Received and Contamination as part of the 
quantitative primary outcome analysis). The remaining components were beyond the 
scope of this PhD. Data were collected and the results analysed prior to the intention 
to treat primary analysis of the main RCT. This removed a potential bias in the 
interpretation of process evaluation results. The process evaluation became even more 
relevant as the primary D6 outcome showed no change in glycaemic control in either 
the intervention or control group.  
 
The process evaluation of D6 used both quantitative and qualitative methods to 
enhance understanding of the main RCT outcome data. The use of mixed 
methodologies is necessary to capture the range of processes and mechanisms that 
may explain the how and why of the effect of an intervention on the outcome. The 
synthesis of these two complimentary approaches mean that quantitative and 
qualitative data can assist in the interpretation of one another’s findings, for example 
quantitative fidelity data revealed that D6 nurses were not competent in delivery of 
certain MI skills, while qualitative data revealed that they were not confident in 
providing psychological care to patients because they felt they were overstepping 
their roles as nurses. While quantitative data provides information on fidelity, dose 
and reach, qualitative data can provide in-depth understanding of mechanisms of 
action within an intervention, or reveal barriers, which have prevented its success.  
 
However, combining data collected using quantitative and qualitative methods can be 
complex (Carey, 1993; Driscoll, Appiah-Yeboah, Salib, & Rupert, 2007; Fetters, 
Curry, & Creswell, 2013; Grafton, Lillis, Malina, Nørreklit, & Selto, 2011). The two 
approaches have fundamentally different philosophical underpinnings, and have given 
rise to different journals, funding sources, areas of expertise, sets of methods and 
language used (Sale et al., 2002). As a result, it may be that these methods are more 
appropriate as complementary perspectives within the same research design, rather 
than in forced combination or ‘synthesis’ (Sale et al., 2002). This may be particularly 
relevant for the study of psychological interventions where there are many levels and 




The MRC framework for conducting process evaluations suggests that quantitative 
RCT outcome measures are supplemented with qualitative approaches. However, as 
Blackwood et al state, there is a ‘fundamental ontological contradiction’ at the heart 
of the framework (Blackwood, O'Halloran, & Porter, 2010) which concerns the 
difference between efficacy and effectiveness in healthcare evaluation research. The 
MRC framework suggests that researchers should measure both efficacy, which is 
‘the extent to which an intervention produces a beneficial result under ideal 
conditions’ (Higgins & Wells, 2011) and effectiveness ‘the extent to which a specific 
intervention, when used under ordinary circumstances, does what it is intended to do’ 
(Singal et al., 2014), something which is impossible according to the MRC’s 
argument that the RCT is the gold standard method for measuring trials of new 
healthcare interventions. There is therefore an important philosophical tension central 
to the MRC framework, in which the positivist assumptions of the RCT are at odds 
with the relativism of qualitative approaches. It is a tension between the idea that 
psychological research is founded firmly in data, logic and inductive inference, and 
the perspective that truth and knowledge exist within the human experience (Fletcher, 
1996). Realistic evaluation must combine these two perspectives coherently.  
 
Mixed methods research places quantitative and qualitative research on a continuum 
rather than as distinct approaches to be combined (Newman, Benz, & Ridenour, 
1998). Mixed methods designs vary widely, and Tashakkori and Teddlie identified 40 
types of mixed methods designs in the literature (Teddlie & Tashakkori, 2003). These 
approaches were summarised into 4 categories by Creswell and Clark: the 
triangulation design, the embedded design, the explanatory design and the exploratory 
design (Creswell & Clark, 2017). These designs can be further categorised as one-
phase (quantitative and qualitative methods applied simultaneously) and two-phase 
(quantitative and qualitative methods applied sequentially) approaches. Process 
evaluation may combine elements of both one-phase approaches (triangulation, 
embedded design) and two-phase approaches (explanatory design, exploratory 
design). Triangulation involves combining quantitative and qualitative methods in 
order to play to their relative strengths and weaknesses, for example the large sample 
size and generalisablity of quantitative research versus the small sample size and in 
depth data of qualitative research. This represents the most commonly used approach 
to mixed methods research (Creswell, Plano Clark, & Hanson, 2003). Process 
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evaluations may also use an embedded design, in which one data set provides support 
as a secondary set of data to a study primarily designed around either quantitative or 
qualitative methods. An embedded experimental model may be applied as a two-
phase approach, for example when the researcher has conducted a quantitative RCT 
but wants to collect qualitative data about participants’ perspectives after the RCT has 
taken place, as was the case with D6. An explanatory design may be a two-phase 
mixed methods design in which the purpose is to obtain quantitative outcome data 
then compliment it with a qualitative phase, while an exploratory design may use the 
first dataset to further inform or develop the second (Gelo, Braakmann, & Benetka, 
2008).  
 
The use of mixed methods also opens up the possibility that they will yield divergent 
datasets. For example, a pilot RCT to examine the impact of welfare rights advice on 
126 older people in primary care found little evidence for differences in quantitative 
health and welfare outcomes at 24 months after receiving welfare rights advice. 
However, qualitative semi-structured interview data suggested ‘wide-ranging 
impacts’ (Moffatt, White, Mackintosh, & Howel, 2006). The authors posit a lack of 
power in this pilot study; the ability of the outcome measures used to accurately 
capture relevant outcomes in an older population; and that insufficient numbers of 
people had received benefits for long enough to allow health outcomes to have 
changed when comparisons were made as explanations for the lack of quantitative 
difference. The qualitative study however, found that some participants experienced 
significant impact as a result of receiving additional financial resources, reporting a 
wide range of uses for the extra money. The authors devised 6 ways of interpreting 
the divergent data including (i) treating the methods as fundamentally different; (ii) 
exploring the methodological rigour of each component; (iii) exploring dataset 
comparability; (iv) collection of additional data and making further comparisons; (v) 
exploring whether the intervention under study worked as expected and (vi) exploring 
whether the quantitative and qualitative components match. From this detailed 
analysis of the discrepancies between the two datasets, the authors concluded that the 
divergent findings arose from the fact they were exploring different research 
problems; that the pilot study may have been too underpowered to detect a significant 
effect; and that the qualitative study may have been measuring dimensions not 
measured by the quantitative study, which led them to look more carefully at the 
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measures used and conclude they were not wholly applicable to an older population. 
They also sought further funding to undertake additional data collection at follow up, 
which verified the findings of the original study (Moffatt et al., 2006).  
 
This study highlights the need for better synthesis and interpretation of process 
evaluation data. However, much of the difficulty lies in the fact that public health 
interventions such as D6 attempt to capture complex psychological phenomena using 
standardised measurement tools. While the inclusion of mixed methods attempts to 
address this issue, ‘the practice of research is a messy and untidy business which 
rarely conforms to the models set down in methodology textbooks’ (Brannen, 2017) 
and process evaluation is no different.  
 
This thesis represents an important and original approach to conducting a process 
evaluation, which has been performed without the benefit of more than 100 years of 
study, as is the case with the RCT. The first RCT of a psychological study was 
conducted in the 1880’s (Stigler, 1992), while process evaluation is an emerging field.   
 
The Future of Process Evaluation  
 
Process evaluation can be conducted in the same spirit and vigour as adhering to the 
CONSORT guidelines but the frameworks and methods are still in their infancy. 
Many researchers are time poor and will be looking for a framework that can be used 
quickly and easily. This will lead to cost saving measures. It is crucial that 
frameworks are adopted if the field is to move towards theoretical development and 
methodological consistency.  
 
The MRC guidance provides the most up to date guide for researchers, but lacks a 
checklist (Moore G, 2014). Although representing an important advancement in the 
field, and acknowledging the importance of process evaluation, the guidance reads 
more like a review of the literature than a guidance document. In attempting to 
provide a ‘one size fits all’ approach they have produced guidelines that could be 
considered vague. It may be that specific process evaluation guidelines must be 
produced for different contexts and different long-term conditions. The framework 
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presented in this thesis identified the core components of process evaluation, which 
can be applied to evaluations of psychological interventions. The MRC is currently 
updating their guidance on developing and evaluating complex interventions, but 
running behind schedule (Moore G, 2014). Publication is expected in 2020. Perhaps 
the new guidance will offer more detailed instruction for researchers on how adapt the 
framework to their own work.  
 
Realist RCTs  
 
The future of process evaluation lies in the synthesis of quantitative and qualitative 
methods. At the heart of the MRC framework is a tension between the positivist 
rigour of the RCT and the relativist position of qualitative methods. Resolving this 
tension is key. The MRC guidance resonates with the idea of realist evaluation, which 
pays attention to mechanisms, context and outcomes (Pawson, 2013). In recent years 
there has been lively debate in the literature around the concept of ‘realist RCTs’ 
(Bonell, Fletcher, Morton, Lorenc, & Moore, 2012; Bonell, Warren, Fletcher, & 
Viner, 2016; Marchal et al., 2013; Van Belle et al., 2016). Realists argue that RCTs 
fail to account for the complexity of social causation and ask which interventions 
work under which circumstances and for whom (Pawson, Tilley, & Tilley, 1997), 
while proponents of the RCT argue that the randomisation process takes account of 
the complexity of social causation through study design (Bonell et al., 2012). The 
realist RCT aims to use the realist critique of RCTs as a method for modifying them 
to be more useful in the evaluation of public health interventions.  
 
A realist RCT may be one that attempts to identify the effects of intervention 
components separately and in combination, in an attempt to identify the most 
powerful combination of active ingredients. There is a tendency in process evaluation 
to focus on intervention components rather than mechanisms of change. For example, 
a process evaluation of a pilot RCT to test the effect of microfinance and gender/HIV 
training on sexual behaviour and partner violence in rural South Africa determined 
that a community intervention component was the least effective in positively 
influencing outcomes. However, this conclusion was based on the poor 
implementation of this component rather than evidence regarding mechanisms of 
change (Hargreaves et al., 2010). The process evaluation also did not determine which 
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of the properly implemented components did or did not contribute to positive effects. 
Bonell et al (Bonell et al., 2016) suggest that a realist RCT with multiple arms which 
test various combinations of intervention components in each arm could provide a 
solution to this problem. They also suggest factorial trials comparing 2 intervention 
components and 4 groups: two groups receive individual intervention components, 1 
group receives both, and 1 group receives neither (Montgomery, Peters, & Little, 
2003). Realist RCTs also emphasise measurement of active ingredients, which are 
often already measured as secondary outcomes. For example, a school based youth 
programme to reduce smoking behaviour among young people measured self-efficacy 
as a secondary outcome and potential active ingredient influencing outcome 
(Winkleby et al., 2004). Ten high schools in California were randomly assigned to 
receive an intervention designed to reduce smoking activity, or education only. There 
was a significant reduction in smoking behaviour among regular smokers in the 
intervention versus control group, which was maintained at 6 months post-
intervention. There was also a significant difference in perceived self-efficacy 
between intervention and control groups, which led the authors to conclude that the 
construct of self-efficacy may map onto an underlying casual pathway in smoking 
behaviour.  
 
Realist RCTs should also attempt to formally test hypotheses relating to Context and 
its effect on outcome. A key aspect of realist evaluation is seeking to understand how 
an intervention works by anticipating mechanisms of action and generating 
hypotheses to be empirically tested (Jamal et al., 2015). Pawson and Tilley suggest 
using observational data to investigate how context interacts with intervention 
mechanisms to generate outcomes (‘context-mechanism-outcome configurations’) 
(Pawson, 2013). For example in D6, observational data on existing working patterns 
within GP surgeries could be used to generate hypotheses about how these patterns 
may affect pilot implementation of the RCT, which could be tested during the main 
trial. The data reported in Chapter 7 showed that D6 nurses felt they needed support 
from other practice staff in order to incorporate D6 into their workload. However, 






Future Process Evaluation Purposes and Methods  
 
There may be further purposes for process evaluation than those incorporated into the 
framework proposed in this thesis. Pragmatic formative evaluation could be 
incorporated into the Formative Process Evaluation component. Pragmatic formative 
evaluation is discussed in Chapter 3 and refers to formative evaluations of 
interventions that are already used in routine practice but have not yet been subjected 
to rigorous theoretical assessment. They are often distinguished by a lack of a robust 
evidence base (Evans et al., 2015). The MRC guidance on process evaluation states 
that if an intervention is already widely employed, then a testing phase may not be 
essential (Moore G, 2014). However, if there are mechanisms of change active within 
an intervention it is likely that they have not been sufficiently theorised or tested. For 
example, Evans et al conducted a formative process evaluation of a school-based 
emotional and social learning intervention which had been recommended as best 
practice in managing children’s challenging behaviour by the Welsh school 
inspectorate. The evaluation found iatrogenic effects due to a stigmatising targeting 
process, which led to negative labeling of children as intervention participants, 
labeling of students as ‘at risk’ for future deviancy and escalation of deviant 
behaviours (Evans, Scourfield, & Murphy, 2014). Methods used to guide a pragmatic 
formative evaluation could reflect those used in a Formative Process Evaluation, 
including systematic review, identification of potential active ingredients, mapping of 
theoretical concepts and consultation with stakeholders. Pragmatic formative 
evaluation is an exciting area of development because it moves process evaluation 
beyond the assessment of the RCT. Conducting a process evaluation on an existing 
intervention in a real world setting means it is not only complementary to the RCT but 
can be applied to different types of research, for example quality improvement 
studies.  
 
A process evaluation framework may also be applied as an evaluative tool in wider 
research contexts such as systematic review. A framework could be used to assess 
quality of studies included for review, applied alongside the PRISMA statement, 
which provides an evidence based minimum set of criteria for reporting systematic 
reviews and meta-analyses (Moher et al., 2009). While PRISMA provides a 
minimum, a process evaluation framework could assess underpinning theoretical 
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constructs, reported or potential barriers and facilitators to implementation and 
contextual variables. At present, there is no standard guidance for reporting on 
implementation in systematic reviews. The PRISMA guidelines for the reporting of 
systematic reviews of quantitative studies does not include instructions for reporting 
intervention implementation nor does its extension for the reporting of systematic 
reviews focusing on complex interventions, PRISMA-CI (Guise et al., 2017) 
(Flemming et al., 2018).  
 
Process evaluation may learn from other approaches to the improvement of healthcare 
interventions. For example the Plan-Do-Study Act (PDSA) is a widely implemented 
structure for iterative testing of changes to improve quality of complex interventions. 
The 4-stage model is a cyclical learning approach, which plans, executes, studies and 
acts on changes in an iterative and constantly adapting cycle. It’s possible that this 
highly adaptive approach could be beneficial to a process evaluation. However, the 
evidence base for PDSA is lacking and under-theorised and there is no formal 
framework (Taylor et al., 2014). Other approaches such as implementation science, 
which studies the use of strategies to adapt and use evidence based interventions in 
public health may offer insights on the translation of new interventions into practice 
(Lobb & Colditz, 2013); and it may be that quality improvement interventions can 
inform the best way to make use of limited resources in public health systems (Dilley, 
Bekemeier, & Harris, 2012).  
 
Methodologies used to conduct process evaluation should also move beyond those 
identified in this thesis. For example, a process evaluation of an internet-delivered 
sexual health education intervention in The Netherlands used Google Analytics as a 
source of data on website visitor demographics, website traffic sources and content 
exposure. The authors concluded that Google Analytics provided useful quantitative 
data, which can be interpreted further using qualitative methods. This method of data 
collection involves minimal effort and could be valuable given the rate of expansion 
of internet-based interventions (Crutzen, Roosjen, & Poelman, 2013). Social media 
metrics may represent a further source of data, with application specific evaluation 
metrics encompassing ‘reach’ (the number of people who have been exposed to 
content) and ‘engagement’ (the number of people who have interacted with content 
rather than merely acknowledging it) (Neiger et al., 2012; Nguyen et al., 2013).  
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Future Challenges  
 
A significant challenge for the researcher conducting a process evaluation is one of 
resources. Process evaluations require significant resources at every stage, demanding 
separate research studies be conducted alongside an already costly RCT. It is essential 
therefore that funding bodies are convinced of the enhanced explanatory power of 
process evaluations when allocating funding. Due to these resource limitations, a 
major challenge faced by researchers planning a process evaluation is the selection of 
process evaluation components for study. Researchers will rarely have the luxury of 
adequate resources to study each of the components outlined in this thesis, and so will 
need to prioritise. It is important for the development of the field that these decisions 
are stated and justified in process evaluation reports in the spirit of transparency. This 
will enable other researchers to fully understand the decision making process when 
designing and implementing a process evaluation, and to further their own 
understanding of process evaluation frameworks as a whole.  
 
A further reason for limiting the components of process evaluation studied may be the 
vast amount of data yielded, which may not represent efficient use of resources. 
Qualitative studies in particular generate large amounts of data, and mixed methods 
analysis is time consuming (Klassen, Creswell, Plano Clark, Smith, & Meissner, 
2012). Many researchers come from clinical healthcare positions which do not offer 
opportunities to develop the ‘methodological bilingualism’ necessary to conduct 
mixed methods research (Curry et al., 2009). Often, this type of research is secondary, 
or part of a PhD thesis. It takes longer than an RCT and funding may run out before it 
is completed. A process evaluation may also delay the reporting of the main trial 
findings.  
 
Researchers should still make every effort to publish process evaluation findings, as at 
present there exists a trend for conducting process evaluations and reporting results as 
a single sentence within the main RCT publication. Separate publications will allow 
other researchers to replicate methods and contribute towards building a body of 
literature. Furthermore, it would promote the publication of qualitative research.  At 
present, part of the problem is the reluctance of high impact journals to publish 





This thesis reviewed existing frameworks and methods for conducting process 
evaluations; developed a theoretical framework for process evaluations of 
psychological interventions based on the review; described the extent to which an 
RCT of a psychological intervention in T2D evaluated underlying process and tested 
the face validity of a framework on a nurse-led psychological intervention, the D6 
study.  
 
The process evaluation yielded data on the implementation of a trial designed to target 
a specific group of patients within a primary care setting using a psychological 
therapy. The process evaluation revealed that the intervention was not implemented as 
intended; it revealed important barriers to implementation from the perspectives of 
both patients and providers, and the findings have implications for the design of 
future research. These data were even more important in light of the fact that the main 
intervention RCT results were non-significant.  
 
What is clear from the results of this process evaluation, and the existing MRC 
guidance, is that process evaluation guidelines cannot be developed with a ‘one size 
fits all approach’. The process evaluation reported in this thesis cannot offer 
speculation about what methods may work for other populations, in different settings. 
It may be that specific approaches best evaluate specific research designs. Although 
the CONSORT criteria for reporting of RCTs include assessment of trial 
generalisability, few trials include it, and a framework for empirically assessing and 
reporting it is lacking.  
 
While the development of the framework reported in this thesis made an important 
contribution in scoping the history of process evaluation, identifying the core 
components of process evaluation and revealing the processes that contributed 
towards the null finding of the D6 intervention, more work is required. The 
framework was a useful starting point that was refined in light of testing and now 
requires further development, particularly on the synthesis of quantitative and 




The future of process evaluation research will be a constantly evolving field which 
should be highly iterative, whereby researchers test methodologies, theoretical 
concepts and techniques and, crucially, revise them, publishing findings and inviting 
discourse. Over the next 10 years, the field is likely to see rapid development in 
theoretical frameworks and consensus among researchers on constructs to include, 
and in turn we may see rapid development of more appropriate intervention designs, 
which can be replicated in the light of process evaluation findings. RCTs of 
interventions to improve outcome in T2D are reporting increasingly low effect sizes. 
Process evaluations are urgently needed to understand the reasons for this so that 
either we abandon this type of intervention or use the learning from process 
evaluation to innovate. 
 
It is time to move beyond the idea that the binary yes or no answer provided by the 
RCT is sufficient. The complexity of healthcare interventions has had to develop to 
support the increasing challenges of managing long-term conditions, and our methods 
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1. exp Diabetes Mellitus/	
2. diabet$.ab,ti.	
3. (DKA or IDDM).mp. or DMI.ab,ti. [mp=title, original title, abstract, name of 
substance word, subject heading word]	
4. (MODY or DM2 or NIDDM).mp. or IIDM.ti,ab. [mp=title, original title, 
abstract, name of substance word, subject heading word]	
5. insulin$ secret$ dysfunc$.ti,ab.	
6. insulin$ resist$.ti,ab.	
7. ((impaired glucose tolerance or glucose intoleran$ or insulin$ resist$) and (DM 
or DM2)).ti,ab.	
8. insulin$ depend$.mp. or insulin?depend$.ti,ab. [mp=title, original title, abstract, 
name of substance word, subject heading word]	
9. (non insulin$ depend$ or nonisulin$ depend$ or nonisulin?depend).mp. or non 
insulin?depend$.ti,ab. [mp=title, original title, abstract, name of substance 
word, subject heading word]	
10. (("typ$ 1" or typ$ I) adj6 DM).ti,ab.	
11. (("typ$ 2" or typ$ II) adj6 DM).ti,ab.	
12. ((juvenil$ or child$ or keto$ or labil$ or brittl$ or earl$ onset) adj6 (DM or 
DM1)).ti,ab.	
13. ((keto$ prone or autoimmun$ or auto immun$ or sudden onset) adj6 (DM or 
DM1)).ti,ab.	
14. ((keto$ resist$ or nonketo$ or non keto$ or adult$ onset or matur$ onset or 
late$ onset or slow onset or stabl$) adj6 (DM or DM2)).ti,ab.	
15. exp Insulin Resistance/	
16. (insulin$ defic$ adj6 (absolut$ or relativ$)).ti,ab.	
17. metabolic$ syndrom$.ti,ab.	
18. (syndrom$ X not (fragil$ X or X linked)).ti,ab.	
















33. behavio?r adj5 (intervention or therap* or modific*)	
34. cognitive adj5 (therap* or intervention or program* or train* or theory)	







42. (assert$ adj5 training).mp	
43. Narrative therap$.mp.	
44. nondirective therap$.mp	
45. (problem solving adj5 therap$).mp	














60. acceptance adj2 (commitment therap*)	
61. coping skills training.mp.	
62. exp Mindfulness/	
63. motivation* adj2 (interview* or therap*)	
64. multisystemic therapy	
65. or/21-64	
66. Randomized Controlled Trials as Topic/	
67. randomized controlled trial/	
68. Random Allocation/	
69. Double Blind Method/	
70. Single Blind Method/	
71. clinical trial/	
72. clinical trial, phase i.pt	
73. clinical trial, phase ii.pt	
74. clinical trial, phase iii.pt	
75. clinical trial, phase iv.pt	
76. controlled clinical trial.pt	





80. exp Clinical Trials as topic/	
81. (clinical adj25 trial$).tw	
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93. 20 AND 65 AND 92	
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or trebl$ or tripl$) 










 (insulin$ defic$ adj6 




 metabolic$ syndrom$.ti,ab. 32 behavio?r adj5 
(intervention or therap* or 
modific*)  
  
 (syndrom$ X not (fragil$ X or 
X linked)).ti,ab. 
33 cognitive adj5 (therap* or 
intervention or program* 
or train* or theory)  
  
  34 family adj3 
(intervention or 
treatment or 
counsel* or therap*) 
  
  35 colo?r 
therap$.mp. 
  


















  40 milieu 
therap$.mp 
  
  41 (assert$ adj5 
training).mp 
  
  42 Narrative 
therap$.mp. 
  
  43 nondirective 
therap$.mp 
  
  44 (problem solving 
adj5 therap$).mp 
  
  45 (self control adj5 
therap$).mp 
  
  46 person cent$.mp   






  49 paradoxical 
technique$.mp 
  
  50 play therap$.mp 
 
  
  15 rational 
emotive.mp 
  
  52 reality 
therap$.mp 
  
  53 role play$.mp   
  54 (relax$ adj5 
training).mp 
  
  55 sociotherap$.mp   
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  56 socioenvironmen
tal.mp 
  
  57 supportive 
therap$.mp 
  
  58 transactional.mp   




  60 coping skills 
training.mp. 
  
  61 exp Mindfulness/   




  63 multisystemic 
therapy 
  
  64 Or/16-63   






Cochrane Controlled Trials  
 
Keyword Diabetes mellitus  Psychological 
therapies 
 Clinical trials 
1 MeSH descriptor: [Diabetes 
Mellitus] explode all trees 
18 MeSH descriptor: 
[Psychotherapy] 
explode all trees 
• 61 Limit to ‘trials’ 
Limit to ‘2003-
current’  
2 diabet*:ti,ab 19 MeSH descriptor: 
[Problem Solving] 
explode all trees 
• 62  




4 dmi:ti,ab • 21 MeSH descriptor: 
[Stress, Psychological] 
explode all trees 
64  




6 (iidm):ti,ab • 23 psycho* 66  
7 insulin* next secret* next 
dysfunc* 
• 24 counsel* 67  
8 (insulin* next resist*):ti,ab • 25 depression 68  
9 ((impaired next glucose next 
tolerance) or (glucose next 
intoleran*) or (insulin* next 
resist*):ti) and (DM:ti,ab or 
DM2:ti,ab) 
• 26 depressive 69  
10 ((juvenile* or child* or keto* 
or labil* or brittl* or "early 
onset") and (diabetes or DM 
or DM1)) 
• 27 (interpersonal NEAR/5 
therap*) 
70  
11 (("keto* prone" near/6 
diabet*) or (autoimmun* 
near/6 diabet*) or ("auto 
immun*" near/6 diabet*) or 
("sudden onset" near/6 
diabet*)) 
• 28 art therap* 71  
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12 ((keto* and (resist* near/6 
diabet*)) or (nonketo* near/6 
diabet*) or (non and (keto* 
near/6 diabet*)) or (adult* 
and (onset near/6 diabet*)) or 
(matur* and (onset near/6 
diabet*)) or (late* and (onset 
near/6 diabet*)) or (slow* and 
(onset near/6 diabet*)) or 
(stabl* near/6 diabet*)) 
• 29 aversion therap* 72  
13 MeSH descriptor: [Insulin 
Resistance] explode all trees 
• 30 balint 73  
14 ("insulin* depend*" or 
"noninsulin* depend*" or 
"non insulin-depend*" or 
(typ* and (I near/6 diabet*)) 
or (typ* and (II near/6 
diabet*))) 
• 31 behavio?r near/5 
(intervention or therap* 
or modific*) 
74  
15 ((insulin* and (defic* near/6 
absolut)) or (insulin* and 
(defic* near/6 relativ*))) 
• 32 cognitive near/5 
(therap* or intervention 
or program* or train* or 
theory) 
75  
16 ((metabolic* and 
syndrom*:ti) or (metabolic* 




syndrom*:ab) or (pluri and 
metabolic* and syndrom*:ti) 
or (pluri and metabolic* and 
syndrom*:ab)) 
• 33 family near/3 
(intervention or 
treatment or counsel* or 
therap*) 
76  
17 #1 or #2 or #3 or #4 or #5 or 
#6 or #7 or #8 or #9 or #10 or 
#11 or #12 or #13 or #14 or 
#15 or #16  
• 34 colo?r therap* 77  
  • 35 crisis intervention 78  
  • 36 dance therap* 79  
  • 37 gestalt therap* 80  
  • 38 music therap* 81  
  • 39 milieu therap* 82  
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  • 40 assert* near/5 training 83  
  • 41 Narrative therap* 84  
  • 42 nondirective therap* 85  
  • 43 problem solving near/5 
therap* 
86  
  • 44 self control near/5 
therap* 
87  
  • 45 person cent* 88  
  • 46 client cent* 89  
  • 47 psychodrama*   
  48 paradoxical technique*   
  • 49 play therap*   
  • 50 rational emotive   
  51 reality therap*   
  • 52 role play*   
  • 53 relax* near/5 training   
  • 54 sociotherap*   
  • 55 socioenvironmental   
  • 56 supportive therap*   
  • 57 transactional   
  • 58 acceptance near/2 
(commitment therap*) 
  
  • 59 coping skills training   
  • 60 motivation* near/2 
(interview* or therap*) 
  
  • 61 multisystemic therapy   
  • 62 #18 of #19 or #20 or 




#24 or #25 or #26 or 
#27 or #28 or #29 or 
#30 or #31 or #32 or 
#33 or #34 or #35 or 
#36 or #37 or #38 or 
#39 or #40 or #41 or 
#42 or #43 or #44 or 
#45 or #46 or #47 or 
#48 or #49 or #50 or 
#51 or #52 or #53 or 
#54 or #55 or #56 or 
#57 or #58 or #59 or 









 Diabetes  Psych interventions  Clinical trials  






(MH "Clinical Trials+") 
 
2 TI diabet* 31 (MH "Counseling+")  73  
PT Clinical trial 
3 AB diabet* 32 (MH "Affective 
Disorders+") 
74  
TX clinic* n1 trial* 
4 DKA or IDDM or TI 
DMI or AB DMI 
33 TX Psycho* 75  
TX ( (singl* n1 blind*) or 
(singl* n1 mask*) )  
or TX ( (doubl* n1 
blind*) or (doubl* n1 
mask*) ) 
or TX ( (tripl* n1 blind*) 
or (tripl* n1 mask*) )  
or TX ( (trebl* n1 blind*) 
or (trebl* n1 mask*) ) 
5 MODY or DM2 or 
NIDDM or TI IDDM 
or AB IDDM 
34 TX Counsel* 76  
TX randomi* control* 
trial* 
6 TI insulin* secret* 
dysfunc* or AB 
insulin* secret* 
dysfunc* 
35 TX depress* 77  
(MH "Random 
Assignment") 
7 TI insulin* resist* or 
AB insulin* resist* 
36 TX (interpersonal n5 
therap*) 
78  
TX random* allocat* 
8 impaired glucose 
tolerance or glucose 
intoleran* or insulin* 
resist* 




9 TI DM or AB DM or 
TI DM2 or AB DM2 









11  insulin* depend* or 
AB insulin* depend* or 
TI insulin* depend* 
40 TX balint 82  
TX allocat* random* 
12  TX non insulin* 
depend* or nonisulin* 
depend* or non isulin* 
depend* 
41 TX behavio#r n5 
(intervention or therap* 
or modific*) 
83 S72 OR S73 OR S74 
OR S75 OR S76 OR 
S77 OR S78 OR S79 




13 "typ* 1" or "typ* I" 42 TX cognitive n5 (therap* or 
intervention or program* or 
train* or theory) 
84 S29 AND S71 
AND S83 
14 TI DM or AB DM 43 TX Colo#r therap* 85  
15 S14 and S13 44 TX (family n3 
(intervention or 




16 "typ* 2" or "typ* II" 45 TX crisis intervention 
 
  
17 S16 and S14 46 TX dance therap*   
18 TI DM or AB DM or 
TI DM1 or AB DM1 
47 TX gestalt therap* 
 
  
19 TX juvenil* or child* 
or keto* or labil* or 
brittl* or "earl* onset” 
48 TX music therap*   
20 S19 and S18 49 TX milieu therap*   
21 TX keto* prone or 
autoimmun* or auto 
immun* or "sudden 
onset" 
50 TX (assert* n5 training)   
22 S21 and S18 51 TX nondirective 
therap* 
  
23 TX keto resist* or 
nonketo* or non keto* 
or "adult* onset" or 
matur* or "late* onset" 
or "slow onset" or 
stabl* 
52 TX (problem solving 
n5 therap*) 
  
24 S23 and S18 53 TX (self control n5 
therap*) 
  
25 MH INSULIN 
RESISTANCE 
54 TX person cent*   
26 insulin* defic* 55 TX client cent*   
27 TI metabolic* 
syndrom* or AB 
metabolic* syndrom* 
56 TX Psychodrama*   
28 syndrom* X not ( 
fragil* X or X linked ) 





29 S28 or S27 or S26 or 
S25 or S24 or S22 or 
S20 or S17 or S15 or 
S12 or S11 or S10 or 
S7 or S6 or S5 or S4 
or S3 or S2 or S1 
58 TX play therap* 
 
  
  59 TX rational emotive   
  60 TX reality therap*   
  61 TX role play*   
  62 TX (relax* n5 training)   
  63 TX Sociotherap*   
  64 TX socioenvironmental   
  65 TX supportive therap*   
  66 TX transactional   
  67 TX coping skills 
training 
  
  68 TX mindfulness    
  69 TX acceptance n2 
(commitment therap*) 
  
  70 TX motivation* n2 
(interview* or therap*) 
  
  71 Or / S30-S72   
      
      
      






EMBASE search strategy   
 Diabetes mellitus   Psychological 
interventions 
 Clinical trials  
1 exp Diabetes Mellitus/ 21 exp Psychotherapy/ 69 Clinical trial/ 
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2 diabet$.ab,ti. 22 exp Counseling/ 70 Randomized 
controlled trial/ 
3 (DKA or IDDM).mp. or 
DMI.ab,ti. 
23 exp Mood disorders/ 71 Randomization/ 
4 (MODY or DM2 or 
NIDDM).mp. or 
IIDM.ti,ab. 
24 exp Depression/ 72 Single blind 
procedure/ 
5 insulin$ secret$ 
dysfunc$.ti,ab. 








7 ((impaired glucose 
tolerance or glucose 
intoleran$ or insulin$ 
resist$) and (DM or 
DM2)).ti,ab. 
27 depression.mp. 75 Placebo/ 
8 insulin$ depend$.mp. or 
insulin?depend$.ti,ab. 
28 depressive.mp. 76 Randomi?ed 
controlled trial$.tw. 
9 (non insulin$ depend$ or 
nonisulin$ depend$ or 
nonisulin?depend).mp. or 
non insulin?depend$.ti,ab. 





10 (("typ$ 1" or typ$ I) adj6 
DM).ti,ab. 
30 art therap$.mp. 78 Random 
allocation.tw. 
11 (("typ$ 2" or typ$ II) adj6 
DM).ti,ab. 
31 aversion therap$.mp. 79 Randomly 
allocated.tw. 
12 ((juvenil$ or child$ or 
keto$ or labil$ or brittl$ or 
earl$ onset) adj6 (DM or 
DM1)).ti,ab. 
32  balint.mp. 80 Allocated 
randomly.tw. 
13 ((keto$ prone or 
autoimmun$ or auto 
immun$ or sudden onset) 
adj6 (DM or DM1)).ti,ab. 
33 colo?r therap$.mp. 81 (allocated adj2 
random).tw. 
14 ((keto$ resist$ or 
nonketo$ or non keto$ or 
adult$ onset or matur$ 
onset or late$ onset or 
slow onset or stabl$) adj6 
(DM or DM2)).ti,ab. 
34 crisis intervention.mp. 82 Single blind$.tw. 
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15 exp Insulin Resistance/ 35 dance therap$.mp. 83 Double blind$.tw. 
16 (insulin$ defic$ adj6 
(absolut$ or 
relativ$)).ti,ab. 




37 music therap$.mp. 85 Placebo$.tw. 
18 (syndrom$ X not (fragil$ 
X or X linked)).ti,ab. 
38 milieu therap$.mp. 86 Prospective study/ 
19 (plurimetabolic$ 
syndrom$ or pluri 
metabolic$ 
syndrom$).ti,ab. 
39 (assert$ adj5 training).mp. 87 Or /69-86 
20 or/1-19 40 Narrative therap$.mp. 88 Case study/ 
  41 nondirective therap$.mp. 89  
Case report.tw. 
 
  42 (problem solving adj5 
therap$).mp. 
90 Abstract report/ or 
letter/ 
  43 (self control adj5 
therap$).mp. 
91 Or /88-90 
  44 person cent$.mp. 92 87 NOT 91 
  45 client cent$.mp. 93 Limit 2003-
current 
  46 psychodrama$.mp.   
  47 paradoxical 
technique$.mp. 
  
  48 play therap$.mp.   
  49 rational emotive.mp.   
  50 reality therap$.mp.   
  51 role play$.mp.   
  52 (relax$ adj5 training).mp.   
  53 sociotherap$.mp.   
  54 socioenvironmental.mp.   
  55 supportive therap$.mp.   
  56 transactional.mp.   
  57 (behavio?r adj5 
(intervention or therap* or 
modific*)).mp. 
  
  58 coping skills training.mp.   
  59 (family adj3 (intervention 
or treatment or counsel* 
or therap*)).mp. 
  
  60 exp Mindfulness/   
  61 multisystemic therapy.mp.   








  64 (cognitive adj5 (therap* 
or intervention or 
program* or train* or 
theory)).mp. 
  
  65 problem solving/   
  66 stress management/   
  67 mindfulness.mp.   






Web of Science  
 
Keyword Diabetes mellitus  Psychological 
therapies 
 Clinical trials 
1 TI=(diabet*) • 21 TS=Psycho* 
 
• 63 TS=Random* 
2 TS=(DKA or IDDM) • 22 TS=Counsel* •   
3 TS=(MODY or DM2 or 
NIDDM) 
• 23 TS=Depression   
4 TS=(insulin* secret* 
dysfunc*) 
• 24 TS=Depressive   
5 TS=(insulin* resist*) • 25 TS=(interpersonal 
NEAR/5 therap*) 
  
6 TS=((impaired glucose 
tolerance or glucose 
intoleran* or insulin* resist*) 
and (DM or DM2)) 
• 26 TS=(art therap*) 
 
  
7 TS=(insulin* depend*) • 27 TS=(aversion 
therap*) 
  
8 TS=(non insulin* depend* or 
nonisulin* depend* or 
nonisulin?depend)  
• 28 TS=balint   
9 TS=(non insulin$depend*) • 29 TS=((behavio?r) 
NEAR/5 (intervention or 
therap* or modific*)) 
  
10 TI=(("typ* 1" or "typ* I") 
NEAR/6 (DM)) 
• 30 TS=((cognitive) NEAR/5 
(therap* or intervention 
or program* or train* or 
theory)) 
  
11 TI=(("typ* 2" or "typ* II") 
NEAR/6 (DM)) 







12 TS=((juvenil* or child* or 
keto* or labil* or brittl* or 
"earl* onset") NEAR/6 (DM 
or DM1)) 
• 32 TS=(colo?r therap*)   
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13 TS=(("keto* prone" or 
autoimmun* or "auto 
immun*" or "sudden onset") 
NEAR/6 (DM or DM1)) 
• 33 TS=( crisis 
intervention) 
  
14 TS=(("keto* resist*" or 
nonketo* or "non keto*" or 
"adult* onset" or "matur* 
onset" or "late* onset" or 
"slow onset" or stabl*) 
NEAR/6 (DM or DM2)) 
• 34 TS=(dance therap*) 
 
  
15 TS=Insulin Resistance • 35 TS=(gestalt therap*) 
 
  
16 TS=((insulin* defic*) 
NEAR/6 (absolut* or 
relativ*)) 
• 36 TS=(music therap*)   
17 TS= metabolic* syndrom* • 37 TS=(milieu therap*)   
18 TS=((syndrom* X) not 
(fragil* X or X linked)) 




syndrom* or pluri metabolic* 
syndrom*) 
• 39 TS=(Narrative 
therap*) 
  
20 #19 OR #18 OR #17 OR #16 
OR #15 OR #14 OR #13 OR 
#12 OR #11 OR #10 OR #9 
OR #8 OR #7 OR #6 OR #5 
OR #4 OR #3 OR #2 OR #1 
• 40 TS=(nondirective 
therap*) 
  




  • 42 TS=(self control 
NEAR/5 therap*) 
  
  • 43 TS=(person cent*)   
  • 44 TS=(client cent*)   
  • 45 TS=psychodrama*   
  • 46 TS=(paradoxical 
technique*) 
  
  • 47 TS=(play therap*)   
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  48 TS=(rational 
emotive) 
  
  • 49 TS=(reality therap*)   
  • 50 TS=(role play*)   
  51 TS=(relax* 
NEAR/5 training) 
  
  • 52 TS=sociotherap*   
  • 53 TS=socioenvironme
ntal 
  
  • 54 TS=(supportive 
therap*) 
  
  • 55 TS=transactional   





  • 57 TS=(coping skills 
training) 
  
  • 58 TS=Mindfulness   





  • 60 TS=(multisystemic 
therapy) 
  
  • 61 TS=(stress 
management) 
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Author Note: The Motivational Interviewing Treatment Integrity (MITI) Code 
is an instrument-in-development. We are making it available now for use in 
research and scholastic endeavors, and we expect that many improvements will 
be needed before this coding system is complete. If you find errors, 
inconsistencies or have suggestions for improvement or other feedback, please 
contact us. We look forward to improving the MITI, with your help. 
 














Learn, compare, collect the facts!  
Pavlov  1849-1936 
 
How well or poorly is a practitioner using motivational interviewing? The MITI 
is a behavioral coding system that provides an answer to this question. The MITI 
also yields feedback that can be used to increase clinical skill in the practice of 
motivational interviewing. The MITI is intended to be used: 1) as a treatment 
integrity measure for clinical trials of motivational interviewing and 2) as a 
means of providing structured, formal feedback about ways to improve practice 
in non-research settings. 
 
It should be noted that the MITI and its parent instrument, the Motivational 
Interviewing Skills Code (MISC), are not competing instruments for the same 
task. They are different tools designed to accomplish different tasks. The MISC 
is typically more useful in conducting detailed process research investigating the 
critical elements and causal mechanisms within motivational interviewing. It 
cannot be replaced by the MITI for these purposes. Alternatively, the MITI may 
be more useful when a simpler question is posed (how much is this treatment like 
motivational interviewing?) or when more targeted feedback is needed (how can 
our clinicians improve in their use of motivational interviewing?) for training. 
Specific differences between the MITI and the MISC are: 
 
1) The MISC provides a comprehensive examination of interviewer and client 
behaviors, as well as the interaction between the two, while the MITI measures 
only interviewer behaviors.  
2) The MISC may require up to three separate reviews or “passes” of the tape 
segment, while the MITI typically uses a single pass. 
3) The MISC captures dimensions of the client’s readiness to change and 
commitment language, while the MITI does not. Such client behavior can be 
important in predicting outcomes. 
4) The MISC is a mutually exclusive and exhaustive coding system, but the 
MITI is not. Many specific behaviors that are coded in the MISC are collapsed 
into a single category in the MITI, or left uncoded entirely. 
 
A. COMPONENTS OF THE MITI 
 
The MITI has two components: the global scores and the behavior counts. 
 
A global score requires the coder to assign a single number from a five-point 
scale to characterize the entire interaction. These scores are meant to capture 
the rater’s global impression or overall judgment about the dimension, 
sometimes called the “gestalt”. Five global dimensions are rated: Evocation, 
Collaboration, Autonomy/Support, Direction, and Empathy. This means that 




A behavior count requires the coder to tally instances of particular interviewer 
behaviors. These running tallies occur from the beginning of the segment being 
reviewed until the end. The coder is not required to judge the quality or overall 




Typically both the global scores and behavior counts are assessed within a 
single review of the tape, and typically a random 20-minute segment is used. 
Careful attention should be paid to ensuring that the sampling of the tape 
segments is truly random, especially within clinical trials, so that proper 
inferences about the overall integrity of the MI intervention can be drawn. 
 
The tape may be stopped as needed, however excessive stopping and restarting 
in actual coding (as opposed to training or group review) may disrupt the ability 
of the coder to form a gestalt impression needed for the global codes. Coders 
may therefore decide to use two passes through the tape until they are proficient 
in using the coding system. In that case, Pass One should be used for the global 
scores and Pass Two for the behavior counts. 
 
B. DESIGNATING A TARGET BEHAVIOR 
 
An important component of using motivational interviewing well involves the 
interviewer’s attention to facilitating change of a particular behavior or problem. 
Skillful interviewers will attempt to reinforce and elicit client change talk about 
that specific change when they can. Coders should know, in advance of the 
coding task, what is the designated target behavior for the intervention, assuming 
that there is one. This will allow coders to judge more accurately whether the 
clinician is directing interventions toward the target behavior, is floundering or 
hopelessly lost. The MITI is not designed to be used for interventions in which a 
target behavior cannot be identified. 
 
C. GLOBAL SCORES 
 
“What is the short meaning of a long speech?”  
Schiller (1759-1805) 
 
Global scores are intended to capture the rater’s overall impression of how well 
or poorly the interviewer meets the intent of the scale. While this may be 
accomplished by simultaneously evaluating a variety of elements, the rater’s 
gestalt or all-at-once judgment is paramount. The global scores should reflect the 
holistic evaluation of the interviewer, one that cannot necessarily be separated 
into individual elements. Global scores are given on a five-point Likert scale, 
with the coder assuming a beginning score of “3” and moving up or down from 
there. 
 
In the MITI 3.0, the Spirit global rating has been parsed into three global ratings: 
Evocation, Collaboration, and Autonomy/Support. These ratings are not 
orthogonal; rather they may be related and influenced by each other. Evocation, 
Collaboration, and Autonomy/Support are averaged together to yield a Spirit 
global. It is recommended that you average to two decimal points.
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  Evocation   
Low    High 
1 2 3 4 5 
Clinician actively Clinician relies on Clinician shows no Clinician is Clinician works 
provides reasons education and particular interest in, accepting of proactively to 
for change, or information giving or awareness of, client’s own evoke client’s own 
education about at the expense of client’s own reasons 
reasons for 
change reasons for change 
change, in the exploring client’s for change and how and ideas about and ideas about 
absence of personal change should how change how change 
exploring client’s motivations and occur. May provide should happen should happen. 
knowledge, efforts ideas. information or when they are  
or motivation.  education without offered in  
  tailoring to client interaction. Does  
  circumstances. not attempt to  
   
educate or direct 
if  
   client resists.  
 
This scale is intended to measure the extent to which the clinician conveys an 
understanding that motivation for change, and the ability to move toward that 
change, reside mostly within the client and therefore focuses efforts to elicit and 
expand it within the therapeutic interaction. 
 
Low on Scale  
Clinicians low on this scale have only superficial interest in the client’s 
ambivalence or reasons for change, and miss opportunities to explore these in 
detail. They may make assumptions about the client’s intent to change (or not 
change) without exploring this in detail, or may ignore the client’s ideas when 
they are offered. Clinicians low in Evocation may rely on persistent fact 
gathering or information-giving as a means of facilitating change, and often 
convey a distrust of the client’s current knowledge base about the problem 
under consideration. Clinicians on the low end of this scale do not respond to 
change talk when it is offered, or do so in a perfunctory manner. They are likely 
to provide the clients with reasons to change, rather than eliciting them. 
 
High on Scale  
Clinicians high on this scale are curious about their clients’ personal and unique 
ideas about why change is a good idea or might not be. They not only follow up 
on these ideas when the client offers them, but also actively seek to explore them 
when the client does not. Although they might provide information or education, 
clinicians high in evocation do not rely on it as a means of helping clients to 
change. Instead, they prioritize exploration of the client’s personal reasons for 
change and the means to go about it, and do not allow this exploration to be 
neglected amid other content or information in the session. Clinicians high on the 
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Evocation scale understand the value of hearing the client’s own language in 
favor of change, and actively create opportunities for that language to occur. 
 
Verbal Anchors  
1. Clinician actively provides reasons for change, or education about 





• Ignores or misunderstands client statements about target behavior  
• Rigidly provides education although client indicates prior knowledge  
• Uses list of questions that do not account for uniqueness of client’s response  
• Dismisses or ignores client contributions  
• Lack of curiosity about client circumstances  
• Attempts to talk client into changing 
 
2. Clinician relies on education and information giving at the expense of 
exploring client’s personal motivations and ideas. 
 
Examples:  
• Does not incorporate client contributions into discussions about change  
• Vague or incomplete efforts to respond to client change talk  
• Mild or superficial interest in client views and circumstances 
 
3. Clinician shows no particular interest in or awareness of client’s own 
reasons for change and how change should occur. May provide some 
information or education without tailoring to client circumstances. 
 
Examples:  
• Misses opportunities to investigate client motivation for change (for 
example, by discussing past successes when mentioned)  
• Neutral regarding client views and circumstances  
• Occasional responses to client change talk 
 
4. Clinician is accepting of client’s own reasons for change and ideas about how 
change should happen when they are offered in interaction. Does not attempt to 
educate or direct if client resists. 
 
Examples:  
• Permits client’s ideas about change and motivation to provide 
direction for interview  
• Acknowledges client reasons for change at face value when offered, but 
does not elicit or elaborate  
• Consistently responds to change talk when it occurs with reflections, 




5. Clinician works proactively to evoke client’s own reasons for change and 
ideas about how change should happen. 
 
Examples:  
• Curious about client’s ideas and experiences, especially regarding target 
behavior  
• Helps client talk self into changing  
• Uses structured therapeutic tasks as a way of reinforcing and eliciting change 
talk  
• Does not miss opportunities to explore more deeply when client offers 
reasons for change  
• Seeks client’s ideas about change and motivation to provide direction to 
interview  
• Strategically elicits change talk and consistently responds to it when offered 
 
  Collaboration   
Low      High 
1 2  3  4 5 
Clinician actively 
Clinician 
responds  Clinician  Clinician fosters Clinician actively 
assumes the expert to opportunities to incorporates  collaboration and fosters and 
role for the collaborate  client’s goals,  power sharing so encourages power 
majority of the superficially.  ideas and values  that client’s ideas sharing in the 
interaction with the   but does so in a  impact the session interaction in such 
client.   lukewarm or  in ways that they a way that client’s 
Collaboration is   erratic fashion.  otherwise would ideas substantially 
absent.   May not perceive  not. influence the 
   or may ignore   nature of the 
   opportunities to   session. 
   deepen client’s    
   contribution to the    
   interview.    
 
This scale measures the extent to which the clinician behaves as if the 
interview is occurring between two equal partners, both of whom have 
knowledge that might be useful in the problem under consideration. 
 
Low on Scale  
Clinicians low in Collaboration do not work towards a mutual understanding 
during the session. They rely on one-way communication based on the 
clinician’s authority and expertise for progress. They may be dismissive, overly 
passive or so acquiescent that they do not make a genuine contribution to the 
interaction. These clinicians rely on their knowledge to respond to the client’s 
problem and do not appear to value the client’s knowledge. They are often ahead 
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of their clients in prescribing both the need for change and the means to achieve 
it. Their interactions with clients appear more like wrestling than dancing. 
 
High on Scale  
Clinicians high in Collaboration work cooperatively with the client toward the 
goals of the interview. They do not rely on dominance, expertise or authority to 
achieve progress. They are curious about client ideas, and are willing to be 
influenced by them. These clinicians can hold the reins on their own expertise, 
using it strategically and not before the client is ready to receive it. Clinicians 
high in Collaboration appear to be dancing with their clients during an 
interview—one moment leading, the next following—in seamless motion. 
 
Verbal Anchors  
1. Clinician actively assumes the expert role for the majority of the interaction 
with the client. Collaboration is absent. 
 
Examples:  
• Explicitly takes the expert role  
• Denies or minimizes client ideas  
• Dominates conversation  
• Argues when client offers alternative approach  
• Is passive, disconnected or dismissive 
 
2. Clinician discourages collaboration or responds to opportunities superficially. 
 
Examples:  
• Difficulty surrendering expert role  
• Superficial querying of client input  
• Often sacrifices opportunities for mutual problem solving in favor of 
supplying knowledge or expertise  
• Minimal response to client input  
• Distracted or impatient with client 
 
3. Clinician incorporates client’s goals, ideas and values but does so in a 
lukewarm or erratic fashion. May not perceive or may ignore opportunities to 
deepen client’s contribution to the interview. 
 
Examples:  
• May take advantage of opportunities to collaborate, but does not 
structure interaction to solicit this 
• Some connected following, but superficial  
• Can yield floor most of the time, but instances of disagreeing  
• Sacrifices some opportunities for mutual problem solving in favor of 




4. Clinician fosters collaboration and power sharing so that client’s ideas 
impact the session in ways that they otherwise would not. 
 
Examples:  
• Some structuring of session to insure client input  
• Solicits client views  
• Engages client in problem solving  
• Does not insist on resolution unless client is ready 
 
5. Clinician actively fosters and encourages power sharing in the interaction in 
such a way that client’s ideas substantially influence the direction and outcome 
of the session. 
 
Examples:  
• Actively structures session in a manner that facilitate client input  
• Querying client ideas  
• Incorporating client suggestions  
• Actively “mines” for client input  
• Explicitly identifying client as the expert  





 Autonomy/Support  
Low    High 
1 2 3 4 5 
Clinician actively Clinician Clinician is Clinician is Clinician adds 
detracts from or discourages client’s neutral relative to accepting and significantly to the 
denies client’s perception of choice client autonomy supportive of feeling and 
perception of or responds to it and choice. client autonomy. meaning of client’s 
choice or control. superficially.   expression of 
    autonomy, in such 
    a way as to 
    markedly expand 
    client’s experience 
    of own control and 
    choice. 
 
This scale is intended to convey the extent to which the clinician supports and actively 
fosters client perception of choice as opposed to attempting to control the client’s 
behavior or choices. Scores on the autonomy scale include the avoidance of particular 
behaviors and proactively pursuing strategies to enhance autonomy or support. 
 
Low on Scale  
Clinicians low on Autonomy/Support view the client as incapable of moving in the 
direction of health without input from clinician. They may assume that the client will 
change their behavior in the direction that the clinician thinks is best. The clinician may 
explicitly tell that client that he or she has no choice. In addition, the clinician may imply 
that external consequences (such as arrest, coercion from others) have removed choice. 
Clinicians may also insist that there is only one way to approach a target behavior or they 
may be pessimistic or cynical about the client’s ability to change. Clinicians low on 
Autonomy/Support may convey choices but do so dismissively or with sarcasm. 
 
*Note: Do not lower Autonomy/Support scores if the clinician is empathizing with 
the client’s perceived lack of choices, hopelessness or resentment about current 
circumstance. 
 
High on Scale  
Clinicians high on Autonomy/Support ensure, either directly or implicitly, that the topic 
of choice and control is raised in session. They view the client as having the potential to 
move in the direction of health. Clinicians high on this scale work to help the client 
recognize choices with regard to the target behavior. In addition, clinicians may 
explicitly acknowledge that the client has the choice to change or maintain the status 
quo. They may also express an optimism about the client’s ability to change. 
 
Verbal Anchors  
1. Clinician actively detracts from or denies client’s perception of choice or control. 
 
Examples:  
• Explicitly states that client does not have a choice  
• Implies that external consequences remove choice  
• Is pessimistic, cynical or sarcasm in exploring options and choices  




2. Clinician discourages client’s perception of choice or responds to it superficially. 
 
Examples:  
• Does not elaborate or attend to topic of choice when raised by client  
• Minimizing client choice or superficially attending to it  
• Dismissing topic of choice after acknowledging it  
• Absence of genuineness when discussing client’s choice  
• Actively ignores client choice when client brings it up 
 
3. Clinician neutral relative to client autonomy and choice. 
 
Examples:  
• Does not deny options or choice, but makes little effort to actively instill it  
• Does not bring up topic of choice in the interview 
 
4. Clinician is accepting and supportive of client autonomy. 
 
Examples:  
• Explores clients options genuinely  
• Agrees when client states he cannot be forced to change 
 
5. Clinician adds significantly to the feeling and meaning of client’s expression of 




• Clinician is proactive in eliciting comments from the client that lead to a 
greater perceived choice regarding the target behavior  
• Explores options in deeply genuine and non-possessive manner  
• Explicitly acknowledges client option not to change without sarcasm  
• Provides multiple opportunities to discuss client’s options and ability to control if 
client does not respond at first attempt  






















  Direction   
Low    High 
1 2 3 4 5 
Clinician does not Clinician exerts Clinician exerts Clinician Clinician exerts 
influence the topic minimal influence some influence generally able to influence on the 
or course of the on the session and on the session, influence direction session and 
session, and misses most but can be easily of the session generally does not 
discussion of the opportunities to diverted away toward the target miss opportunities 
target behavior is direct client to the from focus on behavior; to direct client 
entirely in the target behavior. target behavior. however, there toward the target 
hands of client.   may be lengthy behavior or referral 
   episodes of question. 
   wandering when  
   clinician does not  
   attempt to re-  
   direct.  
 
This scale measures the degree to which clinicians maintain appropriate focus on a 
specific target behavior or concerns directly tied to it. Unlike the other global scales, 
clinicians high scores on this scale do not necessarily reflect better use of MI. 
 
Low on Scale  
Clinicians low in Direction exert little influence concerning the topic and course of the 
session. They do not appear to explore any particular behavior change on the part of the 
client, and do not take opportunities to bring change into the discussion. Sessions with 
clinician low in Direction may lack structure, and are likely to have an aimless quality. 
Clients may end up discussing any topic of interest to them, without attempts by the 
clinician to focus on any particular troublesome behavior. The clinician may accept an 
excessive focus on historical topics or theoretical explanations that divert attention from 
changing a current behavior. Clinicians low in Direction appear to lack a compass to 
help them move the session toward to a specific, desirable end. 
 
High on Scale  
Clinicians high in Direction exert substantial influence concerning the topic and course of 
the session. They are transparent in their focus on a target behavior or referral question 
and they make consistent efforts to return to the target behavior when conversation 
wanders. A clinician who is domineering and unyielding in their focus on the problem at 
hand would score high in Direction, however clinicians high in Direction need not be 
harsh or authoritarian. They may exert direction by selectively reinforcing client 
discussion toward the possibility of concern or change with regard to the target behavior. 
Clinicians high in Direction seem to use a compass to implement course corrections when 
the focus of the session drifts too far away from the target behavior. 
 
Verbal Anchors  
1. Clinician does not influence the topic or course of the session, and discussion of 
the target behavior is entirely in the hands of client. 
 
Examples:  
• Fails to provide structure for session 
 




• Clinician focuses discussion on client’s personality, childhood or trauma 
history with only superficial attention to target behavior 
• Clinician engages in non-directive, client-centered listening  
• Passively follows as the client wanders off in various directions  
• A target behavior is not stated or cannot be inferred from the session 
 
2. Clinician exerts minimal influence on the session and misses most opportunities to 
direct client to the target behavior. 
 
Examples:  
• Provides some structure, but session wanders markedly from stated intent  
• Some discussion of target behavior, but majority of session is spent on 
other topics 
• Clinician makes only superficial attempts to tie client’s discourse to target 
behavior 
• Most of the session is spent in non-directive, client-centered listening with no 
evidence of selective reinforcement toward consideration of target behavior 
 
3. Clinician exerts some influence on the session, but is easily diverted away from 
focus on target behavior. 
 
Examples:  
• Clinician provides some structure for session, but is inconsistent in following it  
• Clinician provides some selective reinforcement of client discourse regarding 
target behavior, but does so inconsistently 
• Clinician is willing to bring up target behavior, but is easily diverted  
• Clinician focuses substantial parts of session on off-target discussion  
• Balance of session time spent on discussing history rather than present or future 
 
4. Clinician generally able to influence direction of the session toward target behavior; 
however, there may be lengthy episodes of wandering when clinician does not 
attempt to re-direct. 
 
Examples:  
• Clinician makes modest attempts to use stated plan for session  
• A target behavior is apparent but the clinician seems uncertain about whether 
to focus attention on it  
• Clinician can easily be diverted by the client away from the target behavior  
• Clinician misses several opportunities to turn the conversation toward the 
target behavior once it wanders 
 
5. Clinician exerts influence on the session and generally does not miss opportunities to 
direct client toward the target behavior or referral question. 
 
Examples:  
• Agenda-setting mentions the target behavior 
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• Clinician is transparent in concern about the target behavior  
• Clinician manages time well and transitions between therapeutic tasks 
smoothly  
• Clinician consistently and smoothly directs the client’s discourse toward 
change of a target behavior  
• Balance of time in the session is spent discussing possible change, rather 
than the history of the problem  
• Clinician dominates session and does not allow client to wander 
from target behavior 
 
Empathy  
 Low    High  
 1 2 3 4 5  
 Clinician has no Clinician makes Clinician is Clinician shows Clinician shows  
 apparent interest sporadic efforts to actively trying to evidence of evidence of deep  
 in client’s explore the client’s understand the accurate understanding of  
 worldview. Gives perspective. client’s understanding of client’s point of  
 little or no Clinicians’ perspective, with client’s worldview. view, not just for  
 attention to the understanding may modest success. Makes active and what has been  
 client’s be inaccurate or  repeated efforts to explicitly stated but  
 perspective. may detract from  understand client’s what the client  
  the client’s true  point of view. means but has not  
  meaning.  Understanding yet said.  
    mostly limited to   
    explicit content.   
 
This scale measures the extent to which the clinician understands or makes an 
effort to grasp the client’s perspective and feelings: literally, how much the 
clinician attempts to “try on” what the client feels or thinks. Empathy should not 
be confused with warmth, acceptance, genuineness, or client advocacy; these are 
independent of the empathy rating. Reflective listening is an important part of this 
characteristic, but this global rating is intended to capture all efforts that the 
clinician makes to understand the client’s perspective and convey that 
understanding to the client. 
 
Low on Scale  
Clinicians low in Empathy show indifference or active dismissal of the client’s 
perspective and experiences. They may probe for factual information or to 
pursue an agenda, but they do so to “build a case” for their point of view, rather 
than for the sole purpose of understanding the client’s perspective. There is little 
effort to gain a deeper understanding of complex events and emotions, and 
questions asked reflect shallowness or impatience. They might express hostility 




High on Scale  
Clinicians high in Empathy approach the session as an opportunity to learn 
about the client. They are curious. They spend time exploring the client’s 
opinions and ideas about the target behavior especially. Empathy is evident 
when providers show an active interest in understanding what the client is 
saying. It can also be apparent when the clinician accurately follows or 
perceives a complex story or statement by the client or probes gently to gain 
clarity. 
 
Verbal Anchors  
1. Clinician has no apparent interest in client’s worldview. Gives little or no 
attention to the client’s perspective. 
 
Examples:  
• Asking only information-seeking questions (often with an ulterior motive)  
• Probing for factual information with no attempt to understand the 
client’s perspective 
 
2. Clinician makes sporadic efforts to explore the client’s perspective. 
Clinicians’ understanding may be inaccurate or may detract from the 
client’s true meaning. 
 
Examples:  
• Clinician offers reflections but they misinterpret what the client had said.  
• Clinician displays shallow attempts to understand the client. 
 




• Clinician displays average empathy to client.  
• Clinician may offer a few accurate reflections, but may miss the client’s point.  
• Clinician makes an attempt to grasp the client’s meaning throughout the 
session, but does so with mild success. 
 
4. Clinician shows evidence of accurate understanding of client’s worldview. 
Makes active and repeated efforts to understand client’s point of view. 
Understanding mostly limited to explicit content. 
 
Examples:  
• Clinician conveys interest in the client’s perspective or situation  
• Clinician offers accurate reflections of what the client has said.  




5. Clinician shows evidence of deep understanding of client’s point of view, not 




• Clinician effectively communicates an understanding of the client 
beyond what the client says in session.  
• Showing great interest in client’s perspective or situation  
• Attempting to “put self in client’s shoes”  
• Often encouraging client to elaborate, beyond what is necessary to 
merely follow the story  
• Using many accurate complex reflections 
 
 
D. BEHAVIOR COUNTS  
 
“It has long been an axiom of mine that the little things are infinitely the most 
important.”  
Sherlock Holmes (A.Conan Doyle, 
1892) 
A Case of Identity 
 
Behavior counts are intended to capture specific behaviors without regard to how 
they fit into the overall impression of the interviewer’s use of MI. While the 
context of the exchange will have some influence on the rater, behavior counts 
will generally be determined as a result of categorization and decision rules 
(rather than attempting to grasp an overall impression). Relying on inference to 
determine a behavior count is to be avoided. 
 
Parsing Interviewer Speech to Assign Behavior Codes 
 
An utterance is defined as a complete thought. An utterance ends when one 
thought is completed. A new utterance begins when a new idea is introduced. 
One utterance can succeed another in the flow of the interviewer’s speech, as 
with a sentence that conveys successive ideas. A client response always 
terminates an interviewer utterance, and the next interviewer response 
following client speech is therefore always a new utterance. 
 
Not all interviewer utterances will receive behavior codes. Unlike the MISC, the 
MITI does not represent an exhaustive list of all possible codes; therefore, some 
clinician utterances will likely remain uncoded. Although they are not 
exhaustive, MITI codes are mutually exclusive, such that the same utterance does 
not receive more than one code. 
 
Any utterance may be assigned one of six primary behavior codes. Within three 
categories, further sub -classification is required. As mentioned before, each 
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utterance receives one and only one code: the same utterance may not receive 
more than one code. However, consecutive utterances, even if they occur in the 
same sentence, may each receive different codes. Thus, in the course of a 
relatively long reply, if a clinician reflects, then confronts, then asks a question, 
these could each qualify for a distinct behavior count, assuming they are separate 
utterances (ideas). 
 
A volley is defined as uninterrupted sequence of utterances by the interviewer. 
Once a behavior code is assigned once within the volley, it is not assigned 
again. A volley may contain only one of each behavior code. 
 
Consider the following interviewer statement: 
 
Well, let me ask you this: since you’ve been forced to come here and 
since you’re feeling like everyone’s kind of pecking on you like a crow, 
there’s a bunch of crows flying around pecking on you about this thing 
about your drinking, what would you like to do with the time you spend 
here? What would be helpful for you? 
 
This statement is parsed in the following way: 
 
Utterance One: Well, let me ask you this: since you’ve been forced to 
come here and since you’re feeling like everyone’s kind of pecking on 
you like a crow, there’s a bunch of crows flying around pecking on you 
about this thing with your drinking, 
 
Utterance Two: What would you like to do with the time you spend 
here? What would be helpful for you? 
 
What about this interviewer statement? 
 
What you say is absolutely true, that it is up to you. No one makes that 
choice for you. No one can make that choice for you. Even if your wife 
wanted to decide for you, or your employer wanted to decide for you, or I 
wanted to decide for you; nobody can. It really is completely your own 
choice; how you live your life, what you do about drugs, where you’re 
headed; so that is yours. And what I hear you struggling with is, “what do 
I want? Is it time for me to change things? Is this drug test a wake-up 
call?” 
 
We’ve parsed it like this: 
 
Utterance One: What you say is absolutely true, that it is up to you. No 
one makes that choice for you. No one can make that choice for you. 
Even if your wife wanted to decide for you, or your employer wanted to 
decide for you, or I wanted to decide for you; nobody can. It really is 
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completely your own choice; how you live your life, what you do about 
drugs, where you’re headed; so that is yours. 
 
Utterance Two: And what I hear you struggling with is, “what do I 






1. Giving Information 
 
This category is used when the interviewer gives information, educates, 
provides feedback or discloses personal information. When the interviewer 
gives an opinion, without advising, this category would be used. No 
subcodes are assigned for giving information. Specific examples of Giving 
Information include: 
 
1a. Providing Feedback from assessment instruments 
 
You indicated during the assessment that you typically drink about 18 
standard drinks per week. This places you in the 96th percentile for 
American men your age. (Giving Information) 
 
* Note that this is not a reflection. Reviewing information contained on 
assessment instruments does not typically qualify as a reflection, although 
the reflection code MAY be given if the interviewer skillfully emphasizes 
or enriches the material the client has given. 
 
1b. Personal Feedback about the client that is not already available. 
 
Your doctor tells me you’ve been struggling with your glycemic control. 
(Giving Information) 
 
I talked to your wife and she said she was really worried about your drinking.  
(Giving Information) 
 
1c. Explaining ideas or concepts relevant to the intervention 
 
This homework assignment on logging your cravings is important 
because we know that cravings often lead to relapses. A craving is like a 
warning bell, telling you to do something different. (Giving Information) 
 
1d. Educating about a topic 
 
Individuals who eat five fruits and vegetables each day reduce their 
cancer risk five fold. For certain kinds of cancer, like colon cancer, it’s 
even more of a reduction. (Giving Information) 
 
If I do find that you’ve relapsed, I’ll have to disclose that to your 





Coders need not distinguish among types of Giving Information. Once the coder 
has decided that the behavior is either one or another item in this category, she 
assigns the Giving Information code without further distinction. 
 
Differentiating Giving Information from MI Non-Adherent Behaviors  
Giving information should not be confused with giving advice, warning, 
confronting, or directing. 
 
You indicated during the assessment that you typically drink about 18 
standard drinks per week. This far exceeds social drinking. (MI 
Inconsistent) 
 
Keep track of your cravings, using this log, and bring it in next week 
to review with me. (Direct) 
 
Well, you are only eating two fruits per day according to this chart, even 
though you said you are eating five. It can be easy to deceive yourself. 
(Confront) 
 
It worked for me, and it will work for you if you give it a try. We need to 






2a. Closed Question 
 
This behavior code is used when the interviewer asks the client a question 
that can be answered with a “yes” or “no” response. 
 
Did you use heroin this week?  
Did you eat five fruits and vegetables this week? 
Have you been having trouble with your memory? 
 
It is also coded when the question specifies a very restricted range or one that is 
intended to satisfy a questionnaire. 
 
How long have you been using heroin?  
How many fruits and vegetables did you eat each day this week? 
Who is the president of the United States? 
 




An open question is coded when the interviewer asks a question that allows a 
wide range of possible answers. The question may seek information, may invite 
the client’s perspective or may encourage self-exploration. The open question 
allows the option of surprise for the questioner. 
 
“Tell me more” statements are coded as open questions unless the tone and 
context clearly indicate a Direct or Confront code. 
 
How did it go with your heroin cravings since we last met?  
Tell me about your fruit and vegetable intake this week. 




In general, stacked questions (before the client gives an answer), are coded as 
only one question. Sometimes a clinician will stack questions by asking an open 
question and then giving a series of “for example” follow up questions before the 
client answers. These are coded as one open question (not, in this case, as one 
open and two closed questions). 
 
In what ways has your drinking caused problems for you? Has it caused 
problems in your relationships or with your memory? What about trouble 





Occasionally the interviewer will offer a statement that otherwise meets the 
criteria for a reflection, but is given with an inflection at the end (thereby 
making it “sound like” a question). These statements are coded as Questions 





This category is meant to capture reflective listening statements made by the 
clinician in response to client statements. A Reflection may introduce new 
meaning or material, but it essentially captures and returns to clients something 
about what they have just said. Reflections must be further categorized into 
Simple or Complex categories. 
 
3a. Simple Reflection 
 
Simple reflections typically convey understanding or facilitate client/clinician 
exchanges. These reflections add little or no meaning (or emphasis) to what 
clients have said. Simple reflections may mark very important or intense client 
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emotions, but do not go far beyond the client’s original intent in the statement. 
Clinician summaries of several client statements may be coded as simple 
reflections if the clinician does not use the summary to add an additional point or 
direction. 
 
3b. Complex Reflection 
 
Complex reflections typically add substantial meaning or emphasis to what the 
client has said. These reflections serve the purpose of conveying a deeper or 
more complex picture of what the client has said. Sometimes the clinician may 
choose to emphasize a particular part of what the client has said to make a point 
or take the conversation in a different direction. Clinicians may add subtle or 
very obvious content to the client’s words, or they may combine statements from 
the client to form summaries that are complex in nature. 
 
Speeding Tickets  
Client: This is her third speeding ticket in three months. Our insurance is 
going to go through the roof. I could just kill her. Can’t she see we need that 
money for other things? 
Interviewer: You’re furious about this. (Reflection, Simple) 
Interviewer: This is the last straw for you. (Reflection, Complex) 
 
 
Controlling Blood Sugar  
Interviewer: What have you already been told about managing your blood 
sugar levels? (Open Question) 
Client: Are you kidding? I’ve had the classes, I’ve had the videos, I’ve had the 
home nurse visits. I have all kinds of advice about how to get better at this, but I 
just don’t do it. I don’t know why. Maybe I just have a death wish or 
something, you know? Interviewer: You are pretty discouraged about this. 
(Reflection, Simple) Interviewer: You haven’t given it your best effort yet. 
(Reflection, Complex) 
 
Mother’s Independence  
Client: My mother is driving me crazy. She says she wants to remain 
independent, but she calls me four times a day with trivial questions. Then she 
gets mad when I give her advice. 
Interviewer: Things are very stressful with your mother. (Simple 
Reflection) Interviewer: You’re having a hard time figuring out what your 
mother really wants. (Reflection, Complex) 
Interviewer: Are you having a hard time figuring out what your mother really 
wants? (Closed Question) 
Interviewer: What do you think your mother really wants? (Open Question) 
 




reflection, the simple designation should be used. Default category: simple. 
 
3d. Reflection and Question in Sequence 
 
Sometimes the interviewer begins with a reflection, but adds a question to 
“check” the reliability of the reflection (either open or closed). Both elements 
should be coded. 
 
So you don’t ever want to use heroin again. Is that right? (Reflection, 
Closed Question) 
 
Your boss said you can’t work overtime anymore. What do you make 




Occasionally the interviewer will offer a statement that otherwise meets the 
criteria for a reflection, but is given with an inflection at the end (thereby 
making it “sound like” a question). These statements are coded as Questions 




4. MI Adherent 
 
This category is used to capture particular interviewer behaviors that are 
consistent with a motivational interviewing approach. Coders may be tempted to 
code especially good examples of MI practice in one of these categories, even if 
they do not genuinely “fit”. Instead, the coder should consider such examples 
within the overall rating assigned for Global Ratings, as appropriate, reserving the 
MI Consistent behavior counts for the designated behaviors only. The MI 
Adherent Category is comprised of: 
 
 
4a. Asking permission before giving advice or information or asking what the 
client already knows or has already been told about a topic before giving advice 
or information. Permission is implied when the client asks directly for the 
information or advice and the clinician is answering. Indirect forms of permission 
can also occur, such as when the clinician invites the client to disregard the 
advice as appropriate. 
 
I have some information about how to reduce your risk of colon 
cancer and I wonder if I might discuss it with you. (MI Adherent) 
 
What have you already been told about drinking during 




This may not be the right thing for you, but some of my clients have 
had good luck setting the alarm on their wristwatch to help them 
remember to check their blood sugars 2 hours after lunch. (MI 
Adherent) 
 
Note: when permission is asked prior to advising, the MI Non-Adherent 




4b. Affirming the client by saying something positive or complimentary. 
Affirming may also take the form of commenting on the client’s strengths, 
abilities or efforts in any area (not simply related to the target behavior). 
 
You are the kind of person that, once you make up your mind, you 
usually get the job done. (MI Adherent) 
 
It’s important to you to be a good parent, just like your folks were for 
you. (MI Adherent) 
 
4c. Emphasizing the client’s control, freedom of choice, autonomy, ability to decide. 
 
Yes, you’re right. No one can force you stop drinking. (MI Adherent) 
 
You’re the one who knows yourself best here. What do you think ought 
to be on this treatment plan? (MI Adherent) 
 
The number of fruits and vegetables you choose to eat is really up to 
you. (MI Adherent) 
 
You’ve got a point there. (MI Adherent) 
 
4d. Supporting the client with statements of compassion or sympathy. 
 
With the parking problems and the rain coming down, it hasn’t been 
easy to get here. (MI Adherent) 
 
I know it’s really hard to stop drinking. (MI Adherent) 
 
Well, there is really a lot going on for you right now. (MI Adherent)  
 
No differentiating subcodes are assigned to the MI Adherent behaviors. The rater 





4e. DECISION RULE: The MI Adherent code takes precedence when the 
utterance clearly falls into the MI Adherent category. When in doubt, an 
alternate code (for example, Open Question or Reflection) should be given. 
 
 
5. MI Non-Adherent 
 
This category is used to capture those interviewer behaviors that are inconsistent 
with a motivational interviewing approach. No differentiating subcodes are 
assigned to the MI Non-Adherent behaviors. The rater merely identifies them as 
belonging to this category and assigns the MI Non-Adherent code. 
 
5a. Advising without permission by making suggestions, offering solutions or 
possible actions without first obtaining permission from the client. Language 
usually, but not always, includes words such as: should, why don’t you, 
consider, try, suggest, advise, how about, you could, etc. Note that if the 
interviewer first obtains permission either directly or indirectly, before 
advising, the code would be different. 
 
What about trying to get a ride from a friend? (MI Non-Adherent) 
 
Checking your blood sugars five times a day is best in the beginning. 
(MI Non-Adherent) 
 
It might not be as bad as you think. People are usually civil if you give 
them a chance. (MI Non-Adherent) 
 
5b. Confronting the client by directly and unambiguously disagreeing, arguing, 
correcting, shaming, blaming, criticizing, labeling, moralizing, ridiculing, or 
questioning the client’s honesty. Such interactions will have the quality of 
uneven power sharing, accompanied by disapproval or negativity. Included here 
are instances where the interviewer uses a question or even a reflection, but the 
voice tone clearly indicates a confrontation. 
 
Restating negative information already known or disclosed by the client can be 
either a confront or a reflection. Most confrontations can be correctly 
categorized by careful attention to voice tone and context. 
 
You were taking Antabuse but you drank anyway? (MI Non-Adherent) 
 
You think that is any way to treat people you love? (MI Non-Adherent) 
 







Wait a minute. It says right here that your A1C is 12. I’m sorry, but 
there is no way you could have been counting your carbohydrates like 
you said if it’s that high. (MI Non-Adherent) 
 
5c. Directing the client by giving orders, commands or imperatives. The 
language is imperative. 
 
Don’t do that! (MI Non-Adherent) 
 
Bring this homework back next week. (MI Non-Adherent) 
 
You need to go to 90 meetings in 90 days (MI Non-Adherent) 
 
Again, coders are not required to subcategorize MI Non -Adherent behaviors. 
Once a coder has decided that the behavior is either a Confront or a Direct (or 
has narrowed it down to any other two codes in this category), he assigns the MI 
Non-Adherent code and moves on. 
 
5d. DECISION RULE: The MI Non-Adherent code takes precedence when the 
utterance clearly falls into the MI Non-Adherent category. When in doubt, an 
alternate code (for example, Giving Information) should be given. 
 
Tantrums  
Client: “What do you think I should do about these tantrums my child is having? 
You’re the doctor.”  
Interviewer: “Solving this yourself hasn’t worked, so you’re finally willing to 
ask for help.” (MI Non-Adherent) 
 
Client: “What do you think I should do about these tantrums my child is having? 
You’re the doctor.” 
Interviewer: “Your child is normal. These are not tantrums.” (MI Non-Adherent) 
 
 
E. CHOOSING THE LENGTH AND TYPE OF THE CODED SEGMENT 
 
The development of the MITI was done using 20-minute segments of therapy 
tapes. It may be possible to use the MITI for longer segments of tape (for 
example, the entire therapy session). We only caution that our attempt to 
increase the length of the coding segment was associated with 1) problems with 
sustained coder attention, 2) difficulty forming global judgments with 
increased data, and 3) logistical difficulties in obtaining uninterrupted work 




Similarly, most of our initial data have been gathered using audiotapes rather 
than videotapes. The MITI can be used to code videotapes, but should not be 
altered to gather visual information.
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F. SUMMARY SCORES FOR THE MITI  
 
Because critical indices of MI functioning are imperfectly captured by frequency 
counts, we have found that many applications of therapy coding are better served 
with summary scores computed from codes, rather than the individual scores 
themselves. For example, the ratio of reflections to questions provides a concise 
measure of an important MI process. Below is a partial list of summary scores 
that serve as outcome measures for determining competence in MI, as well as 
formulas for calculating them. 
 
• Global Spirit Rating = (Evocation + Collaboration + Autonomy/Support) / 3 
 
• Percent Complex Reflections (% CR)  
= Rc / Total reflections 
 
• Percent Open Questions (% OC)  
= OQ / (OQ + CQ) 
 
• Reflection-to-Question Ratio (R:Q)  
= Total reflections/(CQ + OQ) 
 
• Percent MI Adherent (% MiA)  




. TRAINING STRATEGY FOR THE MITI  
 




Training coders to competency, as measured by interrater reliability and matching 
to a gold standard, usually requires a stepped learning process. We have found 
that coders do best beginning with fairly simple tasks, proceeding to more 
complex ones only when competence on the simpler tasks is solid. We 
recommend that coders begin by learning Level I tasks to an acceptable reliability 
standard prior to attempting Level II tasks. Only when acceptable standards for 
simultaneous I and II tasks have been accomplished should coders begin on Level 
III tasks. The self-review of MI text and video learning tools can be used at any 
time (perhaps as a prelude to beginning Level I tasks).  
Behavior Count or Summary Score Thresholds Beginning Competency 
 Proficiency  
Global Clinician Ratings Average of Average of 4 
 3.5  
Reflection to Question Ratio (R:Q) 1 2 
Percent Open Questions (%OC) 50% 70% 
Percent Complex Reflections (%CR) 40% 50% 
Percent MI-Adherent (% MIA) 90% 100% 
 
The use of pre-scored gold standard transcripts will assist in evaluating coder 
competency and areas for improvement. We have found that coders often have 
difficulty in one area or another, requiring a more intensive focus. Problem areas 
can be identified using standardized transcripts as a quiz for each level. More than 
one quiz per level is often needed. We have found that coders typically require 40 
hours of training to reach interrater reliability using the MITI. In addition, regular 
(probably weekly) group coding sessions are optimal to insure drift does not 
occur. Clinical experience (i.e. being a clinician) has not predicted ease of training 
or eventual competence in our laboratory. 
 
Level I  competencies: parsing utterances, giving information and open/closed 
questions  
Level II competencies: add reflections, MiA and MiNa 





Below are recommended proficiency and competency thresholds for clinicians, 
based on the MITI coding system. Please note that these thresholds are based on 
EXPERT OPINION, and currently lack normative or other validity data to 
support them. We are in the process of gathering normative data for the revised 
MITI now. Until such normative data is available, these thresholds should be used 
in conjunction with other data to arrive at an assessment of clinician competency 
and proficiency in using MI.
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Motivational Interviewing Treatment Integrity Code (MITI)     
  Coding Sheet Revised June, 2007     
Tape #____________________ Coder:_____________ Date:__________   
   Global Ratings      
Evocation      
1 2 3 4 5 
 
      
       Low     
Hig
h 
                            
Collaboration      
1 2 3 4 5 
 
      
       Low     
Hig
h               
Autonomy/      
1 2 3 4 5 
 
Support 
      
      Low     
Hig
h 
                            
Direction      
1 2 3 4 5 
 
       
       Low     
Hig
h 
                            
Empathy      
1 2 3 4 5 
 
       
       Low     
Hig
h 
            
   Behavior Counts      
Giving              
Information              
MI Asking permission, affirm,        
Adherent 
emphasize control, support.        
             
             
MI 
Advise, confront, 
direct.            
Non-adherent              
Question 
Closed Question            
             
(subclassify) Open Question            
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Reflect Simple            
              
(subclassify) Complex                     
 TOTAL REFLECTIONS:         








List of MITI Codes 
 
EVOCATION (Global rating of evocation)  
COLLABORATION (Global rating of collaboration) 
AUTONOMY/SUPPORT  (Global rating of 
Autonomy/Support) 
DIRECTION (Global rating of direction) 
EMPATHY (Global rating of empathy) 




GI (Giving Information) 
MiA (MI Adherent) 
MiNa (MI Non-adherent) 
OQ (Open Question) 
CQ (Closed Question) 
Rs (Reflection simple) 











Note: Coded transcripts of two MI interviews, taken from the 
Professional Training Series, are available to assist you in learning to use 
the MITI. For ease in learning, each interview is coded twice—once for 
global ratings and once for behavior counts—although in practice both 
tasks would usually be done simultaneously. These transcripts, along 












Behaviour Change Counselling Index (BECCI) 
 
BECCI is an instrument designed for trainers to score practitioners’ use of Behaviour 
Change Counselling in consultations (either real or simulated). To use BECCI, circle a 
number on the scale attached to each item to indicate the degree to which the 
patient/practitioner has carried out the action described. 
 
Before using BECCI, please consult the accompanying manual for a detailed explanation of 
how to score the items. As a guide while using the instrument, each number on the scale 
indicates that the action was carried out: 
 
A. Not at all  
5) Minimally 
6) To some extent 
7) A good deal 
8) A great extent 
 
The Topic:   
 Item    Score 
       
1. Practitioner invites the patient to talk about behaviour not at all   a great extent 
 change Not Applicable 0 1 2 3 4 
       
2. Practitioner demonstrates sensitivity to talking about other not at all   a great extent 
 issues  0 1 2 3 4 
       
3. Practitioner encourages patient to talk about current not at all   a great extent 
 behaviour or status quo  0 1 2 3 4 
       
4. Practitioner encourages patient to talk about change not at all 
1 2 3 
a great extent 
   0 4 
       
5. Practitioner asks questions to elicit how patient thinks and not at all   a great extent 
 feels about the topic  0 1 2 3 4 
       
6. Practitioner uses empathic listening statements when the not at all   a great extent 
 patient talks about the topic  0 1 2 3 4 
       
7. Practitioner uses summaries to bring together what the patient not at all   a great extent 
 says about the topic  0 1 2 3 4 
       
8. Practitioner acknowledges challenges about behaviour not at all   a great extent 
 change that the patient faces  0 1 2 3 4 
       
9. When practitioner provides information, it is sensitive to not at all   a great extent 
 patient concerns and understanding Not Applicable 0 1 2 3 4 
       
10. Practitioner actively conveys respect for patient choice about not at all   a great extent 
 behaviour change  0 1 2 3 4 
       
11. Practitioner and patient exchange ideas about how the patient not at all   a great extent 
 could change current behaviour (if applicable) Not Applicable 0 1 2 3 4 
         
 
Practitioner BECCI Score:   
Practitioner speaks for (approximately):- 
 
 



































Participant Information Sheet 
 
Title of Study: Understanding the patients' experience of receiving 
integrated psychological and diabetes care 
 
Invitation to the study 
You are invited to take part in this study. Before you decide I would like to provide you 
with some information so that you can be clear what it will involve. Please take time to 
read the following information and discuss it with your family, friends, relatives or your 
GP if you wish. If you need any further information you are very welcome to contact 
Helen Graves, the researcher and PhD student who will carry out the interviews. 
 
Purpose of the study 
The study is sponsored by the NHS with the aim of finding out the views and 
experiences of patients with newly diagnosed type 2 diabetes who have participated in 
the Diabetes-6 Study, so that we can improve research in the future.  
 
Why have I been chosen? 
You are already participating in the Diabetes-6 Study and this study is an additional 
Diabetes-6 Study. We are contacting you because you have taken part in the main 
Diabetes-6 study and you also agreed to be contacted for future Diabetes-6  studies. 
The researcher Helen Graves will contact you by phone and ask you whether you 
want to take part in this new study. The aim is to approach about 40 patients.  
 
Do I have to take part? 
It is up to you to decide whether or not to participate in this study. If you agree the 
researcher will explain the study to you and this information sheet. You are free to 
withdraw from the study at any time and without giving a reason. Your future treatment 
will not be affected by your decision.  
 
What will happen if I take part? 
The researcher will contact you by phone after 2-3 days to establish that you want to 
participate in the study. If you agree they will then arrange a time with you to conduct 
the interview as part of your Diabetes 6 follow up appointment, which will be 
conducted at your GP practice.  
 
Before the interview the researcher will make time to clarify any questions you may 




The interview may last for approximately 30 minutes to an hour. The interview will be 
audio taped, so that the researcher and/or a research colleague, employed in the 
same department can type out the information you provide. The tape recorder can be 
stopped at your request at any time, if you do not wish certain information to be 




What might be the possible concerns taking part in this study? 
Any effort will be made to arrange the interview with the researcher at a mutually 
convenient time. If for any reason you are unable to make the time arranged in 
advance, a new appointment can be made. If you provide information you do not wish 
to have recorded, the tape recorder can be stopped whenever you wish and restarted 
with your agreement. 
 
What are the possible benefits of taking part in this study? 
We hope that the information you provide will give us a better understanding of your 
experience of taking part in the Diabetes 6 study. In addition other patients with 
diabetes might be interested when the findings are published.  
 
Will my participation in this study be kept confidential? 
All information you provide during the interview with the researcher will be kept strictly 
confidential. Only the researcher will have access to the information you give. The 
external transcribing agency has a contract with the researchers department to treat 
all the information on the tape confidential. Information will not be given to the clinical 
team involved in your care without your specific consent. Your name will be replaced 
by a code only known to the researcher, so that you cannot be identified by any other 
person, including the external transcribing agency staff. 
  
What will happen to the results of the study? 
The information you provide together with the other patients will be analysed and 
written up as a report. The findings from the study will be published within one to two 
years after completion and a summary can be made available to you by posting it to 
you. You will not be identified in any of the future publications or reports we have to 
submit to the funding body (NIHR). 
 
Who is funding the research? 
The National Institute for Health Research (NIHR) is funding this study. The NIHR is 
the body which conducts research for the NHS.  
 
Who has reviewed the study? 
The research proposal has been reviewed by staff in the Department of Diabetes and 
Nutritional Sciences at King’s College London and by the local Research Ethics 
Committee at Dulwich, London.  
 
Contact for further information 
If you have any questions or require further information about this study now or at any 
time during the study, you are very welcome to get in touch with the researcher Helen 
Graves on Tel. 0207 848 5780. If you have any questions concerning your rights as a 
study participant you may wish to read the following leaflet: Getting Involved in 
Research: A guide for consumers, available at: 
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http://www.invo.org.uk/pdfs/guide_for_consumers.pdf or contact the Consumers in 
NHS Research Support Unit, Tel: 01962 872247. 
 
 







Research Ethics Ref: PNM/12/13-27 
 
Participant Information Sheet 
 
Title of Study: The Range and Diversity of Nurses’ Personal Experiences 
and Views of the D6 Intervention 
 
Invitation to the study 
You are invited to take part in this study. Before you decide I would like to provide you 
with some information so that you can be clear what it will involve. Please take time to 
read the following information and discuss it with your family, friends or relatives is you 
wish. If you need any further information you are very welcome to contact Helen 
Graves, the researcher and PhD student who will carry out the interviews. 
 
Purpose of the study 
The study aims to find out the views and experiences of nurses who participated in the 
Diabetes 6 Study. The purpose of this is to improve research in the future.   
 
Why have I been chosen? 
You are already participating in the Diabetes-6 Study and the aim is to approach all 
nurses who took part.  
 
Do I have to take part? 
It is up to you to decide whether or not to participate in this study. If you agree the 
researcher will explain the study to you and this information sheet. You are free to 
withdraw from the study at any time during the interview and to withdraw your data at 
any point up until the data is analysed (01/10/2014), without giving any reason.   
 
Should you feel uncomfortable asking the researcher to withdraw your data, you may 
do so via the researcher’s supervisor, Dr. Khalida Ismail, whose contact details are 
provided at the bottom of this information sheet.  
 
What will happen if I take part? 
If you agree to participate the researcher will make time to clarify any questions you 
may have. She will ask you to sign a consent form to say that you are happy to take 
part. The interview may last for approximately 30 minutes to an hour. The interview will 
be audio taped, so that the researcher and/or a research colleague, employed in the 
same department can type out the information you provide. The tape recorder can be 
stopped at your request at any time, if you do not wish certain information to be 
recorded, and may be re-started with your agreement.  
 
What might be the possible concerns taking part in this study? 
Any effort will be made to arrange the interview with the researcher at a mutually 




advance, a new appointment can be made. If you provide information you do not wish 
to have recorded, the tape recorder can be stopped whenever you wish and restarted 
with your agreement. 
 
What are the possible benefits of taking part in this study? 
We hope that the information you provide will give us a better understanding of your 
experience of taking part in the Diabetes 6 study. In addition other health professionals 
might be interested when the findings are published.  
 
Will my participation in this study be kept confidential? 
All information you provide during the interview with the researcher will be kept strictly 
confidential. Only the researcher will have access to the information you give. The 
external transcribing agency has a contract with the researchers department to treat 
all the information on the tape confidential. Your name will be replaced by a code only 
known to the researcher, so that you cannot be identified by any other person, 
including the external transcribing agency staff. 
  
What will happen to the results of the study? 
The information you provide together with the other nurses will be analysed and 
written up as a report. The findings from the study will be published within one to two 
years after completion and a summary can be made available to you by posting it to 
you. You will not be identified in any of the future publications or reports we have to 
submit to the funding body (NIHR). 
 
Who is funding the research? 
The National Institute for Health Research (NIHR) is funding this study. The NIHR is 
the body which conducts research for the NHS.  
 
Who has reviewed the study? 
The research proposal has been reviewed by staff in the Department of Diabetes and 
Nutritional Sciences at King’s College London and the study has been approved by 
King’s College London, Psychiatry, Nursing and Midwifery Research Ethics 
Subcommittee.  
 
Contact for further information 
If you have any questions or require further information about this study now or at any 
time during the study, you are very welcome to get in touch with the researcher Helen 
Graves on Tel. 0207 848 5780. If you have any questions concerning your rights as a 
study participant you may wish to read the following leaflet: Getting Involved in 
Research: A guide for consumers, available at: 
http://www.invo.org.uk/pdfs/guide_for_consumers.pdf or contact the Consumers in 
NHS Research Support Unit, Tel: 01962 872247. 
 
If this study has harmed you in any way, you can contact King’s College London using 
the details below for further advice and information.  
 
Prof. Khalida Ismail 
Department of Psychological Medicine 
Weston Education Centre 
King’s College London 




















Consent Form                             
Title of Project: Understanding the patients’ experiences of receiving integrated 
psychological and diabetes care 
 
Name of Researcher: Helen Graves 
                  Please initial box 
 
1.  I confirm that I have read and understand the Information 
       Sheet for the above study and that I have had the opportunity 
to ask questions.  
 
2. I understand that my participation is voluntary and that I             
am free to withdraw at any time, without giving any reason. 
       My withdrawal will not affect my future care. 
 
3. I agree to take part in the study. 
 









Researcher                      Date   Signature 
 
 

























Research Ethics Ref: PNM/12/13-27 
 
Title of Project: The Range and Diversity of Nurses’ Personal Experiences and Views 
of the D6 Intervention 
 
 
           
1. I confirm that I have had the opportunity to consider my participation in the study and to ask 
any questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
during the interview and I am free to withdraw my data at any point up until the final report is 
written (01/10/2014), without giving any reason.  
 
 
3.    I agree to take part in the above study. 
 
 
4.    I agree for this interview to be audio recorded.                            
 
 
5.    I consent to the processing of my personal information for the purposes explained to me 
I understand that such information will be handled in accordance with the terms of the UK        





________________                     ________________                          __________________ 
 Name of Participant           Date             Signature  
 
Diabetes Research Group 
Division of Diabetes & Nutritional Science 
King’s College London School of Medicine 
King’s College Hospital Campus 












_________________                ________________           __________________  
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D6 Patient Exit Interview Schedule  
 
I would like to talk to you about your experience of taking part in the D6 study. The 
questions I ask will cover three key areas: the timings of your appointments with the 
nurse; any problems you may have encountered in taking part and your views about the 
treatment you received. At the end I would also welcome any additional information 
which I may have left out but which you feel is relevant about your experience of taking 
part.  
 
Before we begin the interview, I must say that everything we talk about today will remain 
completely confidential. In order for me to listen back to our conversation later on 
however, I need your consent for me to record the conversation. Could you please 
confirm to me now that you are happy for me to do this?  
If you provide any information which you do not wish to be recorded, the tape recorder 
can be stopped at any time and restarted at your request.  
 
Timetable 
First of all I would like to ask you about the timing of the extra appointments you had 
with [name of nurse] at [name of GP surgery]. 
• What are your views about the number of appointments you had with [nurse 
name]?  
• What are your views about the length of the appointments? 
• Now that the extra appointments with [nurse name] have come to an end, can you 
tell me what you think about seeing her less frequently again? 
Barriers to Attending 
• How did you find the first appointment with the researcher, the one before you 
started seeing the nurse? 
• Could you tell me about any difficulties that you had attending the appointments 
with [nurse name]? 
 
o What would have made it easier to attend? 
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• What did you think about the way [nurse name] talked to you during the 
appointments? 
o Her style of talking?  
• How do you think your relationship with [nurse name] has changed, if at all? 
Treatment 
• What are your views about the issues that you discussed with the nurse during the 
appointments?  
o Were there other issues you would rather have discussed? 
o If so, which ones? 
• Can you tell me about any changes you’ve made to the way you manage your 
diabetes as a result of taking part in the research? 
• Can you tell me about any changes in the way you feel about your diabetes as a 
result of taking part?  
• Half the nurses taking part in D6 had special training in psychological skills, 
which were designed to help motivate people to manage their diabetes more 
effectively. Your nurse, [nurse name], did/did not have this special training. 
What are your views about this?  
• Aside from the D6 study, what are your views about this kind of research in 
general?  
• What are your views about using psychological therapies to help people manage 
their diabetes? 
• How do you think we could have improved the treatment? 
Final Comments 




D6 Nurse Interview Schedule (Intervention) 
 
I would like to talk to you about your experience of taking part in the D6 study. 
The questions I ask will cover 5 key areas: the D6 training; the intervention itself; 
the support you received during D6; any difficulties you encountered taking part 
and your opinions about research in general. At the end I would also welcome 
any additional information which I may have left out but which you feel is 
relevant about your experience of taking part.   
If you provide any information which you do not wish to be recorded, the tape 
recorder can be stopped at any time and restarted at your request.  
 
Training  
You were allocated to the intervention arm of the trial, which meant that you 
attended King’s for training in the D6 skills. 
• How did you feel about the timing of the training sessions?  
o Frequency  
o Length 
• Can you tell me about any problems you experienced with the training? 
o What would have made it easier for you? 
• Can you tell me any ways in which you think the training could have been 
improved?  
Support  
• What are your views about the supervision received throughout the study? 
• What are your views about the support you received from the research team in 
general?  
• How did other members of staff at your practice feel about you taking part in the 
study? 
o Were they supportive/not supportive? How so?  
o What would have made it easier for you to participate? 
D6 Intervention  
• How did you feel about being randomised to the intervention arm of the study? 
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• How did you find the actual sessions with patients?  
o How did you find the length of the sessions?  
• What are your feelings about the admin time involved in the study? 
• What are your views about D6 as a potential training for other practice nurses? 
 
Competency and Self Efficacy  
• How confident did you feel about delivering the intervention?  
• How confident did you feel about managing the caseload? 
Patients  
• Can you tell me about any difficulties you experienced in getting patients to 
attend the sessions?  
o Did you book the patients in yourself or did a researcher or receptionist do 
this for you? 
• Thinking about the patients that did attend, how do you think they feel about 
seeing you less often again now that the extra sessions have come to an end? 
• What were the challenges that you faced in using D6 skills with these patients? 
Values about Psychological Research  
• What are your feelings about the value of psychological interventions in general?  
• How has participating in D6 affected your feelings about taking part in other 
research studies in the future? 
Final Comments 
• Finally, can you tell me about any ways in which you think we could have 
improved the research? 




D6 Nurse Interview Schedule (Control) 
 
I would like to talk to you about your experience of taking part in the D6 study. The 
questions I ask will cover 5 key areas: training; the support you received during D6; the 
appointments with patients; any difficulties you encountered in taking part and your 
opinions about research in general. At the end I would also welcome any additional 
information which I may have left out but which you feel is relevant about your 
experience of taking part.   
If you provide any information which you do not wish to be recorded, the tape recorder 
can be stopped at any time and restarted at your request.  
 
Training  
You were allocated to the control arm of the trial, which meant that you did not attend 
King’s for training in the D6 skills. 
• What were your views about being randomised to the control arm of the trial? 
• Have you had any previous training in psychological therapies? 
Supervision 
• What are your views about the supervision you received throughout the study? 
• What are your views about the support you received from the research team in 
general?  
• How did other members of staff at your practice feel about you taking part in the 
study? 
o Were they supportive/not supportive? How so?  
o What would have made it easier for you to participate? 
D6 Intervention  
• How did you find the actual sessions with patients?  
o How did you find the length of the sessions?  
• What are your views about the admin time involved in the study? 





• How confident did you feel about delivering the intervention?  
• How confident did you feel about managing the caseload? 
Patients  
• Can you tell me about any difficulties you experienced in getting patients to 
attend the sessions?  
o Did you book the patients in yourself or did a researcher or receptionist do 
this for you? 
• Thinking about the patients that did attend, how do you think they feel about 
seeing you less often again now that the extra sessions have come to an end? 
• What were the challenges that you faced in seeing these patients? 
Values about Psychological Research  
• What are your views about the value of psychological interventions to improve 
outcomes in diabetes?  
• How has participating in D6 affected your views about taking part in other 
research studies in the future? 
Final Comments 
Is there anything else at all you would like to say that we have not already covered?
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A D-6 Background 
1 Skill 1: Active listening (MI) 
2 Skill 2: Managing resistance (MI) 
3 Skill 3: Directing change (MI) 
4 Skill 4: Supporting self efficacy (MI + CBT) 
5 Skill 5:  Addressing health beliefs (CBT) 
6  Skill 6:  Shaping behaviour (CBT) 
B Integrating the skills 
C Trouble shooting 
D Identifying mental health problems  
E Longer case examples 
F Useful tools appendix 
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This handbook is written for the NIHR funded D-6 study.  
 
It is intended as a training resource and reference handbook for diabetes professionals 
working with Type 2 Diabetes patients with persistent suboptimal glucose control.  
 
The handbook covers six core psychological skills for diabetes professionals. It draws 
on Motivational Interviewing and Cognitive Behavioural Therapy, which are 
introduced in the first section. Each section includes a rationale for why the skill is 
useful, a description of specific techniques and how to administer them. Each section 
also considers potential problems which may arise for the clinician in using each skill.  
 
The following sections of the handbook cover how to integrate these skills depending 
on the patient’s needs, a trouble shooting section which considers possible reasons for 
no change in the patient’s behaviour and longer case examples. Examples of dialogue 
between diabetes patients and clinicians are used throughout the handbook to illustrate 
the skills in action. 
 
The final sections of the handbook consider how to assess for common mental health 
problems and provide a list of local community resources to support lifestyle changes. 
A useful tools section will also be found at the end of the handbook, with handouts for 



















Thanks to Melanie Rimes for the illustrations 
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 century, the management of long-term conditions is an increasing priority  
for the NHS. With chronic disease management comes a greater responsibility for the 
patient in managing their own health. For some patients, taking on this role is much 
harder than for others. The patients who struggle continue to mistreat themselves or 
fail to make lifestyle adjustments, despite the prospect of disease progression. In Type 
2 diabetes, 60% of patients are failing to achieve target (Massi-Benedetti, 2006) 
despite access to sophisticated technology and health education. This is frustrating for 
everyone concerned. 
 
Both Motivational Interviewing and Cognitive Behaviour Therapy are psychological 
approaches that tackle the area of behaviour change. They have been shown to 
improve outcomes for diabetes patients and reduce HbA1c (Ismail, Winkley, Rabe-
Hesketh, 2004). These approaches suggest that how we talk to a patient, the questions 
we ask and the attitude we bring to our consultation can significantly affect outcome. 
The aim of the D-6 study is to train practice nurses in some of these techniques to 
support those patients who are struggling.   
 
 
Introduction to Motivational Interviewing (MI) 
 
What is Motivational Interviewing? 
Motivational interviewing is a consultation style designed to strengthen a patient’s 
commitment towards change. MI is both person centred (understanding and affirming 
the patient’s point of view) and directive (guiding them towards behaviour change).  
 
The key tasks in MI can be summarised as follows: 
 
EE Expressing Empathy 
RR Rolling with Resistance 
AA Avoiding Arguments 
SS Supporting Self efficacy 
DD Developing Discrepancy 
 
A useful acronym for remembering these is DEARS. These areas will be covered in 
detail in the subsequent chapters. 
 
The development of MI 
MI was originally developed from the field of alcohol misuse. Bob Miller, an 
American Psychologist, and his colleagues became interested in finding cost effective 
treatments for people with alcohol problems. They noticed that some therapists had 
more success with their clients than others, even when the clients had been randomly 
assigned. The researchers started to look at the transcripts from these sessions and 
investigated what factors predicted better outcomes. Surprisingly, they found that 
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resistance was a by-product of the interaction between the therapist and the client. 
This challenged the notion that resistance was exclusively to do with the client. 
 
Specifically, they found that when counsellors gave confrontational responses (even 
with good intentions), this would elicit increased defensiveness (i.e. resistance or 
denial) from the client. Therapists who expressed high empathy had patients with 
better outcomes. Furthermore, if therapists changed their style from a confrontational 
to a client-centred approach, client defensiveness reduced. Looking at transcripts of 
client responses, they found that client defensiveness could predict lack of behaviour 
change. This body of research suggested that the degree of resistance or motivation 
displayed by a client could be modified by the therapist’s behaviour.  
 
For more information regarding the theories associated with MI, see Appendix. 
 
The ‘spirit’ of MI 
MI is more than just a collection of techniques. The ‘spirit’ of MI is about adopting a 
certain attitude or mindset that will promote behaviour change. The underlying 
principles of MI can be summarised as follows: 
• Collaborative – a joint decision making process, with both parties having an 
equal share of the power. Only the patient can enact a behaviour change – their 
viewpoint needs to be respected and utilised. 
• Evocative – the art of MI is to connect healthy behaviour with what patients 
care about or value. MI seeks to draw out from the patient their reasons, 
values, resources and beliefs about change. Consequently, patients provide 
their own arguments for change. 
• Honouring patient autonomy – an acceptance that people are allowed to make 
their own choices about their health. Ironically, acknowledging a person’s 
right not to change can sometimes give space for change to occur. 
 
When you are in the flow with MI, consultations feel different; you meet patients 
where they are; you demonstrate you understand – the sense of struggle is abated. 
When patient defensiveness has gone down, you then have 
room to manoeuvre to guide them towards better self care. 
Rollnick (2008) reminds us that MI is “about guiding more 
than directing; dancing rather than wrestling; listening at least 
as much as telling” (p.6). Consequently, this handbook has 
been divided into ‘what to do’ sections i.e. technique and 
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The process of change 
The MI approach draws upon Prochaska & DiClemente’s (1983) Stages of Change 
(SoC) model. This model suggests that change is not an ‘all or nothing’ concept but 
that people pass through different stages (including contemplating a change and 
making preparations), moving backwards and forwards, before reaching a 




















The skill of MI is to meet your patient where they are on the cycle of change and  to 
adapt your consultation accordingly. For example, if you proceed with goal setting 
with a patient who is still weighing up the pros and cons of doing exercise, you may 
notice an increase in resistance. This is because the clinician is in ‘action’ and the 
patient is in ‘contemplation’. According to this model, resistance occurs when the 
patient and clinician are at different stages on the change cycle. (see Appendix for 
more information regarding the Stages of Change model).   
 
The majority of patients with poorly controlled diabetes are not ready to move into 
action to improve self-care when they first present. The resistance may not always be 
easy to recognise. Patients may avoid expressing their irritation, anger or rebellion to 
you directly. However, the resistance becomes obvious when they come back the next 
month with their sugar levels unchanged.  
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Introduction to Cognitive Behavioural Therapy (CBT) 
 
What is Cognitive Behavioural Therapy? 
Cognitive Behavioural Therapy was first developed as a treatment for depression by 
Beck (1967). It arose from the realisation that how a patient reacted emotionally 
depends on how they interpret events. Consequently, CBT rests upon the idea that 
cognitions (e.g. thoughts, beliefs, attitudes) influence our emotional, physical and 

























What Beck discovered is that these thoughts can appear so quickly and so fleetingly 
that the person may not be consciously aware of them. For example, if you ask 
someone to give a speech in front of a room full of people, they may notice that their 
heart rate increases and that they start to perspire. However, they may not be aware of 
any thoughts at the time. By asking the person specific questions, we can find uncover 
the ‘hidden’ interpretation of the event i.e “I might mess it up”, “my face will go red” 
or “my boss will judge me negatively”. These sorts of thoughts are called Negative 
Automatic Thoughts (NATs) and the role of therapy is to help the patient become 
aware of them. 
 
CBT works on the assumption that when patients are suffering from an emotional 
disorder e.g. depression or anxiety, they may hold unrealistic or unhelpful beliefs 
which are contributing to the problem. Common unhelpful ways of thinking include: 
 
• Catastrophising  - focussing on the worst case scenario 
• Personalising - assuming anything that goes wrong is my fault 
• Black and white thinking - viewing a situation from extreme positions 
Trigger 
Someone you know ignores 
you in the supermarket 
Thought 
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The aim of therapy is to help patients identify these automatic thoughts, using certain 
questions e.g. what went through your mind just then?; what does that say about you 
as a person?, what conclusions do you draw from this event? Patients may be asked to 
keep thought records to make a note of habitual ways of responding. Once the thought 
has been identified, the therapist will support the patient in exploring alternative 
viewpoints. This helps the patient to realise that their experience (e.g. sadness) is 
being coloured by their thoughts and that there may be an alternative or more helpful 
way of viewing the situation (cognitive restructuring). The behavioural part of CBT 
involves behavioural experiments. This involves testing out a patient’s predictions by 
trying out new behaviours and observing the results objectively. Goal setting and 
problem solving are other behavioural techniques used in CBT. 
 
The aim of this course is not to turn you into a CBT therapist, but to understand the 
theory linking thoughts to behaviours/feelings and to provide a few techniques e.g 
downward arrow (see Chapter 5) to enhance your consultations. These skills may be 




Working with health beliefs 
Even if a person is not feeling clinically depressed or anxious, the way they think 
about their illness will influence how they manage it. There are several theories from 
health psychology which highlight the role of beliefs in health behaviours e.g 
Leventhal’s self regulatory model (2001) and Ajzen’s theory of planned behaviour 
(see Appendix). These theories hold that patients will form certain ideas about their 
illness, the value of self care behaviours, the success of past efforts to manage it and 
other people’s perceptions. For example, if a patient believes their diabetes is 
temporary, they may not see the need for medication. Seen in this way, seemingly 
“irrational” behaviour can start to make more sense. The D-6 model assumes that 
there is always a rationale for a patient’s behaviour (even if it isn’t immediately 
obvious). By asking the right sorts of questions, we can use our consultations more 
effectively to target the unhelpful thoughts or beliefs that are maintaining poor self 
care. As a result, you will be better equipped to deal with some of the psychological 
barriers to glycaemic control. D-6 is not about offering psychotherapy but providing 
psychologically enhanced consultations around diabetes. 
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Psychological skills in a medical setting 
 
A normal question to ask at this stage is how different the D6 skills might be to what 
you do already. You have a level of expertise to fall back upon in terms of your 
nursing and diabetes experience and no doubt have had to handle patients of varying 
complexity. As you read this handbook, you will probably notice skills that you 
already use in day-to-day practice. Indeed, the D6 skills build upon already 
established good nursing practice (e.g. active listening). However, there will be some 
areas that feel very different to routine practice and that highlight the challenges of 
adopting a psychological model. It is best to be prepared for this culture shift.  
 
Who’s the expert? 
MI encourages you to view the patient as the ‘expert’. This is very different from the 
patient seeking ‘expert’ advice and treatment from the clinician. In this situation the 
patient is passive and knows less than the healthcare provider. In behaviour change 
work, however, the patient becomes ‘active’. You may suggest exercise/dietary 
changes, but it is the patient who knows best how to integrate this into their lives - 
they know when they go shopping, when they feel most tired, who can help with 
childcare, what exercise they prefer etc. In order to liberate that knowledge, we need 
to suppress our own ‘righting reflex’ i.e. telling them what’s best!   
 
One way to view this is that the patient becomes the Consultant or Specialist about 
themselves. This means you are consulting them about how to change their behaviour, 
rather than the other way round. This can be particularly difficult for healthcare 
professionals who are drawn to this work because they actively want to help others. A 
sign that we are doing our job well is that we have informed, educated, problem- 
solved, prescribed and ultimately fixed our patients. Although helpful in a lot of 
situations, when it comes to long-term lifestyle changes, the patient needs to take over 
the reins of responsibility. Letting go of this can feel unsettling at first, especially 
when we are well versed in problem-solving on the patient’s behalf. 
 
How do I know I’m doing anything useful? 
The D6 intervention will encourage you to expand your idea of clinical ‘work’. For 
instance, there is more emphasis on ‘listening’ as a clinical tool. This is where we can 
become unstuck. Work is often conceptualised as writing a prescription, taking 
someone’s blood pressure or giving health advice (i.e. practical directive action). A 
good outcome will involve some sort of goal-setting or plan. Without this it may feel 
like we haven’t done our job very well.  
 
However, this intervention will also involve listening, reflecting and tolerating some 
ambivalence (i.e. the patient is in two minds). Through listening we give space for the 
patient to explore their ambivalence, show that we are interested in them and obtain 
vital information to guide our consultation. We will learn to respond in ways that fuel 
motivation. In this way, our ‘talk’ is also part of our therapeutic armoury – potentially 
as powerful as the drugs we administer. 
 
For D-6, ‘work’ about moving a patient along in their thinking. The goal for a session 
is to increase the amount of pro-change statements made by the patient (i.e. moving 
them through the stages of change). This is still ‘work’ even if it’s not accompanied 
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by a more practical action. In fact, by focussing prematurely on action we may induce 
further resistance from the patient. Sometimes not doing something can be the more 
skilful response. 
 
The ticking clock 
It is common to worry that by asking patients what they think and how they you’re 
your consultation time will overrun. Remember that you’re not being asked to do 
‘therapy’ with a patient. Your questions will focus upon diabetes related concerns and 
with practice you will become more skilled at steering the conversation in the relevant 
direction. In addition, it is not your job to ‘fix’ all the problems you unearth in one 
session. Sometimes, this means ending a session with a sense that things are still 
‘undone’. This is to be expected for a long-term intervention such as D-6.  
 
It is also common to overestimate the amount of time that has passed when someone 
else is talking and to underestimate the amount of time that has passed when we are 
talking. Research suggests that even one to two minutes of real listening (without a 
hidden agenda) can make a significant difference to the outcome of your consultation. 
Yet two minutes can feel like an eternity to a silent healthcare professional! 
 
Worry about time can actually provide a very real distraction. If we approach a task 
thinking “I’ve only got 5 minutes” the whole project may take much longer because 
we are distracted by the urgency of time.  However, if we approach a task as if it will 
take 15 minutes (i.e. take the time pressure off) we can be more fully present to the 
task at hand and therefore respond more skilfully. Paradoxically, this often has the 
effect of achieving the same outcome in less time i.e. of speeding things up.  
 
These are some comments made by Swedish primary care nurses
1
 who underwent 
some training in Motivational Interviewing. 
 
‘After 25 years, old habits die hard’ ‘the difficult part is the re-learning, as the 
method in itself really isn’t that difficult. It’s important to be really focussed 
because it’s easy to revert to what is habitual’ 
 
‘We didn’t listen much before …instead we used to bombard people with 
advice, which was something we had been taught to do’ 
 
“The more you understand the principles[of MI], the more you really begin 
to appreciate motivational interviewing” 
 
 
                                                
1
 Reported by Soderlund et al 2008 
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Skill 1: Active Listening 
 
 
Why is Active Listening important? 
 
Listening can appear a deceptively simple task. In fact, it 
is a very complex skill and forms the foundation for all 
therapeutic interventions. Poor listening can result in 
missing vital information, the patient feeling 
misunderstood and disengaged from the consultation. 
Listening is often perceived as a passive skill, but we will 
go on to show that good listening involves being highly 
active and is more than asking questions and remaining 
silent during the answer.  
 
Good listening demonstrates to the patient that you are 
interested in what they are saying and are able to express empathy with their 
difficulties. Both these messages are the building blocks from which a therapeutic 
rapport is formed. Without this rapport, patients may not feel able to be honest about 
their struggles and hopes (i.e. their ambivalence) and to try out new behaviours. This 
is particularly relevant to diabetes patients, whose ‘unheard’ stories may be driving 
poor glycaemic control.   
 
Active listening is the cornerstone of all motivational interviewing. However, there 
are situations when it is particularly relevant.  
• At the start of a consultation, when the focus is on understanding what has 
brought the patient into the room 
• When the interaction between you and the patient feels particularly stuck or 
resistant 
• When the patient is highly emotional e.g. tearful, angry or anxious 
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Active listening – WHAT to do 
 
The following acronym summarises four techniques which can be used to promote 
active listening: OARS. 
 





As oars are used to steer a rowing boat, 
these metaphorical oars can help steer the 
consultation in a pro-change direction. 
How you use them, in terms of attitude 
and body language, will also have a 






Most consultations will involve a mixture of closed and open questions. The use of 
open questions is an important tool in behaviour change work. Open questions allow 
patients to elaborate on their answers. The more patients talk about their reasons for 
changing or not changing, the more pointers we receive about how to direct and pace 
the consultation. Closed questions can be counter productive in behaviour change 
because they can produce “yes/no” answers which tell us very little about any 
motivation to change.  
 
Open questions also shift the balance of power towards the patient. It is easy to fall 
into the ‘question/answer’ trap which places the onus on you to think of the next 
question for the passive patient. It maintains the status quo (i.e. that you must do all 
the work in the consultation) and moves away from a collaborative approach. A string 
of closed questions can also provoke resistance in a patient. It contributes to a sense of 
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Example 1     Example 2 
 
. 

















In the second example the clinician has revealed some of the reasons for change and 
the patient’s readiness to take on new information. In the first example, we have little 
indication of what the patient thinks about their HbA1c, what difficulties it’s causing 
them, what might be the driver for change, and whether they are at all ready to think 
about change. The patient has become passive in the whole process, not volunteering 
any more information than the bare minimum.  
 
An open question encourages more than a one word response. They can start with: 
 
• What / Why / How  
• Tell me more about … 
• Say some more about … 
• That’s interesting  - please expand on that … 
 
Closed questions are more likely to start with:  
• Can you … 
• Do you … 
• Have you … 
• How many … 
• When … 










C: Do you know your latest HbA1c? 
P: No 
C: It’s 10.2% 
C: Do you know what that means? 
P: Not sure 
C: It’s not a good sign. The glucose 
levels in your body are too high, putting 
you at risk for a number of 
complications. 
C: Does that concern you? 
P: I suppose that’s not good 
C: Well, we need to do something about 
that then. Let’s start by looking at your 
diet … 
 
C: Do you know your latest HbA1c? 
P: No 
C: It’s 10.2% 
C: What does that mean to you? 
P: Maybe that’s why I’ve been feeling so 
tired and thirsty? 
C: So you’ve noticed having less energy 
and needing to drink more. How does that 
impact on your life? 
P: Well it’s a hassle when I go to new 
places with the kids – I’m always worrying 
where the nearest loo is.  
C: Maybe we could think about ways to 
improve this for you – what do you think? 
P: I’m prepared to listen to what you’ve 
got to say … 
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CLOSED  Do you have any worries about your diabetes?   
OPEN  What worries you the most about your diabetes? 
    
CLOSED  Does your wife know about your hypos? 
OPEN  How does your wife feel about your hypos?    
     
CLOSED  Have you tried Weight Watchers before?    
OPEN  What are your thoughts about the Weight Watchers programme?  
  
The patient has indicated they aren’t taking all their injections   
CLOSED  How many injections do you miss a week?     
OPEN   What makes it harder for you to take your insulin sometimes? 
 
 
Closed questions can shut down the patient prematurely. Therefore, it gives you less 
to work with and the responsibility for change is back in your court. Open questions 
allow the patient to take some control with the direction of the answer. It also signals 






Affirmations are statements which demonstrate support for the patient. They may 
reflect positive aspects of a patient’s behaviour, highlight their attributes or validate 
their efforts. Affirmations are important for a number of reasons. They colour the 
emotional tone of the consultation – creating a positive, hopeful and constructive 
atmosphere. It is important to consider what feelings a patient will be left with once 
they have left the room. Will they feel uplifted or downcast? Long after the words 
have faded, it is the emotional tone of a consultation that will stay with the patient and 
influence their subsequent behaviour outside the clinic room. 
 
Affirmations can encourage positive self talk in the patient. Patients who are 
depressed have a tendency to focus upon the negative aspects of themselves or the 
world and discount the positive (see chapter 5). By providing affirmations, you are 
highlighting their capabilities and strengths e.g. resilience, problem-solving, or 
flexibility. You also demonstrate that their efforts are worth acknowledging. This 
provides an opportunity for patients to hear new ‘stories’ about themselves, build their 
confidence and their sense of hopefulness. 
 
Consider these examples: 
 
P: I know I should have done better  
C: Your health is important to you 
---------------------------- 
C: You sound like someone who can multitask very well  - how might that skill 
apply to your diabetes? 
---------------------------- 
Affirmations 
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[20 minutes late ] 
C: I’m sorry you’ve had so many obstacles to get here, but I’m impressed with 
your persistence to still attend the appt 
---------------------------- 
 
P: I missed a few doses – not very good – I’m falling back into old habits.  
C: Can we slow things down?  
P: OK. 
C: How many were you missing, in average week, when we first met? 
P: About 4 or 5 
C: And how many now? 
P: 2 
C: That’s an improvement of 50% - well done. What do you think about that? 
P: Well I suppose I didn’t see it like that 
C: Tell me how you managed that? 
---------------------------- 
 
P: I can’t get it down. I eat sensibly, I always take my background, I just hate 
my mealtime injections.  
C: You really take your diabetes seriously and put a lot of work into managing 




In the above examples, it would have been easy to get dragged down by the patient’s 
pessimism and immediately focus on what could have been improved. This means we 
are giving attention to the wrong behaviour i.e. what they haven’t done, not what they 






Reflections demonstrate to the patient that you are listening and have understood what 
they have said. The key to reflective listening is to think in terms of hypothesis 
testing. The patient has told you something and you form a hypothesis (best guess) 
about what you think the patient means. Then you reflect your hypothesis back to 
them. One way to approach this is to imagine saying the words “Do you mean ….?” 
In practice, you leave the “do you mean” part out and just present the patient with the 
second part i.e. the reflective statement. 
 
There are different levels of reflection: 
 
Simple reflections 
This is a basic acknowledgement of what a patient has said. It involves either 
repeating back to them what they have said or rephrasing it by changing a few of the 
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 P: When I try and lose weight, I always end up piling on the pounds again 
C: You’ve tried losing weight in the past, but it’s been hard to maintain  
 
P: I always take my tablets. There isn’t a day that goes past that I miss one. 
C: You take your tablets every single day, no matte what 
 
P: I feel really disappointed in myself that I couldn’t come here and say I’ve 
achieved more this week 
C: You feel disappointed. 
 
Complex reflections 
Complex reflections add something additional to what the patient has said. This may 
mean drawing out what has been implied but not said explicitly (e.g. an emotion) or 
creating a shift in emphasis. The latter allows you to use reflective statements 
strategically to emphasise ambivalence, roll with resistance or elicit change talk. 
There will be more on these complex reflections in further chapters. The following are 
types of complex reflection: 
 
Selective attention / Positive reframing (see Chapter 2 and 4) 
Overshooting/undershooting – amplified reflections (see Chapter 3) 
Double sided reflections (see Chapter 3) 
Reflecting emotional tone (see Chapter 2) 
 
Complex reflections are more appropriate when the clinician has got to know the 
patient, formed a rapport and has a better sense of their perspective and feelings. 





A summary is an expanded group of reflective statements. Summaries provide a way 
to assess where you have got to in a conversation. They can provide a pause, time to 
reflect and digest what has been said. This can be particularly helpful if the pace of 
the dialogue is starting to feel frenzied.  A summary may provide a turning point, after 
which you can change direction in a consultation. Summaries are often used to mark 




P:  I find that diabetes consumes all my life, because all I’m thinking is, what can 
I eat? What can I eat? What can I do? What can’t I do? And I don’t want to 
become obsessive about it. But everything is geared up towards your next 
blood test. Everything is geared up towards your next injection and I find it’s 
very oppressive …It’s the vastness of it, it’s the … thinking you’re doing the 
right things and having hypos. Thinking you’re doing the right things and your 
blood sugar is way off the scale, you know! Not even being able to pin point 
anything specific to say … oh! This is what triggered that, or that’s what 
triggered … you know! You think you got it there, you think you’ve got it 
under control and the next thing you know … it’s frustrating as I say. I mean I 
Summaries 
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got a booklet erm … to record my testing in, and on the front of it, there is a 
picture of a man playing a trombone and it says “diabetes does not have to 
control your life” …huh I wish! 
C:  So let me see if I’ve got this right Sarah. There are several things you were 
saying there. That diabetes has an impact on so many areas of your life like 
the testing, what you’re eating, managing hypos -  that it feels like there is a 
possibility of  getting obsessed with it, because there are so many things you 
could be monitoring all the time. The other thing I’m hearing is that no matter 
what you do, you’re not even sure if it’s even having the right impact on your 
diabetes and that’s frustrating. 
P: Yeah exactly 
C: Where do you think you’re at now with your diabetes management? 
 
In the above example, the patient is feeling extremely frustrated. The clinician uses 
the summary as an opportunity to reflect back the patients concerns and create a pause 
in the consultation. Notice how the clinician does not try to problem solve or 
challenge what the patient is saying. The summary is used to establish rapport and 
reduce patient defensiveness.   
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Active listening – HOW to do it 
 
Open Questions 
The attitude behind open questions is one of curiosity, of showing a genuine interest 
as to how your patient views their diabetes. Remember that the patient has the 
answers if we hold out long enough to hear them. Try to hold back from making any 
assumptions at this point or thinking of solutions. The approach is exploratory. 
Keeping this is mind will enable you to really listen to what the patient is telling you. 
Having a hidden agenda is distracting and will diminish the quality of your listening.  
 
Affirmations 
Affirmations may feel difficult at first. The key is to constantly be on the look out for 
the ‘green shoots’ (see more about this in Hotspots). Try and keep your praise specific 
and authentic. Useful questions to ask yourself are: 
 
• What exactly are you congratulating them for and why is it worth commenting 
on?  
• What effort will they have had to put in to achieve this?  
 
Specific praise tends to carry more weight than vague praise. Consider these 
examples: 
 
C1: Well done for losing 4 pounds – that’s brilliant! 
 
C2: I’m really impressed that you stuck with your diet over Christmas. It must 
have taken a lot of commitment to avoid temptation at that time of the year. 
------------------------------ 
C1: It’s really good that you’ve taken those injections over the past week. 
 
C2: You’ve shown courage in facing your fears about injections. There may have 
been times that you felt like not going through with it, but you found a way to 
get beyond that. How did you manage it? 
----------------------------- 
C1: Congratulations on making it to the gym this week! 
 
C2: It’s fantastic news that you’ve signed up to the gym. It’s been something 
you’ve been putting off for a while, but this week you decided to bite the bullet 
and make your health a priority. How did that feel? 
 
In the C2 examples, the clinician is not only giving praise but communicating an 
understanding of the struggles/sacrifices that needed to be overcome. This sort of 
affirmation is longer but follows the principle (from behavioural psychology) of 
giving more attention to the constructive behaviours. The C2 examples also lend 
themselves more readily to further elaboration from the patient e.g. How did you 
manage that? How did that feel? 
  
Following from this, it can be useful to reflect upon how much of your consultation 
style focuses on ‘what could be better’ statements v ‘what has already gone well’ 
statements. By focussing exclusively on the former, we subtly communicate (albeit 
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unintentionally) a message of disappointment, failure and not being good enough. 
Instead consider every interaction with a patient as an opportunity to motivate rather 
than de-motivate; to engender optimism rather than pessimism. 
 
Reflections 
According to the MI model, reflections should be presented as statements rather than 
questions. Once we start using reflections, it can sometimes feel more comfortable to 
use phrases such as ‘so it sounds like …?’ ‘I wonder if …?’ ‘Maybe you are 
feeling…?’ or allowing our voices to go up at the end of a statement to imply a 
question. However, by turning reflections into questions, we imply that the patient 
needs to respond. This can interrupt the flow of a patient’s thoughts and is less helpful 
in expressing empathy. Reflections don’t need to be responded to. However, if a 
reflection sounds inaccurate to a patient, they will usually let you know. See below: 
 
P: My husband says ‘oh why don’t you just take better care of your diabetes’. He 
makes it sound so simple. 
C: You’re angry at your husband 
P: Not so much angry, just disappointed that he will never really understand 
what it’s like for me to live with diabetes. 
------------------------------------- 
Example 1 
P:  I have tried to lose weight before and it just becomes really tedious – always 
thinking, ‘can I eat this?’ ‘can I eat that?’ Deep sigh 
C: Dieting can start to feel overwhelming. 
P: It just makes you want to put up with the pounds for an easy life. 
 
Example 2 
P: I have tried to lose weight before and it just becomes really tedious – always 
thinking ‘can I eat this?’ ‘can I eat that?’ Deep sigh 
C: So it sounds like dieting in the past has become a bit of a chore? 
P: Well yeah, it’s always on your mind 24/7… you never get a break from it – do 
you know what I mean? 
 
In Example 1, the patient is able to move on to her current state of mind i.e. wanting 
an easy life. By posing a reflection as a statement, the clinician has communicated 
that they have understood, no response is needed from the patient and they can move 
on to reveal further information. In the second example, the patient feels obliged to 




For most of the consultation the patient should be doing most of the talking, with the 
clinician providing a skilful nudge in the right direction. Summaries are when the 
‘taking stick’ passes to you. Allow yourself the time and space to be heard. 
Sometimes patients may feel excited that you have understood them and want to add 
their own comments. Gently but firmly allow yourself to be heard at this point. It can 
help to preface your statements, by introducing it as a summary and to avoid going off 
on a tangent midway in response to patient interruptions.  
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C: So to summarise, testing regularly does not fit easily into your life. You have 
been asked many times by the doctors to bring in your record book and feel 
somewhat embarrassed that you have an empty book.  
P: Yeah, totally awful – like I know what they must be thinking… 
C: Yet there are pressures in your life that make it very difficult to test and this is 
something that the doctors seem less aware of. You would like to think of ways 
to make testing more realistic for you, given the real limitations you have. 
What might be a helpful place to start with this? 
 
An MI summary usually tries to incorporate a presentation of the patient’s current 
position (the pros and the cons) but also adds some forward momentum, in a gentle 
but purposive way. 
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Active Listening - clinician HOTSPOTS    
 
It feels like I’m doing nothing  
Sometimes asking, listening and reflecting can indeed feel like ‘doing nothing’. The 
patient is doing most of the talking and the clinician is not giving advice or problem 
solving. There is no obvious intervention in the conventional sense. However, the 
clinician is really being highly active - choosing which open question to ask, selecting 
what to reflect back to the patient and how to summarise the issues. The clinician may 
not be saying much at this stage, but what they do say will be strategic with the aim of 
building rapport and expressing empathy – the foundations to behaviour change. In 
addition, remember that the talking we are trying to elicit from the patient is itself an 
intervention. Patients hearing themselves articulate their ambivalence encourages 
them to resolve these dilemmas.   
 
It takes so much longer 
Using OARS to facilitate good listening can feel like a time consuming process. 
However, it is common to over-estimate how much time is passing when we are not 
talking. Being fully present with a patient (without an agenda) for even one to two 
minutes can go a long way. Research reports that patients feel more satisfied with 
their care and also perceive the clinician to have spent more time with them than they 
actually did. Done well, patients’ responses to open questions will often provide the 
answers to specific closed questions. 
 
Giving praise feels fake to me 
As clinicians are also human beings (!) some of us also have a tendency to be overly 
self-critical and to neglect our achievements. It’s important to be aware of when we’re 
doing this so that we don’t reinforce our patients’ self-deprecation.  
 
It will also be important to find a language that works for you. There are a variety of 
ways of providing affirmations  - some more colourful than others. We may view this 
approach as artificially upbeat or sycophantic. However, a few statements delivered 
authentically will carry more weight than a barrage of forced compliments.  
 
There is nothing to praise! 
The most challenging patients can provoke this response. They don’t seem to be 
making an effort to manage their diabetes and health information falls on deaf ears. 
How can we validate non-existent efforts? With the MI approach, we might say that 
effort (like beauty) is in the eye of the beholder. We look for the ‘green shoots’ no 
matter how small or fragile e.g. just attending the appointment. We may need to look 
outside of diabetes – how do they manage their home, their work, their hobbies, their 
relationships – all the time looking for transferable skills/positive attributes. We do 
this to create some momentum for change. By ignoring the small efforts, we join our 
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Rolling with Resistance 
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Skill 2: Managing resistance 
 
 
Why do patients display resistance? 
 
Resistance to change can make working as a diabetes clinician a challenging and 
sometimes frustrating process. However, the skills of motivational interviewing are 




















The model of motivational interviewing rests on three central concepts: 
• Resistance is a normal part of the change process 
• Resistance is not in the patient, but in the interaction between the clinician and 
the patient. After all, you can’t be resistant unless you have something to be 
resistant against! 
• Resistance occurs when there is a mismatch between the patient’s stage of 
change and the clinician’s stage of change e.g. the clinician is in ‘action’ but 
the patient is in ‘precontemplation’  
 
Unhelpful ways of managing resistance include: arguing, raising our voice, talking 
over the patient, blaming the patient, labelling the patient and giving up on the patient. 
This is often the consequence of feeling disheartened that a patient is rejecting our 
help or not listening to good sense. Learning the skills to address resistance not only 
makes change more likely to happen but it can also enhance our own levels of 
motivation and job satisfaction. 
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Obvious forms of resistance include aggression/hostility, not taking medication as 
prescribed or avoiding appointments. However, resistance appears in many guises and 
we should also be on the look out for less obvious forms of resistance which can 
include: 
• Changing the subject or giving irrelevant details 
• Promising to make changes and not following through 
• Perpetually turning up late for appointments 
• “Yes, but ….” patient responses 
• Passive behaviours e.g. one word answers 
• Minimising concern or down playing problems 
These are subtle ways that the patient can re-gain some control over the pace and 
direction of the sessions. These all indicate that we may not be in the same place as 
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Managing resistance – WHAT to do 
 
The techniques to manage resistance are divided into three categories:  
1) Dealing with barriers - when there is active resistance  
2) Dealing with avoidance - when there is passive resistance  
3) Dealing with heated situations - when the emotional temperature is high 
 
 
Dealing with barriers 
This section is for situations when the patient’s talk returns again and again to the 
barriers they are facing. It may sound like a ‘yes, but’ conversation or a catalogue of 
reasons why the patient feels they can’t change. They may refer to life events, 
unhelpful family members / medical professionals, inconvenience, stigma and 
discomfort. 
 
Remember that in these situations, the patient is actually thinking very hard about 
change. It is only because they are considering the possibility of change, that they are 
starting to see the obstacles and this can signal a step forward. In these situations the 
patient may be feeling overwhelmed, confused or even hopeless. The task is to 
express empathy at the difficulty of the situation, whilst at the same time looking for 
areas of hope and possibility. 
 
MI introduces the concept of ‘rolling with resistance’. This involves suppressing our 
knee jerk reaction to react to resistance. Rolling with it means having the knowledge 
that change is a process which takes time, involves backward and forward steps and 
that resistance is malleable. Consequently, we treat resistance as something to side 






This is a type of complex reflection. It involves selectively reflecting back the ‘green 
shoots’ from a mix of positive and negative comments. 
 
P: I just hate injections, so I suppose that puts me off. I mean what other 
condition do you have to inject yourself X times a day? It’s such a hassle, 
although I suppose the pen thingy makes it easier. 
 
C: Injecting is not a pleasant experience for you, but you’re also aware that 
some needles could be a lot worse. Tell me more about what makes the pen 
easier to use. 
 
It is tempting here to talk about other conditions where the treatment could be worse, 
feel aggravated that without insulin they wouldn’t be alive, or feel that you’re 
supposed to join in the argument or agree that nothing is fair. 
 
Selective attention 
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P: It doesn’t help that my husband is not interested in healthy eating. When he 
shops – the fridge is full of junk food. I mean if I didn’t have to contend with 
that, life would be a lot easier. 
 
C: You are concerned about having healthy food in the house – tell me about 
when you go shopping 
 
In this example, we could have chosen to confront the patient i.e. “you may not like it, 
but you have to contend with it, so how are you going to manage?” But then we miss 
the opportunity to expand on times when healthy food is bought. Consequently, we 
side step the barrier for change (i.e the husband) for now. You may choose to return to 





This type of complex reflection gives you the opportunity to present an alternative 
interpretation of an event. It can be helpful if the patient can only see the negative 
viewpoint, which is keeping them stuck 
 
P: I think my wife thinks I bring on the hypos myself 
C: Your wife sounds concerned about your health 
 
This reframes the wife’s comments as possible concern rather than being accusatory. 
Positive reframing helps to steer the conversation into more hopeful and optimistic 
waters.  
 
P: With diabetes, you have to pay so much more attention to everything – even 
your feet! I spend half my life seeing doctors. 
C: There are lots of people paying close attention to your health to give you 
the best quality of life. 
 -------------------------- 
P: They say I need to take Metformin – I suppose they wouldn’t say it if I 
didn’t need it, but I feel fine. 
C: It’s good to hear that you’re not feeling unwell at the moment.  
 
With these examples, it is easy to take the bait i.e “doctors are only trying to help you 
for your own good” or “but you’re not fine, and here’s why ….” However, the latter 
responses can fuel further resistance as the patient defends their position from attack. 
 
P: I hate testing my blood sugars – feels so miserable when you see a high 
blood sugar, and you think, oh god, what’s happened now? 
C: You are conscientious about getting your blood sugars near to target 
 
Again, one might have chosen to respond to this patient by providing more education 
about why they should be testing their blood sugar. However, this would miss the 
opportunity to highlight the positive aspects of his experience and therefore engender 
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In this type of reflection – you overshoot i.e. use stronger language to create an 
opportunity for pro change talk. 
 
P: I know I should try and think about smoking, but it’s tricky, I enjoy my 
cigarettes  - sometimes I think it’s my only pleasure in life 
C: Giving up smoking will be an impossible task. 
P: Well I know other people who have managed it, so … 
 
P: I don't have a problem managing my diabetes 
C: There’s no room for improvement whatsoever 
P: Well, I guess I don’t always eat the right things 
 
P: I’ve never been a gym person, I can’t see myself doing anything like that 
C: So there’s absolutely no form of activity you would consider 




This section is about situations when patients deny or minimise any difficulties with 
their diabetes management. They may say very little, or get defensive or just divert 
you onto what’s going well. Remember in these situations it’s highly unlikely that the 
patient doesn’t perceive there to be a problem, in fact quite the opposite. The problem 
seems so insurmountable that denial can help them cope with it. Your task is to gently 
guide them towards acknowledging some ambivalence. If a patient won’t engage with 
you about their diabetes, you may need a lead to help you get a foot in the door. Here 





This is useful for patients who do not say much or find it hard to reflect upon their 
behaviour and the consequences. Often talking about practical events/activities can be 
an easier place to start  
 
C: In what ways has diabetes affected your: 
Physical health 
Moods / feelings 
Family / partner 
Social life / friends 




Refer to areas that you know are of particular interest to your patient e.g. their job; 
their grandchildren; their dance lessons; their driving. Use specific questions about 
how reported symptoms e.g. having a hypo, being thirsty, being tired, needing the loo 
a lot, blurred vision affect their functioning in these areas. 
Overshooting reflections 
Typical day question 
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For people in the precontemplative stage, it can be helpful to start them talking about 
other areas of their life / their values and see how diabetes impacts on that. This is in 
contrast to working the other way round (as you might do with more motivated 
patients) i.e. starting with diabetes and seeing how it interferes with their life/values. 
 
 
P: I got a touch of sugar but it ain’t so bad. The numbers go up and down all 
the time, you know. I feel pretty ok at the moment and my doctor said my blood 
pressure is down.  
C: So it’s a bit of a mystery why you’re here. 
P: There’s really nothing to worry about – you doctors always getting worried 
over summit. I have my two eyes, my two legs and my mental faculties 
(pointing to head) 
C: So physically you’re fit as a fiddle, you’re not noticing any unwanted 
symptoms from your diabetes. But I’m interested in how diabetes may or may 
not affect all parts of your life and not just your body. Could I do a little card 
sorting exercise with you? 
P: Ok 
 
P: My family would be my top priority 
C: Tell me more about that 
P: Well I always put my children first. They are the most precious thing. 
C: How do you spend time with your children? 
P: Well they’re grown up now (laughing) so really they’re adults. I see them 
some weekends – they come over with their families 
C: So you have grandchildren too 
P: Oh yes, plenty of those 
C: Family is a big part of your life, and you enjoy the time you spend with 
them. How might diabetes get in the way of this? 
P: Well I’ve seen people in wheelchairs – I don’t want to end up like that. But 
at the moment I feel fine. 
C: What’s your understanding about how people end up in a wheelchair? 
P: Their diabetes had got bad 
C: I’m wondering whether it’s possible that those people also felt fine like you 
at some point? 
P: I guess so …  maybe things just got worse for them. 
C: You recognise that diabetes can progress and get worse for people, 
sometimes leading to needing a wheelchair. That’s not somewhere you want to 
go.  
 
C: Can I show you a diagram
2
 that some people find helpful? 
P: OK 
C: These are some of the ways we think we can slow down diabetes.   
What areas seem relevant to you? 
                                                
2
 See Menu Options handout (Appendix) 
Values Question 
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P: Well I don’t smoke, I eat ok I guess, I do a spot of walking I suppose that’s 
exercise 
C: You sound as if you have a good grasp of the basic concepts, that healthy 
eating and exercise are very important, but you still have some specific 
questions about the details. Have I got that right? 
P: I just need to avoid the chocolate bars don’t I?  
 
The clinician how has a way in – an opening has been created about an issue that the 





This is about highlighting the difficulties in managing diabetes and that poor 
adherence to healthy advice is not unusual. If patients feel they are not being singled 
out as the only ‘culprit’, they can be more open to a dialogue about their difficulties. 
 
Patient with a disabled child – clinician suspects that they are not taking medication: 
 
C: So you must get really busy in the afternoons taking care of your daughter 
P: Oh yes, my mind is always somewhere else 
C: When people have other pressures in their life, it’s not unusual to forget 
their insulin – how is that for you? 
P: Sometimes it does slip my mind, yes 
 
In this example, the clinician offers a statement describing what can considered as the 
‘norm’ or a generalised way of behaving. This gives the patient ‘permission’ to talk 
about her own omissions. Another way to normalise the difficulties of managing 
diabetes is to ask the patient if they know anyone else who has diabetes and what 
problems and coping strategies these other patients use. The purpose here is to 
encourage the patient to express the challenges that other people might also face.   
 
In heated situations 
Sometimes the emotional tone of a consultation can feel quite heated. In these 
situations, it would not be unusual to feel antagonised. The task is not to engage in the 





In the heat of the moment, it can be helpful to simply reflect back what the patient has 
said. It also gives an opportunity to make sure you have understood what they have 
told you, as an emotionally laden statement may be less coherent. 
 
P: I’m fed up with diabetes. I just don’t want to think about it anymore, ok? 
C: You’ve had it with diabetes and talking about it makes you feel worse.  
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P: I don’t want another meter, because I’m not going to test my sugars, so 
there’s no point. 
C: Right now, you don’t want to do any blood glucose testing, so it seems silly 
for me to give you another meter. 
P: Yeah, exactly. 
C: What feels like a more useful area for us to talk about today?  
 





This means acknowledging shared responsibility for the situation. It is useful when 
the consultation feels very hostile. By the clinician acknowledging some 
responsibility, the patient no longer needs to attack or justify – this provides a 
temporary reprieve. Taking a one down position removes some of the heat out of the 
interaction and steers the consultation towards move constructive ground.  
 
 
P: I’m ok with my diabetes -  I do what I’m told, I don’t know why these blood 
tests keep coming back so bad. (spoken forcefully) 
C: I’m sorry to hear that. We have obviously failed you in some way, because 
your sugars are still running high. What information would you find helpful to 
hear from me today? 
 
------------------- 
P: It’s not my fault they’re running high, everyone gets high readings 
sometimes.  




P: I’ve got to see you now have I? I’ve just been waiting over an hour in the 
hospital. Nobody tells you what’s going on. I suppose you’re just going to 
have a go at me about my diet or something. 
C: I’m really sorry that you’ve had to wait so long and that nobody’s been 
communicating with you. That doesn’t sound like you’ve been treated very 
well. How can we make the next 30 minutes useful for you? 
 ----------------------- 
 
These examples highlight powerful ways to defuse the situation and minimise patient 
defensiveness.  
Taking a one down position 
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Managing resistance – HOW to do it 
 
With Motivational Interviewing, the clinician does not feel obliged to answer a 
client’s objection or resistance. Instead we side step, roll with, highlight the ‘green 
shoots’ rather than the weeds. By holding this position consistently something will 
finally shift in the consultation – creating momentum for change. In contrast, by 
confronting or challenging anti-change talk, we are giving our attention to the wrong 
behaviours.    
 
It is important to be aware of what not to do when managing resistance. This includes 
taking resistance personally. If necessary, take a breath or provide a summary to 
create some mental space. Remember it is not anyone’s fault when there is resistance 
in the room – it just describes the interaction between you both. Try and assume that 
the patient is ambivalent - we just need to find the pro change statements.  
 
In MI, resistance is viewed as useful information. It is a signal for the interviewer to 
shift their approach. In this way, resistance is not viewed as ‘the enemy’ but as a 
signpost. Viewing resistance in this way means we are less likely to be punitive 
towards ourselves and also to the patient. Being worn down by resistance can be 
draining and dispiriting, whereas being ‘informed’ by resistance can allow us to work 
more constructively with the patient. 
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Managing resistance – clinician HOTSPOTS 
 
These patients don’t really want to change 
Well this might be true, but it might not. By giving people the benefit of the doubt, we 
have something to work with. Always assume the patient is ambivalent – that part of 
them is considering change.  
 
Why should I be the one apologising? 
If a patient is angry or not managing their diabetes more actively, it can feel quite 
uncomfortable or even insincere for you to be the one to apologise. However, taking a 
one down position is a way to signal to a patient that 
arguing with you is a futile exercise. Offering an 
apology can quickly de-escalate a situation, and make 
room for a more productive conversation. 
 
They just need to listen to reason 
Patients definitely need to listen to the reasons to take 
care of their health. However, information which falls 
on deaf ears is no use to anyone. Therefore, the timing 
of when you provide the information is important. 
Taking the time to reduce the level of resistance in the room is a vital first step before 
providing further diabetes education. 
 
They just need to be scared 
Scare mongering is a seductive technique! If we can raise people’s fear levels it might 
just jolt them into action. The problem with this is twofold: people who can’t manage 
anxiety very well may slip further into avoidance and denial. Scaring them will 
reinforce this unhelpful way of coping with difficult things. Secondly, fear driven 
behaviour change may work in the short term, but not in the long term. When patients 
have a lapse (which is a normal part of the change process) they may anticipate more 
‘fear talk’ from the clinician, meaning they are less likely to come back and be honest 
about their struggles. 
 
I can’t be that calm all the time! 
We, like our patients, are human and fallible – prone to losing our temper, feeling hurt 
or saying something insensitive. This is the norm. The point of these techniques is to 
increase the likelihood that more of your consultations will be constructive. This will 
never be 100%. Beware your own black and white thinking (see Chapter 5)! 
 
They keep going back to the same old excuses – it’s like listening to a broken record 
If patients keep returning to anti-change statements and it feels like you are covering 
the same ground at each consultation, you may need to take a more pro-active stance 
to addressing these barriers. Often patients repeat issues if they aren’t sure that they 
have been properly heard or understood. This is a sign that the patient needs more 
active listening. Going back to the OARS, slowing down the pace of change and 
expressing empathy may help you move beyond this impasse. 
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Skill 3: Directing change 
 
 
Why is directing change important? 
   
Although motivational interviewing is about listening to the patient in an empathic  
manner and respecting their autonomy, it is also about directing them towards change.  
 
In order for anyone to change they will need to have considered the reasons for 
change and weighed them up against the losses in making that change. Being in two 
minds i.e. ambivalence is a normal part of the change process. The problem with 
ambivalence is that people can get stuck there. They may think of one argument for 
change and then another argument against change (“yeah but, no but”), and it’s as if 
they cancel one another out. If patients can’t resolve their ambivalence, they may stop 

















Your OARS will help in keeping you afloat in the consultation and steer you and the 
patient in the direction you want to go. However, they may not get you to the final 
destination. Directing change is a strategy aimed towards resolving ambivalence. It 
involves raising awareness of the pros and cons of making a change, strengthening the 
pro-change talk and highlighting the incompatibility between the current situation and 
the patient’s values or goals. 
 
It can be summarised as: 
 
• Eliciting change talk (DARN Questions) 
• Amplifying change talk 
• Activating change talk (CAT Questions) 
 
Ambivalence 
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You can direct change by getting the patient to tell you their reasons for change. The 
trap we often fall into is to tell patients why they should change. If we give patients 
the reasons to change they are left either to passively agree or to resist through a “yes, 
but …” answer. Neither option engages the patient constructively. By doing all the 
talking, we also deprive the patient of the opportunity to hear themselves articulate 
their reasons for change. According to Bem’s self perception theory, verbalising this 
out loud is an important mediator for change.  
 
The drivers for change can be summarised as DARN- CAT*:  
 
D – Desire: “want” “wish” “like” 
   e.g. I would like to get better control of my diabetes 
A – Ability: “can” “could” “able” 
   e.g. My sister could help me with baby sitting 
R – Reason:  Stating a specific reason for change 
   e.g. Better control would mean I feel less tired during the day 
N – Need: “need to” “have to” “must” “important” 
e.g. I need to get better control of my diabetes 
 
*CAT statements are considered in the next section. 
 
These are all examples of preparatory talk – laying the mental foundations on which 
to support behaviour change. Questions that elicit DARN statements from a patient 
will be fuelling the “human engines for change” (Rollnick, Miller & Butler, 2008, 
p.40). Here are some examples of questions to elicit change talk around diabetes: 
 
Why would you want to slow down your diabetes? (desire) 
How would you do it, if you decided to? (ability) 
What, for you, are the three best reasons to get better control? (reason) 
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By asking these questions you are not only eliciting change talk, but also have an 
opportunity to check out the patient’s understanding of their health education (more 
on this later in Chapter 5). In addition, you are connecting with their values. For 
instance, we might think that reducing the risk of a heart attack is a major reason to 
give up smoking, but the patient might be more motivated by the thought of saving 
money or nicer smelling breath.  
 
There are tools you can use which will extract similar information to the above 
questions. These are the readiness/confidence rulers (see Appendix) and the Decision 
matrix (see Appendix). These tools will help explore a patient’s ambivalence – 
eliciting the reasons for and against change. If a patient is able to come up with 
reasons for and against change, you may choose a double sided reflection (this is a 
type of complex reflection) to reflect their ambivalence. See example below: 
 
C: What concerns do you have about taking your insulin? 
P: Insulin makes you put on weight 
C: So you feel heavier from taking insulin. How does being overweight affect 
you? 
P: I don’t fit into my clothes, and I can’t move about easily and my joints they 
really hurt. 
C: So there’s a sense of feeling bigger and less mobile when you’re 
overweight, but on top of that, you’re telling me that it leads to pain. That 
must be very distressing. That must make you want to avoid the weight. 
P: Yes I do 
C: I guess there is a dilemma – on the one hand you recognise a need to take 
your insulin, on the other you feel it will lead to weight gain. 
What benefits might insulin give you? 
 
In the last two sentences the clinician delivers a double sided reflection and follows 






When you hear change talk, don’t just sit there, say something! Remember that any 
signs of change talk coming out of the patient’s mouth are like young shoots 
struggling to grow. Without water or sunshine they will struggle to thrive and may be 
overtaken by weeds. Our task is to amplify the change talk, so that it starts to carry 
more weight than the anti-change talk. Amplification can happen in a number of 
ways: 
 
 1) Provide affirmations i.e. statements of support for pro change ideas e.g. 
It’s great that you see the value of attending your appointments 
  You’re thinking really hard about how to fit exercise into your life 
2) Encourage elaboration e.g. 
  How did you manage that? 
  How did it feel? 
  Why would that be important to you? 
Amplifying change talk 
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 3) Selective attention 
Your task here is to look out for the pro-change statements amidst the 
anti-change talk (see Chapter 2) 
 
e.g  P: I can’t really cook and so I tend to buy junk food – usually too 
knackered to think about anything else after work. I don’t think I’m a 
junk food addict – I can quite happily munch on carrots and stuff like 
that, but it’s a lot easier to grab a chocolate bar on the way home.  
C: If healthy food is presented to you, you don’t mind eating it. When 
do you come across stuff like carrots? 
 
The clinician is selectively reflecting back the positive angle i.e. the patient enjoys 
eating healthy food and then asks them to elaborate on how they might come across 
healthy food. In this example, there is some rolling with resistance. 
 
You can also apply the above techniques to amplify anti-sustain talk i.e. a statement 
that reflects the downsides of not changing. Consider these examples: 
  
P: This can’t really go on I know. 
 C: What is it that needs to change?  
 P: I’m just tired all the time, and have ended up in A&E a few times 
 C: What do you imagine will happen if this continues? 
--------------------- 
P: I suppose my eyes are already showing some changes – I wasn’t really 
expecting that.  
C: What does that suggest to you? 
P: My diabetes is racing on ahead - more than I thought. 
 
In both examples, the patient is starting to hint at the negative sides of having poorly 
controlled diabetes. Instead of letting this pass, the clinician is using elaboration to 
strengthen the anti-sustain talk i.e. encouraging the patient to talk further about the 





The following are examples of implementing talk – statements that suggest the patient 
is ready to consider action. 
 
C – Making a commitment: “will” “intend to” “going to” 
 e.g. I will renew my insulin prescription 
A – Activation: “ready to” “willing to” (without specific commitment) 
 e.g. I am willing to test more frequently 
T – Taking steps: Reporting recent action towards change 
  e.g. I signed up to join a gym last week 
 
Commitment language signals the strength of change talk. For example, a patient may 
say “yes it’s important for me to put diabetes first (need)” or “I would like to be 
slimmer (desire)” or “I could buy healthier ready meals (ability)” - none of these 
statements are providing an actual commitment towards change. The task here is to 
CAT Questions 
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support the patient in translating their ‘good’ intentions into action (i.e. a preparation 
phase in the cycle of change) 
 
The following are examples of questions to move patients towards activation: 
 
 Where could you go from here? 
 Who could help you with this? 
What do you intend to do?  
 What are you going to do next?  
What would you be willing to consider?  
What could be your first step? 
What feels like a reasonable change/goal for you to make? 
What feels manageable/realistic for you? 
 
Check out with the patient what are the obstacles/barriers to change occurring: 
 
What’s preventing that happening now? 
 What’s stopping that being the case? 
Who / where / how are the obstacles preventing you from getting the outcome 
you want? 
 
Help the patient to start problem-solving around this (more on this in chapters 4 and 
6) 
  
What might be a way around this? 
  What needs to change for you to move forward with this? 
 Who/what could help you with this? 
 
Knowing when to ask questions that are action-oriented will be a matter of timing and 
clinical judgement (see How to section below). 
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Directing change - HOW to do it 
 
In order for a patient to resolve their ambivalence, they need to see a good enough 
reason to change (eliciting and amplifying change talk) and to believe that they can 
change (activating change talk). 
 
Eliciting and amplifying change talk 
The key to directing change is to adopt the mindset that the patient has the answers. 
The patient needs to convince you of the reasons why they should change, rather than 
the other way around. This means they need to come up with robust evidence, like a 
lawyer presenting their case in court, as to why change is worthwhile. Remember that 
the more patients verbalise why they should change, they more likely they are to 
change their behaviour. Your task is to simply facilitate this process by asking the 
sorts of questions that will elicit change talk. However, don’t forget to intersperse 




As soon as a patient has given you a reason for change, they may come up with 
another reason to cancel it out. You may need to spend more time than you think in 
the land of ambivalence. This means reflecting on the pros and cons, expressing 
empathy in relation to the difficulties and strengthening the pro-change talk. At this 
point, the clinician should normalise this process – letting the patient know that 
ambivalence is normal and that attachment to ‘unhealthy’ behaviours is not unusual. 
Things may feel like they have stalled at this point. However, by gently but 
consistently reflecting the current dilemma (e.g. inconvenience ‘v’ poor health) back 
to the patient you will start to generate some internal momentum (see Appendix on 
Cognitive Dissonance). Think of this preparatory talk as the scaffolding without 
which the ‘house of change’ will collapse. 
 
Activating change talk 
Timing is a crucial factor in directing change. If you move to ‘action’ prematurely 
patients may feel threatened, misunderstood or inadequate, leading to disengagement.  
As always, your patient will be your best guide as to when they are ready to 
implement change. Listen out for when there is some momentum towards change i.e. 
when you hear the DARN-CAT statements coming from the patient’s mouth (not 
yours!). Only when you hear pro-change talk emerging, might you could consider 
dipping your toe in the water of ‘action’. This means supporting patients to think 
about how they will translate their ‘good’ intentions into action.  
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Directing change – clinician HOTSPOTS 
 
Asking DARN-CAT questions – What if patients just tell me what I want to hear? 
This may be the case at first. However, as the patient learns to trust you, they will take 
the risk to say things that move away from ‘textbook’ answers. If trust is an issue, the 
focus should be on building up further rapport with the patient through active 
listening.  
 
Thinking about pros and cons of change – what if the patient doesn’t see any pros? 
If a patient cannot think of any good reasons for change, try some further exploratory 
questioning. Areas to consider are: 
 Why they have come to see you today? 
 What they imagine life could be like if their diabetes was better controlled? 
 What other people who are close to them feel about their diabetes? 
It is possible that patients are genuinely unaware of the positive benefits associated 
with improved diabetes control. This can be provided through further diabetes 
education or sharing the benefits other patients have reported. In Motivational 
Interviewing information can be provided to the patient, after seeking permission first 
(see chapter 5) 
 
 Thinking about pros and cons of change  - what if the patient feels the cons 
outweigh the pros? 
Again, you will want to explore exactly how the patient has reached this conclusion to 
check for any inaccurate or missing health information. Ways to do this are 
considered in chapter 5. After considering all the pros and cons, a patient may decide 
it is not worth changing their behaviour and this is something they are within their 
rights to do. This can be a bitter pill for clinicians to swallow. However, it is worth 
considering whether the patient may be more amenable to change at a different time 
in their life (e.g when their domestic situation is more stable) or whether the goal can 
be modified (e.g. aiming for a smaller drop in HbA1c) 
 
What if I ask about goal setting before they are ready? 
If a patient is not ready for goal setting – they will signal this in some way e.g. not 
completing the goal, not attending the appointment, going quiet etc. It is normal for 
clinicians to get it wrong sometimes and to prematurely push a patient towards action. 
The important thing is to pick up on the feedback you are getting from the patient so 
you have an opportunity to change tack and rescue the situation. The art of MI is 
being responsive to any feedback (negative or positive) the patient gives you and 
using this to guide your next move. 
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Thinking about learning 
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Learning new skills 
 
I’m not sure about this psychology stuff! 
At this point and before you launch into the 
rest of the handbook, it may be worth 
thinking about the process of learning itself. 
You may find that your head is already 
spinning with all the new concepts, words 
and jargon you have just read and how you 
might fit this into your practice. Learning the 
D6 skills will involve some changes to your 
established practice. Therefore, we are not 
just talking about changing our patient’s 
behaviour but also changing our own! 
 
We now know that the process of change comes with ambivalence and is not an ‘all or 
nothing’ concept. There will be some aspects you are keen to change about the way 
you communicate with patients, and others you are reluctant to let go off. It is 
important to acknowledge that being in two minds is a normal part of the process. In 
addition, take a moment to reflect where you might be on the Stages of Change model 
– are you in action or contemplation or somewhere else? Observe how your position 
on the change cycle may vary, going forwards as well as backwards as you proceed 
through training.  
 
Will I ever ‘get’ it? 
Even if one is motivated to acquire new skills, this motivation can soon dwindle as the 
reality of making mistakes, feeling incompetent and possibly hopeless kick in. 
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It can be helpful to keep this model in mind to prepare yourself for the peaks and 
troughs that inevitably arise from leaning a new skill. During the first stage you may 
be ‘blissfully’ unaware of what you don’t know (unconscious incompetence). During 
the process of learning you become conscious of what areas are lacking (conscious 
incompetence). When you start to consciously change how you respond to a patient, 
to try something different and see the results, this can be rewarding and uplifting 
(conscious competence). Over time and with consistent practice, your skills become 
more ingrained, your instinct improves and the responses come more easily. 
Eventually, you may lose sight of the skills that you have gained because they become 
so automatic. (unconscious competence).  
 
Kolb learning cycle 
How do we learn a new skill? The old fashioned way of ‘chalk and talk’ i.e. being 
taught information whilst we listen passively is not always the optimal way to learn. 
What is missing is the component of experience i.e. of having a go ourselves. This 
experience is unique to each individual and will highlight for them what went well, 
what needs tweaking and what’s to be avoided for next time. This process of feedback 
and reflection is very important for learning to occur. See diagram below:  
 
Kolb Learning Cycle 
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One of the key phrases to highlight is ‘saying what you did without being 
judgemental’. All too often, especially in those who are highly conscientious, the 
feedback stage can be overly critical or berating of our ability “I should have …” “ I’ll 
never get it” “I’m so stupid”. The process of learning simply requires that we view the 
data objectively and consider what we might do differently the next time, without the 
need for unhelpful judgements or labels.  The experience of mistakes/set backs is part 
of the process it’s expected and fertile learning ground.  
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Skill 4: Supporting Self-efficacy 
 
 
Why is supporting self-efficacy important? 
 
Self efficacy is defined as a person’s belief in his of her ability to carry out a specific 
act or behaviour. It comes from Albert Bandura’s social learning theory in the 1980’s. 
In an MI context, it is about increasing a patient’s confidence in their ability to make 
changes. One way to quickly undermine this confidence is to provide all the answers 
for the patient. This subtly communicates the message that the patient doesn’t have 
their own resources.  
 
In behaviour change work, supporting self efficacy is about helping patients to come 
up with their own solutions to the 
problems they raise. It follows from the 
idea that although we are the experts on 
diabetes and general principles of 
behaviour change, the patient is an 
expert on themselves. They will know 
what will and won’t work for them, and 
what has worked for them in the past. 
They will also know how much change 
is feasible for them, given their current 
commitments and limitations - although 




A patient’s confidence in their ability to make changes is an important mediator for 
long term change. Firstly, they can set the rate and amount of change that feels 
comfortable for them, giving a greater likelihood that they will achieve it. Secondly, 
by asking questions that ask patients to think for themselves, it demonstrates that you 
have confidence in them and their resources to make change. The sense of 
achievement is likely to be greater if patients can come up with their own ideas. 
Thirdly, it helps patients become more self reliant in the long term, and less dependent 
on their healthcare provider. In addition, self efficacy is a transferable skill than 
patients can apply to or from other areas in their life. 
 
Very often a patient’s sense of self efficacy can be low during their diabetes 
consultations. This is because they may expect the healthcare professional to tell them 
what to do, and also because they may have already experienced failed attempts to 
self regulate their diet, exercise levels and insulin needs. A low sense of self efficacy 
(and often self esteem) can be associated with feelings of hopelessness and is a 
maintaining factor in depression. Hence, by supporting self efficacy you are not only 
helping the patient manage their diabetes but may also help to alleviate mild to 
moderate symptoms of depression.  
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Supporting self efficacy - WHAT to do 
 
Supporting self efficacy is more about the particular attitude we adopt with patients, 
rather than a specific technique (see How to do it). However, there are some useful 





Supporting self efficacy draws on making affirmations. These are the points where 
you can highlight what the patient has already achieved and make explicit the link 
between their actions and positive consequences.  
 
C: Given you’re under the weather and didn’t fancy coming here, how did you 
manage that? 
P: Well I thought I might feel better if I go outside and it might make me feel 
like I’m doing something positive for my health 
C: How do you feel now you’re here? 
P: Yeah, I’m glad I made the effort actually 
C: Telling yourself to come here, even though you didn’t feel like it was a 
useful strategy. 
 
In the above example, for instance, the patient has demonstrated that low mood can be 
temporary, that positive self talk (ie. telling yourself motivating statements) can lead 
to action and that there may be benefits to doing something that you may not feel like 
doing initially. These are all areas that could be later applied to his/her diabetes 
control.   
 
To support self efficacy through affirmations, you are asking the patient how they 
managed to achieve something and what the consequences were. This reinforces their 
role as an active, effective agent in the world i.e. things just don’t happen to me, I can 
make them happen. Use every opportunity to find out a patient’s personal toolkit of 
resources. You may have to look outside diabetes initially to find them e.g. being a 
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Solution focussed questions are useful at later stages when the patient is starting to 
think about making changes. By asking these sorts of questions, you are hoping 
activate a different sort of change talk: C A T 
 
C Commitment (Will, intend to, going to etc) 
 What do you intend to do? 
A Activation (Ready to, willing to – without specific commitment) 
 What are you ready or willing to do? 
T Taking steps (Reporting specific action/steps towards change) 
 What have you done already?  
 
Further types of questions to help patients draw on their own resources are listed 
below: 
 
Using past experience (useful in the ‘preparation’ stage of change) 
What have you found has worked for you before? 
Was there ever a time when you were having more success with this? Tell me 
about that …. 
What factors support you with this? 
What factors get in the way? 
Who has helped you in the past? 
When are you more likely to make progress with this? 
 
Using other people  
Who could support you with this? How might they best support you? 
What might you say to a friend in this situation / facing this obstacle? 
Imagine other patients with diabetes were listening to your dilemma  – what 
might they say/do/suggest, if they were here? 
What might your best friend/wife/family member say is the way forward? 
 
Using hypothetical scenarios  
Imagine that you felt more in control of your diabetes, what would need to 
change to enable you to feel that way? 
What do you think is standing in the way of that? 
What do you think would work for you on this? 




Sometimes patients will find it impossible to think of a way forward and you may find 
yourself needing to make a suggestion. However, always check in with yourself:  
 
• Have I really given the patient enough opportunity to come up with 
their own ideas?  
• Is this the ‘righting reflex’ creeping in through the back door?  
• Am I rushing the session on? 
Solution Focussed Questions 
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There are ways we can limit the potential damage of making suggestions: 
1) To view suggestions as a last resort 
2) To ask for permission before we offer them 
 
We ask for permission because it honours the patient’s autonomy, it seeks their active 
involvement in the information exchange and it lowers resistance i.e. you are not 
foisting upon them anything they didn’t agree to.  
 
Would you like to hear about some things that other patients have found 
helpful? 
Would it be ok if I tell you one concern I have with this plan? 
There are several things you can do to keep your blood sugar levels under 
control. Do you want to hear them, or are there other things that we should 
talk about first? 
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Supporting self efficacy - HOW to do it 
 
In order to support self efficacy in our patients, we need think about the questions we 
ask, how we ask them and to suppress a very natural tendency to give advice. Certain 
questions (such as those above) encourage patients to reflect upon their own 
resources. They should be asked with an open, curious attitude which models a belief 
that patients do have their own resources (albeit unexpressed) and that it is our task to 
elicit these. As this approach will be unusual for most patients, it may require some 
gentle persistence on the part of the clinician to encourage this way of thinking. For 
instance, approaching the question from a few different angles. 
 
 
P: I keep forgetting to take my tablets. I only see what I’ve missed the day 
after. 
C: So forgetting your tablets is something you’ve identified as a problem. 
What would make it easier for you to remember them? 
P: No idea 
C: Have you ever managed to take them more regularly? 
P: No 
C: Say a good friend of yours was having the same dilemma – forgetting their 
tablets – what might you suggest to them? 
P: Oh I might suggest they were losing their marbles like me (laughing) 
C: You seem to manage very well in many aspects of your life. Would you 
make any practical suggestions to your friend? 
P: Well maybe they could take them at a certain time of day, with a TV 
programme or something 
C: And how might that work for you? 
P: I’ve never really thought about that. I suppose I watch Coronation Street 
religiously … 
 
After each initial ‘no’ response, the clinician could have exited the conversation, or 
jumped in with a suggestion, but instead he/she gently perseveres so that the patient 
can come up with their own idea. 
 
Beware the ‘righting reflex’ – when you sense you are slipping into ‘you should’ ‘you 
must’ ‘why don’t you …’  you are moving towards an authoritarian stance. It is easy 
then to fall into the question/answer trap which can fuel a ‘yes, but’ line of 
conversation or silence an already passive patient. A useful rule of thumb is the ‘three 
strike rule’. This means asking the question three different ways, before changing 
tack or offering a suggestion.   
 
Supporting self efficacy should be highlighted throughout e.g. though affirmations. 
However, beware of timing in relation to moving towards action. The solution 
focussed questions outlined above are for patients who have started to resolve some of 
their ambivalence and are starting to think about change in more concrete terms.  
 
P: I know about all these horrible complications. But my life just gets too 
hectic sometimes, you know. The injections just slip down the priority list.  
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C: So what might you say to a friend about this problem? 
P: You’re screwed? 
 
At this point, reflections and exploratory questions may be more useful to build up 




P: I know about all these horrible complications. But my life just gets too 
hectic sometimes, you know. The injections just slip down the priority list.  
C: You recognise how important the injections are for your long term health, 
but you’re struggling to fit them into a very busy life. 
P: Yeah exactly. 
C: Tell me more about why you feel the injections are important? 
Or 
C: Tell more about how you manage to juggle the different areas of your life? 
 
In this example you are looking for change talk (Desire / Reason / Need) or 
skills/strengths (Ability) than can be applied to diabetes care. It is a more appropriate 
strategy (given where this patient is at) than asking them to think about steps toward 
action. 
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Supporting self efficacy – clinician HOTSPOTS 
 
What if they don’t come up with anything? 
It is quite possible that some patients will struggle to come up with their own ideas. 
The danger is to assume that all patients are like this or to give up at the first hurdle 
when asking about their ideas. In situations where the patient seems genuinely stuck, 
it is not off limits to make suggestions (see above).  
 
But I’m the professional / expert in this relationship! 
There is no doubt that you hold a vast amount of expertise about diabetes and how to 
manage it. However, our task here is behaviour change. If we are talking about the 
patient’s behaviour, then it will be the patient who knows themselves best. Ultimately 
they are in charge of their own life, and must make an informed choice about whether 
to prolong its quality. 
 
Sometimes you have to take charge e.g. DKA / a severe hypo 
Without a doubt, there are times when the clinician needs to take charge and it would 
be inappropriate to have a lengthy discussion or ask the patient to come up with their 
own solutions. This mindset is appropriate for emergency / rapid response situations. 
A question to ask ourselves is: are we leaping into the same ‘emergency mode’ for 
long-term lifestyle changes? 
 
What if their suggestions are ‘wrong’, ill advised or inappropriate? 
A patient may decide to cut out all sugar from their diet or to tackle their exercise 
levels, when really you are more concerned about their poor adherence to medication. 
In either case you may want to intervene. There are a couple of ways to handle this 
depending on the clinical situation: 
1) To allow them to start with something they are motivated to attend to, and look out 
for transferable skills 
2) To allow them to start with something they are motivated to attend to, and reflect 
with them what could be done differently the next time 
3) To ask permission to comment on their plan of action 
 
If I just give them this piece of information, it could make all the difference 
It is tempting to believe that patients don’t have the knowledge to make sensible 
decisions, and if we just provided this knowledge, they would change. However, we 
know from numerous health promotion campaigns, that education isn’t enough. 
Furthermore, it is unlikely that diabetes patients with long term poor control will be 
ignorant of the facts. More likely, is that patients will block out information that 
they’re not ready to hear, which is why the decision for more information should 
come from them not you. 
 
Patients want us to be the expert 
When starting to work in this way, you may encounter responses such as “well if I 
knew that I wouldn’t be here, would I?” or “I thought you’re supposed to be the 
expert!”.  Some patients may seek to maintain the status quo i.e. active clinician / 
passive patient and feel threatened by any attempts to reverse this. This is a form of 
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resistance which we can choose to roll with (see Chapter 2), all the while maintaining 
that you are interested in their perspective and believe they may have some useful 
ideas. 
C: What might make it easier for you to avoid buying unhealthy foods? 
P: Well if I knew that I wouldn’t be here, would I love? 
C: I think you’re a resourceful woman, and I’m interested in any ideas you 
might have about this… 
 
If I just tell them what to do, it’ll speed up the whole process 
This is false economy with speed. Telling patients what to do may get create the 
illusion that you are moving forward, that the patient has heard you, is compliant and 
will follow through with action. The high rates of poor diabetes control however, 
suggest that the information we provide does not lead to long term behaviour change.   
 
They’re too depressed   
If a patient is appearing very stuck, hopeless or passive, it is even more tempting to 
provide them with advice/solutions. However, remember that by ‘rescuing’ the patient 
in this way, we might be inadvertently reinforcing their sense of being ‘useless’. In 
these situations, we may need to slow down the pace of change, be gently persistent in 
encouraging them to come up with their own ideas and have the ‘three strike rule’ at 
the forefront of our minds. Remember that the rate of change will invariably be slower 
with a depressed patient than a non depressed patient. If these strategies fail, we may 
need to discuss this patient with a mental health colleague.    
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Addressing health beliefs 
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Skill 5: Addressing health beliefs 
 
 
Why are health beliefs important? 
 
This section draws on ideas from the Health Belief Model (Lewinsohn, 2001) and 
Cognitive Behavioural Theory (Beck, 1967). These models make the assumption that 
health behaviours do not arise out of thin air but are driven, in part, by a patient’s 
thoughts and beliefs about their diabetes. When a patient displays an unhelpful 
behaviour e.g. not taking Metformin, the assumption from the above models is that 
there will be an underlying thought/belief which justifies the behaviour e.g. I’m not 
really ill. 
 
In an ideal world, health information would be translated into accurate and helpful 
health beliefs by the patient. In the real world however, information is often missed 
(e.g. that diabetes is a chronic condition), misunderstood (e.g. I must avoid all 
carbohydrate) or distorted (e.g. all hypos are severe) When this happens, problems in 
behaviour change are more likely to occur. Therefore, it is important to identify how a 
patient is thinking about their condition. 
 
If we can understand the thought process or rationale underlying a behaviour, this can 
make the seemingly “irrational” actions of our patients more rationale. Furthermore, 
once we understand their viewpoint, it can help us feel more empathy for the patient, 
and therefore less frustrated by their ‘non compliance’. Feeling empathy rather than 
frustration is a good place to start in supporting our patients to make changes. 
 
On a pragmatic level, much time can be wasted when we fail to take into account a 
patient’s individualised health beliefs and instead assume what is underlying their 
actions. Consider these two examples. They both start with the same scenario: 
  
C: It seems that your symptoms really vary from day to day. Pause  
Are you sometimes not taking your tablets? (spoken gently) 
P: Yes, I don’t always take them … usually when I’m going out 
 
















C: Have you thought about keeping your 
pills in a little box? 
P: No 
C: Then you can take them with you 
when you go out. Pause 
Is that something you could maybe try? 
P:  Nods head 
 
 
C: I wonder what makes it harder for you 
to remember when you are going out? 
P: Shrugs shoulders 
C: What would be the worst thing about 
taking them more regularly? 
P: Well, you’ll get more side effects, so I 
don’t like to take too many. 
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In the first example, the clinician assumes that the issue is a memory problem. The 
second example reveals how a few well chosen questions have uncovered the 
patient’s real concern around side effects. Without this probing, the clinician may 
have used the time to discuss dossette boxes, when the consultation really needs to be 
about the patient’s concerns around side effects. Addressing health beliefs help make 
your consultations more effective by targeting the key cognitions that contribute to 
poor glycaemic control. 
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Addressing health beliefs – WHAT to do 
 
Identifying health beliefs 
The first step is to identify the health belief which is maintaining the problematic 
behaviour. It sounds simple but can be quite challenging. Firstly, the patient isn’t 
always consciously aware of what health beliefs they have and even if they are, may 
not feel comfortable disclosing them to you. In the latter case, building trust through 
rapport (see Active Listening section) will go some way to address this.  
 
The upward arrow and downward arrow techniques can be used to ‘uncover’ less 
obvious health beliefs. These techniques involve asking a number of repeated 
questions along a specific line of enquiry. They build on the DARN-C questions 





The upward arrow is a useful technique to identify information that the patient may be 
missing or misunderstanding in relation to why a specific behaviour change may be 
beneficial to them. The central line of enquiry is:  
 
Why is X beneficial for you?  
X being whatever behaviour the patient is avoiding.  
 
You continue to ask this same question (maybe phrased in different ways) until a gap 
in knowledge is found.  
  
Why might that be important? 
How would that be of benefit to you? 
Why might the doctor / I suggest this? 
Why is that a good thing for you? 
How does that help you in your life? 
 
All the while, you are asking yourself what is this patient missing or not seeing or 
underestimating? 
 
Consider this example 
 
A Type 2 diabetic patient is not taking his insulin regularly, but does complain of 
fatigue and going to the toilet a lot. He’s not sure why he needs to inject when he feels 
“pretty ok” at the moment. 
 
 C: Why would we recommend taking insulin? 
  P: To treat my diabetes 
 C: And how might the insulin do that? 
 P:  It gets the sugar down doesn’t it? 
 C: Right. And why might you think it’s important to get the sugar down? 
 P: To treat the diabetes 
Upward Arrow 
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An upward arrow line of enquiry has revealed that this patient has made a link 
between insulin and treating diabetes. However, how insulin can help his day to day 
symptoms (which do concern him) is not evident. Therefore, he has no real rationale 
for taking his medication other than an abstract concept of it “treating his diabetes”. It 
may have been tempting to stop at “it gets the sugar down” and be satisfied that this 
patient understands why insulin is of benefit to him. Yet, if we assume that this 
patient is not taking his insulin because he is missing or misunderstanding some vital 
information we would not be satisfied with this answer, but continue the upward 
arrow line of enquiry:  
 
 C: OK. So how might getting your sugar level down improve your energy? 
 P: I don’t know actually. I mean sugar gives you energy doesn’t it? 
 C: Would it be helpful for me to explain how we think the insulin works? 
 P: Yeah it would 
Clinician goes on to use key/lock metaphor for insulin action and putting fuel 
in the engine for energy - see Appendix 
 
In ideal world, patients would have attended some form of diabetes education. 
However, this is not always the case, especially with older patients, and furthermore, 
what patients hear and what they interpret or retain at the time can be very different. 
The point of this technique is to find out what the patient has understood regardless of 
what they’ve been told. Consider the following example: 
 
A patient consistently attends appointments, but always fails to bring a record of any 
testing 
 
C: So it seems it’s really difficult to test regularly. Could we talk some more 
about that? 
P: Yeah, I know I should. 
C: Right, so I’d be interested to know why you think it might be important to 
test your blood sugar levels. 
P: Well I need to write them down innit. 
C: Uhuh. So you feel you need to keep a record – why’s that? 
P: So you can see my readings, if I’m going high or low. 
C: Right – and why is it important to see that? 
P: To see if I’m managing my diabetes ok – keeping my sugars low. You guys 
wanna keep an eye on me. 
 
So at this point, it’s not at all clear what’s in it for the patient i.e how it might benefit 
them.  
 
C: So you feel it’s about keeping an eye on you. Tell me more 
P: Well yeah if I write it down, you’ll be having a go at me, about getting good 
numbers 
 
So the upward arrow has revealed that the patient actually believes that this is no more 
than a ‘big brother’ exercise. It’s clear now that the aim of the consultation is to link 
how recording data might actually be of benefit to the patient. 
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C: Mmm, well I’m not sure you’ve got it quite right there.  
P: Oh? 
C: We do need to see the numbers but really that’s for your benefit – can I 
explain how that might be? 
P: OK. 





This technique is similar to the above except its central line of enquiry is:  
Why is X a problem for you?  
X being whatever behaviour the patient is avoiding.  
 
A downward arrow line of questioning was used in the first example given in this 
chapter.  
 
C: It seems that your symptoms really vary from day to day. Pause  
Are you sometimes not taking your tablets? (spoken gently) 
P: Yes, I don’t always take them … usually when I’m going out 
C: I wonder what makes it harder for you to remember when you are going 
out? 
P: Shrugs shoulders 
C: What would be the worst thing about taking them more regularly? 
P: Well, you’ll get more side effects, so I don’t like to take too many. 
 
Other useful questions include: 
 
What might that be a problem? 
What concerns you about that? 
What worries you most about? 
Why is that a bad thing for you? 
How does that hinder you in your life? 
 
Your aim is to find out what is this patient overestimating, distorting or 
misinterpreting? The downward arrow can reveal unhelpful health related cognitions 
which may be keeping the patient stuck. Consider the following examples: 
 
C: Just looking at your record book there seem to be quite a few hypos here 
P: Yeah I guess so 
C: How do you respond when you see those readings? 
P: Oh well I usually know that my meal isn’t far off  
C: What would be your concern about treating a hypo straight away? 
P: Erm well I just don’t see the point in making a fuss really 
C: It feels like an unnecessary hassle to treat a mild hypo. What sort of hassles 
would it cause you? 
P: Well it’s not so much me, but my daughter is always around you see. I think 
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In this case the consultation needs to be about addressing needs of the daughter e.g 
further education, a joint session, ways for mum to explain mild hypos to her 
daughter. 
 
C:How would you feel about starting some sort of exercise? 
P: I’m not really up for that.  
C: What concerns do you have about exercise? 
P: Nothing. It’s just not my cup of tea. 
C: Right. I’m really curious as the word exercise can mean such different 
things to different people – what would it mean to you? 
P: Going down to the gym – circuits and weights. I’m not really a gym person 
– never felt comfortable in those places 
 
In this case, the consultation needs to address other forms of exercise that the patient 
might be more willing to consider. 
 
P: There’s no way I’m going to start on insulin 
C: Insulin does not feel like an option for you. What would be the worst thing 
about taking insulin for you? 
P: Well let’s just say I know people on insulin  
C: Uhuh, and what have you gathered from that? 
P: Well it’s a hassle isn’t it? You have to have injections with you when you go 
out. Injecting in restaurants – out and about. No way I’m gonna do that. 
C: Ok Leroy... I think there might have been a misunderstanding between you 
and the doctor 
P: Oh? What’s that then? 
C: Well you’re right the doctor does want you to start on injectable insulin. 
However, he was just talking about an injection once a day, which you could 
give at home, before bed. 
P: Just once a day? 
C: Yes – would that be something you might consider? 
P: Well once a day… in the privacy of my home … I would have to think about 
that... 
  
In the example above, the clinician has de-escalated the situation, found out the 
relevant health belief and given new information (with permission). Instead of 
building further resistance or making assumptions (e.g. he must be scared of needles), 
the clinician has skilfully moved the patient from pre-contemplation (“No way I’m 
gonna do that”) towards contemplation (“I would have to think about that …”). It 
might be tempting here to react to the resistance e.g. ‘well insulin is what’s going to 
control your diabetes’ or stop the enquiry prematurely by making assumptions e.g. he 
must be scared of needles. Actually the patient is concerned about being seen in 
public and this gives you something to work with constructively. 
 
 
Unhelpful thinking styles 
It is always important to check that patients have the correct information about their 
diabetes and a clear rationale for why behaviour change might improve their quality 
of life. However, some patients may have developed maladaptive or unhelpful 
thinking styles which can make the thought of change very distressing. This is 
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especially true in patients who are anxious or depressed. In this population, the same 
thinking style which contributes to their depression or anxiety might also prevent 
them from managing their diabetes more optimally.  
 
Common thinking errors include:   
 
Personalising Attributing all negative outcomes to a personal deficit, often 
neglecting the role of other factors 
Catastophising  Only attending to the worst case scenario 
All or nothing  Responses are on either extreme of a continuum 
 
The end of this chapter has a table with examples of common thinking ‘errors’ in 
diabetes. Consider the examples below which show how the same thinking style can 
be present in diabetes and non diabetes scenarios alike.  
 
If my boss shouts at me, I must have done something wrong (personalising)  
If I have a ‘bad’ blood glucose reading, it’s always my fault (personalising) 
 
All hypos will result in me passing out (catastophising) 
 If my chest hurts, I must be having a heart attack (catastrophising) 
 
If I can’t go back to my old job, then I can never work again (all or nothing) 
If I can’t achieve consistent weight loss etc there’s no point trying (all or 
nothing) 
 
When using the downward arrow technique it can be useful to be on the look out for 
these unhelpful thinking styles. With practice, they become easier to spot. There can 
be subtle clues in the language: 
• the use of extreme words such as always, never, no, all, always, everyone 
• what the patient says sounds like a rule e.g. should, must, if … then.  
• statements have little room for flexibility, distort the facts or set the bar too 
high 
• responses may be self demeaning or overly critical e.g. I’m an idiot 
 
Consider the above examples again, with the clue words highlighted. 
 
If my boss shouts at me, I must have done something wrong (personalising)  
If I have a ‘bad’ blood glucose reading, it’s always my fault (personalising) 
 
All hypos will result in me passing out (catastophising) 
 If my chest hurts, I must be having a heart attack (catastrophising) 
 
If I can’t go back to my old job, then I can never work again (all or nothing) 
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Creating new health beliefs (cognitive restructuring) 
Once you have a better understanding of a patient’s unhelpful health beliefs, you may 
need to intervene at a cognitive level i.e. changing their reasoning. This is called 
cognitive restructuring. For some patients, this may be a relatively straightforward 
task of providing the information they are missing in a meaningful way. However, if 
the patient has an unhelpful thinking style which is distorting the information they 
have been given, some additional psychological tools may also be helpful (see next 
section).  
 
By using the arrow techniques you can pinpoint the key misunderstanding and tailor 
the information you provide to address this. In providing new health information, 
pictures can be a useful way to explain complex information and make it more 
memorable. Some common misunderstandings in diabetes knowledge are outlined 
below with associated visual aids. However, you may well have your own visual 





The patient does not really understand the importance of taking insulin and its role in 
managing their diabetes symptoms and/or progression. They may know it’s to treat 
diabetes but hasn’t made a link with their day to day symptoms. Use of a key/lock 
metaphor*
3






The patient does not understand how collecting data may benefit them. They might 
think it’s for your purposes only or they might have a ‘one size fits all’ idea about 
insulin doses. Using a bespoke tailoring* analogy and emerging patterns* diagram 





The patient is concerned that they will put on weight. There may be some unhelpful 
assumptions tied to this: 1) the insulin makes them hungry 2) the insulin makes them 
put on extra weight 3) the weight will be ongoing. Using a weight gain plateau*
4
 
graph and a discussion related to weight being related to consumption rather than 
‘extra’ calories. Discussion points may include only putting on what you consume; 





                                                
3
* See Appendix 
 
The role of insulin 
The purpose of blood glucose testing 
Insulin and weight gain 
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Working with unhelpful thinking styles 
The next section provides some ‘psychoeducation’ rather than diabetes education. It 
introduces ways to help restructure the information which may have got distorted due 
to cognitive bias (i.e. an unhelpful thinking style). This section considers ways to help 





If a patient tends to attribute all negative outcomes to themselves it is likely that they 
will start to feel bad about themselves, experience excessive distress in response to 
their diabetes management and possibly give up. For these patients there is too much 
responsibility on their shoulders. Too much attention is given to the factors they can 
control and not enough attention is given to the factors beyond their control. They feel 
fed up because their efforts aren’t translated into results and this 
gives them an overall sense of failure or not being ‘good enough’. 
 
Using a Spider diagram* (for blood glucose control and for 
weight - see Appendix) is one way to re-focus a patient’s attention 
on the multiple factors that influence a health outcome. 
 
Key points in using this visual aid: 
Draw it out if possible on a blank piece of paper. Start with the 
blood glucose/weight circle in the middle. Ask the patient to come 
up with all the factors they know that influence this reading. Try 
and reach a blank with the patient. Ask for permission to complete 
the diagram if any are missing. Key questions: What are within 
your control and what are less easy to control or outside of your 
control? Make sure you check back to see if and how this new 
piece of information may have altered their perspective. 
 
Example 
C: Would it be ok to look at what affects your blood glucose in more detail? 
P: Ok 
C: If this is a blood glucose reading in the middle, what would you say are the 
factors that will influence this number? 
P: Erm well what I eat obviously and when I’ve taken my insulin and how 
much. 
C: Great – so I’ll write here ‘food’ and ‘insulin’. What else? 
P: If I’ve done lots I suppose – been rushing around y’know. 
C: OK, so ‘level of activity’ (writes this down). What else? 
P: Erm … dunno … that’s it isn’t it? 
C: Might there be anything else that can cause your blood sugars to go up or 
down? 
P: I suppose if I’ve been ill 
C: Yes so ‘illness’ is another one. What else? 
P: Can’t think anymore 
C: Can I add some more to this picture? 
P: ok 
Personalising 
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C: We know that ‘stress’ can affect your blood glucose readings, also your 
‘hormones’ – where you are in your menstrual cycle. And your ‘genes’ will 
also affect this – so some people will respond better to insulin than others. 
What are your thoughts about that? 
P: Yeah, I sort of know that but I guess I don’t really think of those things on a 
day to day basis. There’s a lot going on really isn’t there? 
C: Precisely. What factors are within your control? 
P: These ones (points to food, insulin, exercise) 
C: What factors are outside your control? 
P: I guess these ones (points to the others) 
C: So what might that say about why your readings are sometimes 
disappointing despite your best efforts? 
P: Well there’s all this stuff going on all the time. Some of which you’re 
probably not even aware of … like whether you’re coming down with a cold or 
not noticing you’re stressed. 
C: Uhuh. Your body is a complex processing machine – trying to juggle all 





If a patient tends to focus on the worst case scenario they may be feeling overly 
anxious in response to diabetes cues. Very often a high arousal state will mean that 
the most threatening outcomes become highly salient and the less severe outcomes are 
neglected. With this thinking 
style, patients may over-react 
to low or high blood sugars, 
driving them in the opposite 
direction to bring down their 
anxiety. In addition, some 
patients may find the anxiety 
so overwhelming that they 
cope through avoidance. 
 
A useful analogy for these 
patients is to think about the 
function of fear. Fear can be 
protective e.g not jumping off a cliff or not putting your hand in a fire, but it can also 
paralyse us when it goes into overdrive e.g. preventing us from going to a job 
interview. In this case, fear is not helpful anymore. Another useful analogy is to relate 
their diabetes worry to a guitar string – it needs to be neither too taut nor too loose for 
optimal self care. Therefore, some worry is understandable and helpful to keep us safe 





For these patients, it will be important to draw out the cumulative nature of risk. 
Useful discussion points are that there will be mild hypos as well as severe hypos, that 
                                                
5
 See Appendix 
Catastrophising 
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complications are related to ongoing raised blood glucose levels as opposed to 
occasional readings and that not all complications are life threatening. 
 
   
 
 
Patients who have an ‘all or nothing’ thinking style may not attempt any sort of 
behaviour change, unless it can achieve 100% success. This may mean they avoid 
trying anything or give up at the first sign of a lapse. They generally hold high 
standards and find it hard to tolerate anything less. Paradoxically, patients who appear 
to not care about their 
diabetes may actually hold 
this thinking style. The 
thought of not doing a 
‘perfect’ job causes 
intolerable disappointment 
and/or anxiety. Their 
response patterns can be 
quite rigid i.e. it has to be 
done this way and no 
compromise is possible. 





This attitude can be very unhelpful with diabetes. This is because managing diabetes 
is all about managing setbacks, unexpected results, outliers etc. Your response to 
when it goes wrong (rather than when it goes right) is a key indicator of successful 
management. 
 
There are some psychological tools that may address the issue of ‘all or nothing’ 
thinking. The perspective taking graph (see appendix) demonstrates that the path to 
improvement can be a bumpy ride. This can apply to weight loss as well as glycaemic 
control. The idea is that the person is continually improving (the dotted line) but at 
any one time can be experiencing a lapse (solid line). It is at the point of a lapse, that 
we may lose sight of the bigger picture, lose hope and give up (the magnified area). 
The danger is not the lapse, but the patient’s reaction to the lapse. 
 
The self defeating cycle
6
 diagram can be drawn out with the patient for a variety of 
different behaviours. It demonstrates how high standards can drive change, but are not 
so helpful in managing lapses. At the lowest point in the cycle, patients attempt to get 
back on track by setting themselves another high standard and thus get caught in a 
vicious cycle. The diagram illustrates the need to allow for some ‘slack’ in the system 
in order to bring about realistic and sustainable change. 
 
                                                
6
 See Appendix 
All or nothing thinking 
From one extreme to other 
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Addressing health beliefs – HOW to do it 
 
Identifying health beliefs 
Use gentle persistence when looking for health beliefs. You may need to phrase the 
questions differently, several times, to uncover a patient’s true understanding of their 
illness and how to manage it. You may find it helpful to think about different thoughts 
as layers of an onion and that the ‘arrow questions’ allow you to peel back the layers, 
until you reach a key belief. Try not to give up at the first hurdle, remember that 
patients may not be used to exploring or expressing their beliefs, and therefore some 
gentle direction may be needed. If the behaviour doesn’t make sense to you, keep 
going until it does. 
 
P: The dietician says I need to eat less rice and potatoes 
C: Why might that be a good idea? 
P: It’ll help my diabetes 
 
The patient knows they need to eat less carbohydrate, because it will help their 
diabetes, but they’re still not doing it, therefore their behaviour does not make sense 
to the clinician, so they keep going with their line of enquiry.   
 
C: How might that be? 
P: Well I suppose I might lose some weight but I’m happy as I am you know. 
My husband thinks I look fine. 
 
So the patient has only linked dietary changes to weight loss and not the progression 
of diabetes. Furthermore, the patient does not even view weight as an important issue. 
Consequently, the non adherence to dietary advice now makes more sense. 
 
The upward or downward arrow needs to be used sensitively, otherwise there is a risk 
of it sounding like an interrogation or knowledge test. Speak with a gentle tone of 
voice and express genuine curiosity about a patient’s viewpoint. It can be helpful to 
preface your questions with phrases such as: 
 
“I’m really interested in your take on this ..” 
“People interpret health information in all sorts of different ways …”  
 
Beware of a tendency to make assumptions (see more about this in the ‘Hotspots’ 
section below). Follow a line of enquiry with a patient, rather than jumping to 
predefined conclusions. The common thinking errors in diabetes table, is merely a 
guide to inform your questioning, not a substitute for asking the patient.  
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Creating new health beliefs 
The most important part about providing new information is to check back with the 
patient. A useful sequence for medical consultations is: 
 
Elicit – Provide – Elicit 
 
This means asking about what the patient has understood (elicit), providing 
information to address the gaps or misunderstandings (provide) and then checking 
back with what the patient has taken in (elicit). Never assume a patient has heard what 
you have told them. Some useful questions: 
 
What does that mean to you? 
How does that sound to you? 
What have you heard from this? 
What might you take away from this? 
What’s the take home message? 
How would that fit with how you see things?  
How do you see things now? 
How does that change how you view things? 
 
Notice how all of the above are open questions. This avoids the closed question trap: 
 
C: Does that make sense?  
P: Yes 
End of consultation 
 
Open questions are much more likely to identify potential areas of misunderstanding. 
 
When using the visual aids in the appendices (e.g. blood glucose spider diagram), it is 
usually more constructive to draw them out live in the session rather than using a 
photocopied template. Firstly, this helps to keep the patient’s attention as they watch 
an unfolding picture emerge. Secondly, it gives the patient more time to process each 
part of the diagram as you draw it out. Thirdly, it allows you to use the patient’s own 
words. A ready made template is far less engaging for the patient. 
 
When you present new information which challenges old beliefs this can be 
threatening for the patient e.g. I’ve spent all my life trying to control my diet and now 
you’re telling me I’m too much of a perfectionist. Rather than presenting new 
information as the ‘gospel truth’ or the only way to view a situation, present it as a 
hypothesis, an alternative. e.g. 
 
A common worry is …does this make sense to you? 
Some people find that thinking about it in this way helps …. 
It can be confusing when you’ve approached things in a certain way for most 
of your life, but I wonder if you might consider an alternative ….? 
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Addressing health beliefs – clinician HOTSPOTS 
 
But I know why they’re not taking it, it’s obvious …I wouldn’t want to swallow 
huge Metformin pills / inject myself 4 times a day 
Putting ourselves in the place of the patient can be useful in evoking empathy, but it 
can also leave us quite stuck or alternatively barking up the wrong tree. The obvious 
reasons to you may not be the reasons that are most significant for the patient. 
Furthermore, patients may actually put up with quite a lot if they believe it’s in the 
interest of their well-being. Consequently, it may be a health belief which stands in 
the way of behaviour change, rather than the practical obstacles of tablet size and 
injection regimes. 
 
African people are less concerned with their weight 
You may have never thought the above, but the point being illustrated is that it is 
tempting to make assumptions about our patients. The human mind is often drawn to 
spot patterns and make stereotypes. This could be helpful in situations which require 
quick and decisive action and where we don’t have time to analyse each individual 
situation. However, in behaviour change work, these assumptions are problematic for 
many reasons: 1) they prevent us from engaging with the patient’s individual story 
and the possibility of exceptions 2) it shuts down creative thinking or problem solving 
3) it can often leave us feeling quite helpless or stuck in a situation. In behaviour 
change work, it is often the exceptions rather than the rule which bear more fruit. 
 
But they might have a hypo … that’s not a distortion! 
There are some very real risks involved in having diabetes. However, some patients 
manage to live with these risks more successfully than others. One factor which will 
influence this will be how they evaluate that risk e.g.  are they viewing all hypos as 
severe (catastrophising) or do they feel having a hypo means they are weak or have 
failed (personalising) or do they feel they need to avoid all forms of exercise (all or 
nothing)? These questions are important because they will influence the amount of 
distress one patient will feel compared to another patient, faced with the same risk 
factor. 
 
It’s not the fact that the patient might have a hypo which is the distortion but the 
subtle nuances regarding severity, frequency, responsibility and action which may be 
distorted. The downward arrow technique allows you to move beyond medical facts to 
personal interpretation. This is where you have room to manoeuvre.
D-6 Handbook V2 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































D-6 Handbook V2 





















D-6 Handbook V2 







D-6 Handbook V2 
Intellectual property of King’s College, London. Do not reproduce without permission. V2.  
 
74
Skill 6: Shaping behaviour 
 
 
Why is shaping behaviour important? 
 
So far we have been considering the skills that help our 
patients move towards a position of wanting to make a 
change in their life. Once a patient feels ready for action, it 
can be tempting to think that the work is done. However, the 
process of change will present the patient with a number of 
challenges: the risk of failing, the risk of getting it wrong, 
the risk that other people will react negatively and/or that 
they will judge themselves negatively. In one way, the work 
is just beginning. Patients may fall at the first hurdle without 
adequate preparation, encouragement and support to manage 
set backs. Consequently, the main focus of this chapter is 




The key principles are:  
• Setting realistic goals 
• Encouraging experimentation 
• Managing set backs 
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Setting goals with a patient serves several functions. It helps break the task down into 
manageable steps, it gives the patient defined markers to aim for and it is an 
opportunity to ground any fantasies before they take flight (e.g. I can only be happy as 
a size 0 supermodel). In brief, you are setting the patient up to succeed.  
 
A useful acronym when goal setting with a patient is to make SMART goals. There are 
several variations of this acronym, this is one of them: 
 




T Time based 
 
(S)pecific 
The following questions can be used to help the patient pinpoint exactly what they are 
aiming to achieve and setting tangible markers for achieving this. 
 
What do you want to specifically achieve? 
When will you feel able to try this? 
How will you attempt this?  
Which way will you try and make this change? 
Who will be involved in you meeting this goal? 
 
P: I’d really like to get in shape 
C: That’s a very positive goal for your health 
P: Yeah I know 
C: We often find people are more likely to succeed if they have really prepared 
themselves to meet the challenge. May I ask you a few questions about how you 
might tackle this? 
P: OK 
C: When you say “get in shape” – what would you like to specifically achieve? 
P: I’d like to drop a few dress sizes 
C: So “a few” being ….? 




The goal must be meaningful i.e have some value for the patient. Encourage the patient 
to be explicit about the value of their chosen course of action. This builds on the MI 
skill of eliciting change talk (Chapter 3). Once again, according to Bem’s theory of self 
perception, if a patient hears themselves articulating the reasons for change, they are 
more likely to act upon them. 
Goal setting 
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Why have you chosen this particular goal? 
If you succeed, how might your life be different? 
How might your friends / family /  healthcare professionals view the change? 
 
(A)ttainable 
The goal must be realistic. This is an opportunity to check that the patient is not setting 
themselves up to fail. 
 
Does this feel like a realistic goal to you? 
What would be a more realistic goal? 
Do you feel you have the resources to achieve this task at the moment? 
Might it be possible to break it down further? 
 
(R)ewarding 
Behavioural psychology teaches us that attaching a positive incentive to a behaviour is 
more likely to result in that behaviour occurring. Patients can become disheartened if 
they do not see rewarding results for their efforts. This can be particularly challenging 
in relation to long term changes, where the benefits are not immediately apparent e.g 
giving up smoking, or achieving sustainable weight loss. 
 
How can you make this task rewarding for yourself? 
How might you reward yourself? 
How will you know if the change is working? 
What are the positive signs to look out for? 
  
(T)ime-based 
The patient has set a realistic time frame to achieve their goal. 
 
Over what time period can this goal be achieved? 





This involves thinking through with the patient how this goal will be met and what 
might get in the way. The purpose of the conversation is to prepare a patient in advance 
so that they don’t have to come up with solutions at their most vulnerable time (i.e 
when things have gone wrong). Some questions might include: 
 
What might get in the way of achieving your goal? 
How might you address this barrier? 
What will help you remember? 
When you’re feeling down, what will help you stay motivated? 
What people in your life could help you achieve your goal? 
 
Playing devil’s advocate 
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If a task is particularly challenging for a patient e.g. injecting/testing when they don’t 
like needles, break the task down into small but cumulative steps.  
 
Climbing the mountain worksheet (see appendix) 
 
This is also a particularly useful technique for patients who are suffering with anxiety 
and/or depression. For these patients, relatively simple tasks may feel overwhelming, 
thereby lead to avoidance. Helping these patients to view the task in small manageable 





Anxiety can prevent patients from making healthy changes (e.g. testing their blood 
glucose levels, walking into a new gym, visiting the doctor) and it can also maintain 
unhealthy behaviours (e.g. smoking, drinking, not thinking about diabetes). Teaching 
patients basic relaxation skills can help patients approach anxiety provoking situations. 
 
Controlled Breathing (see appendix) 
Progressive Muscle Relaxation (see appendix) 
Distraction (see appendix – using senses) 
 
Patients may find they are plagued by persistent worry e.g. about complications, having 
a hypo, having a heart attack. These concerns are usually grounded in reality for the 
diabetic patient. The task is not to eliminate the worry since it is appropriate that the 
patient has some level of concern about these issues, but rather to make it a less 
intense. The following tools can help with this: 
  
 Healthy v unhealthy fear (see appendix) 
 The worry tree (see appendix) 





Behaviour can be shaped through positive 
reinforcement i.e. praise and rewards. Very 
often patients don’t reward themselves 
because they think they don’t deserve it or 
their focus is on what they haven’t achieved 
as opposed to what they have (discounting 
the positive). This especially prominent in 
depressed patients. Rewards can provide a 
strong motivational pull to continue the 
good work. It can be useful to explain to 
patients that in psychological terms, 
Using a graded hierarchy 
Anxiety management 
Using rewards 
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changing behaviour is more successful when it’s linked to an incentive (see SMART 
and (R)ewards section).  
 
Of course coming to see an understanding and supportive clinician is also a reward in 
and of itself and should not be underestimated as a powerful mediator of change. 
Talking about rewards shows the patient that you think their behaviour is worth 
rewarding. You’re also acknowledging the work that has gone into the change. After 
all if it was easy, they would have made the change years ago. 
 
Diary and reward chart (see appendix) 
 Pleasant events list (see appendix) 
  
Focussing on increasing self-care activities can also improve mood. This means it can 
be a helpful intervention for patients who are depressed. However, there can sometimes 
be a lag between increased activity and improved mood, in the same way, there might 
be a lag between starting exercise and weight loss or taking medication and HbA1c i.e. 
there is a delayed reward. The following diagram can be useful in explaining the 
importance of persevering in the absence of immediate, positive feedback. 
 





The path to change is often fraught with obstacles. When a patient hits a road block, it 
really tests their problem solving skills. 
e.g.  When my daughter is ill, I tend to forget my medication 
 When I eat out, my diet goes out of the window 
 The exercise prescription hasn’t come through from my GP yet 
 
Good problem solving skills will help patients move beyond the obstacles and will 
support their sense of self efficacy. The following steps can be useful: 
 
1) Ask the patient to brain storm all the options to overcoming the problem, no matter 
how silly they sound  
2) Weigh up the pros / cons of each option 
3) Select upon one option (reinforcing that this is an experiment) 
4) Encourage the patient to try it out and report back 
 
C: When there are other priorities in your life, it can be difficult to put diabetes at 
the top of the agenda 
P: Exactly 
C: This is a barrier to you taking your medication as consistently as you would 
like. 
Might we use the session today to think about some ways forward … 
 
Again if patients are suffering with anxiety or depression overcoming obstacles can 
present a significant challenge. Impaired concentration and memory can affect a 
person’s problem solving abilities and low mood can diminish a person’s confidence in 
Problem solving 
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being able to handle those problems. Consequently, helping patients develop problem 
solving skills is very relevant to this population.  
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Shaping behaviour – HOW to do it 
 
How you talk about the process of change is very important. Encourage the patient to 
view any step they take as an “experiment” – a try it and see approach. In this way, 
there is no pressure to make a permanent commitment and the patient is more likely to 
try out a new behaviour. 
 
Normalise the occurrence of set backs. This cannot be overestimated. Patients are 
vulnerable to relapse when their plans don’t run smoothly. If they are prepared in 
advance, they are more likely to use set backs constructively. You can normalise the 
presence of set backs, by talking with patients about set backs during goal setting i.e. 
how they might manage them when not if they occur.  
 
Secondly, when set backs do occur, they need to be managed sensitively, as the patient 
may be judging themselves harshly or expect you to be disappointed in them. This may 
even lead to them no longer attending appointments. When a patient attends an 
appointment after experiencing a set back, this provides a natural opportunity for 
affirmation:  
 
C: well I’m really impressed you still came along to see me today even 
though you don’t feel you have ‘good’ news to tell me 
 
Again, let the patient know that although they are feeling frustrated, what they are 
going through is part of the normal process of change. The use of the following visual 
aids can be helpful here: 
 
 Perspective taking (see appendix) 
 Spirals diagram (see appendix) 
 
Useful phrases to help patients deal with set backs can also be helpful. This is called 
positive self talk e.g. 
 
There is no such thing as failure, only feedback 
  The path to success is a bumpy road,  not a straight line 
 I’m allowed to make mistakes  - it’s how we learn 
There is always an opportunity to have done things better, but there’s 
also an opportunity to do things worse. 
 
The CBT skills of shaping behaviour need to be combined with the spirit of MI. 
Always check what resources the patient already has. The skills presented in this 
chapter are merely tools, and you may not need to use any of them, if a patient has 
already found a way to overcome obstacles e.g. 
 
P: If I’m getting anxious about my injections, I just remember I want to be 
around for my children and that gets me through. 
 
It would be inappropriate to introduce anxiety management techniques without 
enquiring how the patient is already coping and whether this is working for him/her. If 
you feel that the patient is genuinely lacking in resources or missing vital information, 
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then it is ok to provide this. However, once again, always ask for permission before 
giving advice or making suggestions and check back with the patient, using the ‘elicit – 
provide – elicit’ sequence. 
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Shaping behaviour - clinician HOTSPOTS 
 
It seems tedious to go into this much detail 
It is important to check exactly how a patient will go about changing their behaviour. 
By examining the minutiae of their plan, you and the patient can see where the pitfalls 
will be in advance. This means you can plan for these obstacles before they happen. 
Preparing patients for change is just as important as getting them to the point of 
wanting to change. The former is often neglected, risking that good intentions fizzle 
out. 
 
I thought I was home and dry with this patient 
Reaching the action stage, can feel like a significant landmark. You have worked hard 
to help the patient process their ambivalence and reach a point where the patient is 
starting to make changes. It can be utterly dispiriting when patients start to falter with 
their good intentions. Remember this disappointment will be felt by the patient as well 
as you, even if it is unexpressed.  It is just as important to prepare yourself for set 
backs, as well as the patient. Keep in the forefront of your mind that lapses are normal, 
as opposed to abnormal and a sign of defeat. By not over reacting to them, you 
demonstrate that backward steps are to be expected and are surmountable. 
 
But I’m not a Psychologist! 
Basic mood/anxiety management can be carried out by other health professionals. 
Indeed, it can make more sense sometimes for the patient to do this work with the 
person they have built a relationship with rather than being referred on to a stranger. A 
few basic suggestions/instructions in managing low mood or anxiety can make all the 
difference between a patient trying out a new behaviour and giving up. Remember that 
in cases of extreme distress, it is always possible to refer on to a specialist mental 
health professional. 
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Integrating the skills 
 
So far we have talked about individual 
skills to promote behaviour change. This 
chapter considers how to weave the skills 
together. Remember that a patient’s stage 
of change may vary from week to week 
and even within a single session. 
Therefore, it is important to use these 
skills flexibly, adapting them to the 
shifting needs of the patient. 
 
The overall attitude 
It is common to focus on specific techniques when first learning a new methodology. 
Indeed, this is how this handbook has been structured. However, the overall spirit or 
attitude of the clinician is more important than getting the ‘right technique’. This is 
because there may be more than one (MI congruent) way to approach a specific 
situation. Consequently, the underlying ‘spirit’ of MI should dictate how we proceed 
rather than being bound by technique. Furthermore, the techniques themselves will 
flow more comfortably, if the clinician has adopted a particular mindset. This mindset 
assumes the following: 
 
i)  The patient has the answers 
ii)  The patient is in two minds i.e. part of them wants to change 






Starting the intervention 
The patient will have been told about participating in a trial already. This provides the 
first opportunity to provide an affirmation i.e. acknowledging their contribution to 
research and willingness to try a different approach. You may consider the following 
example as a guide to introducing the research: 
 
“Thank-you for enrolling in this study. We recognise that managing diabetes 
can be a difficult and challenging task.  
 
The purpose of these sessions is to support you in getting your diabetes control 
as good as you feel you are able to.  
 
Although we have some expertise about diabetes, we recognise that you are the 
expert about your life and how diabetes fits into it. Therefore, these sessions are 
not about me telling you what to do. In this way, these sessions might feel quite 
different to other appointments you’ve had with a practice nurse. 
 
Beginning 
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Instead, we will use these conversations to think about some of the difficulties 
around diabetes self management and what options might exist to help you 
move forward with your diabetes. 
 




Remember that all participants will have had to sacrifice something (time, resources, 
and energy) to participate in the study. Acknowledge this in the first phase of the 
intervention e.g. 
 
“I am impressed that you have gone to the effort to come and join this project. 
You have had to get time off work/arrange child care/ prioritise your health 
over other activities etc, to get here today. This shows commitment to approach 
your diabetes in a new way and is a good place to start.” 
  
Try to avoid the use of terms such as random, trial and motivational interviewing as 
they can be open to misinterpretation. Instead, consider talking about the study, the 
research, your diabetes meetings or project. Similarly, try to avoid overly simple 
statements such as good or bad control. Such phrases contain an implicit moral 
judgement about the patient i.e. that they are good or bad, thereby presenting the 
clinician as judgemental.  Consider more neutral language e.g. tighter control, a lower 
HbA1c. 
 
Starting an individual session 
The aim of the beginning of a session is usually to establish rapport and then to set a 
focus. As we considered in Chapter 1, you will be using your OARS to express 
empathy and genuine interest in their perspective, thereby facilitating a therapeutic 
rapport.  In the early phases of a session / intervention, the patients should be doing 
most of the talking. Your role will be to show that you’ve understood what they’ve said 
and are on their side. 
 
Using a menu sheet (see appendix) can be a good place to start. It describes most of the 
factors that influence diabetes control. By asking patients to tell you which areas they 
may need to work on, you achieve several aims: 
 
i)  To identity whether the patients understanding of what needs to be 
tackled is the same as yours. 
ii)  You demonstrate to the patient that you are interested in their 
perspective and don’t have a pre-determined agenda 
iii)  It provides a natural opportunity for patient’s to expand upon their 
reasons/barriers for change. 
 
If the patient chooses more than one area, ask them how they would prioritise these 
areas. If the patient has chosen an area which seems less important for their diabetes 
management (e.g. exercise rather than taking their insulin). You have a couple of 
options: 
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1) Ask permission to explain why you would consider insulin a greater priority. Check 
their understanding of your rationale using the ‘Elicit-Provide-Elicit’ strategy  
 
2) Go with the patient’s agenda. You can use success in their chosen area as an 
opportunity to apply transferable skills.  
 
Which option you choose will depend on your clinical judgment. Look out for how 
engaged/motivated a patient appears by listening out for resistance. With a less 
engaged patient you may choose to go with their agenda. Where you feel there is a 
stronger rapport with a patient i.e. they are more engaged, you may decide to offer an 
alternative agenda. 
 
Consider this first phase as fact finding. By the end you want a really good 
understanding of the drivers and barriers to change for this patient. That is your only 
task. Along the way, you might discover some inaccurate or unhelpful beliefs, and 
where some education might be needed. Remember you don’t need to tackle this 
straight away. For example, you may choose to make a mental note of health beliefs 
that need to be changed and come back to them later, especially if the patient seems 
particularly bored, irritated or angry. On the other hand, if they appear very 
anxious/despairing, you may find it a useful time to provide some correct health 
information. However, always ask permission first. 
 
Your main goal at this stage is that the patient will return to the next session. Patients 
that have struggled with their health may be low in motivation and the use of 
text/phone reminders can be helpful in keeping them engaged with the study. At the 
beginning of the next session, you will want to gauge the ‘motivational temperature’ of 
the session. The following questions can provide a useful starting point: 
 
 What do you recall from last week? 
 What were your thoughts about what we spoke about last time? 





The middle phase of a session/intervention is usually where you start to look for and 
amplify pro change talk. You will be using your ‘eliciting change talk’ and ‘supporting 
self efficacy’ skills. You hope to evoke some forward momentum. The pace and goal of 
this momentum must be in tune with the patient’s capacity of change. Going too fast 
may risk losing a patient or producing temporary but not sustainable change. In 
addition, setting yourself unrealistic goals for a patient, may affect your own levels of 
frustration and job satisfaction.  
 
A key indicator for pace is resistance. Consider resistance as your friend – when a 
patient starts to resist e.g. not saying much, becoming defensive or offering lots of anti 
change talk, it is a sign to take your foot off the accelerator for change. Go back to 
reflective listening and see if there may be room to manoeuvre in a different direction 
(more on this in next chapter ‘Trouble Shooting’). 
 
Midway 
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A key indicator for what is a realistic goal will be the patient’s position on the change 
cycle. If a patient is in ‘pre-contemplation’, a goal for the clinician might be to move 
them towards ‘contemplation’. Similarly, if a patient is in ‘contemplation’ the next 
realistic step may be ‘preparation’. Note that in neither of these cases is the goal 
‘action’. Remember that behaviour change isn’t just about concrete actions. Doing 
behaviour change work is also about promoting change in thoughts and feelings which 
scaffold or provide the foundations for action. The table below summarises how 
different stages of change may direct you towards different tasks in the session. 
 
 
Stage of change Task 
Pre-
contemplation 
When patients are in this phase, they may not realise they have a 
problem or feel very defensive about approaching it.  
 
Key tasks are to express empathy i.e. reflecting back the difficulties  
and to gently develop discrepancy i.e. eliciting from them reasons 
for change. Another task is to avoid argumentation! 
 
Key skills: OARS; DARN; double sided reflections, overshooting 
reflections 
 
The main goal is to encourage the patient to start to take an interest 
in their health. 
 
Contemplation The patient realises there is a problem, but is not ready to take 
action. 
 
Key tasks are to elicit pros/cons for change and to amplify the pro-
change talk. 
 
Key skills: OARS; DARN; amplification questions 
 
The main goal is that the patient starts to view change as the more 
appealing option. 
 
Preparation The patient is thinking about change, but has not taken any steps 
yet. 
 
Key tasks are to support self efficacy and express empathy 
regarding any concerns or anxieties.  
 
Key skills: OARS; CAT; solution focussed questions; resisting the 
righting reflex 
 
The main goal is that the patient starts to believe they can make this 
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Action The patient is taking practical steps to make health related 
changes. Without appropriate acknowledgement patients can fall 
back a stage. 
 
Key tasks are to express empathy for the effort, sacrifice, 
resourcefulness needed to make this change. Also to elicit change 
talk about why these actions may be beneficial. 
 
Key skills: OARS; amplification questions; affirmations 
 
The main goal is to stop and note the achievement and not rush on 
to the next task. 
Maintenance The patient is making consistent changes. The patient may start to 
become weary of the effort required to maintain the change or 
worry how long it will last. 
 
Key tasks are to elicit change talk about why these actions are 
useful/beneficial. To problem solve with the patient about what 
could get in the way and to support their self efficacy in thinking 
about solutions. 
 
Key skills: OARS; playing devil’s advocate; using rewards; 
problem solving; set back management  
 
The main goal is to prepare the patient for setbacks and potential 
strategies to start moving forward again. 
 
Lapse The patient has gone back to old habits, after starting to make 
changes. 
 
Key tasks are to express empathy about any disappointment, regret 
they may be feeling. Also to normalise the presence of setbacks 
and to support self efficacy in moving forward again. To 
acknowledge where they have got to. 
 
Key skills: OARS; affirmations; solutions focussed questions, 
setback management 
 
The main goal is for the patient to put their lapse into context (i.e. a 
temporary setback) and to develop the momentum to move forward 
again. 
 
The above table is merely a guide to working with patients at different stages of 
change. Throughout all the phases, you want to consider if there are any unhelpful 
health beliefs that are preventing change, especially in the ‘pre-
contemplation/contemplation’ phase. Use your resistance barometer (i.e. your sense of 
how engaged the patient is) to deliver health education when the patient is likely to be 
most receptive to it. In the preparation/action phase, you can make more use of the 
‘shaping behaviour’ skills e.g. anxiety management, problem solving, using rewards. 
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Ending a session 
Ending sessions on time is an important skill. It may feel difficult to keep to time when 
you are working in this psychologically informed way. However, good time 
management is important for the patient, the next patient (in the waiting room) and for 
your own preservation. Some practical tips: 
 
• Aim to finish 5 minutes early. This 5 minutes is usually always taken up e.g. 
sorting out the next appointment time, walking them to the door, saying good 
bye 
• 10 minutes before the end, be mindful of drawing the session to a close  
o Avoid opening up complex topics during this time 
o Use summaries to signal the session is winding down 
• Ending questions: 
o What would it be helpful to take away from today? 
o What might stay with you from today’s session? 
o How does that fit for you? (after you’ve given a summary) 
 
The above ending questions are ways to gently explore where you have got to by the 
end of the session. They should not be used as inadvertent ‘goal setting’ questions. 
Remember that pushing patients towards goal setting before they are ready (ie. in 
‘Action’ on the stages of change) will risk increasing resistance. 
 
It can be difficult to end a session when you don’t feel you have got to where you had 
wanted. In these cases, it is tempting to extend the session or to push the patients just 
that little bit further towards ‘action’. Instead, try and view your work as sewing seeds 
– some green shoots will appear in the session but others will take time to mature 
during the weeks/months ahead. Remember the spirit of dancing rather than wrestling 
with the patient, and staying close to where they are on the cycle of change. This will 
require some patience. 
 
After your session, it is advisable to make some notes to aid your memory. The 
following headings can be helpful: 
 
Review – life events e.g. doctors appts, child starting school, dog died 
Progress – what has gone well re. diabetes care 
Difficulties – what areas have gone less well re. diabetes care 
Support – what support you offered the patient affirmations; pros/cons of 
change etc. 
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Ending the intervention 
As the intervention comes to an end or the sessions become less frequent, consider 
preparing the patient for this transition. In practical terms: 
 
• Make the boundaries of your contact explicit. When it will start, end, how long 
each session is and who they can contact between sessions. 
• Count down your sessions - “today is the second session out of four” etc. 
• Consider what support a patient has outside the surgery to continue supporting 
them with behaviour change (e.g. a supportive friend, buddy, counsellor, 
befriender, gym, walking group, diabetes patient group etc.) 
• In the last few sessions, the skill of ‘Supporting Self Efficacy’ will be very 
important. Encourage patients to come up with their own solutions and offer 
recognition and affirmations for any strengths/resources they use. 
• If the patient is in ‘Action’ you may want to consider using a ‘Change Plan’ 
(see Appendix). This is a way to record their achievements and strategies for 
staying on track.  
 
Be prepared for setbacks towards the end. Some patients will be more demonstrative 
about their struggles towards the end of an intervention. This does not mean that your 
work has been in vain, but rather that the patient is reluctant to let you go! Remember 
the green shoots that have occurred over the course of the intervention and the 






Begin very gently; be open to what the patient brings and let go of a predetermined 
agenda. Remember that patient defensiveness may be high at the start of a 
session/intervention and you need to reduce this first.  
 
Introduce the behaviour change menu (see appendix) to start the process of exploration: 
what are THEIR thoughts/beliefs/attitudes to their diabetes? You are looking for the 
drivers and enemies to change – finding where the momentum for change will come 
from.  
 
Be on the lookout for unhelpful health beliefs and make sure patients have the correct 
information by eliciting, providing and then eliciting again. Always ask for the 
patient’s permission. 
 
When resistance arises - roll with it; refocus your attention on the green shoots – 
elaborating and nurturing them. Expect lapses and you won’t be dismayed by them.  
 
Keep to time as best you can.  
 
 
In a nutshell: The D-6 flow 
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Using the D6 skills may not work for every patient. Remember that these skills 
increase the likelihood that more of your consultations will be successful, but it’s 
unrealistic to think this will provide a 100% success rate. This chapter deals with what 
to do when things don’t seem to be working. The following are some common 
dilemmas you may come across: 
 
The patient is attending, but nothing is changing 
The patient says the ‘right things’, but nothing is changing 
The patient is becoming more defensive / less engaged 
 
Remember that the above dilemmas represent some form of resistance. When you meet 
resistance in diabetes (albeit passive) you may feel anxious that you are not doing your 
job properly. Your patient is not playing the doctor-patient game by the agreed rules. 
Your offer to provide help and advice is being rejected. You may be tempted to bully 
the patient and shake them into sense. Or you may feel rejected and want to shrug your 
shoulders, walk away or label them. 
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Before throwing in the towel with a patient take some time to reflect upon your own 
practice. Below are some of the common traps that can fuel resistance (including 
passive resistance). We are all liable to fall into these traps from time to time and 
therefore it is worth pausing to reflect upon how these dilemmas might arise and how 





This is the most common reason for resistance: the clinician is already in action but the 
patient is in pre-contemplation/contemplation. Prematurely pushing a patient towards 
action can result in potential disengagement e.g. a patient may agree to do something, 
but repeatedly turn up having failed to do the task.  
 
Remember that motivational interviewing is about helping a patient resolve their 
ambivalence. This might mean that the ‘work’ is about strengthening a patient’s 
reasons for change through eliciting change talk. In order to do this, we need to move 
away from the notion that ‘action’ is the only valuable outcome. The preparation steps 
are still ‘work’ and patients can be congratulated for doing the ‘thinking’ around 
behaviour change e.g. preparing, researching, weighing up pros and cons, discussing 
with partner. 
 
The best way to fine tune our practice, is to listen to our patients. Use your recorded 
transcripts to do this. Our patients are our best teachers and will provide a wealth of 
feedback, if we are receptive to it (e.g. how did this patient respond after what I said?) 
 
Key reflections: 
Am I at the same stage of change as the patient? 





Another common reason patients disengage is because they don’t feel understood. 
Patients in this situation worry that their difficulties aren’t being heard and that they will 
be judged or pushed into a situation they don’t feel ready for. In this position a patient 
may become more defensive or disengage from their healthcare service altogether. 
Consequently, building rapport through active listening is another vital, and sometimes 
overlooked, piece of work. 
 
We may feel a huge amount of empathy for our patients, and it is easy to assume that by 
listening and nodding our patients will realise that we understand. However, the skill of 
‘active listening’ involves making your response explicit through verbal statements. 
Simple reflections and affirmations can be very effective in communicating empathy. 
 
Key reflections:   
A mismatch on the change cycle 
Not feeling understood 
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Am I expressing empathy? 





It is easy to slip into advice giving mode or to ask lots of closed questions to identify a 
‘solution’. Consider how much space the patient has to think about and articulate their 
own dilemmas/solutions. Remember Bem’s self perception theory and the importance of 
patients’ hearing themselves talk. Also remember the subtle messages communicated by 
‘stealing’ this opportunity from the patient (that you are the expert, you have the answers 
and that they have fewer resources than you). This encourages passivity and dependence. 
Persevere in helping patients become more creative and self reliant – remember the 3 
strike rule. It can feel like a quick and easy solution to provide the answers, but this does 
the patient no favours in the long run. 
 
Key reflections:  
Am I resisting the righting reflex? 





If it feels like nothing is changing, is it really true that nothing is changing? It may be 
true that the patient’s HbA1c is not coming down yet, but exclusively focussing on this 
is a surefire way to fuel burnout for the patient and the clinician. Remember that the 
role of MI is to engender hope. This means looking out for the small successes e.g. 
coming to appointments, verbalising thoughts about change, trying new things out, 
making a phone call, discussing self care with partner. With hope in the consulting 
room there is momentum to move forward. 
 
Conversely, when patients are doing well, it can be very tempting to focus on the next 
goal, on how things can be improved. But pause here. Allow yourself to expand on the 
positive narrative: how did they manage the change; how did they feel afterwards; 
other people’s reactions – even if this takes the entire consultation. Sowing these seeds 
of optimism will fuel the behaviour change process when they leave the consultation 
room. By not fully acknowledging what they have already achieved, patients are then 
left with the message that they still are not quite ‘good enough’.  
 
Key reflections:  
Am I giving more weight to what still needs to be improved upon ‘vs’ what they have  
already achieved? 
How does the patient feel when they leave the consultation – hopeful or hopeless? 
Not getting a word in 
Discounting the positive 
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Sometimes we can become overly ‘patient centred’. We follow, empathise and affirm 
at every consultation. The patient enjoys coming, talks a lot, feels understood - but not 
a lot is changing. This is particularly true when patients present us with so many 
barriers for change that we end up feeling as overwhelmed as they do – we are then 
buying into the patient’s hopelessness. Remember that motivational interviewing is 
both person centred AND directive. Try to include some ‘eliciting change talk’ 
questions in every consultation. By just following the patient we don’t give them an 
opportunity to consider alternative behaviours and fuel the engines for change.  
 
Key reflections:  
Am I getting stuck in the patient’s story? 
Am I neglecting to ask change talk questions? 
 
See Appendix  (What MI is not and MI adherent/non adherent behaviours) for more 
advice about staying on the right track. 
Buying into hopelessness / the patient story 
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Re-visiting the dilemmas outlined above: 
 
The patient is attending, but nothing is changing 
The patient says the ‘right things’, but nothing is changing 
The patient is becoming more defensive / less engaged 
 
The success of the D6 skills will depend, to some extent, on the competency of the 
clinician. However, we should not overlook the type of patient we are presented with. 
There are some situations in which it becomes extremely challenging to use these 
skills. In these situations we may need to get extra resources (e.g. refer to another 
service) or to adjust our expectations as to what is a realistic goal. Areas to consider: 
 
Is the patient excessively distressed? 
Distress can present itself in many different forms: shaking, shouting, crying or 
remaining silent. If the emotional temperature is high in the consultation it makes this 
type of work very challenging. In this situation, expressing empathy (through active 
listening) can be a helpful response. In addition, avoid effortful questions and keep 
your statements simple. Very often this can allow the strong emotion to subside.  
 
You may also need to consider the frequency and severity of the distress – is this a 
brief intense moment in the room or an ongoing problem for the patient. If the latter, 
you may need to consider a mental health assessment. See Appendix for common 
mental health problems. 
 
Does the patient struggle with relationships? 
Patients may face interpersonal challenges – that is, they may find it hard to trust 
people e.g. healthcare professionals. They may expect to be put down, hurt, rejected or 
abandoned because earlier experiences have taught them that people can’t be trusted. 
They might reject or be hostile towards you, pushing you away. Alternatively they may 
become overly dependent or make demands on you.  It is very hard to do this work, 
unless a patient has at least the potential of developing some kind of therapeutic 
alliance. Again you will need to seek further support from supervision for these cases. 
Expressing empathy while maintaining your boundaries (e.g. level of contact) will be 
very important. 
 
Does the patient have resource limitations? 
Consider whether your patient is lacking vital resources (e.g transport, housing, child 
care, money, intellectual capacity or health literacy). This may affect their ability to 
attend appointments, to store their medication, to prioritise their diabetes or to 
understand their health needs. In this case, consider support from other 
agencies/sources e.g. social services, advocate, carer involvement, use of more visual 
aids. If their needs are more complex, the package of care should reflect this. 
 
In summary, remember to consider the type of patient you are dealing with and the 
challenges they face. Use this information to evaluate the appropriateness of behaviour 
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change work at this time. In any situation, you can always rely on your basic 
communication skills (O-A-R-S) to minimise resistance and find out what the patient 
wants/needs. However, the goal of improved diabetes control needs to be considered 
carefully in terms of timing, input from other services and what is a realistic level of 
change, given the limitations of each patient. Seek supervision for these more complex 
cases and where necessary refer to other services e.g. mental health; social services; 
learning disability services. (see Appendix). 
  
 
